data_2l65_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l65 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 . . . . . 0 N--CA 1.479 1.008 0 N-CA-C 110.471 -0.196 . . . . 10.0 110.471 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . 0.318 0.5 OUTLIER 67.2 -51.49 0.48 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.933 1.827 . . . . 10.0 115.933 178.369 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -92.46 -58.45 0.22 Allowed Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 112.674 0.62 . . . . 10.0 112.674 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -75.57 -25.81 10.64 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.211 1.941 . . . . 10.0 112.475 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -178.67 140.6 0.19 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.677 -0.692 . . . . 10.0 110.138 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.7 p -97.56 115.08 36.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 121.365 0.602 . . . . 10.0 111.389 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 21.7 mtt180 -153.57 112.01 3.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.648 -0.706 . . . . 10.0 110.572 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -128.61 141.06 51.47 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.448 -0.575 . . . . 10.0 109.448 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.3 m -125.6 128.62 48.19 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.716 0.293 . . . . 10.0 111.029 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.2 t -119.59 136.8 55.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.324 -0.398 . . . . 10.0 110.264 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 34.4 m -105.08 125.36 50.9 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.372 -0.376 . . . . 10.0 110.415 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.3 t -110.19 125.92 67.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.952 0.406 . . . . 10.0 110.067 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.8 mmmp? -91.7 28.34 1.8 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.742 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -130.46 -152.98 0.53 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.89 -0.596 . . . . 10.0 110.202 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -108.67 173.87 6.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.057 0.455 . . . . 10.0 112.055 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -60.6 -38.59 85.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.491 -0.777 . . . . 10.0 112.434 -178.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -74.45 -45.43 46.38 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.497 0.554 . . . . 10.0 112.497 -178.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.2 p -62.14 -36.95 83.37 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.92 -0.312 . . . . 10.0 111.832 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.1 -37.81 75.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.97 0.414 . . . . 10.0 111.197 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -74.01 -39.85 63.32 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.956 0.408 . . . . 10.0 111.488 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.3 tttm -66.48 -33.75 76.39 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.392 0.516 . . . . 10.0 112.392 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.0 p -79.52 -5.14 54.23 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.431 0.53 . . . . 10.0 112.431 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -112.19 -34.59 5.88 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.493 0.553 . . . . 10.0 112.493 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -110.01 5.31 22.14 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 113.342 0.867 . . . . 10.0 113.342 -178.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -139.93 -55.44 0.55 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.288 0.477 . . . . 10.0 112.288 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.39 92.57 0.87 Allowed Glycine 0 C--O 1.224 -0.529 0 C-N-CA 120.889 -0.672 . . . . 10.0 112.607 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.402 ' C ' ' H ' ' A' ' 29' ' ' GLU . 2.0 t80 -96.83 -58.89 0.17 Allowed Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 112.384 0.512 . . . . 10.0 112.384 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -79.92 22.43 0.73 Allowed 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.367 2.045 . . . . 10.0 111.375 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.402 ' H ' ' C ' ' A' ' 27' ' ' PHE . 14.0 mt-10 -109.09 9.62 26.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.796 -0.638 . . . . 10.0 110.518 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 46.9 m0 -87.08 -151.83 0.18 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.192 -0.458 . . . . 10.0 110.12 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 34.9 t90 -172.77 -51.17 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 112.204 0.446 . . . . 10.0 112.204 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -18.82 -63.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.369 1.618 1 C-N-CA 125.648 4.232 . . . . 10.0 117.227 -178.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -148.11 36.66 0.84 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.093 0.473 . . . . 10.0 110.69 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -123.79 48.59 1.86 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.356 0.598 . . . . 10.0 110.825 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -78.69 58.15 2.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.622 -0.717 . . . . 10.0 110.489 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -168.63 174.91 6.41 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.65 -0.5 . . . . 10.0 109.65 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.21 161.76 36.63 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.355 -0.609 . . . . 10.0 109.355 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.7 m 72.03 -65.43 0.35 Allowed 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.644 0.609 . . . . 10.0 112.644 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.5 mmtp -68.97 -33.39 73.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.231 0.538 . . . . 10.0 111.688 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.0 p -153.15 121.17 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.591 -0.731 . . . . 10.0 109.289 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.34 54.73 1.79 Allowed Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.608 -0.997 . . . . 10.0 110.608 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.55 163.77 48.07 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.553 -0.324 . . . . 10.0 110.39 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -72.08 43.44 0.59 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.832 2.355 . . . . 10.0 113.014 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 33.5 tp -165.39 -91.23 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.266 -0.425 . . . . 10.0 110.025 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.73 -57.2 3.85 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.213 -0.518 . . . . 10.0 113.076 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.9 t -99.82 135.11 36.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.765 0.317 . . . . 10.0 111.006 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -105.91 112.58 25.69 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.527 -0.546 . . . . 10.0 109.527 178.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.77 19.73 16.58 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.933 -0.576 . . . . 10.0 110.752 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -96.3 -57.31 2.36 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 109.393 -0.595 . . . . 10.0 109.393 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -105.81 -36.16 2.84 Favored Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 110.805 -0.918 . . . . 10.0 110.805 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.67 68.3 0.46 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.647 -0.787 . . . . 10.0 112.25 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -156.14 -179.27 7.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.8 0.333 . . . . 10.0 111.33 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -122.73 136.88 55.01 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.422 -0.584 . . . . 10.0 109.422 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -165.98 122.34 1.33 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.799 0.333 . . . . 10.0 111.775 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -86.12 149.54 25.06 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.071 -0.513 . . . . 10.0 110.297 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.9 mm -103.42 110.53 30.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.363 -0.38 . . . . 10.0 112.01 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -108.34 165.73 11.29 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.612 -0.514 . . . . 10.0 109.612 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -57.22 -27.06 61.67 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.999 0.74 . . . . 10.0 112.999 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -103.03 -1.24 29.57 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.103 0.409 . . . . 10.0 112.103 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 132.29 -160.92 23.84 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.957 -0.64 . . . . 10.0 111.745 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 60.4 mp0 -69.45 128.03 35.1 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.821 -0.437 . . . . 10.0 109.821 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.7 -95.35 0.2 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.936 0.717 . . . . 10.0 112.936 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -98.56 166.31 11.41 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.173 0.511 . . . . 10.0 112.232 -178.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.8 t -148.51 150.21 32.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.674 -0.694 . . . . 10.0 109.907 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -89.09 -43.83 10.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.942 -0.572 . . . . 10.0 111.11 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 174.23 -141.2 5.81 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.7 -0.762 . . . . 10.0 111.763 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -135.48 166.06 24.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.736 0.303 . . . . 10.0 111.001 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 65.4 mt -109.76 133.53 54.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.742 -0.466 . . . . 10.0 109.742 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.0 mmt180 -83.12 -54.08 5.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.583 -0.28 . . . . 10.0 110.596 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.6 mtpm? -150.43 147.66 27.81 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.347 -0.388 . . . . 10.0 111.294 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -119.99 82.91 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.517 -0.765 . . . . 10.0 109.728 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -92.33 68.23 4.96 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.772 -0.649 . . . . 10.0 111.191 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 56.11 177.78 0.04 OUTLIER Pre-proline 0 N--CA 1.474 0.731 0 O-C-N 123.922 0.764 . . . . 10.0 112.078 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -71.31 47.36 0.82 Allowed 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.141 1.894 . . . . 10.0 111.532 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -135.82 -43.84 0.66 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.96 -0.564 . . . . 10.0 110.979 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.5 m -129.75 125.89 36.92 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.383 -0.371 . . . . 10.0 110.556 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 27.2 tp -136.5 128.62 29.68 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.487 -0.324 . . . . 10.0 110.773 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.2 t -121.08 123.21 69.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.936 -0.764 . . . . 10.0 108.936 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.8 pt -133.79 168.14 24.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 112.445 0.535 . . . . 10.0 112.445 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -135.2 130.39 5.42 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 110.549 -1.02 . . . . 10.0 110.549 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -106.36 156.91 18.03 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 112.741 0.645 . . . . 10.0 112.741 -178.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 43.6 mtp180 -100.79 -164.76 1.14 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.481 -0.781 . . . . 10.0 109.402 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.2 pp -139.26 161.22 37.97 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.63 0.252 . . . . 10.0 111.431 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -77.54 -160.39 0.18 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.117 -0.492 . . . . 10.0 111.794 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 120.8 135.89 4.97 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.988 -0.845 . . . . 10.0 110.988 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -93.85 -85.92 0.28 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.761 0.315 . . . . 10.0 111.222 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -82.66 67.93 3.64 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.972 -0.632 . . . . 10.0 112.005 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.83 151.71 38.35 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.57 0.224 . . . . 10.0 110.555 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 6.2 tp -62.73 144.67 14.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.718 -0.475 . . . . 10.0 109.718 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -52.39 130.82 43.69 Favored Pre-proline 0 C--N 1.331 -0.234 0 O-C-N 123.255 0.347 . . . . 10.0 111.061 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.88 89.89 0.24 Allowed 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 123.0 2.466 . . . . 10.0 112.776 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -87.77 71.77 9.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.999 -0.546 . . . . 10.0 110.231 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -162.12 -70.57 0.05 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.693 -0.685 . . . . 10.0 109.772 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.8 m 70.77 161.61 0.23 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.285 -0.871 . . . . 10.0 112.69 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.5 m -117.28 133.7 55.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.077 -0.51 . . . . 10.0 110.554 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -93.65 147.32 23.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.128 -0.487 . . . . 10.0 110.881 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -139.48 136.81 34.97 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 123.275 0.359 . . . . 10.0 110.507 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.4 m -101.91 123.01 45.11 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.662 -0.495 . . . . 10.0 109.662 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 95.5 t -107.87 121.95 61.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.189 -0.46 . . . . 10.0 110.948 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.68 129.07 56.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.267 -0.424 . . . . 10.0 110.781 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -101.41 125.45 48.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.812 0.339 . . . . 10.0 110.834 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 90.3 t -117.84 126.34 74.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.095 -0.502 . . . . 10.0 109.769 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -99.99 130.86 46.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.718 -0.219 . . . . 10.0 110.659 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -118.76 100.61 7.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.959 0.409 . . . . 10.0 111.164 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.423 ' C ' ' H ' ' A' ' 107' ' ' LYS . . . 69.05 12.35 65.13 Favored Glycine 0 CA--C 1.52 0.386 0 CA-C-N 116.042 -0.526 . . . . 10.0 113.381 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 68.31 -16.56 0.19 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.578 0.955 . . . . 10.0 113.578 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.423 ' H ' ' C ' ' A' ' 105' ' ' GLY . 46.2 pttt -99.82 -6.56 26.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.064 0.459 . . . . 10.0 111.483 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -136.48 147.84 47.37 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.056 -0.72 . . . . 10.0 109.056 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.83 146.81 47.9 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.272 0.558 . . . . 10.0 111.76 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -131.9 139.26 48.7 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.779 -0.646 . . . . 10.0 109.435 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.2 p -133.75 129.76 55.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-O 120.746 0.308 . . . . 10.0 111.005 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -125.93 155.79 40.75 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.25 -0.432 . . . . 10.0 111.534 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 48.6 t -115.98 127.97 73.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.828 -0.624 . . . . 10.0 109.61 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -127.25 136.97 52.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.35 -0.386 . . . . 10.0 111.671 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -175.99 155.31 1.58 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.857 -0.61 . . . . 10.0 111.347 178.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.4 m -160.14 91.89 0.97 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.772 -0.825 . . . . 10.0 108.772 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 179.01 -62.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 10.0 111.028 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -98.44 14.86 26.68 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.085 -0.507 . . . . 10.0 111.558 -178.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -98.25 -46.06 5.96 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.593 -0.731 . . . . 10.0 109.699 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -78.54 48.81 0.81 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.489 -0.778 . . . . 10.0 111.582 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 19.4 ptt? -146.25 18.22 1.38 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.918 -0.583 . . . . 10.0 109.624 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -74.23 -96.99 0.1 Allowed Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.591 -0.732 . . . . 10.0 112.789 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.1 m 55.24 -91.57 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 122.905 0.482 . . . . 10.0 111.573 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 35.9 pttt -74.04 -36.65 64.41 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.894 -0.41 . . . . 10.0 109.894 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 34.7 m170 -69.48 -24.17 63.74 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.957 -0.565 . . . . 10.0 110.603 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.0 -58.36 8.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.322 -0.854 . . . . 10.0 110.523 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -62.15 -33.07 73.79 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.098 -0.501 . . . . 10.0 111.048 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 30.5 mtp180 -65.06 -44.09 90.11 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.154 -0.476 . . . . 10.0 112.024 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 9.9 p -81.06 -30.83 11.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.849 0.357 . . . . 10.0 111.637 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 48.7 mtp180 -72.49 -4.38 30.1 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.083 0.468 . . . . 10.0 111.827 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -84.54 0.61 49.27 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.757 -0.656 . . . . 10.0 110.517 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -149.37 -53.8 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.584 -0.817 . . . . 10.0 112.988 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -66.23 -37.81 86.43 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.183 0.809 . . . . 10.0 113.183 -178.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -63.55 -22.94 67.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.855 0.359 . . . . 10.0 111.624 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -80.9 38.76 0.47 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.998 0.428 . . . . 10.0 111.465 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 171.18 -34.88 0.16 Allowed Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.774 -0.727 . . . . 10.0 113.419 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 11.2 t90 -57.0 -63.07 4.03 Favored Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 113.541 0.941 . . . . 10.0 113.541 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -65.68 -29.79 51.25 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 121.279 1.32 . . . . 10.0 111.794 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.36 -43.75 76.73 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.799 -0.637 . . . . 10.0 111.493 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 11.2 tt -70.37 -32.55 50.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.561 -0.29 . . . . 10.0 111.461 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 70.6 mt -61.52 -45.76 92.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.039 0.447 . . . . 10.0 111.175 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -67.68 -40.99 84.38 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.713 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 15.2 m -67.37 -35.47 79.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.803 -0.635 . . . . 10.0 111.598 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -59.55 -44.6 93.2 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.842 0.353 . . . . 10.0 111.024 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -58.63 -49.56 77.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.856 -0.611 . . . . 10.0 110.947 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -65.64 -36.02 82.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.062 -0.517 . . . . 10.0 111.796 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -62.03 -53.65 52.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.934 -0.576 . . . . 10.0 110.766 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 57.3 mt -65.84 -34.71 72.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.029 -0.532 . . . . 10.0 110.044 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -61.78 -40.94 96.94 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.107 -0.497 . . . . 10.0 109.93 178.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -70.89 -42.59 69.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.326 -0.397 . . . . 10.0 111.391 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -79.63 26.79 0.3 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.782 0.325 . . . . 10.0 111.798 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -155.28 -60.4 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.552 -0.832 . . . . 10.0 113.199 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -99.21 -48.16 4.93 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.839 0.681 . . . . 10.0 112.839 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -60.95 -42.81 98.95 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.291 0.478 . . . . 10.0 112.291 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 77.9 mttt . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.357 -0.83 . . . . 10.0 110.223 179.454 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 . . . . . 0 N--CA 1.479 0.989 0 CA-C-O 120.463 0.173 . . . . 10.0 110.728 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . 0.283 11.8 p90 50.44 30.18 4.44 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 115.572 1.693 . . . . 10.0 115.572 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -165.65 -63.64 0.01 OUTLIER Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 111.995 0.369 . . . . 10.0 111.995 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -87.8 -31.86 0.19 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 121.77 1.647 . . . . 10.0 112.469 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -174.26 141.6 0.74 Allowed 'General case' 0 C--O 1.24 0.56 0 CA-C-N 115.533 -0.758 . . . . 10.0 109.436 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.6 p -100.79 127.16 54.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.113 0.482 . . . . 10.0 111.258 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -159.23 108.52 1.89 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.843 -0.617 . . . . 10.0 110.348 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -131.33 150.9 51.96 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.045 -0.525 . . . . 10.0 109.832 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.0 m -145.8 135.81 23.65 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.548 0.213 . . . . 10.0 111.084 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.0 t -121.52 132.89 69.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.052 -0.522 . . . . 10.0 109.639 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.97 122.25 39.75 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.501 -0.318 . . . . 10.0 110.746 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.2 t -131.04 141.89 44.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.017 -0.538 . . . . 10.0 109.801 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.497 ' HZ1' ' CG ' ' A' ' 149' ' ' ASP . 31.7 mttp -84.63 54.44 3.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.05 0.452 . . . . 10.0 110.555 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -123.26 -163.03 1.08 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.897 -0.592 . . . . 10.0 110.325 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -113.38 166.97 10.97 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.224 -0.444 . . . . 10.0 111.79 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 36.4 ttt180 -55.11 -38.32 68.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.552 -0.749 . . . . 10.0 112.419 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -74.35 -54.63 7.26 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.96 0.356 . . . . 10.0 111.96 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -52.11 -43.08 63.78 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 112.607 0.595 . . . . 10.0 112.607 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.13 -42.43 80.2 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.992 0.368 . . . . 10.0 111.992 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -69.31 -36.88 77.44 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.182 0.515 . . . . 10.0 111.283 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.3 mtpt -69.66 -32.28 70.84 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 113.265 0.839 . . . . 10.0 113.265 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.28 -9.67 58.96 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.91 0.707 . . . . 10.0 112.91 -178.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -116.94 -19.63 9.73 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.923 0.712 . . . . 10.0 112.923 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.9 mp -120.55 10.77 11.18 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 114.33 1.234 . . . . 10.0 114.33 -178.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -155.64 -45.4 0.08 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.038 0.384 . . . . 10.0 112.038 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.99 104.24 2.2 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.492 -0.861 . . . . 10.0 111.262 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -109.15 -56.14 0.05 OUTLIER Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 112.338 0.496 . . . . 10.0 112.338 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -74.15 14.96 0.65 Allowed 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.261 1.974 . . . . 10.0 112.359 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.63 8.96 37.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.215 0.531 . . . . 10.0 110.034 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 40.8 m0 -87.68 -164.84 1.16 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.621 -0.718 . . . . 10.0 110.363 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 57.5 t90 -169.99 -50.62 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.513 0 CA-C-O 119.257 -0.402 . . . . 10.0 111.957 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -26.28 -55.41 0.09 OUTLIER 'Trans proline' 0 C--N 1.367 1.525 0 C-N-CA 125.154 3.903 . . . . 10.0 116.9 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -128.11 -41.43 1.6 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.694 0.627 . . . . 10.0 112.694 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -77.95 93.87 4.5 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.372 0.605 . . . . 10.0 111.613 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -101.07 0.65 38.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.325 -0.852 . . . . 10.0 111.408 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.3 mtp180 -119.96 -160.18 0.81 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.737 0.303 . . . . 10.0 111.077 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.21 155.47 46.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.253 -0.43 . . . . 10.0 110.567 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . 0.267 9.8 p 67.66 -65.36 0.24 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 114.484 1.29 . . . . 10.0 114.484 178.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -74.81 -10.6 59.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.957 0.408 . . . . 10.0 111.006 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.4 p -173.85 89.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.34 -0.845 . . . . 10.0 109.971 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.69 68.49 0.55 Allowed Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.714 -0.675 . . . . 10.0 111.958 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.06 158.55 41.42 Favored Pre-proline 0 C--N 1.322 -0.591 0 O-C-N 122.656 -0.32 . . . . 10.0 110.799 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -59.44 -28.35 87.32 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.763 2.308 . . . . 10.0 113.144 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 19.0 mt -95.29 -89.0 0.25 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.801 0.334 . . . . 10.0 111.058 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.25 -55.16 5.02 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.928 -0.653 . . . . 10.0 112.824 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.8 t -105.01 132.06 52.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.745 0.307 . . . . 10.0 111.087 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -100.38 118.33 36.4 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.974 -0.557 . . . . 10.0 109.638 178.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.7 pttt -106.13 6.46 30.99 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.958 -0.565 . . . . 10.0 112.351 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.7 pttt -92.65 -24.1 18.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.861 0.362 . . . . 10.0 110.112 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -131.21 -60.02 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 111.269 -0.732 . . . . 10.0 111.269 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 135.02 71.34 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.716 -0.754 . . . . 10.0 112.363 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -159.77 168.5 25.74 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.75 -0.265 . . . . 10.0 110.65 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 43.1 m95 -116.02 135.62 53.79 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.601 -0.889 . . . . 10.0 108.601 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -165.77 122.64 1.41 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.332 0.493 . . . . 10.0 112.332 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -82.17 138.49 34.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.026 -0.534 . . . . 10.0 109.852 178.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 48.1 mm -98.46 124.75 51.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.284 -0.416 . . . . 10.0 110.279 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -120.94 168.4 11.53 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.385 -0.37 . . . . 10.0 110.243 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -62.16 -29.3 70.26 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 122.829 0.452 . . . . 10.0 110.923 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -86.88 -9.59 55.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.28 -0.418 . . . . 10.0 111.463 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 138.59 -103.51 0.4 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.616 -0.802 . . . . 10.0 112.019 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -117.5 154.97 30.54 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.802 0.334 . . . . 10.0 110.892 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -118.29 -146.35 0.39 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.932 -0.576 . . . . 10.0 111.158 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -67.5 172.64 4.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.338 0.59 . . . . 10.0 112.58 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.3 t -147.41 144.19 28.48 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.632 -0.713 . . . . 10.0 110.412 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -84.49 -38.74 19.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.111 -0.495 . . . . 10.0 111.151 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 171.27 -145.51 8.91 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.795 -0.717 . . . . 10.0 111.978 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.0 pp -140.47 161.93 36.55 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.731 0.3 . . . . 10.0 110.942 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 55.0 mt -106.44 123.4 61.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.803 -0.814 . . . . 10.0 108.803 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.3 ttm180 -93.09 -27.67 16.81 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.592 -0.276 . . . . 10.0 111.361 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.2 tptm -157.05 131.16 8.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.994 0.426 . . . . 10.0 111.84 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.0 102.96 8.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.427 -0.806 . . . . 10.0 108.901 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -118.54 78.93 1.31 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.566 -0.288 . . . . 10.0 110.794 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 55.4 178.7 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.663 0 O-C-N 123.971 0.794 . . . . 10.0 111.718 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -71.55 48.69 1.04 Allowed 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 121.955 1.77 . . . . 10.0 111.569 177.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -134.96 -55.52 0.82 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.306 -0.406 . . . . 10.0 111.088 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.0 m -113.23 119.18 36.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.159 -0.473 . . . . 10.0 110.753 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 59.7 tp -129.05 119.65 24.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.13 -0.486 . . . . 10.0 110.937 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 51.2 t -118.91 116.36 50.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.652 -0.499 . . . . 10.0 109.652 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 pp -133.95 161.99 40.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.353 -0.385 . . . . 10.0 111.943 -178.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -129.08 141.79 12.91 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 110.5 -1.04 . . . . 10.0 110.5 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -105.32 166.21 10.58 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.388 0.514 . . . . 10.0 112.388 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 46.7 mtp180 -104.87 -168.76 1.52 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.802 -0.635 . . . . 10.0 110.53 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.29 150.65 51.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.786 -0.643 . . . . 10.0 111.18 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -87.85 -168.49 2.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.883 -0.599 . . . . 10.0 110.529 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 131.73 157.58 8.77 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.828 -0.701 . . . . 10.0 112.915 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -104.98 -85.83 0.47 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.23 0.538 . . . . 10.0 110.046 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -88.73 81.0 1.56 Allowed Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 111.232 -0.747 . . . . 10.0 111.232 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 5.5 ptt85 -141.94 175.53 9.65 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.624 0.249 . . . . 10.0 110.592 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.446 ' CG1' ' H ' ' A' ' 90' ' ' ASP . 10.3 tt -83.21 -174.64 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.011 -0.54 . . . . 10.0 110.612 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.446 ' H ' ' CG1' ' A' ' 89' ' ' ILE . 29.2 t70 -59.8 141.48 89.16 Favored Pre-proline 0 C--N 1.331 -0.236 0 C-N-CA 123.134 0.574 . . . . 10.0 110.972 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -69.37 60.05 1.46 Allowed 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.135 2.557 . . . . 10.0 113.142 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -82.03 92.75 6.85 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.249 0.547 . . . . 10.0 110.714 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -164.41 -69.2 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.761 -0.654 . . . . 10.0 110.21 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.2 m 66.14 90.78 0.09 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.077 0.769 . . . . 10.0 113.077 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.2 m -88.91 107.69 19.14 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.48 -0.563 . . . . 10.0 109.48 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -91.03 151.94 20.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.996 0.427 . . . . 10.0 111.914 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -140.54 142.64 35.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.212 -0.904 . . . . 10.0 109.881 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.7 m -102.23 125.51 48.95 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.582 -0.281 . . . . 10.0 110.446 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.4 t -107.3 126.12 63.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.836 -0.62 . . . . 10.0 110.827 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -112.4 134.39 53.96 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.226 -0.443 . . . . 10.0 110.652 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -102.43 123.63 46.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.27 -0.423 . . . . 10.0 111.532 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.8 t -119.8 119.69 61.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.154 -0.475 . . . . 10.0 109.737 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -104.07 136.07 44.39 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.809 0.338 . . . . 10.0 110.818 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -127.27 115.69 19.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.005 -0.543 . . . . 10.0 111.187 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.34 6.11 52.45 Favored Glycine 0 CA--C 1.518 0.261 0 CA-C-N 115.915 -0.584 . . . . 10.0 112.886 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 67.47 -3.15 1.13 Allowed 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.915 0.709 . . . . 10.0 112.915 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.2 ptmt -119.24 6.21 11.22 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.196 0.522 . . . . 10.0 111.605 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -140.06 132.58 28.66 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.167 -0.679 . . . . 10.0 109.167 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.8 m -117.72 130.37 56.28 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.397 0.517 . . . . 10.0 112.397 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -118.85 113.3 20.86 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.088 -1.078 . . . . 10.0 108.088 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.8 p -113.35 133.93 57.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 C-N-CA 120.449 -0.5 . . . . 10.0 111.29 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -127.9 148.33 50.48 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.048 -0.524 . . . . 10.0 111.795 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.6 t -126.27 113.85 35.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 108.82 -0.807 . . . . 10.0 108.82 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -129.44 144.58 51.31 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.172 0.511 . . . . 10.0 112.094 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -163.55 162.86 24.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.416 -0.811 . . . . 10.0 109.021 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -157.57 77.87 0.85 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.701 0.286 . . . . 10.0 110.491 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -172.41 -67.39 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.296 -0.411 . . . . 10.0 111.919 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -81.57 -16.73 50.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.182 0.515 . . . . 10.0 111.579 -178.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -82.52 -16.8 47.32 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.828 -0.624 . . . . 10.0 110.67 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 77.8 mtt180 -91.65 32.2 1.12 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.181 0.438 . . . . 10.0 112.181 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 21.3 ptp -136.19 23.32 3.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.086 0.47 . . . . 10.0 110.129 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -73.22 -106.67 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.701 -0.681 . . . . 10.0 112.789 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.2 m 53.41 -87.79 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.634 0.605 . . . . 10.0 112.634 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -72.35 -35.61 68.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.838 0.352 . . . . 10.0 110.25 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -71.26 -31.99 68.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 10.0 110.883 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.6 -43.4 97.46 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.712 -0.676 . . . . 10.0 110.818 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -66.61 -37.15 84.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.934 -0.575 . . . . 10.0 111.02 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 45.9 mtp180 -69.31 -45.15 70.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 10.0 111.383 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.8 p -70.29 -20.42 22.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 112.205 0.446 . . . . 10.0 112.205 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 -66.64 -15.42 63.46 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 121.067 0.461 . . . . 10.0 111.057 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -71.59 -4.21 25.8 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.233 0.457 . . . . 10.0 112.233 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -152.81 -50.29 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 119.999 -1.096 . . . . 10.0 113.744 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -63.09 -42.71 99.67 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.207 0.817 . . . . 10.0 113.207 -178.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -71.89 -3.03 20.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.179 0.514 . . . . 10.0 111.853 -179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -98.24 19.42 14.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.272 -0.422 . . . . 10.0 111.3 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -175.08 -35.3 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 119.765 -1.207 . . . . 10.0 113.806 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -56.55 -58.05 19.52 Favored Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 113.457 0.91 . . . . 10.0 113.457 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.87 -41.23 46.97 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.118 1.879 . . . . 10.0 112.038 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.05 -38.18 87.69 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 116.045 -0.525 . . . . 10.0 111.04 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -65.34 -39.67 86.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.163 -0.471 . . . . 10.0 111.669 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 93.4 mt -64.69 -35.59 81.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.498 -0.319 . . . . 10.0 111.275 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -80.4 -32.56 37.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.138 -0.483 . . . . 10.0 112.239 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 2.8 p -75.5 -34.6 60.85 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.987 -0.285 . . . . 10.0 111.368 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -61.13 -37.9 84.47 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.856 0.36 . . . . 10.0 111.27 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -56.76 -54.96 40.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.707 -0.678 . . . . 10.0 111.627 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -61.45 -37.08 82.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.455 -0.339 . . . . 10.0 111.616 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 48.6 tttp -64.9 -55.34 19.91 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.18 0.437 . . . . 10.0 112.18 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 32.7 mt -66.96 -38.38 81.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.722 0.296 . . . . 10.0 111.573 -178.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.497 ' CG ' ' HZ1' ' A' ' 13' ' ' LYS . 1.8 t70 -65.17 -35.32 80.72 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-O 121.357 0.599 . . . . 10.0 109.915 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -67.96 -48.38 66.04 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.391 -0.822 . . . . 10.0 109.724 178.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -79.89 56.97 2.46 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.038 -0.528 . . . . 10.0 110.879 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -177.82 -51.95 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.743 -0.662 . . . . 10.0 112.299 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -126.06 -45.37 1.72 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.332 0.493 . . . . 10.0 112.332 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -60.94 -35.6 77.15 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.496 0.554 . . . . 10.0 112.496 -178.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt . . . . . 0 C--O 1.252 1.213 0 CA-C-O 118.427 -0.797 . . . . 10.0 110.106 179.881 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 110.703 -0.11 . . . . 10.0 110.703 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . 0.365 17.6 p90 63.63 -50.49 0.24 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 116.27 1.952 . . . . 10.0 116.27 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -74.47 -61.61 1.13 Allowed Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 112.886 0.699 . . . . 10.0 112.886 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -80.5 -32.64 1.17 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.292 1.995 . . . . 10.0 111.949 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -176.94 152.5 0.93 Allowed 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.346 -0.843 . . . . 10.0 109.648 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.5 p -101.54 138.58 25.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.021 0.438 . . . . 10.0 111.32 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -171.0 104.63 0.23 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.376 -0.829 . . . . 10.0 110.043 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 72.1 m-70 -131.04 157.21 43.63 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.06 -0.348 . . . . 10.0 110.06 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.2 140.27 25.19 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.442 0.534 . . . . 10.0 112.442 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.9 t -123.45 143.4 36.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 108.91 -0.774 . . . . 10.0 108.91 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.8 m -111.26 105.46 14.13 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.082 0.468 . . . . 10.0 111.991 -178.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 89.2 t -85.97 114.91 26.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.081 -0.509 . . . . 10.0 110.515 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt -98.74 57.95 1.16 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.213 0.53 . . . . 10.0 111.124 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -147.91 -83.26 0.11 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.556 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -163.47 157.99 20.42 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.725 -0.472 . . . . 10.0 109.725 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.7 ttt180 -66.99 -37.39 84.13 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.614 0.598 . . . . 10.0 112.614 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -70.59 -41.08 72.81 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.059 0.392 . . . . 10.0 112.059 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.97 -36.63 84.11 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.818 0.303 . . . . 10.0 111.818 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.58 -44.39 94.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.143 0.497 . . . . 10.0 110.233 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -67.35 -38.71 85.28 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.7 -0.682 . . . . 10.0 110.316 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.0 mmtt -66.17 -43.61 86.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.66 -0.7 . . . . 10.0 112.683 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.4 p -73.24 -26.34 61.08 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.09 0.774 . . . . 10.0 113.09 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -84.16 -34.4 24.04 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.03 0.752 . . . . 10.0 113.03 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.0 mp -102.36 -33.05 9.72 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.842 1.053 . . . . 10.0 113.842 -178.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -124.53 42.42 3.26 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.289 0.477 . . . . 10.0 112.289 -178.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -145.18 30.16 1.77 Allowed Glycine 0 C--O 1.228 -0.254 0 C-N-CA 120.516 -0.849 . . . . 10.0 112.524 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -54.65 -56.36 28.01 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 113.366 0.876 . . . . 10.0 113.366 -179.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -82.94 28.35 0.58 Allowed 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 122.095 1.863 . . . . 10.0 112.376 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -124.0 9.39 8.72 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.2 0.524 . . . . 10.0 111.446 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 19.8 m0 -98.61 162.59 13.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.949 -0.569 . . . . 10.0 109.668 179.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -144.85 46.85 0.64 Allowed Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 112.307 0.484 . . . . 10.0 112.307 179.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -89.88 -45.82 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.364 2.043 . . . . 10.0 112.509 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -157.78 -32.3 0.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.113 0.482 . . . . 10.0 110.137 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -79.67 89.53 5.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.398 0.618 . . . . 10.0 111.168 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -99.73 -21.18 15.91 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.67 -0.695 . . . . 10.0 110.899 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -91.18 109.24 20.49 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.147 -0.479 . . . . 10.0 111.024 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.57 167.47 12.89 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.802 -0.636 . . . . 10.0 111.139 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.3 m 78.51 -62.8 0.32 Allowed 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.515 0.561 . . . . 10.0 112.515 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 17.1 mmtm -76.16 -24.72 54.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.863 0.363 . . . . 10.0 111.814 -179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.4 p -163.21 91.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.77 0.795 . . . . 10.0 110.543 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 126.51 47.61 0.2 Allowed Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.477 -0.783 . . . . 10.0 111.753 -178.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.58 158.71 86.25 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 120.621 0.248 . . . . 10.0 111.097 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -59.82 -20.46 59.33 Favored 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 122.677 2.252 . . . . 10.0 112.88 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.3 mp -98.74 -91.82 0.27 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.7 0.286 . . . . 10.0 110.579 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.85 -63.97 2.47 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.824 -0.703 . . . . 10.0 113.122 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.3 t -106.04 132.51 52.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 120.725 0.298 . . . . 10.0 110.996 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -95.31 125.77 40.16 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.398 -0.365 . . . . 10.0 110.355 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -103.51 10.61 37.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.286 -0.415 . . . . 10.0 110.972 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.0 mtmm -89.09 -54.51 4.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.669 0.271 . . . . 10.0 110.533 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -111.15 -29.83 3.36 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 111.101 -0.799 . . . . 10.0 111.101 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.26 80.32 1.4 Allowed Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.655 -0.783 . . . . 10.0 111.97 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -162.97 167.63 22.27 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.725 0.297 . . . . 10.0 110.505 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 60.0 m95 -107.33 134.52 50.27 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.883 -0.784 . . . . 10.0 108.883 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -164.22 120.05 1.56 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.053 0.454 . . . . 10.0 111.497 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -83.77 133.66 34.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.794 -0.639 . . . . 10.0 109.676 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.0 mm -96.14 111.27 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 116.069 -0.514 . . . . 10.0 110.823 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -106.62 163.49 12.85 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.921 -0.581 . . . . 10.0 109.597 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.38 -23.72 65.61 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.598 0.237 . . . . 10.0 110.514 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -87.42 -4.23 59.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.811 0.339 . . . . 10.0 110.775 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 134.1 -111.64 0.98 Allowed Glycine 0 CA--C 1.519 0.298 0 C-N-CA 121.209 -0.52 . . . . 10.0 112.482 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -115.76 137.24 52.28 Favored 'General case' 0 C--N 1.32 -0.676 0 O-C-N 122.41 -0.465 . . . . 10.0 110.759 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -97.45 -144.46 0.3 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.946 -0.57 . . . . 10.0 111.657 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -75.07 -178.83 4.01 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 113.045 0.757 . . . . 10.0 113.045 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.9 t -152.64 152.63 32.01 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.142 -0.936 . . . . 10.0 110.095 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -96.68 -22.1 17.21 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.475 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 154.12 -146.75 15.22 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 121.032 -0.604 . . . . 10.0 112.42 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.9 pp -132.73 169.24 16.98 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.776 0.322 . . . . 10.0 110.704 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 67.4 mt -109.03 127.13 65.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.095 -0.705 . . . . 10.0 109.095 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -77.83 -45.88 23.11 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.418 -0.356 . . . . 10.0 111.255 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.0 tttm -161.81 145.33 12.3 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.229 -0.441 . . . . 10.0 110.604 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -115.23 84.67 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.206 0.527 . . . . 10.0 110.478 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.26 61.95 5.92 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.982 -0.554 . . . . 10.0 111.161 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.44 ' C ' ' H ' ' A' ' 75' ' ' ASP . 3.8 pt-20 55.04 -179.01 0.03 OUTLIER Pre-proline 0 CA--C 1.547 0.841 0 O-C-N 123.871 0.732 . . . . 10.0 111.886 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -69.29 33.65 0.19 Allowed 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 122.203 1.935 . . . . 10.0 113.359 178.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.44 ' H ' ' C ' ' A' ' 73' ' ' GLU . 17.4 t70 -113.49 -56.46 2.4 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.639 0.257 . . . . 10.0 110.564 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.0 m -127.6 129.33 47.09 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.951 0.405 . . . . 10.0 110.594 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 28.9 tp -129.05 134.01 47.94 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.054 -0.521 . . . . 10.0 110.088 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.6 t -128.35 119.93 51.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.935 -0.394 . . . . 10.0 109.935 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 37.6 pt -133.57 167.7 25.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.719 0.295 . . . . 10.0 111.268 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -123.88 138.49 11.43 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 110.836 -0.905 . . . . 10.0 110.836 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -97.01 156.89 16.16 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.216 0.821 . . . . 10.0 113.216 -178.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.0 ttt180 -105.94 153.35 22.1 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.992 -1.004 . . . . 10.0 109.692 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.6 pp -98.84 170.6 8.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.647 0.26 . . . . 10.0 111.428 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -120.42 -173.05 2.49 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.44 -0.346 . . . . 10.0 110.84 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 134.45 147.01 5.51 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.4 -0.68 . . . . 10.0 111.4 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -83.29 -84.27 0.13 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.993 0.425 . . . . 10.0 110.73 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -87.03 92.73 1.83 Allowed Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.756 -0.735 . . . . 10.0 111.739 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.37 169.29 17.58 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.748 0.309 . . . . 10.0 110.723 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 8.9 tp -74.79 164.59 3.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.151 -0.477 . . . . 10.0 110.606 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.15 146.27 98.96 Favored Pre-proline 0 C--O 1.232 0.176 0 CA-C-O 120.748 0.309 . . . . 10.0 111.241 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -57.89 104.41 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 123.297 2.664 . . . . 10.0 113.914 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -106.77 -25.04 11.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.763 -0.653 . . . . 10.0 109.94 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -68.71 -77.71 0.08 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.514 -0.766 . . . . 10.0 111.134 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.9 m 69.07 161.57 0.21 Allowed 'General case' 0 CA--C 1.534 0.342 0 O-C-N 123.559 0.537 . . . . 10.0 112.216 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 16.1 m -144.34 124.84 13.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.449 -0.341 . . . . 10.0 111.229 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -100.69 153.04 19.76 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.151 -0.477 . . . . 10.0 110.222 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -139.15 147.03 41.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.667 -0.242 . . . . 10.0 110.914 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.18 126.36 42.31 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.363 -0.606 . . . . 10.0 109.363 179.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 39.0 t -116.97 127.25 74.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.419 -0.355 . . . . 10.0 111.31 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.74 130.57 55.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.564 -0.289 . . . . 10.0 110.864 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -100.21 84.14 2.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.391 -0.368 . . . . 10.0 111.109 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 34.6 t -85.66 111.09 20.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 110.01 -0.367 . . . . 10.0 110.01 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -102.82 137.72 40.66 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.734 0.302 . . . . 10.0 111.347 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -124.95 125.95 44.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.998 -0.546 . . . . 10.0 109.616 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 78.3 6.5 87.81 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.743 -0.742 . . . . 10.0 111.881 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 63.36 20.8 12.47 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.685 0.624 . . . . 10.0 112.685 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 16.6 pttt -140.95 -51.95 0.46 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.108 -0.496 . . . . 10.0 110.685 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -82.7 100.2 10.09 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.256 -0.646 . . . . 10.0 109.256 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.2 m -103.25 115.64 30.95 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.774 -0.648 . . . . 10.0 111.268 -178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 64.1 mtt180 -102.67 105.72 16.24 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.036 -0.529 . . . . 10.0 110.14 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.8 p -92.2 123.74 44.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.844 -0.617 . . . . 10.0 110.806 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -114.41 145.44 41.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.021 -0.536 . . . . 10.0 111.483 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.1 t -123.21 122.38 65.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.797 -0.638 . . . . 10.0 109.527 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -135.68 155.51 50.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.206 0.527 . . . . 10.0 112.001 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -177.88 157.44 1.17 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.203 -0.908 . . . . 10.0 108.696 178.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.1 m -156.71 86.07 0.98 Allowed 'General case' 0 C--O 1.237 0.417 0 N-CA-C 109.825 -0.435 . . . . 10.0 109.825 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -177.02 -64.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.021 -0.536 . . . . 10.0 111.197 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -90.07 2.41 55.26 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.276 -0.42 . . . . 10.0 111.919 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.401 ' C ' ' H ' ' A' ' 121' ' ' MET . 19.7 p-10 -90.12 -38.67 13.37 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.177 -0.465 . . . . 10.0 110.827 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -75.63 18.49 0.23 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.766 0.654 . . . . 10.0 112.766 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.401 ' H ' ' C ' ' A' ' 119' ' ' ASP . 23.7 ptt? -118.15 13.67 13.84 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.518 -0.549 . . . . 10.0 109.518 178.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -77.6 -111.77 0.17 Allowed Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.611 -0.722 . . . . 10.0 113.394 -178.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.5 m 56.36 -92.17 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.48 0.312 . . . . 10.0 111.225 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.33 -31.06 70.2 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.62 -0.511 . . . . 10.0 109.62 178.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 7.5 m170 -72.24 -42.2 65.95 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.823 -0.626 . . . . 10.0 109.71 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -66.24 -38.87 88.91 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.757 -0.656 . . . . 10.0 110.04 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -60.03 -31.85 70.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.621 -0.718 . . . . 10.0 110.989 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.78 -43.64 19.81 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.1 -0.5 . . . . 10.0 111.501 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 4.6 p -71.02 -23.37 23.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 112.13 0.419 . . . . 10.0 112.13 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -69.67 -4.59 20.18 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.003 0.372 . . . . 10.0 112.003 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -71.12 -27.54 63.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.867 0.365 . . . . 10.0 110.761 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -133.66 -30.23 0.45 Allowed Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.148 -1.025 . . . . 10.0 114.163 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 12.8 tpt -79.11 -29.87 43.45 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 117.358 0.579 . . . . 10.0 112.012 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -69.14 -9.54 53.32 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.14 -0.482 . . . . 10.0 111.858 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -95.76 -7.49 37.05 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.214 0.45 . . . . 10.0 112.214 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -131.54 -39.78 0.24 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 119.794 -1.193 . . . . 10.0 114.362 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 22.5 t90 -53.11 -59.6 8.72 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 113.781 1.03 . . . . 10.0 113.781 -178.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.17 -36.42 21.58 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 121.551 1.501 . . . . 10.0 112.705 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.8 -41.41 91.97 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.111 -0.495 . . . . 10.0 111.645 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.2 mp -64.97 -41.27 91.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.166 -0.47 . . . . 10.0 111.586 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 96.1 mt -59.1 -47.71 84.25 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.259 -0.428 . . . . 10.0 111.478 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -63.46 -40.19 96.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.984 -0.553 . . . . 10.0 111.057 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 21.7 m -66.32 -43.65 85.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.08 -0.509 . . . . 10.0 111.307 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -63.96 -39.33 93.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.542 -0.299 . . . . 10.0 110.556 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -58.68 -34.59 71.44 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 123.8 0.687 . . . . 10.0 111.074 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -87.96 -35.52 17.6 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.332 0.493 . . . . 10.0 112.332 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -61.79 -50.86 70.64 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 111.616 0.228 . . . . 10.0 111.616 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 48.6 mt -63.81 -32.3 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.18 0.515 . . . . 10.0 110.644 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -73.39 -39.16 65.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.964 -0.562 . . . . 10.0 109.773 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -64.03 -53.32 51.84 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.883 -0.598 . . . . 10.0 109.851 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -87.08 56.87 4.19 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.38 -0.827 . . . . 10.0 110.78 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 175.14 -43.28 0.12 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.041 -1.076 . . . . 10.0 113.317 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -109.55 -49.65 3.08 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.103 0.408 . . . . 10.0 112.103 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 22.0 mttp -65.23 -55.3 19.23 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.791 0.329 . . . . 10.0 110.798 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.024 -0.988 . . . . 10.0 109.705 179.793 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 120.428 0.156 . . . . 10.0 110.806 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . 0.286 0.2 OUTLIER 47.84 -107.18 0.18 Allowed 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 115.899 1.815 . . . . 10.0 115.899 179.606 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -48.54 -64.31 1.18 Allowed Pre-proline 0 N--CA 1.475 0.821 0 N-CA-C 115.353 1.612 . . . . 10.0 115.353 -177.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -51.34 -48.0 23.32 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.458 2.105 . . . . 10.0 112.84 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 51.8 p90 178.66 153.33 0.36 Allowed 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.705 -0.68 . . . . 10.0 109.705 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.9 p -107.27 96.3 4.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.323 0.582 . . . . 10.0 111.304 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -136.57 105.31 5.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.867 -0.606 . . . . 10.0 110.247 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 28.3 m-70 -121.18 152.28 38.97 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.316 -0.402 . . . . 10.0 110.044 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.9 m -140.38 133.28 29.19 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.607 0.241 . . . . 10.0 111.083 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.7 t -123.32 140.45 46.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 109.374 -0.602 . . . . 10.0 109.374 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.1 m -107.93 112.31 24.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.058 0.456 . . . . 10.0 110.91 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.3 t -98.94 132.8 43.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 116.299 -0.41 . . . . 10.0 110.178 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.2 mtmt -115.45 88.16 2.82 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.749 0.309 . . . . 10.0 111.676 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -172.54 -82.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.702 -0.681 . . . . 10.0 109.471 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -168.65 -178.91 3.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.009 -0.541 . . . . 10.0 110.152 178.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 50.2 ttt180 -76.25 -35.58 58.89 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.283 0.475 . . . . 10.0 112.283 -178.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -71.5 -46.58 59.34 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.474 0.546 . . . . 10.0 112.474 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.95 -46.62 75.02 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.031 0.382 . . . . 10.0 112.031 -179.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.93 -46.53 88.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.357 -0.383 . . . . 10.0 111.456 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -67.64 -37.49 82.51 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.309 -0.405 . . . . 10.0 111.613 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.8 mmtt -68.2 -44.65 75.34 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 111.921 0.341 . . . . 10.0 111.921 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.2 p -67.36 -28.17 67.73 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.362 0.505 . . . . 10.0 112.362 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -93.29 7.33 44.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.702 0.286 . . . . 10.0 111.618 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.0 tp -128.26 -55.86 1.25 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.454 0.539 . . . . 10.0 112.454 -178.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -108.82 -12.35 14.92 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.077 0.399 . . . . 10.0 112.077 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.51 86.83 1.5 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.652 -0.785 . . . . 10.0 111.725 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.414 ' C ' ' H ' ' A' ' 29' ' ' GLU . 1.5 m-85 -111.66 -55.6 0.04 OUTLIER Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 112.731 0.641 . . . . 10.0 112.731 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -75.74 27.85 0.39 Allowed 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.273 1.982 . . . . 10.0 112.577 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.414 ' H ' ' C ' ' A' ' 27' ' ' PHE . 8.4 pt-20 -120.48 0.62 10.55 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.318 -0.401 . . . . 10.0 110.762 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 39.7 m0 -76.72 165.07 25.24 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.322 -0.621 . . . . 10.0 109.322 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -146.07 -58.39 0.02 OUTLIER Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 112.585 0.587 . . . . 10.0 112.585 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.31 52.58 2.8 Favored 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 122.068 1.845 . . . . 10.0 112.498 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -170.0 -67.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.978 -0.555 . . . . 10.0 110.659 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -111.82 122.83 48.84 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.334 0.588 . . . . 10.0 111.549 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -112.96 4.75 16.93 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.735 -0.666 . . . . 10.0 110.779 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -133.08 105.08 6.85 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.721 0.296 . . . . 10.0 111.198 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.06 166.19 14.29 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.117 -0.492 . . . . 10.0 110.302 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.1 m 75.46 -47.35 0.59 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 122.91 0.484 . . . . 10.0 111.562 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.1 -30.64 27.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.1 0.476 . . . . 10.0 109.896 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.8 p -161.81 104.19 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 115.301 -0.863 . . . . 10.0 109.343 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.83 62.24 0.56 Allowed Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.939 -0.864 . . . . 10.0 110.939 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.403 ' CB ' ' H ' ' A' ' 56' ' ' ILE . . . -81.31 168.08 27.2 Favored Pre-proline 0 C--N 1.321 -0.669 0 C-N-CA 122.407 0.283 . . . . 10.0 110.896 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -74.74 45.58 1.32 Allowed 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 122.979 2.452 . . . . 10.0 112.963 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 27.4 tp -160.69 -86.85 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.744 -0.465 . . . . 10.0 109.744 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.65 -69.71 3.25 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.93 -0.652 . . . . 10.0 112.991 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.8 t -103.14 134.9 42.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.002 0.43 . . . . 10.0 111.461 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -103.26 112.29 25.1 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.421 -0.585 . . . . 10.0 109.421 178.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.61 23.2 8.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.754 -0.657 . . . . 10.0 111.02 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.5 mttp -99.65 -54.29 2.96 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.94 -0.763 . . . . 10.0 108.94 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -108.55 -21.96 7.3 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.309 -0.86 . . . . 10.0 112.085 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.3 67.43 0.9 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.747 -0.739 . . . . 10.0 112.082 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -151.48 173.87 14.06 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 122.654 -0.321 . . . . 10.0 110.361 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 35.6 m95 -123.79 132.21 53.74 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.402 -0.962 . . . . 10.0 108.402 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -163.29 132.16 3.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.23 0.538 . . . . 10.0 112.142 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -90.01 152.55 21.13 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.379 -0.828 . . . . 10.0 110.046 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.403 ' H ' ' CB ' ' A' ' 42' ' ' ALA . 41.5 mm -107.07 123.78 62.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.292 -0.413 . . . . 10.0 110.528 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -127.13 166.01 18.47 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.973 -0.751 . . . . 10.0 108.973 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -64.15 -26.81 68.69 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.681 0.277 . . . . 10.0 111.629 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -88.4 -5.34 58.34 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.948 0.404 . . . . 10.0 111.066 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 135.18 -105.85 0.56 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.976 -0.631 . . . . 10.0 112.697 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.9 mp0 -115.55 140.2 49.38 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.728 0.299 . . . . 10.0 110.563 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -93.87 -135.26 0.18 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.367 -0.379 . . . . 10.0 110.809 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -79.56 170.48 16.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.098 0.475 . . . . 10.0 111.601 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.4 t -145.11 132.54 20.72 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.027 -0.533 . . . . 10.0 110.652 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -72.83 -32.89 65.81 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.114 -0.494 . . . . 10.0 111.016 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 162.24 -143.32 8.66 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 121.171 -0.538 . . . . 10.0 112.558 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -137.73 168.92 18.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.78 0.324 . . . . 10.0 110.772 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 58.7 mt -106.48 141.13 22.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.968 -0.382 . . . . 10.0 109.968 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -93.06 -44.15 8.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.958 -0.564 . . . . 10.0 110.809 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.3 tttt -157.43 146.63 19.95 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.088 -0.505 . . . . 10.0 110.572 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.08 75.46 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.847 -0.615 . . . . 10.0 110.008 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -86.57 69.42 10.36 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.564 -0.744 . . . . 10.0 111.23 -178.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 54.55 178.29 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.681 0 CA-C-N 115.357 -0.838 . . . . 10.0 112.0 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -72.17 49.49 1.35 Allowed 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 122.008 1.805 . . . . 10.0 110.845 177.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -137.66 -50.53 0.61 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.923 -0.58 . . . . 10.0 110.647 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.7 m -118.39 109.24 16.03 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.769 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 28.6 tp -117.42 126.89 53.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.125 -0.489 . . . . 10.0 110.469 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.5 t -128.04 115.7 39.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-N 116.35 -0.386 . . . . 10.0 110.249 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 31.8 pt -131.08 166.35 28.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.795 0.331 . . . . 10.0 111.543 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -127.27 125.65 5.34 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.393 -0.683 . . . . 10.0 111.393 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -93.1 156.71 16.7 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.606 0.241 . . . . 10.0 110.873 -179.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 50.4 mtp180 -106.5 178.4 4.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.096 -0.502 . . . . 10.0 110.774 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.35 151.97 32.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.323 -0.399 . . . . 10.0 111.374 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -88.73 -165.46 1.34 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.165 -0.471 . . . . 10.0 110.887 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 131.18 156.37 8.48 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 121.091 -0.576 . . . . 10.0 112.067 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -101.66 -86.38 0.41 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.673 0.273 . . . . 10.0 110.611 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -84.44 58.0 5.01 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 121.122 -0.561 . . . . 10.0 111.871 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -121.09 154.55 35.99 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.747 0.308 . . . . 10.0 110.923 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 11.9 tt -68.68 175.39 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 115.738 -0.665 . . . . 10.0 110.319 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -55.99 140.86 68.9 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.021 0.439 . . . . 10.0 111.662 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -85.85 61.41 5.15 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.918 2.412 . . . . 10.0 112.906 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -83.61 71.91 10.34 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.258 0.551 . . . . 10.0 110.45 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -152.29 -63.47 0.17 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.87 -0.789 . . . . 10.0 108.87 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.3 m 62.98 170.76 0.15 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.181 -0.918 . . . . 10.0 112.944 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.3 m -137.99 111.35 8.0 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.531 -0.544 . . . . 10.0 109.531 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.66 140.68 29.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.304 -0.407 . . . . 10.0 111.093 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -132.1 148.4 52.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.164 -0.471 . . . . 10.0 111.066 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.74 121.19 41.95 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.688 -0.486 . . . . 10.0 109.688 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 46.7 t -108.1 131.83 57.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.816 0.341 . . . . 10.0 111.233 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.8 m -118.77 139.89 50.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.024 -0.535 . . . . 10.0 110.287 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -112.97 109.04 18.2 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.35 -0.386 . . . . 10.0 111.181 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.3 t -114.88 110.41 31.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.073 0.463 . . . . 10.0 109.834 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -100.35 143.49 30.47 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.186 0.517 . . . . 10.0 111.508 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -125.83 109.94 13.11 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.741 -0.663 . . . . 10.0 109.32 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 78.96 13.63 82.86 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.908 -0.663 . . . . 10.0 111.96 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 72.28 -42.94 0.55 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.013 0.746 . . . . 10.0 113.013 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 30.3 pttt -73.47 -37.29 65.82 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.637 0.606 . . . . 10.0 112.637 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -96.45 108.69 21.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.668 0.27 . . . . 10.0 110.56 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 11.6 m -109.07 121.33 44.91 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.94 0.4 . . . . 10.0 110.701 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -108.31 130.08 55.2 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.343 -0.389 . . . . 10.0 110.568 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.5 p -118.83 123.25 71.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.196 -0.456 . . . . 10.0 110.014 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -122.37 147.63 46.04 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.322 0.582 . . . . 10.0 111.871 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 38.7 t -113.23 131.16 65.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.48 -0.782 . . . . 10.0 109.672 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.75 135.36 34.61 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 123.282 0.363 . . . . 10.0 110.43 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 -175.09 149.46 1.09 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.129 -0.487 . . . . 10.0 109.98 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -151.63 91.05 1.61 Allowed 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.151 -0.477 . . . . 10.0 110.675 179.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 14.8 t60 -175.82 -59.07 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.905 -0.588 . . . . 10.0 110.268 -179.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -89.62 -4.89 57.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.269 -0.423 . . . . 10.0 111.164 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -86.27 -39.1 16.88 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.058 -0.519 . . . . 10.0 111.564 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -78.91 57.21 2.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.907 0.384 . . . . 10.0 111.899 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 18.3 ptt? -167.81 27.32 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.079 -0.509 . . . . 10.0 110.558 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -77.67 -101.91 0.18 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.845 -0.693 . . . . 10.0 112.85 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 53.3 -101.28 0.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 122.886 0.474 . . . . 10.0 111.945 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -64.88 -34.42 78.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.928 0.394 . . . . 10.0 110.73 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 35.5 m170 -70.26 -38.82 75.2 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.611 -0.514 . . . . 10.0 109.611 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.76 -50.54 66.45 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.543 -0.753 . . . . 10.0 110.301 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -60.17 -29.4 68.65 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.194 -0.457 . . . . 10.0 111.128 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 9.0 mtp180 -79.62 -45.69 18.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.06 -0.518 . . . . 10.0 111.913 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 9.5 p -73.1 -29.63 29.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 112.116 0.413 . . . . 10.0 112.116 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -74.24 -1.33 20.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.131 0.491 . . . . 10.0 111.712 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -72.14 -20.41 61.61 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.534 -0.543 . . . . 10.0 109.534 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -133.54 -44.77 0.12 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.557 -0.83 . . . . 10.0 112.78 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -62.9 -37.75 88.2 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.399 0.518 . . . . 10.0 112.399 -179.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -68.86 -11.32 60.39 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.795 0.331 . . . . 10.0 111.877 -178.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -84.01 -8.08 59.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.699 0.285 . . . . 10.0 111.693 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -141.31 -34.4 0.11 Allowed Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.049 -1.072 . . . . 10.0 114.725 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -56.7 -61.55 6.65 Favored Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 113.573 0.953 . . . . 10.0 113.573 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.51 -14.15 42.85 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 121.795 1.664 . . . . 10.0 112.01 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.3 m -82.12 -47.14 12.91 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.872 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 10.7 tp -71.99 -31.87 41.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.41 -0.359 . . . . 10.0 111.202 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 61.7 mt -55.76 -41.78 74.49 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.036 0.446 . . . . 10.0 111.945 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -82.31 -42.62 18.55 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.481 -0.327 . . . . 10.0 111.405 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 19.6 m -62.16 -38.57 89.52 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.768 0.655 . . . . 10.0 112.768 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -63.49 -34.59 78.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.617 -0.265 . . . . 10.0 111.623 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -63.05 -43.94 97.25 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.981 0.419 . . . . 10.0 110.939 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -72.32 -31.1 65.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.265 -0.425 . . . . 10.0 111.458 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 8.6 ttpp -60.5 -51.0 71.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.495 . . . . 10.0 110.351 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 31.3 mt -67.34 -38.15 80.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.343 -0.39 . . . . 10.0 110.728 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -59.59 -37.34 78.28 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.426 0.631 . . . . 10.0 110.018 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -72.04 -41.12 67.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.816 -0.629 . . . . 10.0 111.645 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -84.05 60.3 5.79 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.257 -0.428 . . . . 10.0 111.627 -179.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 161.39 -44.71 0.39 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.346 -0.93 . . . . 10.0 113.337 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -107.39 -55.66 2.31 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 122.728 -0.278 . . . . 10.0 111.69 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -63.32 -38.47 91.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.083 -0.508 . . . . 10.0 111.931 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 90.9 mttt . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.375 -0.822 . . . . 10.0 110.348 -179.424 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 . . . . . 0 N--CA 1.479 1.008 0 N-CA-C 110.471 -0.196 . . . . 10.0 110.471 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . 0.318 0.5 OUTLIER 67.2 -51.49 0.48 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.933 1.827 . . . . 10.0 115.933 178.369 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -92.46 -58.45 0.22 Allowed Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 112.674 0.62 . . . . 10.0 112.674 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -75.57 -25.81 10.64 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.211 1.941 . . . . 10.0 112.475 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -178.67 140.6 0.19 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.677 -0.692 . . . . 10.0 110.138 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.7 p -97.56 115.08 36.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 121.365 0.602 . . . . 10.0 111.389 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 21.7 mtt180 -153.57 112.01 3.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.648 -0.706 . . . . 10.0 110.572 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -128.61 141.06 51.47 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.448 -0.575 . . . . 10.0 109.448 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.3 m -125.6 128.62 48.19 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.716 0.293 . . . . 10.0 111.029 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.2 t -119.59 136.8 55.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.324 -0.398 . . . . 10.0 110.264 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 34.4 m -105.08 125.36 50.9 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.372 -0.376 . . . . 10.0 110.415 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.3 t -110.19 125.92 67.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.952 0.406 . . . . 10.0 110.067 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.8 mmmp? -91.7 28.34 1.8 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.742 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -130.46 -152.98 0.53 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.89 -0.596 . . . . 10.0 110.202 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -108.67 173.87 6.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.057 0.455 . . . . 10.0 112.055 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -60.6 -38.59 85.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.491 -0.777 . . . . 10.0 112.434 -178.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -74.45 -45.43 46.38 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.497 0.554 . . . . 10.0 112.497 -178.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.2 p -62.14 -36.95 83.37 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.92 -0.312 . . . . 10.0 111.832 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.1 -37.81 75.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.97 0.414 . . . . 10.0 111.197 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -74.01 -39.85 63.32 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.956 0.408 . . . . 10.0 111.488 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.3 tttm -66.48 -33.75 76.39 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.392 0.516 . . . . 10.0 112.392 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.0 p -79.52 -5.14 54.23 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.431 0.53 . . . . 10.0 112.431 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -112.19 -34.59 5.88 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.493 0.553 . . . . 10.0 112.493 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -110.01 5.31 22.14 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 113.342 0.867 . . . . 10.0 113.342 -178.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -139.93 -55.44 0.55 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.288 0.477 . . . . 10.0 112.288 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.39 92.57 0.87 Allowed Glycine 0 C--O 1.224 -0.529 0 C-N-CA 120.889 -0.672 . . . . 10.0 112.607 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.402 ' C ' ' H ' ' A' ' 29' ' ' GLU . 2.0 t80 -96.83 -58.89 0.17 Allowed Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 112.384 0.512 . . . . 10.0 112.384 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -79.92 22.43 0.73 Allowed 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.367 2.045 . . . . 10.0 111.375 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.402 ' H ' ' C ' ' A' ' 27' ' ' PHE . 14.0 mt-10 -109.09 9.62 26.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.796 -0.638 . . . . 10.0 110.518 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 46.9 m0 -87.08 -151.83 0.18 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.192 -0.458 . . . . 10.0 110.12 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 34.9 t90 -172.77 -51.17 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 112.204 0.446 . . . . 10.0 112.204 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -18.82 -63.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.369 1.618 1 C-N-CA 125.648 4.232 . . . . 10.0 117.227 -178.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -148.11 36.66 0.84 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.093 0.473 . . . . 10.0 110.69 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -123.79 48.59 1.86 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.356 0.598 . . . . 10.0 110.825 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -78.69 58.15 2.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.622 -0.717 . . . . 10.0 110.489 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -168.63 174.91 6.41 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.65 -0.5 . . . . 10.0 109.65 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.21 161.76 36.63 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.355 -0.609 . . . . 10.0 109.355 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.7 m 72.03 -65.43 0.35 Allowed 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.644 0.609 . . . . 10.0 112.644 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.5 mmtp -68.97 -33.39 73.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.231 0.538 . . . . 10.0 111.688 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.0 p -153.15 121.17 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.591 -0.731 . . . . 10.0 109.289 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.34 54.73 1.79 Allowed Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.608 -0.997 . . . . 10.0 110.608 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.55 163.77 48.07 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.553 -0.324 . . . . 10.0 110.39 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -72.08 43.44 0.59 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.832 2.355 . . . . 10.0 113.014 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 33.5 tp -165.39 -91.23 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.266 -0.425 . . . . 10.0 110.025 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.73 -57.2 3.85 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.213 -0.518 . . . . 10.0 113.076 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.9 t -99.82 135.11 36.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.765 0.317 . . . . 10.0 111.006 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -105.91 112.58 25.69 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.527 -0.546 . . . . 10.0 109.527 178.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.77 19.73 16.58 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.933 -0.576 . . . . 10.0 110.752 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -96.3 -57.31 2.36 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 109.393 -0.595 . . . . 10.0 109.393 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -105.81 -36.16 2.84 Favored Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 110.805 -0.918 . . . . 10.0 110.805 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.67 68.3 0.46 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.647 -0.787 . . . . 10.0 112.25 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -156.14 -179.27 7.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.8 0.333 . . . . 10.0 111.33 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -122.73 136.88 55.01 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.422 -0.584 . . . . 10.0 109.422 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -165.98 122.34 1.33 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.799 0.333 . . . . 10.0 111.775 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -86.12 149.54 25.06 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.071 -0.513 . . . . 10.0 110.297 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.9 mm -103.42 110.53 30.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.363 -0.38 . . . . 10.0 112.01 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -108.34 165.73 11.29 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.612 -0.514 . . . . 10.0 109.612 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -57.22 -27.06 61.67 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.999 0.74 . . . . 10.0 112.999 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -103.03 -1.24 29.57 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.103 0.409 . . . . 10.0 112.103 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 132.29 -160.92 23.84 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.957 -0.64 . . . . 10.0 111.745 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 60.4 mp0 -69.45 128.03 35.1 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.821 -0.437 . . . . 10.0 109.821 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.7 -95.35 0.2 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.936 0.717 . . . . 10.0 112.936 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -98.56 166.31 11.41 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.173 0.511 . . . . 10.0 112.232 -178.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.8 t -148.51 150.21 32.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.674 -0.694 . . . . 10.0 109.907 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.5 ' CE2' ' C6 ' ' A' ' 627' ' ' MRP . 15.5 m-85 -89.09 -43.83 10.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.942 -0.572 . . . . 10.0 111.11 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 174.23 -141.2 5.81 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.7 -0.762 . . . . 10.0 111.763 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -135.48 166.06 24.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.736 0.303 . . . . 10.0 111.001 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 65.4 mt -109.76 133.53 54.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.742 -0.466 . . . . 10.0 109.742 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.0 mmt180 -83.12 -54.08 5.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.583 -0.28 . . . . 10.0 110.596 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.6 mtpm? -150.43 147.66 27.81 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.347 -0.388 . . . . 10.0 111.294 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -119.99 82.91 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.517 -0.765 . . . . 10.0 109.728 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -92.33 68.23 4.96 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.772 -0.649 . . . . 10.0 111.191 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 56.11 177.78 0.04 OUTLIER Pre-proline 0 N--CA 1.474 0.731 0 O-C-N 123.922 0.764 . . . . 10.0 112.078 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -71.31 47.36 0.82 Allowed 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.141 1.894 . . . . 10.0 111.532 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -135.82 -43.84 0.66 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.96 -0.564 . . . . 10.0 110.979 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.5 m -129.75 125.89 36.92 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.383 -0.371 . . . . 10.0 110.556 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 27.2 tp -136.5 128.62 29.68 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.487 -0.324 . . . . 10.0 110.773 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.2 t -121.08 123.21 69.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.936 -0.764 . . . . 10.0 108.936 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.8 pt -133.79 168.14 24.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 112.445 0.535 . . . . 10.0 112.445 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -135.2 130.39 5.42 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 110.549 -1.02 . . . . 10.0 110.549 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -106.36 156.91 18.03 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 112.741 0.645 . . . . 10.0 112.741 -178.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 43.6 mtp180 -100.79 -164.76 1.14 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.481 -0.781 . . . . 10.0 109.402 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.2 pp -139.26 161.22 37.97 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.63 0.252 . . . . 10.0 111.431 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -77.54 -160.39 0.18 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.117 -0.492 . . . . 10.0 111.794 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 120.8 135.89 4.97 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.988 -0.845 . . . . 10.0 110.988 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -93.85 -85.92 0.28 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.761 0.315 . . . . 10.0 111.222 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -82.66 67.93 3.64 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.972 -0.632 . . . . 10.0 112.005 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.83 151.71 38.35 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.57 0.224 . . . . 10.0 110.555 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 6.2 tp -62.73 144.67 14.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.718 -0.475 . . . . 10.0 109.718 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -52.39 130.82 43.69 Favored Pre-proline 0 C--N 1.331 -0.234 0 O-C-N 123.255 0.347 . . . . 10.0 111.061 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.88 89.89 0.24 Allowed 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 123.0 2.466 . . . . 10.0 112.776 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -87.77 71.77 9.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.999 -0.546 . . . . 10.0 110.231 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -162.12 -70.57 0.05 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.693 -0.685 . . . . 10.0 109.772 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.8 m 70.77 161.61 0.23 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.285 -0.871 . . . . 10.0 112.69 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.5 m -117.28 133.7 55.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.077 -0.51 . . . . 10.0 110.554 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -93.65 147.32 23.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.128 -0.487 . . . . 10.0 110.881 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -139.48 136.81 34.97 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 123.275 0.359 . . . . 10.0 110.507 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.4 m -101.91 123.01 45.11 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.662 -0.495 . . . . 10.0 109.662 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 95.5 t -107.87 121.95 61.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.189 -0.46 . . . . 10.0 110.948 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.68 129.07 56.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.267 -0.424 . . . . 10.0 110.781 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -101.41 125.45 48.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.812 0.339 . . . . 10.0 110.834 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 90.3 t -117.84 126.34 74.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.095 -0.502 . . . . 10.0 109.769 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -99.99 130.86 46.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.718 -0.219 . . . . 10.0 110.659 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -118.76 100.61 7.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.959 0.409 . . . . 10.0 111.164 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.423 ' C ' ' H ' ' A' ' 107' ' ' LYS . . . 69.05 12.35 65.13 Favored Glycine 0 CA--C 1.52 0.386 0 CA-C-N 116.042 -0.526 . . . . 10.0 113.381 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 68.31 -16.56 0.19 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.578 0.955 . . . . 10.0 113.578 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.423 ' H ' ' C ' ' A' ' 105' ' ' GLY . 46.2 pttt -99.82 -6.56 26.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.064 0.459 . . . . 10.0 111.483 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -136.48 147.84 47.37 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.056 -0.72 . . . . 10.0 109.056 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.83 146.81 47.9 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.272 0.558 . . . . 10.0 111.76 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -131.9 139.26 48.7 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.779 -0.646 . . . . 10.0 109.435 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.2 p -133.75 129.76 55.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-O 120.746 0.308 . . . . 10.0 111.005 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -125.93 155.79 40.75 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.25 -0.432 . . . . 10.0 111.534 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 48.6 t -115.98 127.97 73.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.828 -0.624 . . . . 10.0 109.61 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -127.25 136.97 52.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.35 -0.386 . . . . 10.0 111.671 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -175.99 155.31 1.58 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.857 -0.61 . . . . 10.0 111.347 178.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.4 m -160.14 91.89 0.97 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.772 -0.825 . . . . 10.0 108.772 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 179.01 -62.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 10.0 111.028 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -98.44 14.86 26.68 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.085 -0.507 . . . . 10.0 111.558 -178.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -98.25 -46.06 5.96 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.593 -0.731 . . . . 10.0 109.699 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -78.54 48.81 0.81 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.489 -0.778 . . . . 10.0 111.582 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 19.4 ptt? -146.25 18.22 1.38 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.918 -0.583 . . . . 10.0 109.624 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -74.23 -96.99 0.1 Allowed Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.591 -0.732 . . . . 10.0 112.789 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.1 m 55.24 -91.57 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 122.905 0.482 . . . . 10.0 111.573 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 35.9 pttt -74.04 -36.65 64.41 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.894 -0.41 . . . . 10.0 109.894 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 34.7 m170 -69.48 -24.17 63.74 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.957 -0.565 . . . . 10.0 110.603 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.0 -58.36 8.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.322 -0.854 . . . . 10.0 110.523 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -62.15 -33.07 73.79 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.098 -0.501 . . . . 10.0 111.048 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 30.5 mtp180 -65.06 -44.09 90.11 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.154 -0.476 . . . . 10.0 112.024 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 9.9 p -81.06 -30.83 11.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.849 0.357 . . . . 10.0 111.637 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 48.7 mtp180 -72.49 -4.38 30.1 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.083 0.468 . . . . 10.0 111.827 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -84.54 0.61 49.27 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.757 -0.656 . . . . 10.0 110.517 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -149.37 -53.8 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.584 -0.817 . . . . 10.0 112.988 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' MET . . . . . 0.426 ' CE ' ' CX ' ' A' ' 626' ' ' HIB . 0.8 OUTLIER -66.23 -37.81 86.43 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.183 0.809 . . . . 10.0 113.183 -178.588 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -63.55 -22.94 67.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.855 0.359 . . . . 10.0 111.624 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -80.9 38.76 0.47 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.998 0.428 . . . . 10.0 111.465 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 171.18 -34.88 0.16 Allowed Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.774 -0.727 . . . . 10.0 113.419 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 11.2 t90 -57.0 -63.07 4.03 Favored Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 113.541 0.941 . . . . 10.0 113.541 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -65.68 -29.79 51.25 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 121.279 1.32 . . . . 10.0 111.794 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.36 -43.75 76.73 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.799 -0.637 . . . . 10.0 111.493 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 11.2 tt -70.37 -32.55 50.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.561 -0.29 . . . . 10.0 111.461 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 70.6 mt -61.52 -45.76 92.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.039 0.447 . . . . 10.0 111.175 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -67.68 -40.99 84.38 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.713 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 15.2 m -67.37 -35.47 79.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.803 -0.635 . . . . 10.0 111.598 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -59.55 -44.6 93.2 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.842 0.353 . . . . 10.0 111.024 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -58.63 -49.56 77.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.856 -0.611 . . . . 10.0 110.947 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -65.64 -36.02 82.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.062 -0.517 . . . . 10.0 111.796 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -62.03 -53.65 52.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.934 -0.576 . . . . 10.0 110.766 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 57.3 mt -65.84 -34.71 72.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.029 -0.532 . . . . 10.0 110.044 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -61.78 -40.94 96.94 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.107 -0.497 . . . . 10.0 109.93 178.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -70.89 -42.59 69.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.326 -0.397 . . . . 10.0 111.391 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -79.63 26.79 0.3 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.782 0.325 . . . . 10.0 111.798 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -155.28 -60.4 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.552 -0.832 . . . . 10.0 113.199 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -99.21 -48.16 4.93 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.839 0.681 . . . . 10.0 112.839 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -60.95 -42.81 98.95 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.291 0.478 . . . . 10.0 112.291 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 77.9 mttt . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.357 -0.83 . . . . 10.0 110.223 179.454 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 621' ' ' DAG . . . . . 1.143 ' O1 ' ' C1 ' ' A' ' 629' ' ' MTC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 625' ' ' DSR . . . . . 1.45 ' S4 ' ' C7 ' ' A' ' 626' ' ' HIB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 626' ' ' HIB . . . . . 1.45 ' C7 ' ' S4 ' ' A' ' 625' ' ' DSR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 627' ' ' MRP . . . . . 1.439 ' O1 ' ' C2 ' ' A' ' 626' ' ' HIB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 628' ' ' EMP . . . . . 0.74 ' C7 ' ' C5 ' ' A' ' 628' ' ' EMP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 629' ' ' MTC . . . . . 1.143 ' C1 ' ' O1 ' ' A' ' 621' ' ' DAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 . . . . . 0 N--CA 1.479 0.989 0 CA-C-O 120.463 0.173 . . . . 10.0 110.728 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . 0.283 11.8 p90 50.44 30.18 4.44 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 115.572 1.693 . . . . 10.0 115.572 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -165.65 -63.64 0.01 OUTLIER Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 111.995 0.369 . . . . 10.0 111.995 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -87.8 -31.86 0.19 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 121.77 1.647 . . . . 10.0 112.469 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -174.26 141.6 0.74 Allowed 'General case' 0 C--O 1.24 0.56 0 CA-C-N 115.533 -0.758 . . . . 10.0 109.436 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.6 p -100.79 127.16 54.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.113 0.482 . . . . 10.0 111.258 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -159.23 108.52 1.89 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.843 -0.617 . . . . 10.0 110.348 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -131.33 150.9 51.96 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.045 -0.525 . . . . 10.0 109.832 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.0 m -145.8 135.81 23.65 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.548 0.213 . . . . 10.0 111.084 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.0 t -121.52 132.89 69.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.052 -0.522 . . . . 10.0 109.639 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.97 122.25 39.75 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.501 -0.318 . . . . 10.0 110.746 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.2 t -131.04 141.89 44.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.017 -0.538 . . . . 10.0 109.801 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.497 ' HZ1' ' CG ' ' A' ' 149' ' ' ASP . 31.7 mttp -84.63 54.44 3.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.05 0.452 . . . . 10.0 110.555 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -123.26 -163.03 1.08 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.897 -0.592 . . . . 10.0 110.325 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -113.38 166.97 10.97 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.224 -0.444 . . . . 10.0 111.79 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 36.4 ttt180 -55.11 -38.32 68.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.552 -0.749 . . . . 10.0 112.419 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -74.35 -54.63 7.26 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.96 0.356 . . . . 10.0 111.96 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -52.11 -43.08 63.78 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 112.607 0.595 . . . . 10.0 112.607 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.13 -42.43 80.2 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.992 0.368 . . . . 10.0 111.992 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -69.31 -36.88 77.44 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.182 0.515 . . . . 10.0 111.283 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.3 mtpt -69.66 -32.28 70.84 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 113.265 0.839 . . . . 10.0 113.265 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.28 -9.67 58.96 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.91 0.707 . . . . 10.0 112.91 -178.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -116.94 -19.63 9.73 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.923 0.712 . . . . 10.0 112.923 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.9 mp -120.55 10.77 11.18 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 114.33 1.234 . . . . 10.0 114.33 -178.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -155.64 -45.4 0.08 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.038 0.384 . . . . 10.0 112.038 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.99 104.24 2.2 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.492 -0.861 . . . . 10.0 111.262 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -109.15 -56.14 0.05 OUTLIER Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 112.338 0.496 . . . . 10.0 112.338 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -74.15 14.96 0.65 Allowed 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.261 1.974 . . . . 10.0 112.359 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.63 8.96 37.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.215 0.531 . . . . 10.0 110.034 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 40.8 m0 -87.68 -164.84 1.16 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.621 -0.718 . . . . 10.0 110.363 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 57.5 t90 -169.99 -50.62 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.513 0 CA-C-O 119.257 -0.402 . . . . 10.0 111.957 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -26.28 -55.41 0.09 OUTLIER 'Trans proline' 0 C--N 1.367 1.525 0 C-N-CA 125.154 3.903 . . . . 10.0 116.9 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -128.11 -41.43 1.6 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.694 0.627 . . . . 10.0 112.694 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -77.95 93.87 4.5 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.372 0.605 . . . . 10.0 111.613 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -101.07 0.65 38.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.325 -0.852 . . . . 10.0 111.408 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.3 mtp180 -119.96 -160.18 0.81 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.737 0.303 . . . . 10.0 111.077 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.21 155.47 46.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.253 -0.43 . . . . 10.0 110.567 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . 0.267 9.8 p 67.66 -65.36 0.24 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 114.484 1.29 . . . . 10.0 114.484 178.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -74.81 -10.6 59.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.957 0.408 . . . . 10.0 111.006 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.4 p -173.85 89.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.34 -0.845 . . . . 10.0 109.971 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.69 68.49 0.55 Allowed Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.714 -0.675 . . . . 10.0 111.958 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.06 158.55 41.42 Favored Pre-proline 0 C--N 1.322 -0.591 0 O-C-N 122.656 -0.32 . . . . 10.0 110.799 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -59.44 -28.35 87.32 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.763 2.308 . . . . 10.0 113.144 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 19.0 mt -95.29 -89.0 0.25 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.801 0.334 . . . . 10.0 111.058 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.25 -55.16 5.02 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.928 -0.653 . . . . 10.0 112.824 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.8 t -105.01 132.06 52.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.745 0.307 . . . . 10.0 111.087 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -100.38 118.33 36.4 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.974 -0.557 . . . . 10.0 109.638 178.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.7 pttt -106.13 6.46 30.99 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.958 -0.565 . . . . 10.0 112.351 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.7 pttt -92.65 -24.1 18.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.861 0.362 . . . . 10.0 110.112 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -131.21 -60.02 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 111.269 -0.732 . . . . 10.0 111.269 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 135.02 71.34 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.716 -0.754 . . . . 10.0 112.363 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -159.77 168.5 25.74 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.75 -0.265 . . . . 10.0 110.65 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 43.1 m95 -116.02 135.62 53.79 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.601 -0.889 . . . . 10.0 108.601 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -165.77 122.64 1.41 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.332 0.493 . . . . 10.0 112.332 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -82.17 138.49 34.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.026 -0.534 . . . . 10.0 109.852 178.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 48.1 mm -98.46 124.75 51.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.284 -0.416 . . . . 10.0 110.279 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -120.94 168.4 11.53 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.385 -0.37 . . . . 10.0 110.243 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -62.16 -29.3 70.26 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 122.829 0.452 . . . . 10.0 110.923 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -86.88 -9.59 55.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.28 -0.418 . . . . 10.0 111.463 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 138.59 -103.51 0.4 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.616 -0.802 . . . . 10.0 112.019 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -117.5 154.97 30.54 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.802 0.334 . . . . 10.0 110.892 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -118.29 -146.35 0.39 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.932 -0.576 . . . . 10.0 111.158 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -67.5 172.64 4.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.338 0.59 . . . . 10.0 112.58 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.3 t -147.41 144.19 28.48 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.632 -0.713 . . . . 10.0 110.412 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.95 ' CE1' ' C6 ' ' A' ' 632' ' ' MRP . 75.5 m-85 -84.49 -38.74 19.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.111 -0.495 . . . . 10.0 111.151 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 171.27 -145.51 8.91 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.795 -0.717 . . . . 10.0 111.978 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.0 pp -140.47 161.93 36.55 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.731 0.3 . . . . 10.0 110.942 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 55.0 mt -106.44 123.4 61.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.803 -0.814 . . . . 10.0 108.803 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.3 ttm180 -93.09 -27.67 16.81 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.592 -0.276 . . . . 10.0 111.361 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.2 tptm -157.05 131.16 8.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.994 0.426 . . . . 10.0 111.84 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.0 102.96 8.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.427 -0.806 . . . . 10.0 108.901 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -118.54 78.93 1.31 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.566 -0.288 . . . . 10.0 110.794 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 55.4 178.7 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.663 0 O-C-N 123.971 0.794 . . . . 10.0 111.718 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -71.55 48.69 1.04 Allowed 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 121.955 1.77 . . . . 10.0 111.569 177.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -134.96 -55.52 0.82 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.306 -0.406 . . . . 10.0 111.088 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.0 m -113.23 119.18 36.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.159 -0.473 . . . . 10.0 110.753 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 59.7 tp -129.05 119.65 24.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.13 -0.486 . . . . 10.0 110.937 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 51.2 t -118.91 116.36 50.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.652 -0.499 . . . . 10.0 109.652 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 pp -133.95 161.99 40.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.353 -0.385 . . . . 10.0 111.943 -178.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -129.08 141.79 12.91 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 110.5 -1.04 . . . . 10.0 110.5 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -105.32 166.21 10.58 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.388 0.514 . . . . 10.0 112.388 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 46.7 mtp180 -104.87 -168.76 1.52 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.802 -0.635 . . . . 10.0 110.53 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.29 150.65 51.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.786 -0.643 . . . . 10.0 111.18 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -87.85 -168.49 2.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.883 -0.599 . . . . 10.0 110.529 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.709 ' O ' ' O3 ' ' A' ' 630' ' ' DSR . . . 131.73 157.58 8.77 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.828 -0.701 . . . . 10.0 112.915 179.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.715 ' O ' ' C6 ' ' A' ' 622' ' ' DAG . 62.6 m-85 -104.98 -85.83 0.47 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.23 0.538 . . . . 10.0 110.046 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -88.73 81.0 1.56 Allowed Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 111.232 -0.747 . . . . 10.0 111.232 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 5.5 ptt85 -141.94 175.53 9.65 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.624 0.249 . . . . 10.0 110.592 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.446 ' CG1' ' H ' ' A' ' 90' ' ' ASP . 10.3 tt -83.21 -174.64 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.011 -0.54 . . . . 10.0 110.612 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.446 ' H ' ' CG1' ' A' ' 89' ' ' ILE . 29.2 t70 -59.8 141.48 89.16 Favored Pre-proline 0 C--N 1.331 -0.236 0 C-N-CA 123.134 0.574 . . . . 10.0 110.972 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -69.37 60.05 1.46 Allowed 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.135 2.557 . . . . 10.0 113.142 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -82.03 92.75 6.85 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.249 0.547 . . . . 10.0 110.714 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -164.41 -69.2 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.761 -0.654 . . . . 10.0 110.21 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.2 m 66.14 90.78 0.09 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.077 0.769 . . . . 10.0 113.077 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.2 m -88.91 107.69 19.14 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.48 -0.563 . . . . 10.0 109.48 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -91.03 151.94 20.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.996 0.427 . . . . 10.0 111.914 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -140.54 142.64 35.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.212 -0.904 . . . . 10.0 109.881 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.7 m -102.23 125.51 48.95 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.582 -0.281 . . . . 10.0 110.446 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.4 t -107.3 126.12 63.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.836 -0.62 . . . . 10.0 110.827 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -112.4 134.39 53.96 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.226 -0.443 . . . . 10.0 110.652 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -102.43 123.63 46.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.27 -0.423 . . . . 10.0 111.532 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.8 t -119.8 119.69 61.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.154 -0.475 . . . . 10.0 109.737 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -104.07 136.07 44.39 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.809 0.338 . . . . 10.0 110.818 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -127.27 115.69 19.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.005 -0.543 . . . . 10.0 111.187 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.34 6.11 52.45 Favored Glycine 0 CA--C 1.518 0.261 0 CA-C-N 115.915 -0.584 . . . . 10.0 112.886 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 67.47 -3.15 1.13 Allowed 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.915 0.709 . . . . 10.0 112.915 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.2 ptmt -119.24 6.21 11.22 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.196 0.522 . . . . 10.0 111.605 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -140.06 132.58 28.66 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.167 -0.679 . . . . 10.0 109.167 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.8 m -117.72 130.37 56.28 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.397 0.517 . . . . 10.0 112.397 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -118.85 113.3 20.86 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.088 -1.078 . . . . 10.0 108.088 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.8 p -113.35 133.93 57.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 C-N-CA 120.449 -0.5 . . . . 10.0 111.29 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -127.9 148.33 50.48 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.048 -0.524 . . . . 10.0 111.795 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.6 t -126.27 113.85 35.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 108.82 -0.807 . . . . 10.0 108.82 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -129.44 144.58 51.31 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.172 0.511 . . . . 10.0 112.094 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -163.55 162.86 24.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.416 -0.811 . . . . 10.0 109.021 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -157.57 77.87 0.85 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.701 0.286 . . . . 10.0 110.491 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -172.41 -67.39 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.296 -0.411 . . . . 10.0 111.919 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -81.57 -16.73 50.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.182 0.515 . . . . 10.0 111.579 -178.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -82.52 -16.8 47.32 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.828 -0.624 . . . . 10.0 110.67 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 77.8 mtt180 -91.65 32.2 1.12 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.181 0.438 . . . . 10.0 112.181 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 21.3 ptp -136.19 23.32 3.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.086 0.47 . . . . 10.0 110.129 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -73.22 -106.67 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.701 -0.681 . . . . 10.0 112.789 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.2 m 53.41 -87.79 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.634 0.605 . . . . 10.0 112.634 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -72.35 -35.61 68.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.838 0.352 . . . . 10.0 110.25 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -71.26 -31.99 68.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 10.0 110.883 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.6 -43.4 97.46 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.712 -0.676 . . . . 10.0 110.818 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -66.61 -37.15 84.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.934 -0.575 . . . . 10.0 111.02 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 45.9 mtp180 -69.31 -45.15 70.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 10.0 111.383 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.8 p -70.29 -20.42 22.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 112.205 0.446 . . . . 10.0 112.205 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 -66.64 -15.42 63.46 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 121.067 0.461 . . . . 10.0 111.057 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -71.59 -4.21 25.8 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.233 0.457 . . . . 10.0 112.233 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -152.81 -50.29 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 119.999 -1.096 . . . . 10.0 113.744 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -63.09 -42.71 99.67 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.207 0.817 . . . . 10.0 113.207 -178.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -71.89 -3.03 20.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.179 0.514 . . . . 10.0 111.853 -179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -98.24 19.42 14.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.272 -0.422 . . . . 10.0 111.3 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.501 ' CA ' ' C7 ' ' A' ' 632' ' ' MRP . . . -175.08 -35.3 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 119.765 -1.207 . . . . 10.0 113.806 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -56.55 -58.05 19.52 Favored Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 113.457 0.91 . . . . 10.0 113.457 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.87 -41.23 46.97 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.118 1.879 . . . . 10.0 112.038 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.05 -38.18 87.69 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 116.045 -0.525 . . . . 10.0 111.04 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -65.34 -39.67 86.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.163 -0.471 . . . . 10.0 111.669 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 93.4 mt -64.69 -35.59 81.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.498 -0.319 . . . . 10.0 111.275 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -80.4 -32.56 37.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.138 -0.483 . . . . 10.0 112.239 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 2.8 p -75.5 -34.6 60.85 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.987 -0.285 . . . . 10.0 111.368 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -61.13 -37.9 84.47 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.856 0.36 . . . . 10.0 111.27 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -56.76 -54.96 40.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.707 -0.678 . . . . 10.0 111.627 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -61.45 -37.08 82.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.455 -0.339 . . . . 10.0 111.616 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 48.6 tttp -64.9 -55.34 19.91 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.18 0.437 . . . . 10.0 112.18 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 32.7 mt -66.96 -38.38 81.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.722 0.296 . . . . 10.0 111.573 -178.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.497 ' CG ' ' HZ1' ' A' ' 13' ' ' LYS . 1.8 t70 -65.17 -35.32 80.72 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-O 121.357 0.599 . . . . 10.0 109.915 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -67.96 -48.38 66.04 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.391 -0.822 . . . . 10.0 109.724 178.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -79.89 56.97 2.46 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.038 -0.528 . . . . 10.0 110.879 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -177.82 -51.95 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.743 -0.662 . . . . 10.0 112.299 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -126.06 -45.37 1.72 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.332 0.493 . . . . 10.0 112.332 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -60.94 -35.6 77.15 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.496 0.554 . . . . 10.0 112.496 -178.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt . . . . . 0 C--O 1.252 1.213 0 CA-C-O 118.427 -0.797 . . . . 10.0 110.106 179.881 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 622' ' ' DAG . . . . . 1.152 ' O1 ' ' C1 ' ' A' ' 634' ' ' MTC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 630' ' ' DSR . . . . . 1.44 ' S4 ' ' C7 ' ' A' ' 631' ' ' HIB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 631' ' ' HIB . . . . . 1.457 ' C2 ' ' O1 ' ' A' ' 632' ' ' MRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 632' ' ' MRP . . . . . 1.457 ' O1 ' ' C2 ' ' A' ' 631' ' ' HIB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 633' ' ' EMP . . . . . 0.727 ' C7 ' ' C5 ' ' A' ' 633' ' ' EMP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 634' ' ' MTC . . . . . 1.152 ' C1 ' ' O1 ' ' A' ' 622' ' ' DAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 110.703 -0.11 . . . . 10.0 110.703 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . 0.365 17.6 p90 63.63 -50.49 0.24 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 116.27 1.952 . . . . 10.0 116.27 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -74.47 -61.61 1.13 Allowed Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 112.886 0.699 . . . . 10.0 112.886 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -80.5 -32.64 1.17 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.292 1.995 . . . . 10.0 111.949 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -176.94 152.5 0.93 Allowed 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.346 -0.843 . . . . 10.0 109.648 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.5 p -101.54 138.58 25.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.021 0.438 . . . . 10.0 111.32 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -171.0 104.63 0.23 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.376 -0.829 . . . . 10.0 110.043 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 72.1 m-70 -131.04 157.21 43.63 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.06 -0.348 . . . . 10.0 110.06 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.2 140.27 25.19 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.442 0.534 . . . . 10.0 112.442 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.9 t -123.45 143.4 36.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 108.91 -0.774 . . . . 10.0 108.91 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.8 m -111.26 105.46 14.13 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.082 0.468 . . . . 10.0 111.991 -178.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 89.2 t -85.97 114.91 26.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.081 -0.509 . . . . 10.0 110.515 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt -98.74 57.95 1.16 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.213 0.53 . . . . 10.0 111.124 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -147.91 -83.26 0.11 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.556 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -163.47 157.99 20.42 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.725 -0.472 . . . . 10.0 109.725 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.7 ttt180 -66.99 -37.39 84.13 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.614 0.598 . . . . 10.0 112.614 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -70.59 -41.08 72.81 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.059 0.392 . . . . 10.0 112.059 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.97 -36.63 84.11 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.818 0.303 . . . . 10.0 111.818 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.58 -44.39 94.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.143 0.497 . . . . 10.0 110.233 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -67.35 -38.71 85.28 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.7 -0.682 . . . . 10.0 110.316 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.0 mmtt -66.17 -43.61 86.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.66 -0.7 . . . . 10.0 112.683 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.4 p -73.24 -26.34 61.08 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.09 0.774 . . . . 10.0 113.09 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -84.16 -34.4 24.04 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.03 0.752 . . . . 10.0 113.03 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.0 mp -102.36 -33.05 9.72 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.842 1.053 . . . . 10.0 113.842 -178.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -124.53 42.42 3.26 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.289 0.477 . . . . 10.0 112.289 -178.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -145.18 30.16 1.77 Allowed Glycine 0 C--O 1.228 -0.254 0 C-N-CA 120.516 -0.849 . . . . 10.0 112.524 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -54.65 -56.36 28.01 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 113.366 0.876 . . . . 10.0 113.366 -179.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -82.94 28.35 0.58 Allowed 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 122.095 1.863 . . . . 10.0 112.376 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -124.0 9.39 8.72 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.2 0.524 . . . . 10.0 111.446 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 19.8 m0 -98.61 162.59 13.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.949 -0.569 . . . . 10.0 109.668 179.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -144.85 46.85 0.64 Allowed Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 112.307 0.484 . . . . 10.0 112.307 179.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -89.88 -45.82 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.364 2.043 . . . . 10.0 112.509 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -157.78 -32.3 0.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.113 0.482 . . . . 10.0 110.137 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -79.67 89.53 5.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.398 0.618 . . . . 10.0 111.168 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -99.73 -21.18 15.91 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.67 -0.695 . . . . 10.0 110.899 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -91.18 109.24 20.49 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.147 -0.479 . . . . 10.0 111.024 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.57 167.47 12.89 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.802 -0.636 . . . . 10.0 111.139 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.3 m 78.51 -62.8 0.32 Allowed 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.515 0.561 . . . . 10.0 112.515 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 17.1 mmtm -76.16 -24.72 54.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.863 0.363 . . . . 10.0 111.814 -179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.4 p -163.21 91.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.77 0.795 . . . . 10.0 110.543 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 126.51 47.61 0.2 Allowed Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.477 -0.783 . . . . 10.0 111.753 -178.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.58 158.71 86.25 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 120.621 0.248 . . . . 10.0 111.097 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -59.82 -20.46 59.33 Favored 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 122.677 2.252 . . . . 10.0 112.88 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.3 mp -98.74 -91.82 0.27 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.7 0.286 . . . . 10.0 110.579 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.85 -63.97 2.47 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.824 -0.703 . . . . 10.0 113.122 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.3 t -106.04 132.51 52.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 120.725 0.298 . . . . 10.0 110.996 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -95.31 125.77 40.16 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.398 -0.365 . . . . 10.0 110.355 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -103.51 10.61 37.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.286 -0.415 . . . . 10.0 110.972 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.0 mtmm -89.09 -54.51 4.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.669 0.271 . . . . 10.0 110.533 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -111.15 -29.83 3.36 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 111.101 -0.799 . . . . 10.0 111.101 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.26 80.32 1.4 Allowed Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.655 -0.783 . . . . 10.0 111.97 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -162.97 167.63 22.27 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.725 0.297 . . . . 10.0 110.505 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 60.0 m95 -107.33 134.52 50.27 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.883 -0.784 . . . . 10.0 108.883 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -164.22 120.05 1.56 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.053 0.454 . . . . 10.0 111.497 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -83.77 133.66 34.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.794 -0.639 . . . . 10.0 109.676 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.0 mm -96.14 111.27 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 116.069 -0.514 . . . . 10.0 110.823 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -106.62 163.49 12.85 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.921 -0.581 . . . . 10.0 109.597 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.38 -23.72 65.61 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.598 0.237 . . . . 10.0 110.514 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -87.42 -4.23 59.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.811 0.339 . . . . 10.0 110.775 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 134.1 -111.64 0.98 Allowed Glycine 0 CA--C 1.519 0.298 0 C-N-CA 121.209 -0.52 . . . . 10.0 112.482 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -115.76 137.24 52.28 Favored 'General case' 0 C--N 1.32 -0.676 0 O-C-N 122.41 -0.465 . . . . 10.0 110.759 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -97.45 -144.46 0.3 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.946 -0.57 . . . . 10.0 111.657 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 1.041 ' ND1' ' C9 ' ' A' ' 636' ' ' HIB . 3.3 p80 -75.07 -178.83 4.01 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 113.045 0.757 . . . . 10.0 113.045 -179.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.9 t -152.64 152.63 32.01 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.142 -0.936 . . . . 10.0 110.095 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 1.221 ' CE1' ' C6 ' ' A' ' 637' ' ' MRP . 98.5 m-85 -96.68 -22.1 17.21 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.475 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 154.12 -146.75 15.22 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 121.032 -0.604 . . . . 10.0 112.42 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.9 pp -132.73 169.24 16.98 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.776 0.322 . . . . 10.0 110.704 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 67.4 mt -109.03 127.13 65.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.095 -0.705 . . . . 10.0 109.095 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -77.83 -45.88 23.11 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.418 -0.356 . . . . 10.0 111.255 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.0 tttm -161.81 145.33 12.3 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.229 -0.441 . . . . 10.0 110.604 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -115.23 84.67 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.206 0.527 . . . . 10.0 110.478 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.26 61.95 5.92 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.982 -0.554 . . . . 10.0 111.161 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.44 ' C ' ' H ' ' A' ' 75' ' ' ASP . 3.8 pt-20 55.04 -179.01 0.03 OUTLIER Pre-proline 0 CA--C 1.547 0.841 0 O-C-N 123.871 0.732 . . . . 10.0 111.886 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -69.29 33.65 0.19 Allowed 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 122.203 1.935 . . . . 10.0 113.359 178.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.44 ' H ' ' C ' ' A' ' 73' ' ' GLU . 17.4 t70 -113.49 -56.46 2.4 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.639 0.257 . . . . 10.0 110.564 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.0 m -127.6 129.33 47.09 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.951 0.405 . . . . 10.0 110.594 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 28.9 tp -129.05 134.01 47.94 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.054 -0.521 . . . . 10.0 110.088 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.6 t -128.35 119.93 51.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.935 -0.394 . . . . 10.0 109.935 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 37.6 pt -133.57 167.7 25.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.719 0.295 . . . . 10.0 111.268 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -123.88 138.49 11.43 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 110.836 -0.905 . . . . 10.0 110.836 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -97.01 156.89 16.16 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.216 0.821 . . . . 10.0 113.216 -178.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.0 ttt180 -105.94 153.35 22.1 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.992 -1.004 . . . . 10.0 109.692 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.6 pp -98.84 170.6 8.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.647 0.26 . . . . 10.0 111.428 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -120.42 -173.05 2.49 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.44 -0.346 . . . . 10.0 110.84 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 134.45 147.01 5.51 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.4 -0.68 . . . . 10.0 111.4 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -83.29 -84.27 0.13 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.993 0.425 . . . . 10.0 110.73 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -87.03 92.73 1.83 Allowed Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.756 -0.735 . . . . 10.0 111.739 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.37 169.29 17.58 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.748 0.309 . . . . 10.0 110.723 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 8.9 tp -74.79 164.59 3.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.151 -0.477 . . . . 10.0 110.606 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.15 146.27 98.96 Favored Pre-proline 0 C--O 1.232 0.176 0 CA-C-O 120.748 0.309 . . . . 10.0 111.241 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -57.89 104.41 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 123.297 2.664 . . . . 10.0 113.914 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -106.77 -25.04 11.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.763 -0.653 . . . . 10.0 109.94 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -68.71 -77.71 0.08 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.514 -0.766 . . . . 10.0 111.134 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.9 m 69.07 161.57 0.21 Allowed 'General case' 0 CA--C 1.534 0.342 0 O-C-N 123.559 0.537 . . . . 10.0 112.216 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 16.1 m -144.34 124.84 13.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.449 -0.341 . . . . 10.0 111.229 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -100.69 153.04 19.76 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.151 -0.477 . . . . 10.0 110.222 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -139.15 147.03 41.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.667 -0.242 . . . . 10.0 110.914 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.18 126.36 42.31 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.363 -0.606 . . . . 10.0 109.363 179.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 39.0 t -116.97 127.25 74.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.419 -0.355 . . . . 10.0 111.31 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.74 130.57 55.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.564 -0.289 . . . . 10.0 110.864 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -100.21 84.14 2.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.391 -0.368 . . . . 10.0 111.109 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 34.6 t -85.66 111.09 20.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 110.01 -0.367 . . . . 10.0 110.01 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -102.82 137.72 40.66 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.734 0.302 . . . . 10.0 111.347 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -124.95 125.95 44.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.998 -0.546 . . . . 10.0 109.616 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 78.3 6.5 87.81 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.743 -0.742 . . . . 10.0 111.881 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 63.36 20.8 12.47 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.685 0.624 . . . . 10.0 112.685 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 16.6 pttt -140.95 -51.95 0.46 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.108 -0.496 . . . . 10.0 110.685 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -82.7 100.2 10.09 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.256 -0.646 . . . . 10.0 109.256 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.2 m -103.25 115.64 30.95 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.774 -0.648 . . . . 10.0 111.268 -178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 64.1 mtt180 -102.67 105.72 16.24 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.036 -0.529 . . . . 10.0 110.14 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.8 p -92.2 123.74 44.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.844 -0.617 . . . . 10.0 110.806 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -114.41 145.44 41.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.021 -0.536 . . . . 10.0 111.483 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.1 t -123.21 122.38 65.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.797 -0.638 . . . . 10.0 109.527 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -135.68 155.51 50.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.206 0.527 . . . . 10.0 112.001 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -177.88 157.44 1.17 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.203 -0.908 . . . . 10.0 108.696 178.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.1 m -156.71 86.07 0.98 Allowed 'General case' 0 C--O 1.237 0.417 0 N-CA-C 109.825 -0.435 . . . . 10.0 109.825 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -177.02 -64.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.021 -0.536 . . . . 10.0 111.197 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -90.07 2.41 55.26 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.276 -0.42 . . . . 10.0 111.919 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.401 ' C ' ' H ' ' A' ' 121' ' ' MET . 19.7 p-10 -90.12 -38.67 13.37 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.177 -0.465 . . . . 10.0 110.827 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -75.63 18.49 0.23 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.766 0.654 . . . . 10.0 112.766 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.401 ' H ' ' C ' ' A' ' 119' ' ' ASP . 23.7 ptt? -118.15 13.67 13.84 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.518 -0.549 . . . . 10.0 109.518 178.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -77.6 -111.77 0.17 Allowed Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.611 -0.722 . . . . 10.0 113.394 -178.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.5 m 56.36 -92.17 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.48 0.312 . . . . 10.0 111.225 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.33 -31.06 70.2 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.62 -0.511 . . . . 10.0 109.62 178.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 7.5 m170 -72.24 -42.2 65.95 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.823 -0.626 . . . . 10.0 109.71 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -66.24 -38.87 88.91 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.757 -0.656 . . . . 10.0 110.04 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -60.03 -31.85 70.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.621 -0.718 . . . . 10.0 110.989 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.78 -43.64 19.81 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.1 -0.5 . . . . 10.0 111.501 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 4.6 p -71.02 -23.37 23.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 112.13 0.419 . . . . 10.0 112.13 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -69.67 -4.59 20.18 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.003 0.372 . . . . 10.0 112.003 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -71.12 -27.54 63.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.867 0.365 . . . . 10.0 110.761 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -133.66 -30.23 0.45 Allowed Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.148 -1.025 . . . . 10.0 114.163 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 12.8 tpt -79.11 -29.87 43.45 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 117.358 0.579 . . . . 10.0 112.012 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -69.14 -9.54 53.32 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.14 -0.482 . . . . 10.0 111.858 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -95.76 -7.49 37.05 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.214 0.45 . . . . 10.0 112.214 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -131.54 -39.78 0.24 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 119.794 -1.193 . . . . 10.0 114.362 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 22.5 t90 -53.11 -59.6 8.72 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 113.781 1.03 . . . . 10.0 113.781 -178.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.17 -36.42 21.58 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 121.551 1.501 . . . . 10.0 112.705 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.8 -41.41 91.97 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.111 -0.495 . . . . 10.0 111.645 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.2 mp -64.97 -41.27 91.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.166 -0.47 . . . . 10.0 111.586 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 96.1 mt -59.1 -47.71 84.25 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.259 -0.428 . . . . 10.0 111.478 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -63.46 -40.19 96.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.984 -0.553 . . . . 10.0 111.057 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 21.7 m -66.32 -43.65 85.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.08 -0.509 . . . . 10.0 111.307 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -63.96 -39.33 93.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.542 -0.299 . . . . 10.0 110.556 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -58.68 -34.59 71.44 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 123.8 0.687 . . . . 10.0 111.074 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -87.96 -35.52 17.6 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.332 0.493 . . . . 10.0 112.332 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -61.79 -50.86 70.64 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 111.616 0.228 . . . . 10.0 111.616 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 48.6 mt -63.81 -32.3 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.18 0.515 . . . . 10.0 110.644 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -73.39 -39.16 65.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.964 -0.562 . . . . 10.0 109.773 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -64.03 -53.32 51.84 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.883 -0.598 . . . . 10.0 109.851 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -87.08 56.87 4.19 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.38 -0.827 . . . . 10.0 110.78 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 175.14 -43.28 0.12 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.041 -1.076 . . . . 10.0 113.317 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -109.55 -49.65 3.08 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.103 0.408 . . . . 10.0 112.103 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 22.0 mttp -65.23 -55.3 19.23 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.791 0.329 . . . . 10.0 110.798 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.024 -0.988 . . . . 10.0 109.705 179.793 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 623' ' ' DAG . . . . . 1.147 ' O1 ' ' C1 ' ' A' ' 639' ' ' MTC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 635' ' ' DSR . . . . . 1.46 ' S4 ' ' C7 ' ' A' ' 636' ' ' HIB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 636' ' ' HIB . . . . . 1.46 ' C7 ' ' S4 ' ' A' ' 635' ' ' DSR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 637' ' ' MRP . . . . . 1.438 ' O1 ' ' C2 ' ' A' ' 636' ' ' HIB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 638' ' ' EMP . . . . . 0.742 ' C7 ' ' C5 ' ' A' ' 638' ' ' EMP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 639' ' ' MTC . . . . . 1.147 ' C1 ' ' O1 ' ' A' ' 623' ' ' DAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 120.428 0.156 . . . . 10.0 110.806 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . 0.286 0.2 OUTLIER 47.84 -107.18 0.18 Allowed 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 115.899 1.815 . . . . 10.0 115.899 179.606 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -48.54 -64.31 1.18 Allowed Pre-proline 0 N--CA 1.475 0.821 0 N-CA-C 115.353 1.612 . . . . 10.0 115.353 -177.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -51.34 -48.0 23.32 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.458 2.105 . . . . 10.0 112.84 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 51.8 p90 178.66 153.33 0.36 Allowed 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.705 -0.68 . . . . 10.0 109.705 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.9 p -107.27 96.3 4.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.323 0.582 . . . . 10.0 111.304 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -136.57 105.31 5.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.867 -0.606 . . . . 10.0 110.247 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 28.3 m-70 -121.18 152.28 38.97 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.316 -0.402 . . . . 10.0 110.044 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.9 m -140.38 133.28 29.19 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.607 0.241 . . . . 10.0 111.083 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.7 t -123.32 140.45 46.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 109.374 -0.602 . . . . 10.0 109.374 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.1 m -107.93 112.31 24.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.058 0.456 . . . . 10.0 110.91 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.3 t -98.94 132.8 43.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 116.299 -0.41 . . . . 10.0 110.178 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.2 mtmt -115.45 88.16 2.82 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.749 0.309 . . . . 10.0 111.676 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -172.54 -82.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.702 -0.681 . . . . 10.0 109.471 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -168.65 -178.91 3.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.009 -0.541 . . . . 10.0 110.152 178.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 50.2 ttt180 -76.25 -35.58 58.89 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.283 0.475 . . . . 10.0 112.283 -178.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -71.5 -46.58 59.34 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.474 0.546 . . . . 10.0 112.474 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.95 -46.62 75.02 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.031 0.382 . . . . 10.0 112.031 -179.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.93 -46.53 88.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.357 -0.383 . . . . 10.0 111.456 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -67.64 -37.49 82.51 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.309 -0.405 . . . . 10.0 111.613 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.8 mmtt -68.2 -44.65 75.34 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 111.921 0.341 . . . . 10.0 111.921 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.2 p -67.36 -28.17 67.73 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.362 0.505 . . . . 10.0 112.362 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -93.29 7.33 44.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.702 0.286 . . . . 10.0 111.618 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.0 tp -128.26 -55.86 1.25 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.454 0.539 . . . . 10.0 112.454 -178.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -108.82 -12.35 14.92 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.077 0.399 . . . . 10.0 112.077 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.51 86.83 1.5 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.652 -0.785 . . . . 10.0 111.725 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.414 ' C ' ' H ' ' A' ' 29' ' ' GLU . 1.5 m-85 -111.66 -55.6 0.04 OUTLIER Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 112.731 0.641 . . . . 10.0 112.731 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -75.74 27.85 0.39 Allowed 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.273 1.982 . . . . 10.0 112.577 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.414 ' H ' ' C ' ' A' ' 27' ' ' PHE . 8.4 pt-20 -120.48 0.62 10.55 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.318 -0.401 . . . . 10.0 110.762 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 39.7 m0 -76.72 165.07 25.24 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.322 -0.621 . . . . 10.0 109.322 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -146.07 -58.39 0.02 OUTLIER Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 112.585 0.587 . . . . 10.0 112.585 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.31 52.58 2.8 Favored 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 122.068 1.845 . . . . 10.0 112.498 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -170.0 -67.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.978 -0.555 . . . . 10.0 110.659 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -111.82 122.83 48.84 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.334 0.588 . . . . 10.0 111.549 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -112.96 4.75 16.93 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.735 -0.666 . . . . 10.0 110.779 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -133.08 105.08 6.85 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.721 0.296 . . . . 10.0 111.198 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.06 166.19 14.29 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.117 -0.492 . . . . 10.0 110.302 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.1 m 75.46 -47.35 0.59 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 122.91 0.484 . . . . 10.0 111.562 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.1 -30.64 27.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.1 0.476 . . . . 10.0 109.896 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.8 p -161.81 104.19 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 115.301 -0.863 . . . . 10.0 109.343 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.83 62.24 0.56 Allowed Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.939 -0.864 . . . . 10.0 110.939 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.403 ' CB ' ' H ' ' A' ' 56' ' ' ILE . . . -81.31 168.08 27.2 Favored Pre-proline 0 C--N 1.321 -0.669 0 C-N-CA 122.407 0.283 . . . . 10.0 110.896 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -74.74 45.58 1.32 Allowed 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 122.979 2.452 . . . . 10.0 112.963 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 27.4 tp -160.69 -86.85 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.744 -0.465 . . . . 10.0 109.744 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.65 -69.71 3.25 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.93 -0.652 . . . . 10.0 112.991 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.8 t -103.14 134.9 42.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.002 0.43 . . . . 10.0 111.461 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -103.26 112.29 25.1 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.421 -0.585 . . . . 10.0 109.421 178.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.61 23.2 8.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.754 -0.657 . . . . 10.0 111.02 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.5 mttp -99.65 -54.29 2.96 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.94 -0.763 . . . . 10.0 108.94 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -108.55 -21.96 7.3 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.309 -0.86 . . . . 10.0 112.085 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.3 67.43 0.9 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.747 -0.739 . . . . 10.0 112.082 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -151.48 173.87 14.06 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 122.654 -0.321 . . . . 10.0 110.361 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 35.6 m95 -123.79 132.21 53.74 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.402 -0.962 . . . . 10.0 108.402 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -163.29 132.16 3.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.23 0.538 . . . . 10.0 112.142 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -90.01 152.55 21.13 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.379 -0.828 . . . . 10.0 110.046 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.403 ' H ' ' CB ' ' A' ' 42' ' ' ALA . 41.5 mm -107.07 123.78 62.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.292 -0.413 . . . . 10.0 110.528 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -127.13 166.01 18.47 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.973 -0.751 . . . . 10.0 108.973 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -64.15 -26.81 68.69 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.681 0.277 . . . . 10.0 111.629 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -88.4 -5.34 58.34 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.948 0.404 . . . . 10.0 111.066 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 135.18 -105.85 0.56 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.976 -0.631 . . . . 10.0 112.697 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.9 mp0 -115.55 140.2 49.38 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.728 0.299 . . . . 10.0 110.563 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -93.87 -135.26 0.18 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.367 -0.379 . . . . 10.0 110.809 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.645 ' ND1' ' C9 ' ' A' ' 641' ' ' HIB . 3.4 p80 -79.56 170.48 16.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.098 0.475 . . . . 10.0 111.601 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.4 t -145.11 132.54 20.72 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.027 -0.533 . . . . 10.0 110.652 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.963 ' CE1' ' C6 ' ' A' ' 642' ' ' MRP . 78.1 m-85 -72.83 -32.89 65.81 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.114 -0.494 . . . . 10.0 111.016 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 162.24 -143.32 8.66 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 121.171 -0.538 . . . . 10.0 112.558 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -137.73 168.92 18.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.78 0.324 . . . . 10.0 110.772 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 58.7 mt -106.48 141.13 22.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.968 -0.382 . . . . 10.0 109.968 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -93.06 -44.15 8.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.958 -0.564 . . . . 10.0 110.809 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.3 tttt -157.43 146.63 19.95 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.088 -0.505 . . . . 10.0 110.572 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.08 75.46 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.847 -0.615 . . . . 10.0 110.008 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -86.57 69.42 10.36 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.564 -0.744 . . . . 10.0 111.23 -178.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 54.55 178.29 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.681 0 CA-C-N 115.357 -0.838 . . . . 10.0 112.0 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -72.17 49.49 1.35 Allowed 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 122.008 1.805 . . . . 10.0 110.845 177.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -137.66 -50.53 0.61 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.923 -0.58 . . . . 10.0 110.647 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.7 m -118.39 109.24 16.03 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.769 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 28.6 tp -117.42 126.89 53.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.125 -0.489 . . . . 10.0 110.469 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.5 t -128.04 115.7 39.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-N 116.35 -0.386 . . . . 10.0 110.249 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 31.8 pt -131.08 166.35 28.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.795 0.331 . . . . 10.0 111.543 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -127.27 125.65 5.34 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.393 -0.683 . . . . 10.0 111.393 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -93.1 156.71 16.7 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.606 0.241 . . . . 10.0 110.873 -179.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 50.4 mtp180 -106.5 178.4 4.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.096 -0.502 . . . . 10.0 110.774 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.35 151.97 32.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.323 -0.399 . . . . 10.0 111.374 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -88.73 -165.46 1.34 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.165 -0.471 . . . . 10.0 110.887 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 131.18 156.37 8.48 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 121.091 -0.576 . . . . 10.0 112.067 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -101.66 -86.38 0.41 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.673 0.273 . . . . 10.0 110.611 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -84.44 58.0 5.01 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 121.122 -0.561 . . . . 10.0 111.871 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -121.09 154.55 35.99 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.747 0.308 . . . . 10.0 110.923 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 11.9 tt -68.68 175.39 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 115.738 -0.665 . . . . 10.0 110.319 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -55.99 140.86 68.9 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.021 0.439 . . . . 10.0 111.662 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -85.85 61.41 5.15 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.918 2.412 . . . . 10.0 112.906 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -83.61 71.91 10.34 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.258 0.551 . . . . 10.0 110.45 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -152.29 -63.47 0.17 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.87 -0.789 . . . . 10.0 108.87 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.3 m 62.98 170.76 0.15 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.181 -0.918 . . . . 10.0 112.944 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.3 m -137.99 111.35 8.0 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.531 -0.544 . . . . 10.0 109.531 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.66 140.68 29.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.304 -0.407 . . . . 10.0 111.093 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -132.1 148.4 52.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.164 -0.471 . . . . 10.0 111.066 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.74 121.19 41.95 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.688 -0.486 . . . . 10.0 109.688 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 46.7 t -108.1 131.83 57.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.816 0.341 . . . . 10.0 111.233 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.8 m -118.77 139.89 50.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.024 -0.535 . . . . 10.0 110.287 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -112.97 109.04 18.2 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.35 -0.386 . . . . 10.0 111.181 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.3 t -114.88 110.41 31.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.073 0.463 . . . . 10.0 109.834 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -100.35 143.49 30.47 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.186 0.517 . . . . 10.0 111.508 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -125.83 109.94 13.11 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.741 -0.663 . . . . 10.0 109.32 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 78.96 13.63 82.86 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.908 -0.663 . . . . 10.0 111.96 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 72.28 -42.94 0.55 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.013 0.746 . . . . 10.0 113.013 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 30.3 pttt -73.47 -37.29 65.82 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.637 0.606 . . . . 10.0 112.637 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -96.45 108.69 21.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.668 0.27 . . . . 10.0 110.56 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 11.6 m -109.07 121.33 44.91 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.94 0.4 . . . . 10.0 110.701 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -108.31 130.08 55.2 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.343 -0.389 . . . . 10.0 110.568 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.5 p -118.83 123.25 71.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.196 -0.456 . . . . 10.0 110.014 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -122.37 147.63 46.04 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.322 0.582 . . . . 10.0 111.871 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 38.7 t -113.23 131.16 65.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.48 -0.782 . . . . 10.0 109.672 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.75 135.36 34.61 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 123.282 0.363 . . . . 10.0 110.43 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 -175.09 149.46 1.09 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.129 -0.487 . . . . 10.0 109.98 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -151.63 91.05 1.61 Allowed 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.151 -0.477 . . . . 10.0 110.675 179.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 14.8 t60 -175.82 -59.07 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.905 -0.588 . . . . 10.0 110.268 -179.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -89.62 -4.89 57.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.269 -0.423 . . . . 10.0 111.164 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -86.27 -39.1 16.88 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.058 -0.519 . . . . 10.0 111.564 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -78.91 57.21 2.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.907 0.384 . . . . 10.0 111.899 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 18.3 ptt? -167.81 27.32 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.079 -0.509 . . . . 10.0 110.558 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -77.67 -101.91 0.18 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.845 -0.693 . . . . 10.0 112.85 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 53.3 -101.28 0.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 122.886 0.474 . . . . 10.0 111.945 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -64.88 -34.42 78.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.928 0.394 . . . . 10.0 110.73 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 35.5 m170 -70.26 -38.82 75.2 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.611 -0.514 . . . . 10.0 109.611 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.76 -50.54 66.45 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.543 -0.753 . . . . 10.0 110.301 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -60.17 -29.4 68.65 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.194 -0.457 . . . . 10.0 111.128 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 9.0 mtp180 -79.62 -45.69 18.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.06 -0.518 . . . . 10.0 111.913 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 9.5 p -73.1 -29.63 29.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 112.116 0.413 . . . . 10.0 112.116 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -74.24 -1.33 20.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.131 0.491 . . . . 10.0 111.712 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -72.14 -20.41 61.61 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.534 -0.543 . . . . 10.0 109.534 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -133.54 -44.77 0.12 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.557 -0.83 . . . . 10.0 112.78 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -62.9 -37.75 88.2 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.399 0.518 . . . . 10.0 112.399 -179.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -68.86 -11.32 60.39 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.795 0.331 . . . . 10.0 111.877 -178.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -84.01 -8.08 59.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.699 0.285 . . . . 10.0 111.693 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.512 ' CA ' ' O3 ' ' A' ' 642' ' ' MRP . . . -141.31 -34.4 0.11 Allowed Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.049 -1.072 . . . . 10.0 114.725 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -56.7 -61.55 6.65 Favored Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 113.573 0.953 . . . . 10.0 113.573 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.51 -14.15 42.85 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 121.795 1.664 . . . . 10.0 112.01 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.3 m -82.12 -47.14 12.91 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.872 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 10.7 tp -71.99 -31.87 41.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.41 -0.359 . . . . 10.0 111.202 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 61.7 mt -55.76 -41.78 74.49 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.036 0.446 . . . . 10.0 111.945 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -82.31 -42.62 18.55 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.481 -0.327 . . . . 10.0 111.405 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 19.6 m -62.16 -38.57 89.52 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.768 0.655 . . . . 10.0 112.768 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -63.49 -34.59 78.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.617 -0.265 . . . . 10.0 111.623 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -63.05 -43.94 97.25 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.981 0.419 . . . . 10.0 110.939 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -72.32 -31.1 65.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.265 -0.425 . . . . 10.0 111.458 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 8.6 ttpp -60.5 -51.0 71.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.495 . . . . 10.0 110.351 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 31.3 mt -67.34 -38.15 80.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.343 -0.39 . . . . 10.0 110.728 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -59.59 -37.34 78.28 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.426 0.631 . . . . 10.0 110.018 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -72.04 -41.12 67.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.816 -0.629 . . . . 10.0 111.645 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -84.05 60.3 5.79 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.257 -0.428 . . . . 10.0 111.627 -179.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 161.39 -44.71 0.39 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.346 -0.93 . . . . 10.0 113.337 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -107.39 -55.66 2.31 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 122.728 -0.278 . . . . 10.0 111.69 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -63.32 -38.47 91.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.083 -0.508 . . . . 10.0 111.931 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 90.9 mttt . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.375 -0.822 . . . . 10.0 110.348 -179.424 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 624' ' ' DAG . . . . . 1.151 ' O1 ' ' C1 ' ' A' ' 644' ' ' MTC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 640' ' ' DSR . . . . . 1.449 ' S4 ' ' C7 ' ' A' ' 641' ' ' HIB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 641' ' ' HIB . . . . . 1.449 ' C7 ' ' S4 ' ' A' ' 640' ' ' DSR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 642' ' ' MRP . . . . . 1.437 ' O1 ' ' C2 ' ' A' ' 641' ' ' HIB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 643' ' ' EMP . . . . . 0.728 ' C7 ' ' C5 ' ' A' ' 643' ' ' EMP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 644' ' ' MTC . . . . . 1.151 ' C1 ' ' O1 ' ' A' ' 624' ' ' DAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' ASN . . . . . 0.481 ' HA ' ' O ' ' A' ' 5' ' ' PHE . 25.6 p-10 . . . . . 0 N--CA 1.479 1.008 0 N-CA-C 110.471 -0.196 . . . . 10.0 110.471 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.424 ' HE1' ' CB ' ' A' ' 126' ' ' ALA 0.318 0.5 OUTLIER 67.2 -51.49 0.48 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.933 1.827 . . . . 10.0 115.933 178.369 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.744 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 10.9 t70 -92.46 -58.45 0.22 Allowed Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 112.674 0.62 . . . . 10.0 112.674 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.744 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 7.7 Cg_exo -75.57 -25.81 10.64 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.211 1.941 . . . . 10.0 112.475 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.609 ' HA ' ' OD2' ' A' ' 119' ' ' ASP . 36.5 p90 -178.67 140.6 0.19 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.677 -0.692 . . . . 10.0 110.138 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.7 p -97.56 115.08 36.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 121.365 0.602 . . . . 10.0 111.389 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 21.7 mtt180 -153.57 112.01 3.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.648 -0.706 . . . . 10.0 110.572 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -128.61 141.06 51.47 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.448 -0.575 . . . . 10.0 109.448 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.3 m -125.6 128.62 48.19 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.716 0.293 . . . . 10.0 111.029 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.622 ' HB ' HG13 ' A' ' 111' ' ' VAL . 40.2 t -119.59 136.8 55.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.324 -0.398 . . . . 10.0 110.264 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.43 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 34.4 m -105.08 125.36 50.9 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.372 -0.376 . . . . 10.0 110.415 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.556 HG12 ' H ' ' A' ' 14' ' ' ALA . 26.3 t -110.19 125.92 67.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.952 0.406 . . . . 10.0 110.067 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.8 mmmp? -91.7 28.34 1.8 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.742 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.556 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -130.46 -152.98 0.53 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.89 -0.596 . . . . 10.0 110.202 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -108.67 173.87 6.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.057 0.455 . . . . 10.0 112.055 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -60.6 -38.59 85.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.491 -0.777 . . . . 10.0 112.434 -178.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -74.45 -45.43 46.38 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.497 0.554 . . . . 10.0 112.497 -178.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.2 p -62.14 -36.95 83.37 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.92 -0.312 . . . . 10.0 111.832 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.481 ' HB2' HG11 ' A' ' 12' ' ' VAL . . . -70.1 -37.81 75.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.97 0.414 . . . . 10.0 111.197 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -74.01 -39.85 63.32 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.956 0.408 . . . . 10.0 111.488 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.3 tttm -66.48 -33.75 76.39 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.392 0.516 . . . . 10.0 112.392 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.0 p -79.52 -5.14 54.23 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.431 0.53 . . . . 10.0 112.431 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -112.19 -34.59 5.88 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.493 0.553 . . . . 10.0 112.493 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.57 ' HG ' HG11 ' A' ' 46' ' ' VAL . 1.0 OUTLIER -110.01 5.31 22.14 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 113.342 0.867 . . . . 10.0 113.342 -178.544 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -139.93 -55.44 0.55 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.288 0.477 . . . . 10.0 112.288 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.39 92.57 0.87 Allowed Glycine 0 C--O 1.224 -0.529 0 C-N-CA 120.889 -0.672 . . . . 10.0 112.607 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.52 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 2.0 t80 -96.83 -58.89 0.17 Allowed Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 112.384 0.512 . . . . 10.0 112.384 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.52 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 5.5 Cg_exo -79.92 22.43 0.73 Allowed 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.367 2.045 . . . . 10.0 111.375 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -109.09 9.62 26.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.796 -0.638 . . . . 10.0 110.518 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 46.9 m0 -87.08 -151.83 0.18 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.192 -0.458 . . . . 10.0 110.12 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.641 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 34.9 t90 -172.77 -51.17 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 112.204 0.446 . . . . 10.0 112.204 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.641 ' HD2' ' N ' ' A' ' 31' ' ' TRP . 99.7 Cg_exo -18.82 -63.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.369 1.618 1 C-N-CA 125.648 4.232 . . . . 10.0 117.227 -178.478 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -148.11 36.66 0.84 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.093 0.473 . . . . 10.0 110.69 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -123.79 48.59 1.86 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.356 0.598 . . . . 10.0 110.825 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -78.69 58.15 2.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.622 -0.717 . . . . 10.0 110.489 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 36' ' ' ARG . 0.1 OUTLIER -168.63 174.91 6.41 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.65 -0.5 . . . . 10.0 109.65 -179.648 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.21 161.76 36.63 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.355 -0.609 . . . . 10.0 109.355 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.527 HG22 ' HA ' ' A' ' 57' ' ' ASP . 1.7 m 72.03 -65.43 0.35 Allowed 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.644 0.609 . . . . 10.0 112.644 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.429 ' HD3' ' HA ' ' A' ' 39' ' ' LYS . 4.5 mmtp -68.97 -33.39 73.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.231 0.538 . . . . 10.0 111.688 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.0 p -153.15 121.17 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.591 -0.731 . . . . 10.0 109.289 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.34 54.73 1.79 Allowed Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.608 -0.997 . . . . 10.0 110.608 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.55 163.77 48.07 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.553 -0.324 . . . . 10.0 110.39 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -72.08 43.44 0.59 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.832 2.355 . . . . 10.0 113.014 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 33.5 tp -165.39 -91.23 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.266 -0.425 . . . . 10.0 110.025 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.73 -57.2 3.85 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.213 -0.518 . . . . 10.0 113.076 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.57 HG11 ' HG ' ' A' ' 24' ' ' LEU . 1.9 t -99.82 135.11 36.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.765 0.317 . . . . 10.0 111.006 -178.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -105.91 112.58 25.69 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.527 -0.546 . . . . 10.0 109.527 178.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.77 19.73 16.58 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.933 -0.576 . . . . 10.0 110.752 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -96.3 -57.31 2.36 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 109.393 -0.595 . . . . 10.0 109.393 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -105.81 -36.16 2.84 Favored Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 110.805 -0.918 . . . . 10.0 110.805 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.67 68.3 0.46 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.647 -0.787 . . . . 10.0 112.25 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -156.14 -179.27 7.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.8 0.333 . . . . 10.0 111.33 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.478 ' CZ3' HG22 ' A' ' 46' ' ' VAL . 75.3 m95 -122.73 136.88 55.01 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.422 -0.584 . . . . 10.0 109.422 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -165.98 122.34 1.33 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.799 0.333 . . . . 10.0 111.775 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.414 ' O ' ' HA ' ' A' ' 61' ' ' GLU . 2.0 mm-40 -86.12 149.54 25.06 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.071 -0.513 . . . . 10.0 110.297 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.9 mm -103.42 110.53 30.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.363 -0.38 . . . . 10.0 112.01 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.527 ' HA ' HG22 ' A' ' 38' ' ' THR . 13.1 t70 -108.34 165.73 11.29 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.612 -0.514 . . . . 10.0 109.612 178.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -57.22 -27.06 61.67 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.999 0.74 . . . . 10.0 112.999 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -103.03 -1.24 29.57 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.103 0.409 . . . . 10.0 112.103 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 132.29 -160.92 23.84 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.957 -0.64 . . . . 10.0 111.745 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 55' ' ' GLU . 60.4 mp0 -69.45 128.03 35.1 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.821 -0.437 . . . . 10.0 109.821 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.7 -95.35 0.2 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.936 0.717 . . . . 10.0 112.936 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -98.56 166.31 11.41 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.173 0.511 . . . . 10.0 112.232 -178.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.8 t -148.51 150.21 32.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.674 -0.694 . . . . 10.0 109.907 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -89.09 -43.83 10.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.942 -0.572 . . . . 10.0 111.11 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 174.23 -141.2 5.81 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.7 -0.762 . . . . 10.0 111.763 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -135.48 166.06 24.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.736 0.303 . . . . 10.0 111.001 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 65.4 mt -109.76 133.53 54.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.742 -0.466 . . . . 10.0 109.742 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.0 mmt180 -83.12 -54.08 5.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.583 -0.28 . . . . 10.0 110.596 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.6 mtpm? -150.43 147.66 27.81 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.347 -0.388 . . . . 10.0 111.294 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -119.99 82.91 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.517 -0.765 . . . . 10.0 109.728 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.749 ' HB2' ' HB ' ' A' ' 76' ' ' THR . 8.1 m-20 -92.33 68.23 4.96 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.772 -0.649 . . . . 10.0 111.191 -178.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 72' ' ' ASP . 5.5 pt-20 56.11 177.78 0.04 OUTLIER Pre-proline 0 N--CA 1.474 0.731 0 O-C-N 123.922 0.764 . . . . 10.0 112.078 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -71.31 47.36 0.82 Allowed 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.141 1.894 . . . . 10.0 111.532 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -135.82 -43.84 0.66 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.96 -0.564 . . . . 10.0 110.979 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.749 ' HB ' ' HB2' ' A' ' 72' ' ' ASP . 12.5 m -129.75 125.89 36.92 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.383 -0.371 . . . . 10.0 110.556 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 27.2 tp -136.5 128.62 29.68 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.487 -0.324 . . . . 10.0 110.773 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.2 t -121.08 123.21 69.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.936 -0.764 . . . . 10.0 108.936 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.444 HD12 ' CZ3' ' A' ' 81' ' ' TRP . 1.8 pt -133.79 168.14 24.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 112.445 0.535 . . . . 10.0 112.445 -178.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -135.2 130.39 5.42 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 110.549 -1.02 . . . . 10.0 110.549 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 0.444 ' CZ3' HD12 ' A' ' 79' ' ' ILE . 0.8 OUTLIER -106.36 156.91 18.03 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 112.741 0.645 . . . . 10.0 112.741 -178.238 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 43.6 mtp180 -100.79 -164.76 1.14 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.481 -0.781 . . . . 10.0 109.402 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.2 pp -139.26 161.22 37.97 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.63 0.252 . . . . 10.0 111.431 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -77.54 -160.39 0.18 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.117 -0.492 . . . . 10.0 111.794 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 120.8 135.89 4.97 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.988 -0.845 . . . . 10.0 110.988 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -93.85 -85.92 0.28 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.761 0.315 . . . . 10.0 111.222 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -82.66 67.93 3.64 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.972 -0.632 . . . . 10.0 112.005 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.83 151.71 38.35 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.57 0.224 . . . . 10.0 110.555 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 6.2 tp -62.73 144.67 14.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.718 -0.475 . . . . 10.0 109.718 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -52.39 130.82 43.69 Favored Pre-proline 0 C--N 1.331 -0.234 0 O-C-N 123.255 0.347 . . . . 10.0 111.061 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.88 89.89 0.24 Allowed 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 123.0 2.466 . . . . 10.0 112.776 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -87.77 71.77 9.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.999 -0.546 . . . . 10.0 110.231 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -162.12 -70.57 0.05 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.693 -0.685 . . . . 10.0 109.772 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.8 m 70.77 161.61 0.23 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.285 -0.871 . . . . 10.0 112.69 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.5 m -117.28 133.7 55.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.077 -0.51 . . . . 10.0 110.554 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -93.65 147.32 23.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.128 -0.487 . . . . 10.0 110.881 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -139.48 136.81 34.97 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 123.275 0.359 . . . . 10.0 110.507 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 6.4 m -101.91 123.01 45.11 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.662 -0.495 . . . . 10.0 109.662 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 95.5 t -107.87 121.95 61.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.189 -0.46 . . . . 10.0 110.948 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.68 129.07 56.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.267 -0.424 . . . . 10.0 110.781 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -101.41 125.45 48.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.812 0.339 . . . . 10.0 110.834 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 90.3 t -117.84 126.34 74.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.095 -0.502 . . . . 10.0 109.769 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -99.99 130.86 46.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.718 -0.219 . . . . 10.0 110.659 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -118.76 100.61 7.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.959 0.409 . . . . 10.0 111.164 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.05 12.35 65.13 Favored Glycine 0 CA--C 1.52 0.386 0 CA-C-N 116.042 -0.526 . . . . 10.0 113.381 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 68.31 -16.56 0.19 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.578 0.955 . . . . 10.0 113.578 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 46.2 pttt -99.82 -6.56 26.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.064 0.459 . . . . 10.0 111.483 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -136.48 147.84 47.37 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.056 -0.72 . . . . 10.0 109.056 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.83 146.81 47.9 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.272 0.558 . . . . 10.0 111.76 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -131.9 139.26 48.7 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.779 -0.646 . . . . 10.0 109.435 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.622 HG13 ' HB ' ' A' ' 10' ' ' VAL . 2.2 p -133.75 129.76 55.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-O 120.746 0.308 . . . . 10.0 111.005 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -125.93 155.79 40.75 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.25 -0.432 . . . . 10.0 111.534 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 98' ' ' THR . 48.6 t -115.98 127.97 73.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.828 -0.624 . . . . 10.0 109.61 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -127.25 136.97 52.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.35 -0.386 . . . . 10.0 111.671 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -175.99 155.31 1.58 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.857 -0.61 . . . . 10.0 111.347 178.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.4 m -160.14 91.89 0.97 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.772 -0.825 . . . . 10.0 108.772 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 179.01 -62.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 10.0 111.028 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -98.44 14.86 26.68 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.085 -0.507 . . . . 10.0 111.558 -178.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.609 ' OD2' ' HA ' ' A' ' 5' ' ' PHE . 20.6 p-10 -98.25 -46.06 5.96 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.593 -0.731 . . . . 10.0 109.699 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.439 ' HA ' ' O ' ' A' ' 3' ' ' ASP . 98.5 mtt180 -78.54 48.81 0.81 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.489 -0.778 . . . . 10.0 111.582 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 19.4 ptt? -146.25 18.22 1.38 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.918 -0.583 . . . . 10.0 109.624 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -74.23 -96.99 0.1 Allowed Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.591 -0.732 . . . . 10.0 112.789 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.1 m 55.24 -91.57 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 122.905 0.482 . . . . 10.0 111.573 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 35.9 pttt -74.04 -36.65 64.41 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.894 -0.41 . . . . 10.0 109.894 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 34.7 m170 -69.48 -24.17 63.74 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.957 -0.565 . . . . 10.0 110.603 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.424 ' CB ' ' HE1' ' A' ' 2' ' ' TYR . . . -60.0 -58.36 8.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.322 -0.854 . . . . 10.0 110.523 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -62.15 -33.07 73.79 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.098 -0.501 . . . . 10.0 111.048 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 30.5 mtp180 -65.06 -44.09 90.11 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.154 -0.476 . . . . 10.0 112.024 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 9.9 p -81.06 -30.83 11.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.849 0.357 . . . . 10.0 111.637 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 48.7 mtp180 -72.49 -4.38 30.1 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.083 0.468 . . . . 10.0 111.827 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -84.54 0.61 49.27 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.757 -0.656 . . . . 10.0 110.517 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -149.37 -53.8 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.584 -0.817 . . . . 10.0 112.988 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -66.23 -37.81 86.43 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.183 0.809 . . . . 10.0 113.183 -178.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -63.55 -22.94 67.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.855 0.359 . . . . 10.0 111.624 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -80.9 38.76 0.47 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.998 0.428 . . . . 10.0 111.465 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 171.18 -34.88 0.16 Allowed Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.774 -0.727 . . . . 10.0 113.419 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.469 ' HB3' ' HD3' ' A' ' 138' ' ' PRO . 11.2 t90 -57.0 -63.07 4.03 Favored Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 113.541 0.941 . . . . 10.0 113.541 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.469 ' HD3' ' HB3' ' A' ' 137' ' ' TRP . 33.2 Cg_endo -65.68 -29.79 51.25 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 121.279 1.32 . . . . 10.0 111.794 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.36 -43.75 76.73 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.799 -0.637 . . . . 10.0 111.493 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 11.2 tt -70.37 -32.55 50.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.561 -0.29 . . . . 10.0 111.461 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 70.6 mt -61.52 -45.76 92.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.039 0.447 . . . . 10.0 111.175 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -67.68 -40.99 84.38 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.713 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 15.2 m -67.37 -35.47 79.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.803 -0.635 . . . . 10.0 111.598 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.42 ' HD1' ' HA ' ' A' ' 144' ' ' PHE . 0.6 OUTLIER -59.55 -44.6 93.2 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.842 0.353 . . . . 10.0 111.024 179.289 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.43 ' HG3' ' O ' ' A' ' 11' ' ' THR . 51.1 tt0 -58.63 -49.56 77.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.856 -0.611 . . . . 10.0 110.947 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -65.64 -36.02 82.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.062 -0.517 . . . . 10.0 111.796 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -62.03 -53.65 52.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.934 -0.576 . . . . 10.0 110.766 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 57.3 mt -65.84 -34.71 72.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.029 -0.532 . . . . 10.0 110.044 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -61.78 -40.94 96.94 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.107 -0.497 . . . . 10.0 109.93 178.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 1.052 ' HA ' ' HB2' ' A' ' 154' ' ' LYS . 16.7 tt0 -70.89 -42.59 69.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.326 -0.397 . . . . 10.0 111.391 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -79.63 26.79 0.3 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.782 0.325 . . . . 10.0 111.798 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -155.28 -60.4 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.552 -0.832 . . . . 10.0 113.199 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -99.21 -48.16 4.93 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.839 0.681 . . . . 10.0 112.839 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 1.052 ' HB2' ' HA ' ' A' ' 150' ' ' GLU . 46.9 mtpt -60.95 -42.81 98.95 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.291 0.478 . . . . 10.0 112.291 -179.317 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 77.9 mttt . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.357 -0.83 . . . . 10.0 110.223 179.454 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' ASN . . . . . 0.551 ' HA ' ' O ' ' A' ' 5' ' ' PHE . 28.7 p-10 . . . . . 0 N--CA 1.479 0.989 0 CA-C-O 120.463 0.173 . . . . 10.0 110.728 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . 0.283 11.8 p90 50.44 30.18 4.44 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 115.572 1.693 . . . . 10.0 115.572 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.785 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 34.2 t70 -165.65 -63.64 0.01 OUTLIER Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 111.995 0.369 . . . . 10.0 111.995 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.785 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 92.0 Cg_endo -87.8 -31.86 0.19 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 121.77 1.647 . . . . 10.0 112.469 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.551 ' O ' ' HA ' ' A' ' 1' ' ' ASN . 12.6 p90 -174.26 141.6 0.74 Allowed 'General case' 0 C--O 1.24 0.56 0 CA-C-N 115.533 -0.758 . . . . 10.0 109.436 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.6 p -100.79 127.16 54.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.113 0.482 . . . . 10.0 111.258 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 7' ' ' ARG . 0.1 OUTLIER -159.23 108.52 1.89 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.843 -0.617 . . . . 10.0 110.348 -179.651 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -131.33 150.9 51.96 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.045 -0.525 . . . . 10.0 109.832 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 17.0 m -145.8 135.81 23.65 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.548 0.213 . . . . 10.0 111.084 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.0 t -121.52 132.89 69.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.052 -0.522 . . . . 10.0 109.639 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.97 122.25 39.75 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.501 -0.318 . . . . 10.0 110.746 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.2 t -131.04 141.89 44.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.017 -0.538 . . . . 10.0 109.801 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.7 mttp -84.63 54.44 3.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.05 0.452 . . . . 10.0 110.555 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -123.26 -163.03 1.08 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.897 -0.592 . . . . 10.0 110.325 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -113.38 166.97 10.97 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.224 -0.444 . . . . 10.0 111.79 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.477 HH21 ' HB2' ' A' ' 75' ' ' ASP . 36.4 ttt180 -55.11 -38.32 68.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.552 -0.749 . . . . 10.0 112.419 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -74.35 -54.63 7.26 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.96 0.356 . . . . 10.0 111.96 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -52.11 -43.08 63.78 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 112.607 0.595 . . . . 10.0 112.607 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.13 -42.43 80.2 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.992 0.368 . . . . 10.0 111.992 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -69.31 -36.88 77.44 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.182 0.515 . . . . 10.0 111.283 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.3 mtpt -69.66 -32.28 70.84 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 113.265 0.839 . . . . 10.0 113.265 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.28 -9.67 58.96 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.91 0.707 . . . . 10.0 112.91 -178.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -116.94 -19.63 9.73 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.923 0.712 . . . . 10.0 112.923 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.9 mp -120.55 10.77 11.18 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 114.33 1.234 . . . . 10.0 114.33 -178.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -155.64 -45.4 0.08 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.038 0.384 . . . . 10.0 112.038 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.99 104.24 2.2 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.492 -0.861 . . . . 10.0 111.262 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -109.15 -56.14 0.05 OUTLIER Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 112.338 0.496 . . . . 10.0 112.338 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.427 ' CG ' ' HA ' ' A' ' 43' ' ' PRO . 7.8 Cg_exo -74.15 14.96 0.65 Allowed 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.261 1.974 . . . . 10.0 112.359 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.63 8.96 37.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.215 0.531 . . . . 10.0 110.034 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.571 ' HB2' HD21 ' A' ' 34' ' ' ASN . 40.8 m0 -87.68 -164.84 1.16 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.621 -0.718 . . . . 10.0 110.363 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.633 ' H ' ' HD2' ' A' ' 32' ' ' PRO . 57.5 t90 -169.99 -50.62 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.513 0 CA-C-O 119.257 -0.402 . . . . 10.0 111.957 -178.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.633 ' HD2' ' H ' ' A' ' 31' ' ' TRP . 80.4 Cg_exo -26.28 -55.41 0.09 OUTLIER 'Trans proline' 0 C--N 1.367 1.525 0 C-N-CA 125.154 3.903 . . . . 10.0 116.9 -179.029 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -128.11 -41.43 1.6 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.694 0.627 . . . . 10.0 112.694 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.571 HD21 ' HB2' ' A' ' 30' ' ' TRP . 14.3 p-10 -77.95 93.87 4.5 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.372 0.605 . . . . 10.0 111.613 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -101.07 0.65 38.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.325 -0.852 . . . . 10.0 111.408 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.3 mtp180 -119.96 -160.18 0.81 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.737 0.303 . . . . 10.0 111.077 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.21 155.47 46.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.253 -0.43 . . . . 10.0 110.567 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.86 ' HB ' ' HA ' ' A' ' 57' ' ' ASP 0.267 9.8 p 67.66 -65.36 0.24 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 114.484 1.29 . . . . 10.0 114.484 178.726 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.671 ' HA ' ' HG3' ' A' ' 62' ' ' GLU . 5.4 mptt -74.81 -10.6 59.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.957 0.408 . . . . 10.0 111.006 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.4 p -173.85 89.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.34 -0.845 . . . . 10.0 109.971 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.69 68.49 0.55 Allowed Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.714 -0.675 . . . . 10.0 111.958 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.06 158.55 41.42 Favored Pre-proline 0 C--N 1.322 -0.591 0 O-C-N 122.656 -0.32 . . . . 10.0 110.799 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.427 ' HA ' ' CG ' ' A' ' 28' ' ' PRO . 41.7 Cg_exo -59.44 -28.35 87.32 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.763 2.308 . . . . 10.0 113.144 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 19.0 mt -95.29 -89.0 0.25 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.801 0.334 . . . . 10.0 111.058 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.25 -55.16 5.02 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.928 -0.653 . . . . 10.0 112.824 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.8 t -105.01 132.06 52.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.745 0.307 . . . . 10.0 111.087 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.478 ' OD1' ' HG2' ' A' ' 49' ' ' LYS . 1.0 OUTLIER -100.38 118.33 36.4 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.974 -0.557 . . . . 10.0 109.638 178.404 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.7 pttt -106.13 6.46 30.99 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.958 -0.565 . . . . 10.0 112.351 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.478 ' HG2' ' OD1' ' A' ' 47' ' ' ASP . 17.7 pttt -92.65 -24.1 18.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.861 0.362 . . . . 10.0 110.112 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -131.21 -60.02 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 111.269 -0.732 . . . . 10.0 111.269 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 135.02 71.34 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.716 -0.754 . . . . 10.0 112.363 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -159.77 168.5 25.74 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.75 -0.265 . . . . 10.0 110.65 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 43.1 m95 -116.02 135.62 53.79 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.601 -0.889 . . . . 10.0 108.601 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -165.77 122.64 1.41 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.332 0.493 . . . . 10.0 112.332 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -82.17 138.49 34.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.026 -0.534 . . . . 10.0 109.852 178.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 48.1 mm -98.46 124.75 51.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.284 -0.416 . . . . 10.0 110.279 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.86 ' HA ' ' HB ' ' A' ' 38' ' ' THR . 23.7 t70 -120.94 168.4 11.53 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.385 -0.37 . . . . 10.0 110.243 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -62.16 -29.3 70.26 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 122.829 0.452 . . . . 10.0 110.923 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -86.88 -9.59 55.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.28 -0.418 . . . . 10.0 111.463 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 138.59 -103.51 0.4 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.616 -0.802 . . . . 10.0 112.019 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -117.5 154.97 30.54 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.802 0.334 . . . . 10.0 110.892 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.671 ' HG3' ' HA ' ' A' ' 39' ' ' LYS . 3.0 mm-40 -118.29 -146.35 0.39 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.932 -0.576 . . . . 10.0 111.158 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.486 ' H ' ' HB3' ' A' ' 62' ' ' GLU . 4.5 p80 -67.5 172.64 4.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.338 0.59 . . . . 10.0 112.58 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.3 t -147.41 144.19 28.48 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.632 -0.713 . . . . 10.0 110.412 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -84.49 -38.74 19.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.111 -0.495 . . . . 10.0 111.151 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 171.27 -145.51 8.91 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.795 -0.717 . . . . 10.0 111.978 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.0 pp -140.47 161.93 36.55 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.731 0.3 . . . . 10.0 110.942 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.508 HG21 HG13 ' A' ' 71' ' ' VAL . 55.0 mt -106.44 123.4 61.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.803 -0.814 . . . . 10.0 108.803 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.3 ttm180 -93.09 -27.67 16.81 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.592 -0.276 . . . . 10.0 111.361 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.2 tptm -157.05 131.16 8.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.994 0.426 . . . . 10.0 111.84 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.508 HG13 HG21 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -129.0 102.96 8.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.427 -0.806 . . . . 10.0 108.901 178.683 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.76 ' HB2' ' HB ' ' A' ' 76' ' ' THR . 59.5 m-20 -118.54 78.93 1.31 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.566 -0.288 . . . . 10.0 110.794 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.513 ' HG2' ' O ' ' A' ' 72' ' ' ASP . 5.7 pt-20 55.4 178.7 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.663 0 O-C-N 123.971 0.794 . . . . 10.0 111.718 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -71.55 48.69 1.04 Allowed 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 121.955 1.77 . . . . 10.0 111.569 177.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.477 ' HB2' HH21 ' A' ' 16' ' ' ARG . 16.0 t70 -134.96 -55.52 0.82 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.306 -0.406 . . . . 10.0 111.088 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.76 ' HB ' ' HB2' ' A' ' 72' ' ' ASP . 5.0 m -113.23 119.18 36.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.159 -0.473 . . . . 10.0 110.753 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.478 ' HB3' ' HB ' ' A' ' 99' ' ' VAL . 59.7 tp -129.05 119.65 24.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.13 -0.486 . . . . 10.0 110.937 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 51.2 t -118.91 116.36 50.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.652 -0.499 . . . . 10.0 109.652 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 pp -133.95 161.99 40.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.353 -0.385 . . . . 10.0 111.943 -178.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.565 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -129.08 141.79 12.91 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 110.5 -1.04 . . . . 10.0 110.5 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -105.32 166.21 10.58 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.388 0.514 . . . . 10.0 112.388 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 82' ' ' ARG . 46.7 mtp180 -104.87 -168.76 1.52 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.802 -0.635 . . . . 10.0 110.53 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.421 ' HG ' ' HB3' ' A' ' 91' ' ' PRO . 0.3 OUTLIER -130.29 150.65 51.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.786 -0.643 . . . . 10.0 111.18 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -87.85 -168.49 2.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.883 -0.599 . . . . 10.0 110.529 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 131.73 157.58 8.77 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.828 -0.701 . . . . 10.0 112.915 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -104.98 -85.83 0.47 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.23 0.538 . . . . 10.0 110.046 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -88.73 81.0 1.56 Allowed Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 111.232 -0.747 . . . . 10.0 111.232 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 5.5 ptt85 -141.94 175.53 9.65 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.624 0.249 . . . . 10.0 110.592 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.763 HG12 ' H ' ' A' ' 90' ' ' ASP . 10.3 tt -83.21 -174.64 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.011 -0.54 . . . . 10.0 110.612 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.763 ' H ' HG12 ' A' ' 89' ' ' ILE . 29.2 t70 -59.8 141.48 89.16 Favored Pre-proline 0 C--N 1.331 -0.236 0 C-N-CA 123.134 0.574 . . . . 10.0 110.972 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 90' ' ' ASP . 14.8 Cg_exo -69.37 60.05 1.46 Allowed 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.135 2.557 . . . . 10.0 113.142 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -82.03 92.75 6.85 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.249 0.547 . . . . 10.0 110.714 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -164.41 -69.2 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.761 -0.654 . . . . 10.0 110.21 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.2 m 66.14 90.78 0.09 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.077 0.769 . . . . 10.0 113.077 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.2 m -88.91 107.69 19.14 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.48 -0.563 . . . . 10.0 109.48 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.565 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 57.6 mt-10 -91.03 151.94 20.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.996 0.427 . . . . 10.0 111.914 -178.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -140.54 142.64 35.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.212 -0.904 . . . . 10.0 109.881 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.7 m -102.23 125.51 48.95 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.582 -0.281 . . . . 10.0 110.446 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.478 ' HB ' ' HB3' ' A' ' 77' ' ' LEU . 21.4 t -107.3 126.12 63.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.836 -0.62 . . . . 10.0 110.827 -178.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -112.4 134.39 53.96 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.226 -0.443 . . . . 10.0 110.652 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -102.43 123.63 46.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.27 -0.423 . . . . 10.0 111.532 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.8 t -119.8 119.69 61.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.154 -0.475 . . . . 10.0 109.737 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -104.07 136.07 44.39 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.809 0.338 . . . . 10.0 110.818 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -127.27 115.69 19.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.005 -0.543 . . . . 10.0 111.187 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.34 6.11 52.45 Favored Glycine 0 CA--C 1.518 0.261 0 CA-C-N 115.915 -0.584 . . . . 10.0 112.886 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 67.47 -3.15 1.13 Allowed 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.915 0.709 . . . . 10.0 112.915 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.2 ptmt -119.24 6.21 11.22 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.196 0.522 . . . . 10.0 111.605 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -140.06 132.58 28.66 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.167 -0.679 . . . . 10.0 109.167 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.8 m -117.72 130.37 56.28 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.397 0.517 . . . . 10.0 112.397 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -118.85 113.3 20.86 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.088 -1.078 . . . . 10.0 108.088 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 9' ' ' SER . 11.8 p -113.35 133.93 57.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 C-N-CA 120.449 -0.5 . . . . 10.0 111.29 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -127.9 148.33 50.48 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.048 -0.524 . . . . 10.0 111.795 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.6 t -126.27 113.85 35.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 108.82 -0.807 . . . . 10.0 108.82 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -129.44 144.58 51.31 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.172 0.511 . . . . 10.0 112.094 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -163.55 162.86 24.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.416 -0.811 . . . . 10.0 109.021 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -157.57 77.87 0.85 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.701 0.286 . . . . 10.0 110.491 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -172.41 -67.39 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.296 -0.411 . . . . 10.0 111.919 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.463 ' O ' ' HG2' ' A' ' 121' ' ' MET . 82.5 m-85 -81.57 -16.73 50.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.182 0.515 . . . . 10.0 111.579 -178.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -82.52 -16.8 47.32 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.828 -0.624 . . . . 10.0 110.67 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 77.8 mtt180 -91.65 32.2 1.12 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.181 0.438 . . . . 10.0 112.181 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.463 ' HG2' ' O ' ' A' ' 118' ' ' PHE . 21.3 ptp -136.19 23.32 3.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.086 0.47 . . . . 10.0 110.129 179.098 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -73.22 -106.67 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.701 -0.681 . . . . 10.0 112.789 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.2 m 53.41 -87.79 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.634 0.605 . . . . 10.0 112.634 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.479 ' O ' ' HG3' ' A' ' 128' ' ' ARG . 55.7 pttt -72.35 -35.61 68.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.838 0.352 . . . . 10.0 110.25 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -71.26 -31.99 68.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 10.0 110.883 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.6 -43.4 97.46 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.712 -0.676 . . . . 10.0 110.818 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -66.61 -37.15 84.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.934 -0.575 . . . . 10.0 111.02 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' A' ' 124' ' ' LYS . 45.9 mtp180 -69.31 -45.15 70.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 10.0 111.383 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.8 p -70.29 -20.42 22.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 112.205 0.446 . . . . 10.0 112.205 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.523 ' HG3' ' HB3' ' A' ' 134' ' ' ASP . 23.6 ttt180 -66.64 -15.42 63.46 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 121.067 0.461 . . . . 10.0 111.057 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -71.59 -4.21 25.8 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.233 0.457 . . . . 10.0 112.233 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -152.81 -50.29 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 119.999 -1.096 . . . . 10.0 113.744 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -63.09 -42.71 99.67 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.207 0.817 . . . . 10.0 113.207 -178.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.523 ' HB3' ' HG3' ' A' ' 130' ' ' ARG . 34.1 t70 -71.89 -3.03 20.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.179 0.514 . . . . 10.0 111.853 -179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -98.24 19.42 14.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.272 -0.422 . . . . 10.0 111.3 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.461 ' O ' ' HB ' ' A' ' 140' ' ' ILE . . . -175.08 -35.3 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 119.765 -1.207 . . . . 10.0 113.806 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -56.55 -58.05 19.52 Favored Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 113.457 0.91 . . . . 10.0 113.457 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.87 -41.23 46.97 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.118 1.879 . . . . 10.0 112.038 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.05 -38.18 87.69 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 116.045 -0.525 . . . . 10.0 111.04 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.461 ' HB ' ' O ' ' A' ' 136' ' ' GLY . 1.0 OUTLIER -65.34 -39.67 86.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.163 -0.471 . . . . 10.0 111.669 -179.504 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 93.4 mt -64.69 -35.59 81.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.498 -0.319 . . . . 10.0 111.275 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -80.4 -32.56 37.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.138 -0.483 . . . . 10.0 112.239 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 2.8 p -75.5 -34.6 60.85 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.987 -0.285 . . . . 10.0 111.368 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -61.13 -37.9 84.47 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.856 0.36 . . . . 10.0 111.27 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -56.76 -54.96 40.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.707 -0.678 . . . . 10.0 111.627 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -61.45 -37.08 82.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.455 -0.339 . . . . 10.0 111.616 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 48.6 tttp -64.9 -55.34 19.91 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.18 0.437 . . . . 10.0 112.18 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 32.7 mt -66.96 -38.38 81.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.722 0.296 . . . . 10.0 111.573 -178.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -65.17 -35.32 80.72 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-O 121.357 0.599 . . . . 10.0 109.915 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 1.027 ' HA ' ' HB3' ' A' ' 154' ' ' LYS . 32.7 tt0 -67.96 -48.38 66.04 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.391 -0.822 . . . . 10.0 109.724 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -79.89 56.97 2.46 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.038 -0.528 . . . . 10.0 110.879 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -177.82 -51.95 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.743 -0.662 . . . . 10.0 112.299 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -126.06 -45.37 1.72 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.332 0.493 . . . . 10.0 112.332 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 1.027 ' HB3' ' HA ' ' A' ' 150' ' ' GLU . 71.5 tttt -60.94 -35.6 77.15 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.496 0.554 . . . . 10.0 112.496 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt . . . . . 0 C--O 1.252 1.213 0 CA-C-O 118.427 -0.797 . . . . 10.0 110.106 179.881 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 110.703 -0.11 . . . . 10.0 110.703 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . 0.365 17.6 p90 63.63 -50.49 0.24 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 116.27 1.952 . . . . 10.0 116.27 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.81 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 16.7 t70 -74.47 -61.61 1.13 Allowed Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 112.886 0.699 . . . . 10.0 112.886 -178.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.81 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 3.6 Cg_exo -80.5 -32.64 1.17 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.292 1.995 . . . . 10.0 111.949 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.63 ' HA ' ' OD2' ' A' ' 119' ' ' ASP . 47.3 p90 -176.94 152.5 0.93 Allowed 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.346 -0.843 . . . . 10.0 109.648 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.5 p -101.54 138.58 25.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.021 0.438 . . . . 10.0 111.32 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 39.4 ttm180 -171.0 104.63 0.23 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.376 -0.829 . . . . 10.0 110.043 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 72.1 m-70 -131.04 157.21 43.63 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.06 -0.348 . . . . 10.0 110.06 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 0.0 OUTLIER -147.2 140.27 25.19 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.442 0.534 . . . . 10.0 112.442 -179.71 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.402 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 21.9 t -123.45 143.4 36.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 108.91 -0.774 . . . . 10.0 108.91 179.189 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.8 m -111.26 105.46 14.13 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.082 0.468 . . . . 10.0 111.991 -178.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.581 HG13 HG21 ' A' ' 148' ' ' ILE . 89.2 t -85.97 114.91 26.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.081 -0.509 . . . . 10.0 110.515 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt -98.74 57.95 1.16 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.213 0.53 . . . . 10.0 111.124 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -147.91 -83.26 0.11 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.556 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -163.47 157.99 20.42 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.725 -0.472 . . . . 10.0 109.725 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.7 ttt180 -66.99 -37.39 84.13 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.614 0.598 . . . . 10.0 112.614 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -70.59 -41.08 72.81 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.059 0.392 . . . . 10.0 112.059 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.97 -36.63 84.11 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.818 0.303 . . . . 10.0 111.818 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.58 -44.39 94.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.143 0.497 . . . . 10.0 110.233 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -67.35 -38.71 85.28 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.7 -0.682 . . . . 10.0 110.316 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.0 mmtt -66.17 -43.61 86.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.66 -0.7 . . . . 10.0 112.683 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.4 p -73.24 -26.34 61.08 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.09 0.774 . . . . 10.0 113.09 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -84.16 -34.4 24.04 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.03 0.752 . . . . 10.0 113.03 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.0 mp -102.36 -33.05 9.72 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.842 1.053 . . . . 10.0 113.842 -178.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -124.53 42.42 3.26 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.289 0.477 . . . . 10.0 112.289 -178.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -145.18 30.16 1.77 Allowed Glycine 0 C--O 1.228 -0.254 0 C-N-CA 120.516 -0.849 . . . . 10.0 112.524 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.558 ' HD1' ' HA2' ' A' ' 41' ' ' GLY . 0.6 OUTLIER -54.65 -56.36 28.01 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 113.366 0.876 . . . . 10.0 113.366 -179.141 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.654 ' HG3' ' HA ' ' A' ' 43' ' ' PRO . 92.6 Cg_endo -82.94 28.35 0.58 Allowed 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 122.095 1.863 . . . . 10.0 112.376 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -124.0 9.39 8.72 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.2 0.524 . . . . 10.0 111.446 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 19.8 m0 -98.61 162.59 13.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.949 -0.569 . . . . 10.0 109.668 179.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.669 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -144.85 46.85 0.64 Allowed Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 112.307 0.484 . . . . 10.0 112.307 179.172 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.669 ' HD3' ' N ' ' A' ' 31' ' ' TRP . 6.3 Cg_endo -89.88 -45.82 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.364 2.043 . . . . 10.0 112.509 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.446 ' H ' ' HD2' ' A' ' 32' ' ' PRO . 65.8 t30 -157.78 -32.3 0.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.113 0.482 . . . . 10.0 110.137 -179.483 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.439 ' OD1' ' HD2' ' A' ' 32' ' ' PRO . 16.6 p-10 -79.67 89.53 5.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.398 0.618 . . . . 10.0 111.168 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -99.73 -21.18 15.91 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.67 -0.695 . . . . 10.0 110.899 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -91.18 109.24 20.49 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.147 -0.479 . . . . 10.0 111.024 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.57 167.47 12.89 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.802 -0.636 . . . . 10.0 111.139 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.408 HG22 ' OD2' ' A' ' 57' ' ' ASP . 3.3 m 78.51 -62.8 0.32 Allowed 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.515 0.561 . . . . 10.0 112.515 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 17.1 mmtm -76.16 -24.72 54.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.863 0.363 . . . . 10.0 111.814 -179.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.4 p -163.21 91.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.77 0.795 . . . . 10.0 110.543 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.558 ' HA2' ' HD1' ' A' ' 27' ' ' PHE . . . 126.51 47.61 0.2 Allowed Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.477 -0.783 . . . . 10.0 111.753 -178.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.58 158.71 86.25 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 120.621 0.248 . . . . 10.0 111.097 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.654 ' HA ' ' HG3' ' A' ' 28' ' ' PRO . 34.3 Cg_exo -59.82 -20.46 59.33 Favored 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 122.677 2.252 . . . . 10.0 112.88 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.3 mp -98.74 -91.82 0.27 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.7 0.286 . . . . 10.0 110.579 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.85 -63.97 2.47 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.824 -0.703 . . . . 10.0 113.122 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.3 t -106.04 132.51 52.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 120.725 0.298 . . . . 10.0 110.996 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -95.31 125.77 40.16 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.398 -0.365 . . . . 10.0 110.355 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.485 ' HB2' ' HE3' ' A' ' 48' ' ' LYS . 37.3 mtmt -103.51 10.61 37.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.286 -0.415 . . . . 10.0 110.972 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.0 mtmm -89.09 -54.51 4.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.669 0.271 . . . . 10.0 110.533 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -111.15 -29.83 3.36 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 111.101 -0.799 . . . . 10.0 111.101 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.26 80.32 1.4 Allowed Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.655 -0.783 . . . . 10.0 111.97 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 52' ' ' ARG . 13.8 ptt180 -162.97 167.63 22.27 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.725 0.297 . . . . 10.0 110.505 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 60.0 m95 -107.33 134.52 50.27 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.883 -0.784 . . . . 10.0 108.883 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -164.22 120.05 1.56 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.053 0.454 . . . . 10.0 111.497 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -83.77 133.66 34.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.794 -0.639 . . . . 10.0 109.676 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.0 mm -96.14 111.27 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 116.069 -0.514 . . . . 10.0 110.823 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.979 ' HB2' ' HG2' ' A' ' 62' ' ' GLU . 15.9 t70 -106.62 163.49 12.85 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.921 -0.581 . . . . 10.0 109.597 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.38 -23.72 65.61 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.598 0.237 . . . . 10.0 110.514 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -87.42 -4.23 59.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.811 0.339 . . . . 10.0 110.775 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 134.1 -111.64 0.98 Allowed Glycine 0 CA--C 1.519 0.298 0 C-N-CA 121.209 -0.52 . . . . 10.0 112.482 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -115.76 137.24 52.28 Favored 'General case' 0 C--N 1.32 -0.676 0 O-C-N 122.41 -0.465 . . . . 10.0 110.759 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.979 ' HG2' ' HB2' ' A' ' 57' ' ' ASP . 15.2 mm-40 -97.45 -144.46 0.3 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.946 -0.57 . . . . 10.0 111.657 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.507 ' H ' ' HB3' ' A' ' 62' ' ' GLU . 3.3 p80 -75.07 -178.83 4.01 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 113.045 0.757 . . . . 10.0 113.045 -179.041 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.9 t -152.64 152.63 32.01 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.142 -0.936 . . . . 10.0 110.095 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.446 ' HE2' ' HZ ' ' A' ' 27' ' ' PHE . 98.5 m-85 -96.68 -22.1 17.21 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.475 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.463 ' HA3' ' O ' ' A' ' 80' ' ' GLY . . . 154.12 -146.75 15.22 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 121.032 -0.604 . . . . 10.0 112.42 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.9 pp -132.73 169.24 16.98 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.776 0.322 . . . . 10.0 110.704 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.411 HG21 HG13 ' A' ' 71' ' ' VAL . 67.4 mt -109.03 127.13 65.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.095 -0.705 . . . . 10.0 109.095 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -77.83 -45.88 23.11 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.418 -0.356 . . . . 10.0 111.255 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.0 tttm -161.81 145.33 12.3 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.229 -0.441 . . . . 10.0 110.604 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.411 HG13 HG21 ' A' ' 68' ' ' ILE . 0.4 OUTLIER -115.23 84.67 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.206 0.527 . . . . 10.0 110.478 179.555 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.26 61.95 5.92 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.982 -0.554 . . . . 10.0 111.161 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.405 ' C ' ' H ' ' A' ' 75' ' ' ASP . 3.8 pt-20 55.04 -179.01 0.03 OUTLIER Pre-proline 0 CA--C 1.547 0.841 0 O-C-N 123.871 0.732 . . . . 10.0 111.886 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.403 ' CD ' ' HB2' ' A' ' 73' ' ' GLU . 21.5 Cg_exo -69.29 33.65 0.19 Allowed 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 122.203 1.935 . . . . 10.0 113.359 178.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 73' ' ' GLU . 17.4 t70 -113.49 -56.46 2.4 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.639 0.257 . . . . 10.0 110.564 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.0 m -127.6 129.33 47.09 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.951 0.405 . . . . 10.0 110.594 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 28.9 tp -129.05 134.01 47.94 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.054 -0.521 . . . . 10.0 110.088 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.6 t -128.35 119.93 51.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.935 -0.394 . . . . 10.0 109.935 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 37.6 pt -133.57 167.7 25.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.719 0.295 . . . . 10.0 111.268 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.541 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -123.88 138.49 11.43 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 110.836 -0.905 . . . . 10.0 110.836 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -97.01 156.89 16.16 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.216 0.821 . . . . 10.0 113.216 -178.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.0 ttt180 -105.94 153.35 22.1 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.992 -1.004 . . . . 10.0 109.692 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.743 ' HG ' ' HB3' ' A' ' 91' ' ' PRO . 1.6 pp -98.84 170.6 8.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.647 0.26 . . . . 10.0 111.428 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -120.42 -173.05 2.49 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.44 -0.346 . . . . 10.0 110.84 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 134.45 147.01 5.51 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.4 -0.68 . . . . 10.0 111.4 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -83.29 -84.27 0.13 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.993 0.425 . . . . 10.0 110.73 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -87.03 92.73 1.83 Allowed Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.756 -0.735 . . . . 10.0 111.739 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.508 ' HD2' ' O ' ' A' ' 89' ' ' ILE . 0.0 OUTLIER -164.37 169.29 17.58 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.748 0.309 . . . . 10.0 110.723 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.508 ' O ' ' HD2' ' A' ' 88' ' ' ARG . 8.9 tp -74.79 164.59 3.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.151 -0.477 . . . . 10.0 110.606 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.453 ' H ' HG13 ' A' ' 89' ' ' ILE . 1.4 m-20 -65.15 146.27 98.96 Favored Pre-proline 0 C--O 1.232 0.176 0 CA-C-O 120.748 0.309 . . . . 10.0 111.241 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.743 ' HB3' ' HG ' ' A' ' 83' ' ' LEU . 19.2 Cg_endo -57.89 104.41 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 123.297 2.664 . . . . 10.0 113.914 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -106.77 -25.04 11.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.763 -0.653 . . . . 10.0 109.94 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -68.71 -77.71 0.08 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.514 -0.766 . . . . 10.0 111.134 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.9 m 69.07 161.57 0.21 Allowed 'General case' 0 CA--C 1.534 0.342 0 O-C-N 123.559 0.537 . . . . 10.0 112.216 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 16.1 m -144.34 124.84 13.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.449 -0.341 . . . . 10.0 111.229 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.541 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 12.2 pt-20 -100.69 153.04 19.76 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.151 -0.477 . . . . 10.0 110.222 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -139.15 147.03 41.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.667 -0.242 . . . . 10.0 110.914 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.18 126.36 42.31 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.363 -0.606 . . . . 10.0 109.363 179.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 39.0 t -116.97 127.25 74.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.419 -0.355 . . . . 10.0 111.31 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.74 130.57 55.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.564 -0.289 . . . . 10.0 110.864 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -100.21 84.14 2.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.391 -0.368 . . . . 10.0 111.109 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 34.6 t -85.66 111.09 20.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 110.01 -0.367 . . . . 10.0 110.01 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 109' ' ' THR . . . -102.82 137.72 40.66 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.734 0.302 . . . . 10.0 111.347 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -124.95 125.95 44.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.998 -0.546 . . . . 10.0 109.616 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 78.3 6.5 87.81 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.743 -0.742 . . . . 10.0 111.881 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 63.36 20.8 12.47 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.685 0.624 . . . . 10.0 112.685 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 16.6 pttt -140.95 -51.95 0.46 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.108 -0.496 . . . . 10.0 110.685 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -82.7 100.2 10.09 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.256 -0.646 . . . . 10.0 109.256 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 103' ' ' ALA . 7.2 m -103.25 115.64 30.95 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.774 -0.648 . . . . 10.0 111.268 -178.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 64.1 mtt180 -102.67 105.72 16.24 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.036 -0.529 . . . . 10.0 110.14 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 9' ' ' SER . 1.8 p -92.2 123.74 44.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.844 -0.617 . . . . 10.0 110.806 -179.142 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -114.41 145.44 41.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.021 -0.536 . . . . 10.0 111.483 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 24.1 t -123.21 122.38 65.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.797 -0.638 . . . . 10.0 109.527 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -135.68 155.51 50.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.206 0.527 . . . . 10.0 112.001 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -177.88 157.44 1.17 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.203 -0.908 . . . . 10.0 108.696 178.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.1 m -156.71 86.07 0.98 Allowed 'General case' 0 C--O 1.237 0.417 0 N-CA-C 109.825 -0.435 . . . . 10.0 109.825 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -177.02 -64.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.021 -0.536 . . . . 10.0 111.197 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.467 ' O ' ' HG2' ' A' ' 121' ' ' MET . 83.4 m-85 -90.07 2.41 55.26 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.276 -0.42 . . . . 10.0 111.919 -178.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.63 ' OD2' ' HA ' ' A' ' 5' ' ' PHE . 19.7 p-10 -90.12 -38.67 13.37 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.177 -0.465 . . . . 10.0 110.827 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -75.63 18.49 0.23 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.766 0.654 . . . . 10.0 112.766 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.467 ' HG2' ' O ' ' A' ' 118' ' ' PHE . 23.7 ptt? -118.15 13.67 13.84 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.518 -0.549 . . . . 10.0 109.518 178.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.453 ' HA2' ' HB2' ' A' ' 125' ' ' HIS . . . -77.6 -111.77 0.17 Allowed Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.611 -0.722 . . . . 10.0 113.394 -178.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.5 m 56.36 -92.17 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.48 0.312 . . . . 10.0 111.225 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.33 -31.06 70.2 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.62 -0.511 . . . . 10.0 109.62 178.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.453 ' HB2' ' HA2' ' A' ' 122' ' ' GLY . 7.5 m170 -72.24 -42.2 65.95 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.823 -0.626 . . . . 10.0 109.71 178.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.489 ' HA ' HG12 ' A' ' 129' ' ' VAL . . . -66.24 -38.87 88.91 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.757 -0.656 . . . . 10.0 110.04 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -60.03 -31.85 70.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.621 -0.718 . . . . 10.0 110.989 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.78 -43.64 19.81 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.1 -0.5 . . . . 10.0 111.501 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.489 HG12 ' HA ' ' A' ' 126' ' ' ALA . 4.6 p -71.02 -23.37 23.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 112.13 0.419 . . . . 10.0 112.13 -179.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -69.67 -4.59 20.18 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.003 0.372 . . . . 10.0 112.003 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -71.12 -27.54 63.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.867 0.365 . . . . 10.0 110.761 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -133.66 -30.23 0.45 Allowed Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.148 -1.025 . . . . 10.0 114.163 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 12.8 tpt -79.11 -29.87 43.45 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 117.358 0.579 . . . . 10.0 112.012 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -69.14 -9.54 53.32 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.14 -0.482 . . . . 10.0 111.858 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -95.76 -7.49 37.05 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.214 0.45 . . . . 10.0 112.214 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -131.54 -39.78 0.24 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 119.794 -1.193 . . . . 10.0 114.362 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.406 ' HB3' ' HD3' ' A' ' 138' ' ' PRO . 22.5 t90 -53.11 -59.6 8.72 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 113.781 1.03 . . . . 10.0 113.781 -178.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.406 ' HD3' ' HB3' ' A' ' 137' ' ' TRP . 42.7 Cg_endo -67.17 -36.42 21.58 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 121.551 1.501 . . . . 10.0 112.705 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.8 -41.41 91.97 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.111 -0.495 . . . . 10.0 111.645 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.2 mp -64.97 -41.27 91.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.166 -0.47 . . . . 10.0 111.586 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 96.1 mt -59.1 -47.71 84.25 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.259 -0.428 . . . . 10.0 111.478 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -63.46 -40.19 96.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.984 -0.553 . . . . 10.0 111.057 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 21.7 m -66.32 -43.65 85.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.08 -0.509 . . . . 10.0 111.307 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -63.96 -39.33 93.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.542 -0.299 . . . . 10.0 110.556 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -58.68 -34.59 71.44 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 123.8 0.687 . . . . 10.0 111.074 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -87.96 -35.52 17.6 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.332 0.493 . . . . 10.0 112.332 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -61.79 -50.86 70.64 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 111.616 0.228 . . . . 10.0 111.616 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.581 HG21 HG13 ' A' ' 12' ' ' VAL . 48.6 mt -63.81 -32.3 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.18 0.515 . . . . 10.0 110.644 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -73.39 -39.16 65.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.964 -0.562 . . . . 10.0 109.773 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -64.03 -53.32 51.84 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.883 -0.598 . . . . 10.0 109.851 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -87.08 56.87 4.19 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.38 -0.827 . . . . 10.0 110.78 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 175.14 -43.28 0.12 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.041 -1.076 . . . . 10.0 113.317 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -109.55 -49.65 3.08 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.103 0.408 . . . . 10.0 112.103 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 22.0 mttp -65.23 -55.3 19.23 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.791 0.329 . . . . 10.0 110.798 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.437 ' HE3' ' HB2' ' A' ' 155' ' ' LYS . 33.8 mtmt . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.024 -0.988 . . . . 10.0 109.705 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' ASN . . . . . 0.759 ' O ' ' HD2' ' A' ' 4' ' ' PRO . 17.6 p-10 . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 120.428 0.156 . . . . 10.0 110.806 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . 0.286 0.2 OUTLIER 47.84 -107.18 0.18 Allowed 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 115.899 1.815 . . . . 10.0 115.899 179.606 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.504 ' HB2' ' HD3' ' A' ' 4' ' ' PRO . 1.1 m-20 -48.54 -64.31 1.18 Allowed Pre-proline 0 N--CA 1.475 0.821 0 N-CA-C 115.353 1.612 . . . . 10.0 115.353 -177.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.759 ' HD2' ' O ' ' A' ' 1' ' ' ASN . 75.3 Cg_exo -51.34 -48.0 23.32 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.458 2.105 . . . . 10.0 112.84 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.459 ' HA ' ' OD2' ' A' ' 119' ' ' ASP . 51.8 p90 178.66 153.33 0.36 Allowed 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.705 -0.68 . . . . 10.0 109.705 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.9 p -107.27 96.3 4.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.323 0.582 . . . . 10.0 111.304 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.504 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 98.4 mtt180 -136.57 105.31 5.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.867 -0.606 . . . . 10.0 110.247 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 28.3 m-70 -121.18 152.28 38.97 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.316 -0.402 . . . . 10.0 110.044 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.9 m -140.38 133.28 29.19 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.607 0.241 . . . . 10.0 111.083 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.535 ' HB ' HG13 ' A' ' 111' ' ' VAL . 21.7 t -123.32 140.45 46.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 109.374 -0.602 . . . . 10.0 109.374 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.1 m -107.93 112.31 24.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.058 0.456 . . . . 10.0 110.91 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.567 HG11 ' HB2' ' A' ' 19' ' ' ALA . 70.3 t -98.94 132.8 43.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 116.299 -0.41 . . . . 10.0 110.178 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.2 mtmt -115.45 88.16 2.82 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.749 0.309 . . . . 10.0 111.676 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -172.54 -82.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.702 -0.681 . . . . 10.0 109.471 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -168.65 -178.91 3.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.009 -0.541 . . . . 10.0 110.152 178.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 50.2 ttt180 -76.25 -35.58 58.89 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.283 0.475 . . . . 10.0 112.283 -178.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -71.5 -46.58 59.34 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.474 0.546 . . . . 10.0 112.474 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.95 -46.62 75.02 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.031 0.382 . . . . 10.0 112.031 -179.334 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.567 ' HB2' HG11 ' A' ' 12' ' ' VAL . . . -61.93 -46.53 88.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.357 -0.383 . . . . 10.0 111.456 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -67.64 -37.49 82.51 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.309 -0.405 . . . . 10.0 111.613 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.8 mmtt -68.2 -44.65 75.34 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 111.921 0.341 . . . . 10.0 111.921 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.2 p -67.36 -28.17 67.73 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.362 0.505 . . . . 10.0 112.362 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -93.29 7.33 44.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.702 0.286 . . . . 10.0 111.618 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.0 tp -128.26 -55.86 1.25 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.454 0.539 . . . . 10.0 112.454 -178.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -108.82 -12.35 14.92 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.077 0.399 . . . . 10.0 112.077 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.51 86.83 1.5 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.652 -0.785 . . . . 10.0 111.725 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -111.66 -55.6 0.04 OUTLIER Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 112.731 0.641 . . . . 10.0 112.731 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -75.74 27.85 0.39 Allowed 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.273 1.982 . . . . 10.0 112.577 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -120.48 0.62 10.55 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.318 -0.401 . . . . 10.0 110.762 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 39.7 m0 -76.72 165.07 25.24 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.322 -0.621 . . . . 10.0 109.322 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.594 ' H ' ' HD2' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -146.07 -58.39 0.02 OUTLIER Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 112.585 0.587 . . . . 10.0 112.585 -179.735 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.594 ' HD2' ' H ' ' A' ' 31' ' ' TRP . 73.6 Cg_endo -74.31 52.58 2.8 Favored 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 122.068 1.845 . . . . 10.0 112.498 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -170.0 -67.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.978 -0.555 . . . . 10.0 110.659 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.463 HD22 ' HA3' ' A' ' 41' ' ' GLY . 18.2 p-10 -111.82 122.83 48.84 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.334 0.588 . . . . 10.0 111.549 -179.4 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -112.96 4.75 16.93 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.735 -0.666 . . . . 10.0 110.779 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -133.08 105.08 6.85 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.721 0.296 . . . . 10.0 111.198 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.06 166.19 14.29 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.117 -0.492 . . . . 10.0 110.302 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.1 m 75.46 -47.35 0.59 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 122.91 0.484 . . . . 10.0 111.562 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.1 -30.64 27.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.1 0.476 . . . . 10.0 109.896 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.8 p -161.81 104.19 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 115.301 -0.863 . . . . 10.0 109.343 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.463 ' HA3' HD22 ' A' ' 34' ' ' ASN . . . 107.83 62.24 0.56 Allowed Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.939 -0.864 . . . . 10.0 110.939 -178.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.462 ' CB ' ' H ' ' A' ' 56' ' ' ILE . . . -81.31 168.08 27.2 Favored Pre-proline 0 C--N 1.321 -0.669 0 C-N-CA 122.407 0.283 . . . . 10.0 110.896 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -74.74 45.58 1.32 Allowed 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 122.979 2.452 . . . . 10.0 112.963 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 27.4 tp -160.69 -86.85 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.744 -0.465 . . . . 10.0 109.744 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.65 -69.71 3.25 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.93 -0.652 . . . . 10.0 112.991 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.8 t -103.14 134.9 42.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.002 0.43 . . . . 10.0 111.461 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.436 ' HB3' ' HG3' ' A' ' 52' ' ' ARG . 6.6 t70 -103.26 112.29 25.1 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.421 -0.585 . . . . 10.0 109.421 178.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.61 23.2 8.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.754 -0.657 . . . . 10.0 111.02 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.5 mttp -99.65 -54.29 2.96 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.94 -0.763 . . . . 10.0 108.94 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -108.55 -21.96 7.3 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.309 -0.86 . . . . 10.0 112.085 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.472 ' HA2' HD12 ' A' ' 68' ' ' ILE . . . 98.3 67.43 0.9 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.747 -0.739 . . . . 10.0 112.082 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.436 ' HG3' ' HB3' ' A' ' 47' ' ' ASP . 33.1 ptt180 -151.48 173.87 14.06 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 122.654 -0.321 . . . . 10.0 110.361 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 35.6 m95 -123.79 132.21 53.74 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.402 -0.962 . . . . 10.0 108.402 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -163.29 132.16 3.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.23 0.538 . . . . 10.0 112.142 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.448 ' HB2' ' HB2' ' A' ' 62' ' ' GLU . 2.7 mm-40 -90.01 152.55 21.13 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.379 -0.828 . . . . 10.0 110.046 179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.462 ' H ' ' CB ' ' A' ' 42' ' ' ALA . 41.5 mm -107.07 123.78 62.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.292 -0.413 . . . . 10.0 110.528 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.827 ' HB2' ' HG2' ' A' ' 62' ' ' GLU . 21.1 t70 -127.13 166.01 18.47 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.973 -0.751 . . . . 10.0 108.973 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -64.15 -26.81 68.69 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.681 0.277 . . . . 10.0 111.629 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -88.4 -5.34 58.34 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.948 0.404 . . . . 10.0 111.066 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 135.18 -105.85 0.56 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.976 -0.631 . . . . 10.0 112.697 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.9 mp0 -115.55 140.2 49.38 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.728 0.299 . . . . 10.0 110.563 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.827 ' HG2' ' HB2' ' A' ' 57' ' ' ASP . 22.1 mm-40 -93.87 -135.26 0.18 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.367 -0.379 . . . . 10.0 110.809 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.479 ' H ' ' HB3' ' A' ' 62' ' ' GLU . 3.4 p80 -79.56 170.48 16.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.098 0.475 . . . . 10.0 111.601 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.4 t -145.11 132.54 20.72 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.027 -0.533 . . . . 10.0 110.652 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -72.83 -32.89 65.81 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.114 -0.494 . . . . 10.0 111.016 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 162.24 -143.32 8.66 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 121.171 -0.538 . . . . 10.0 112.558 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -137.73 168.92 18.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.78 0.324 . . . . 10.0 110.772 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.48 HG12 HG22 ' A' ' 79' ' ' ILE . 58.7 mt -106.48 141.13 22.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.968 -0.382 . . . . 10.0 109.968 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -93.06 -44.15 8.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.958 -0.564 . . . . 10.0 110.809 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.3 tttt -157.43 146.63 19.95 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.088 -0.505 . . . . 10.0 110.572 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.404 HG13 HG21 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -121.08 75.46 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.847 -0.615 . . . . 10.0 110.008 179.191 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 1.001 ' HB3' ' HB ' ' A' ' 76' ' ' THR . 6.6 t70 -86.57 69.42 10.36 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.564 -0.744 . . . . 10.0 111.23 -178.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 54.55 178.29 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.681 0 CA-C-N 115.357 -0.838 . . . . 10.0 112.0 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -72.17 49.49 1.35 Allowed 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 122.008 1.805 . . . . 10.0 110.845 177.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -137.66 -50.53 0.61 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.923 -0.58 . . . . 10.0 110.647 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . 1.001 ' HB ' ' HB3' ' A' ' 72' ' ' ASP . 11.7 m -118.39 109.24 16.03 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.769 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 28.6 tp -117.42 126.89 53.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.125 -0.489 . . . . 10.0 110.469 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.5 t -128.04 115.7 39.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-N 116.35 -0.386 . . . . 10.0 110.249 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.48 HG22 HG12 ' A' ' 68' ' ' ILE . 31.8 pt -131.08 166.35 28.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.795 0.331 . . . . 10.0 111.543 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -127.27 125.65 5.34 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.393 -0.683 . . . . 10.0 111.393 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -93.1 156.71 16.7 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.606 0.241 . . . . 10.0 110.873 -179.176 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 50.4 mtp180 -106.5 178.4 4.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.096 -0.502 . . . . 10.0 110.774 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.35 151.97 32.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.323 -0.399 . . . . 10.0 111.374 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.461 ' H ' HG23 ' A' ' 129' ' ' VAL . 1.6 t-20 -88.73 -165.46 1.34 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.165 -0.471 . . . . 10.0 110.887 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.498 ' HA3' ' HG2' ' A' ' 88' ' ' ARG . . . 131.18 156.37 8.48 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 121.091 -0.576 . . . . 10.0 112.067 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -101.66 -86.38 0.41 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.673 0.273 . . . . 10.0 110.611 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -84.44 58.0 5.01 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 121.122 -0.561 . . . . 10.0 111.871 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.498 ' HG2' ' HA3' ' A' ' 85' ' ' GLY . 0.4 OUTLIER -121.09 154.55 35.99 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.747 0.308 . . . . 10.0 110.923 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.565 HG12 ' H ' ' A' ' 90' ' ' ASP . 11.9 tt -68.68 175.39 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 115.738 -0.665 . . . . 10.0 110.319 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.565 ' H ' HG12 ' A' ' 89' ' ' ILE . 82.6 m-20 -55.99 140.86 68.9 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.021 0.439 . . . . 10.0 111.662 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 90' ' ' ASP . 43.3 Cg_endo -85.85 61.41 5.15 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.918 2.412 . . . . 10.0 112.906 -178.263 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -83.61 71.91 10.34 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.258 0.551 . . . . 10.0 110.45 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -152.29 -63.47 0.17 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.87 -0.789 . . . . 10.0 108.87 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.3 m 62.98 170.76 0.15 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.181 -0.918 . . . . 10.0 112.944 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.3 m -137.99 111.35 8.0 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.531 -0.544 . . . . 10.0 109.531 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.66 140.68 29.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.304 -0.407 . . . . 10.0 111.093 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -132.1 148.4 52.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.164 -0.471 . . . . 10.0 111.066 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.74 121.19 41.95 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.688 -0.486 . . . . 10.0 109.688 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 46.7 t -108.1 131.83 57.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.816 0.341 . . . . 10.0 111.233 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.8 m -118.77 139.89 50.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.024 -0.535 . . . . 10.0 110.287 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -112.97 109.04 18.2 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.35 -0.386 . . . . 10.0 111.181 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.3 t -114.88 110.41 31.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.073 0.463 . . . . 10.0 109.834 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -100.35 143.49 30.47 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.186 0.517 . . . . 10.0 111.508 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -125.83 109.94 13.11 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.741 -0.663 . . . . 10.0 109.32 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 78.96 13.63 82.86 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.908 -0.663 . . . . 10.0 111.96 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 72.28 -42.94 0.55 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.013 0.746 . . . . 10.0 113.013 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.402 ' H ' ' HG2' ' A' ' 107' ' ' LYS . 30.3 pttt -73.47 -37.29 65.82 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.637 0.606 . . . . 10.0 112.637 -178.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -96.45 108.69 21.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.668 0.27 . . . . 10.0 110.56 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.434 ' HB ' ' HB ' ' A' ' 12' ' ' VAL . 11.6 m -109.07 121.33 44.91 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.94 0.4 . . . . 10.0 110.701 -179.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -108.31 130.08 55.2 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.343 -0.389 . . . . 10.0 110.568 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.535 HG13 ' HB ' ' A' ' 10' ' ' VAL . 1.5 p -118.83 123.25 71.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.196 -0.456 . . . . 10.0 110.014 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -122.37 147.63 46.04 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.322 0.582 . . . . 10.0 111.871 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 38.7 t -113.23 131.16 65.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.48 -0.782 . . . . 10.0 109.672 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.75 135.36 34.61 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 123.282 0.363 . . . . 10.0 110.43 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -175.09 149.46 1.09 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.129 -0.487 . . . . 10.0 109.98 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -151.63 91.05 1.61 Allowed 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.151 -0.477 . . . . 10.0 110.675 179.034 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 14.8 t60 -175.82 -59.07 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.905 -0.588 . . . . 10.0 110.268 -179.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -89.62 -4.89 57.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.269 -0.423 . . . . 10.0 111.164 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.459 ' OD2' ' HA ' ' A' ' 5' ' ' PHE . 22.5 p-10 -86.27 -39.1 16.88 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.058 -0.519 . . . . 10.0 111.564 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -78.91 57.21 2.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.907 0.384 . . . . 10.0 111.899 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 18.3 ptt? -167.81 27.32 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.079 -0.509 . . . . 10.0 110.558 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -77.67 -101.91 0.18 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.845 -0.693 . . . . 10.0 112.85 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.447 ' HB ' ' H ' ' A' ' 124' ' ' LYS . 0.2 OUTLIER 53.3 -101.28 0.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 122.886 0.474 . . . . 10.0 111.945 -179.496 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.447 ' H ' ' HB ' ' A' ' 123' ' ' THR . 53.2 pttt -64.88 -34.42 78.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.928 0.394 . . . . 10.0 110.73 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 35.5 m170 -70.26 -38.82 75.2 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.611 -0.514 . . . . 10.0 109.611 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.76 -50.54 66.45 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.543 -0.753 . . . . 10.0 110.301 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -60.17 -29.4 68.65 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.194 -0.457 . . . . 10.0 111.128 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.436 HH11 ' HD2' ' A' ' 128' ' ' ARG . 9.0 mtp180 -79.62 -45.69 18.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.06 -0.518 . . . . 10.0 111.913 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.461 HG23 ' H ' ' A' ' 84' ' ' ASN . 9.5 p -73.1 -29.63 29.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 112.116 0.413 . . . . 10.0 112.116 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -74.24 -1.33 20.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.131 0.491 . . . . 10.0 111.712 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -72.14 -20.41 61.61 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.534 -0.543 . . . . 10.0 109.534 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -133.54 -44.77 0.12 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.557 -0.83 . . . . 10.0 112.78 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -62.9 -37.75 88.2 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.399 0.518 . . . . 10.0 112.399 -179.067 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -68.86 -11.32 60.39 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.795 0.331 . . . . 10.0 111.877 -178.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -84.01 -8.08 59.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.699 0.285 . . . . 10.0 111.693 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -141.31 -34.4 0.11 Allowed Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.049 -1.072 . . . . 10.0 114.725 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.477 ' HB3' ' HD3' ' A' ' 138' ' ' PRO . 3.5 t90 -56.7 -61.55 6.65 Favored Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 113.573 0.953 . . . . 10.0 113.573 -178.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.477 ' HD3' ' HB3' ' A' ' 137' ' ' TRP . 37.0 Cg_endo -66.51 -14.15 42.85 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 121.795 1.664 . . . . 10.0 112.01 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.3 m -82.12 -47.14 12.91 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.872 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 10.7 tp -71.99 -31.87 41.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.41 -0.359 . . . . 10.0 111.202 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 61.7 mt -55.76 -41.78 74.49 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.036 0.446 . . . . 10.0 111.945 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -82.31 -42.62 18.55 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.481 -0.327 . . . . 10.0 111.405 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 19.6 m -62.16 -38.57 89.52 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.768 0.655 . . . . 10.0 112.768 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -63.49 -34.59 78.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.617 -0.265 . . . . 10.0 111.623 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -63.05 -43.94 97.25 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.981 0.419 . . . . 10.0 110.939 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -72.32 -31.1 65.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.265 -0.425 . . . . 10.0 111.458 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 8.6 ttpp -60.5 -51.0 71.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.495 . . . . 10.0 110.351 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.477 HG21 HG13 ' A' ' 12' ' ' VAL . 31.3 mt -67.34 -38.15 80.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.343 -0.39 . . . . 10.0 110.728 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -59.59 -37.34 78.28 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.426 0.631 . . . . 10.0 110.018 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 1.025 ' HA ' ' HB2' ' A' ' 154' ' ' LYS . 19.6 tt0 -72.04 -41.12 67.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.816 -0.629 . . . . 10.0 111.645 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -84.05 60.3 5.79 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.257 -0.428 . . . . 10.0 111.627 -179.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 161.39 -44.71 0.39 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.346 -0.93 . . . . 10.0 113.337 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -107.39 -55.66 2.31 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 122.728 -0.278 . . . . 10.0 111.69 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 1.025 ' HB2' ' HA ' ' A' ' 150' ' ' GLU . 53.6 mtpt -63.32 -38.47 91.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.083 -0.508 . . . . 10.0 111.931 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 90.9 mttt . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.375 -0.822 . . . . 10.0 110.348 -179.424 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.481 ' HA ' ' O ' ' A' ' 5' ' ' PHE . 25.6 p-10 . . . . . 0 N--CA 1.479 1.008 0 N-CA-C 110.471 -0.196 . . . . 10.0 110.471 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.424 ' HE1' ' CB ' ' A' ' 126' ' ' ALA 0.318 0.5 OUTLIER 67.2 -51.49 0.48 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.933 1.827 . . . . 10.0 115.933 178.369 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.744 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 10.9 t70 -92.46 -58.45 0.22 Allowed Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 112.674 0.62 . . . . 10.0 112.674 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.744 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 7.7 Cg_exo -75.57 -25.81 10.64 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.211 1.941 . . . . 10.0 112.475 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.609 ' HA ' ' OD2' ' A' ' 119' ' ' ASP . 36.5 p90 -178.67 140.6 0.19 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.677 -0.692 . . . . 10.0 110.138 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.7 p -97.56 115.08 36.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 121.365 0.602 . . . . 10.0 111.389 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 21.7 mtt180 -153.57 112.01 3.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.648 -0.706 . . . . 10.0 110.572 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -128.61 141.06 51.47 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.448 -0.575 . . . . 10.0 109.448 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.3 m -125.6 128.62 48.19 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.716 0.293 . . . . 10.0 111.029 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.622 ' HB ' HG13 ' A' ' 111' ' ' VAL . 40.2 t -119.59 136.8 55.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.324 -0.398 . . . . 10.0 110.264 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.43 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 34.4 m -105.08 125.36 50.9 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.372 -0.376 . . . . 10.0 110.415 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.556 HG12 ' H ' ' A' ' 14' ' ' ALA . 26.3 t -110.19 125.92 67.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.952 0.406 . . . . 10.0 110.067 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.8 mmmp? -91.7 28.34 1.8 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.742 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.556 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -130.46 -152.98 0.53 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.89 -0.596 . . . . 10.0 110.202 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -108.67 173.87 6.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.057 0.455 . . . . 10.0 112.055 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -60.6 -38.59 85.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.491 -0.777 . . . . 10.0 112.434 -178.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -74.45 -45.43 46.38 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.497 0.554 . . . . 10.0 112.497 -178.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.2 p -62.14 -36.95 83.37 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.92 -0.312 . . . . 10.0 111.832 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.481 ' HB2' HG11 ' A' ' 12' ' ' VAL . . . -70.1 -37.81 75.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.97 0.414 . . . . 10.0 111.197 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -74.01 -39.85 63.32 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.956 0.408 . . . . 10.0 111.488 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.3 tttm -66.48 -33.75 76.39 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.392 0.516 . . . . 10.0 112.392 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.0 p -79.52 -5.14 54.23 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.431 0.53 . . . . 10.0 112.431 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -112.19 -34.59 5.88 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.493 0.553 . . . . 10.0 112.493 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.57 ' HG ' HG11 ' A' ' 46' ' ' VAL . 1.0 OUTLIER -110.01 5.31 22.14 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 113.342 0.867 . . . . 10.0 113.342 -178.544 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -139.93 -55.44 0.55 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.288 0.477 . . . . 10.0 112.288 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.39 92.57 0.87 Allowed Glycine 0 C--O 1.224 -0.529 0 C-N-CA 120.889 -0.672 . . . . 10.0 112.607 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.52 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 2.0 t80 -96.83 -58.89 0.17 Allowed Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 112.384 0.512 . . . . 10.0 112.384 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.52 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 5.5 Cg_exo -79.92 22.43 0.73 Allowed 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.367 2.045 . . . . 10.0 111.375 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -109.09 9.62 26.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.796 -0.638 . . . . 10.0 110.518 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 46.9 m0 -87.08 -151.83 0.18 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.192 -0.458 . . . . 10.0 110.12 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.641 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 34.9 t90 -172.77 -51.17 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 112.204 0.446 . . . . 10.0 112.204 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.641 ' HD2' ' N ' ' A' ' 31' ' ' TRP . 99.7 Cg_exo -18.82 -63.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.369 1.618 1 C-N-CA 125.648 4.232 . . . . 10.0 117.227 -178.478 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -148.11 36.66 0.84 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.093 0.473 . . . . 10.0 110.69 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -123.79 48.59 1.86 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.356 0.598 . . . . 10.0 110.825 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -78.69 58.15 2.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.622 -0.717 . . . . 10.0 110.489 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 36' ' ' ARG . 0.1 OUTLIER -168.63 174.91 6.41 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.65 -0.5 . . . . 10.0 109.65 -179.648 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.21 161.76 36.63 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.355 -0.609 . . . . 10.0 109.355 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.527 HG22 ' HA ' ' A' ' 57' ' ' ASP . 1.7 m 72.03 -65.43 0.35 Allowed 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.644 0.609 . . . . 10.0 112.644 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.429 ' HD3' ' HA ' ' A' ' 39' ' ' LYS . 4.5 mmtp -68.97 -33.39 73.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.231 0.538 . . . . 10.0 111.688 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.0 p -153.15 121.17 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.591 -0.731 . . . . 10.0 109.289 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.34 54.73 1.79 Allowed Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.608 -0.997 . . . . 10.0 110.608 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.55 163.77 48.07 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.553 -0.324 . . . . 10.0 110.39 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -72.08 43.44 0.59 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.832 2.355 . . . . 10.0 113.014 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 33.5 tp -165.39 -91.23 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.266 -0.425 . . . . 10.0 110.025 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.73 -57.2 3.85 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.213 -0.518 . . . . 10.0 113.076 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.57 HG11 ' HG ' ' A' ' 24' ' ' LEU . 1.9 t -99.82 135.11 36.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.765 0.317 . . . . 10.0 111.006 -178.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -105.91 112.58 25.69 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.527 -0.546 . . . . 10.0 109.527 178.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.77 19.73 16.58 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.933 -0.576 . . . . 10.0 110.752 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -96.3 -57.31 2.36 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 109.393 -0.595 . . . . 10.0 109.393 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -105.81 -36.16 2.84 Favored Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 110.805 -0.918 . . . . 10.0 110.805 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.67 68.3 0.46 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.647 -0.787 . . . . 10.0 112.25 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -156.14 -179.27 7.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.8 0.333 . . . . 10.0 111.33 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.478 ' CZ3' HG22 ' A' ' 46' ' ' VAL . 75.3 m95 -122.73 136.88 55.01 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.422 -0.584 . . . . 10.0 109.422 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -165.98 122.34 1.33 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.799 0.333 . . . . 10.0 111.775 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.414 ' O ' ' HA ' ' A' ' 61' ' ' GLU . 2.0 mm-40 -86.12 149.54 25.06 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.071 -0.513 . . . . 10.0 110.297 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.9 mm -103.42 110.53 30.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.363 -0.38 . . . . 10.0 112.01 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.527 ' HA ' HG22 ' A' ' 38' ' ' THR . 13.1 t70 -108.34 165.73 11.29 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.612 -0.514 . . . . 10.0 109.612 178.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -57.22 -27.06 61.67 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.999 0.74 . . . . 10.0 112.999 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -103.03 -1.24 29.57 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.103 0.409 . . . . 10.0 112.103 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 132.29 -160.92 23.84 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.957 -0.64 . . . . 10.0 111.745 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 55' ' ' GLU . 60.4 mp0 -69.45 128.03 35.1 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.821 -0.437 . . . . 10.0 109.821 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.7 -95.35 0.2 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.936 0.717 . . . . 10.0 112.936 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -98.56 166.31 11.41 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.173 0.511 . . . . 10.0 112.232 -178.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.8 t -148.51 150.21 32.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.674 -0.694 . . . . 10.0 109.907 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.774 ' CD2' ' H61' ' A' ' 627' ' ' MRP . 15.5 m-85 -89.09 -43.83 10.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.942 -0.572 . . . . 10.0 111.11 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 174.23 -141.2 5.81 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.7 -0.762 . . . . 10.0 111.763 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -135.48 166.06 24.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.736 0.303 . . . . 10.0 111.001 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 65.4 mt -109.76 133.53 54.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.742 -0.466 . . . . 10.0 109.742 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.0 mmt180 -83.12 -54.08 5.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.583 -0.28 . . . . 10.0 110.596 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.6 mtpm? -150.43 147.66 27.81 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.347 -0.388 . . . . 10.0 111.294 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -119.99 82.91 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.517 -0.765 . . . . 10.0 109.728 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.749 ' HB2' ' HB ' ' A' ' 76' ' ' THR . 8.1 m-20 -92.33 68.23 4.96 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.772 -0.649 . . . . 10.0 111.191 -178.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 72' ' ' ASP . 5.5 pt-20 56.11 177.78 0.04 OUTLIER Pre-proline 0 N--CA 1.474 0.731 0 O-C-N 123.922 0.764 . . . . 10.0 112.078 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -71.31 47.36 0.82 Allowed 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.141 1.894 . . . . 10.0 111.532 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -135.82 -43.84 0.66 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.96 -0.564 . . . . 10.0 110.979 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.749 ' HB ' ' HB2' ' A' ' 72' ' ' ASP . 12.5 m -129.75 125.89 36.92 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.383 -0.371 . . . . 10.0 110.556 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 27.2 tp -136.5 128.62 29.68 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.487 -0.324 . . . . 10.0 110.773 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.2 t -121.08 123.21 69.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.936 -0.764 . . . . 10.0 108.936 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.444 HD12 ' CZ3' ' A' ' 81' ' ' TRP . 1.8 pt -133.79 168.14 24.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 112.445 0.535 . . . . 10.0 112.445 -178.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -135.2 130.39 5.42 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 110.549 -1.02 . . . . 10.0 110.549 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.444 ' CZ3' HD12 ' A' ' 79' ' ' ILE . 0.8 OUTLIER -106.36 156.91 18.03 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 112.741 0.645 . . . . 10.0 112.741 -178.238 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 43.6 mtp180 -100.79 -164.76 1.14 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.481 -0.781 . . . . 10.0 109.402 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.2 pp -139.26 161.22 37.97 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.63 0.252 . . . . 10.0 111.431 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -77.54 -160.39 0.18 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.117 -0.492 . . . . 10.0 111.794 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 120.8 135.89 4.97 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.988 -0.845 . . . . 10.0 110.988 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -93.85 -85.92 0.28 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.761 0.315 . . . . 10.0 111.222 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.446 ' N ' ' H5 ' ' A' ' 629' ' ' MTC . . . -82.66 67.93 3.64 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.972 -0.632 . . . . 10.0 112.005 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.83 151.71 38.35 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.57 0.224 . . . . 10.0 110.555 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 6.2 tp -62.73 144.67 14.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.718 -0.475 . . . . 10.0 109.718 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -52.39 130.82 43.69 Favored Pre-proline 0 C--N 1.331 -0.234 0 O-C-N 123.255 0.347 . . . . 10.0 111.061 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.88 89.89 0.24 Allowed 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 123.0 2.466 . . . . 10.0 112.776 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -87.77 71.77 9.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.999 -0.546 . . . . 10.0 110.231 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -162.12 -70.57 0.05 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.693 -0.685 . . . . 10.0 109.772 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.8 m 70.77 161.61 0.23 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.285 -0.871 . . . . 10.0 112.69 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.5 m -117.28 133.7 55.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.077 -0.51 . . . . 10.0 110.554 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -93.65 147.32 23.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.128 -0.487 . . . . 10.0 110.881 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -139.48 136.81 34.97 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 123.275 0.359 . . . . 10.0 110.507 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 6.4 m -101.91 123.01 45.11 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.662 -0.495 . . . . 10.0 109.662 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 95.5 t -107.87 121.95 61.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.189 -0.46 . . . . 10.0 110.948 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.68 129.07 56.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.267 -0.424 . . . . 10.0 110.781 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -101.41 125.45 48.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.812 0.339 . . . . 10.0 110.834 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 90.3 t -117.84 126.34 74.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.095 -0.502 . . . . 10.0 109.769 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -99.99 130.86 46.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.718 -0.219 . . . . 10.0 110.659 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -118.76 100.61 7.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.959 0.409 . . . . 10.0 111.164 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.05 12.35 65.13 Favored Glycine 0 CA--C 1.52 0.386 0 CA-C-N 116.042 -0.526 . . . . 10.0 113.381 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 68.31 -16.56 0.19 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.578 0.955 . . . . 10.0 113.578 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 46.2 pttt -99.82 -6.56 26.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.064 0.459 . . . . 10.0 111.483 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -136.48 147.84 47.37 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.056 -0.72 . . . . 10.0 109.056 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.83 146.81 47.9 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.272 0.558 . . . . 10.0 111.76 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -131.9 139.26 48.7 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.779 -0.646 . . . . 10.0 109.435 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.622 HG13 ' HB ' ' A' ' 10' ' ' VAL . 2.2 p -133.75 129.76 55.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-O 120.746 0.308 . . . . 10.0 111.005 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -125.93 155.79 40.75 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.25 -0.432 . . . . 10.0 111.534 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 98' ' ' THR . 48.6 t -115.98 127.97 73.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.828 -0.624 . . . . 10.0 109.61 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -127.25 136.97 52.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.35 -0.386 . . . . 10.0 111.671 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -175.99 155.31 1.58 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.857 -0.61 . . . . 10.0 111.347 178.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.4 m -160.14 91.89 0.97 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.772 -0.825 . . . . 10.0 108.772 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 179.01 -62.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 10.0 111.028 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -98.44 14.86 26.68 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.085 -0.507 . . . . 10.0 111.558 -178.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.609 ' OD2' ' HA ' ' A' ' 5' ' ' PHE . 20.6 p-10 -98.25 -46.06 5.96 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.593 -0.731 . . . . 10.0 109.699 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.439 ' HA ' ' O ' ' A' ' 3' ' ' ASP . 98.5 mtt180 -78.54 48.81 0.81 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.489 -0.778 . . . . 10.0 111.582 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 19.4 ptt? -146.25 18.22 1.38 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.918 -0.583 . . . . 10.0 109.624 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -74.23 -96.99 0.1 Allowed Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.591 -0.732 . . . . 10.0 112.789 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.1 m 55.24 -91.57 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 122.905 0.482 . . . . 10.0 111.573 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 35.9 pttt -74.04 -36.65 64.41 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.894 -0.41 . . . . 10.0 109.894 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 34.7 m170 -69.48 -24.17 63.74 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.957 -0.565 . . . . 10.0 110.603 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.424 ' CB ' ' HE1' ' A' ' 2' ' ' TYR . . . -60.0 -58.36 8.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.322 -0.854 . . . . 10.0 110.523 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -62.15 -33.07 73.79 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.098 -0.501 . . . . 10.0 111.048 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 30.5 mtp180 -65.06 -44.09 90.11 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.154 -0.476 . . . . 10.0 112.024 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 9.9 p -81.06 -30.83 11.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.849 0.357 . . . . 10.0 111.637 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 48.7 mtp180 -72.49 -4.38 30.1 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.083 0.468 . . . . 10.0 111.827 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -84.54 0.61 49.27 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.757 -0.656 . . . . 10.0 110.517 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -149.37 -53.8 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.584 -0.817 . . . . 10.0 112.988 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' MET . . . . . 0.651 ' HE1' ' HX3' ' A' ' 626' ' ' HIB . 0.8 OUTLIER -66.23 -37.81 86.43 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.183 0.809 . . . . 10.0 113.183 -178.588 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -63.55 -22.94 67.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.855 0.359 . . . . 10.0 111.624 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -80.9 38.76 0.47 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.998 0.428 . . . . 10.0 111.465 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.504 ' HA3' ' C7 ' ' A' ' 627' ' ' MRP . . . 171.18 -34.88 0.16 Allowed Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.774 -0.727 . . . . 10.0 113.419 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.469 ' HB3' ' HD3' ' A' ' 138' ' ' PRO . 11.2 t90 -57.0 -63.07 4.03 Favored Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 113.541 0.941 . . . . 10.0 113.541 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.469 ' HD3' ' HB3' ' A' ' 137' ' ' TRP . 33.2 Cg_endo -65.68 -29.79 51.25 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 121.279 1.32 . . . . 10.0 111.794 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.36 -43.75 76.73 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.799 -0.637 . . . . 10.0 111.493 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 11.2 tt -70.37 -32.55 50.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.561 -0.29 . . . . 10.0 111.461 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 70.6 mt -61.52 -45.76 92.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.039 0.447 . . . . 10.0 111.175 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -67.68 -40.99 84.38 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.713 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 15.2 m -67.37 -35.47 79.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.803 -0.635 . . . . 10.0 111.598 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.42 ' HD1' ' HA ' ' A' ' 144' ' ' PHE . 0.6 OUTLIER -59.55 -44.6 93.2 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.842 0.353 . . . . 10.0 111.024 179.289 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.43 ' HG3' ' O ' ' A' ' 11' ' ' THR . 51.1 tt0 -58.63 -49.56 77.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.856 -0.611 . . . . 10.0 110.947 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -65.64 -36.02 82.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.062 -0.517 . . . . 10.0 111.796 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -62.03 -53.65 52.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.934 -0.576 . . . . 10.0 110.766 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 57.3 mt -65.84 -34.71 72.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.029 -0.532 . . . . 10.0 110.044 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -61.78 -40.94 96.94 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.107 -0.497 . . . . 10.0 109.93 178.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 1.052 ' HA ' ' HB2' ' A' ' 154' ' ' LYS . 16.7 tt0 -70.89 -42.59 69.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.326 -0.397 . . . . 10.0 111.391 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -79.63 26.79 0.3 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.782 0.325 . . . . 10.0 111.798 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -155.28 -60.4 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.552 -0.832 . . . . 10.0 113.199 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -99.21 -48.16 4.93 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.839 0.681 . . . . 10.0 112.839 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 1.052 ' HB2' ' HA ' ' A' ' 150' ' ' GLU . 46.9 mtpt -60.95 -42.81 98.95 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.291 0.478 . . . . 10.0 112.291 -179.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 77.9 mttt . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.357 -0.83 . . . . 10.0 110.223 179.454 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 621' ' ' DAG . . . . . 1.162 ' O1 ' ' H12' ' A' ' 629' ' ' MTC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 625' ' ' DSR . . . . . 1.45 ' S4 ' ' C7 ' ' A' ' 626' ' ' HIB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 626' ' ' HIB . . . . . 1.45 ' C7 ' ' S4 ' ' A' ' 625' ' ' DSR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 627' ' ' MRP . . . . . 1.439 ' O1 ' ' C2 ' ' A' ' 626' ' ' HIB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 628' ' ' EMP . . . . . 0.998 ' H72' ' C5 ' ' A' ' 628' ' ' EMP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 629' ' ' MTC . . . . . 1.162 ' H12' ' O1 ' ' A' ' 621' ' ' DAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.551 ' HA ' ' O ' ' A' ' 5' ' ' PHE . 28.7 p-10 . . . . . 0 N--CA 1.479 0.989 0 CA-C-O 120.463 0.173 . . . . 10.0 110.728 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . 0.283 11.8 p90 50.44 30.18 4.44 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 115.572 1.693 . . . . 10.0 115.572 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.785 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 34.2 t70 -165.65 -63.64 0.01 OUTLIER Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 111.995 0.369 . . . . 10.0 111.995 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.785 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 92.0 Cg_endo -87.8 -31.86 0.19 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 121.77 1.647 . . . . 10.0 112.469 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.551 ' O ' ' HA ' ' A' ' 1' ' ' ASN . 12.6 p90 -174.26 141.6 0.74 Allowed 'General case' 0 C--O 1.24 0.56 0 CA-C-N 115.533 -0.758 . . . . 10.0 109.436 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.6 p -100.79 127.16 54.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.113 0.482 . . . . 10.0 111.258 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 7' ' ' ARG . 0.1 OUTLIER -159.23 108.52 1.89 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.843 -0.617 . . . . 10.0 110.348 -179.651 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -131.33 150.9 51.96 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.045 -0.525 . . . . 10.0 109.832 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 17.0 m -145.8 135.81 23.65 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.548 0.213 . . . . 10.0 111.084 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.0 t -121.52 132.89 69.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.052 -0.522 . . . . 10.0 109.639 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.97 122.25 39.75 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.501 -0.318 . . . . 10.0 110.746 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.2 t -131.04 141.89 44.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.017 -0.538 . . . . 10.0 109.801 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.7 mttp -84.63 54.44 3.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.05 0.452 . . . . 10.0 110.555 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -123.26 -163.03 1.08 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.897 -0.592 . . . . 10.0 110.325 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -113.38 166.97 10.97 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.224 -0.444 . . . . 10.0 111.79 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.477 HH21 ' HB2' ' A' ' 75' ' ' ASP . 36.4 ttt180 -55.11 -38.32 68.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.552 -0.749 . . . . 10.0 112.419 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -74.35 -54.63 7.26 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.96 0.356 . . . . 10.0 111.96 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -52.11 -43.08 63.78 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 112.607 0.595 . . . . 10.0 112.607 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.13 -42.43 80.2 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.992 0.368 . . . . 10.0 111.992 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -69.31 -36.88 77.44 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.182 0.515 . . . . 10.0 111.283 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.3 mtpt -69.66 -32.28 70.84 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 113.265 0.839 . . . . 10.0 113.265 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.28 -9.67 58.96 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.91 0.707 . . . . 10.0 112.91 -178.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -116.94 -19.63 9.73 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.923 0.712 . . . . 10.0 112.923 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.9 mp -120.55 10.77 11.18 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 114.33 1.234 . . . . 10.0 114.33 -178.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -155.64 -45.4 0.08 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.038 0.384 . . . . 10.0 112.038 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.99 104.24 2.2 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.492 -0.861 . . . . 10.0 111.262 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -109.15 -56.14 0.05 OUTLIER Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 112.338 0.496 . . . . 10.0 112.338 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.427 ' CG ' ' HA ' ' A' ' 43' ' ' PRO . 7.8 Cg_exo -74.15 14.96 0.65 Allowed 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.261 1.974 . . . . 10.0 112.359 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.63 8.96 37.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.215 0.531 . . . . 10.0 110.034 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.571 ' HB2' HD21 ' A' ' 34' ' ' ASN . 40.8 m0 -87.68 -164.84 1.16 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.621 -0.718 . . . . 10.0 110.363 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.633 ' H ' ' HD2' ' A' ' 32' ' ' PRO . 57.5 t90 -169.99 -50.62 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.513 0 CA-C-O 119.257 -0.402 . . . . 10.0 111.957 -178.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.633 ' HD2' ' H ' ' A' ' 31' ' ' TRP . 80.4 Cg_exo -26.28 -55.41 0.09 OUTLIER 'Trans proline' 0 C--N 1.367 1.525 0 C-N-CA 125.154 3.903 . . . . 10.0 116.9 -179.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -128.11 -41.43 1.6 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.694 0.627 . . . . 10.0 112.694 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.571 HD21 ' HB2' ' A' ' 30' ' ' TRP . 14.3 p-10 -77.95 93.87 4.5 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.372 0.605 . . . . 10.0 111.613 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -101.07 0.65 38.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.325 -0.852 . . . . 10.0 111.408 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.3 mtp180 -119.96 -160.18 0.81 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.737 0.303 . . . . 10.0 111.077 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.21 155.47 46.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.253 -0.43 . . . . 10.0 110.567 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.86 ' HB ' ' HA ' ' A' ' 57' ' ' ASP 0.267 9.8 p 67.66 -65.36 0.24 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 114.484 1.29 . . . . 10.0 114.484 178.726 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.671 ' HA ' ' HG3' ' A' ' 62' ' ' GLU . 5.4 mptt -74.81 -10.6 59.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.957 0.408 . . . . 10.0 111.006 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.4 p -173.85 89.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.34 -0.845 . . . . 10.0 109.971 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.69 68.49 0.55 Allowed Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.714 -0.675 . . . . 10.0 111.958 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.06 158.55 41.42 Favored Pre-proline 0 C--N 1.322 -0.591 0 O-C-N 122.656 -0.32 . . . . 10.0 110.799 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.427 ' HA ' ' CG ' ' A' ' 28' ' ' PRO . 41.7 Cg_exo -59.44 -28.35 87.32 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.763 2.308 . . . . 10.0 113.144 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 19.0 mt -95.29 -89.0 0.25 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.801 0.334 . . . . 10.0 111.058 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.25 -55.16 5.02 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.928 -0.653 . . . . 10.0 112.824 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.8 t -105.01 132.06 52.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.745 0.307 . . . . 10.0 111.087 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.478 ' OD1' ' HG2' ' A' ' 49' ' ' LYS . 1.0 OUTLIER -100.38 118.33 36.4 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.974 -0.557 . . . . 10.0 109.638 178.404 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.7 pttt -106.13 6.46 30.99 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.958 -0.565 . . . . 10.0 112.351 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.478 ' HG2' ' OD1' ' A' ' 47' ' ' ASP . 17.7 pttt -92.65 -24.1 18.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.861 0.362 . . . . 10.0 110.112 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -131.21 -60.02 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 111.269 -0.732 . . . . 10.0 111.269 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 135.02 71.34 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.716 -0.754 . . . . 10.0 112.363 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -159.77 168.5 25.74 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.75 -0.265 . . . . 10.0 110.65 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 43.1 m95 -116.02 135.62 53.79 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.601 -0.889 . . . . 10.0 108.601 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -165.77 122.64 1.41 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.332 0.493 . . . . 10.0 112.332 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -82.17 138.49 34.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.026 -0.534 . . . . 10.0 109.852 178.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 48.1 mm -98.46 124.75 51.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.284 -0.416 . . . . 10.0 110.279 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.86 ' HA ' ' HB ' ' A' ' 38' ' ' THR . 23.7 t70 -120.94 168.4 11.53 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.385 -0.37 . . . . 10.0 110.243 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -62.16 -29.3 70.26 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 122.829 0.452 . . . . 10.0 110.923 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -86.88 -9.59 55.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.28 -0.418 . . . . 10.0 111.463 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 138.59 -103.51 0.4 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.616 -0.802 . . . . 10.0 112.019 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -117.5 154.97 30.54 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.802 0.334 . . . . 10.0 110.892 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.671 ' HG3' ' HA ' ' A' ' 39' ' ' LYS . 3.0 mm-40 -118.29 -146.35 0.39 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.932 -0.576 . . . . 10.0 111.158 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.486 ' H ' ' HB3' ' A' ' 62' ' ' GLU . 4.5 p80 -67.5 172.64 4.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.338 0.59 . . . . 10.0 112.58 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.3 t -147.41 144.19 28.48 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.632 -0.713 . . . . 10.0 110.412 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 1.185 ' CD1' ' H61' ' A' ' 632' ' ' MRP . 75.5 m-85 -84.49 -38.74 19.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.111 -0.495 . . . . 10.0 111.151 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 171.27 -145.51 8.91 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.795 -0.717 . . . . 10.0 111.978 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.0 pp -140.47 161.93 36.55 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.731 0.3 . . . . 10.0 110.942 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.508 HG21 HG13 ' A' ' 71' ' ' VAL . 55.0 mt -106.44 123.4 61.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.803 -0.814 . . . . 10.0 108.803 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.3 ttm180 -93.09 -27.67 16.81 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.592 -0.276 . . . . 10.0 111.361 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.2 tptm -157.05 131.16 8.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.994 0.426 . . . . 10.0 111.84 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.508 HG13 HG21 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -129.0 102.96 8.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.427 -0.806 . . . . 10.0 108.901 178.683 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.76 ' HB2' ' HB ' ' A' ' 76' ' ' THR . 59.5 m-20 -118.54 78.93 1.31 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.566 -0.288 . . . . 10.0 110.794 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.513 ' HG2' ' O ' ' A' ' 72' ' ' ASP . 5.7 pt-20 55.4 178.7 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.663 0 O-C-N 123.971 0.794 . . . . 10.0 111.718 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -71.55 48.69 1.04 Allowed 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 121.955 1.77 . . . . 10.0 111.569 177.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.477 ' HB2' HH21 ' A' ' 16' ' ' ARG . 16.0 t70 -134.96 -55.52 0.82 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.306 -0.406 . . . . 10.0 111.088 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.76 ' HB ' ' HB2' ' A' ' 72' ' ' ASP . 5.0 m -113.23 119.18 36.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.159 -0.473 . . . . 10.0 110.753 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.478 ' HB3' ' HB ' ' A' ' 99' ' ' VAL . 59.7 tp -129.05 119.65 24.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.13 -0.486 . . . . 10.0 110.937 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 51.2 t -118.91 116.36 50.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.652 -0.499 . . . . 10.0 109.652 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 pp -133.95 161.99 40.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.353 -0.385 . . . . 10.0 111.943 -178.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.565 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -129.08 141.79 12.91 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 110.5 -1.04 . . . . 10.0 110.5 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -105.32 166.21 10.58 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.388 0.514 . . . . 10.0 112.388 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 82' ' ' ARG . 46.7 mtp180 -104.87 -168.76 1.52 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.802 -0.635 . . . . 10.0 110.53 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.421 ' HG ' ' HB3' ' A' ' 91' ' ' PRO . 0.3 OUTLIER -130.29 150.65 51.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.786 -0.643 . . . . 10.0 111.18 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -87.85 -168.49 2.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.883 -0.599 . . . . 10.0 110.529 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.709 ' O ' ' O3 ' ' A' ' 630' ' ' DSR . . . 131.73 157.58 8.77 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.828 -0.701 . . . . 10.0 112.915 179.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.735 ' O ' ' H61' ' A' ' 622' ' ' DAG . 62.6 m-85 -104.98 -85.83 0.47 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.23 0.538 . . . . 10.0 110.046 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -88.73 81.0 1.56 Allowed Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 111.232 -0.747 . . . . 10.0 111.232 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 5.5 ptt85 -141.94 175.53 9.65 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.624 0.249 . . . . 10.0 110.592 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.763 HG12 ' H ' ' A' ' 90' ' ' ASP . 10.3 tt -83.21 -174.64 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.011 -0.54 . . . . 10.0 110.612 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.763 ' H ' HG12 ' A' ' 89' ' ' ILE . 29.2 t70 -59.8 141.48 89.16 Favored Pre-proline 0 C--N 1.331 -0.236 0 C-N-CA 123.134 0.574 . . . . 10.0 110.972 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 90' ' ' ASP . 14.8 Cg_exo -69.37 60.05 1.46 Allowed 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.135 2.557 . . . . 10.0 113.142 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -82.03 92.75 6.85 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.249 0.547 . . . . 10.0 110.714 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -164.41 -69.2 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.761 -0.654 . . . . 10.0 110.21 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.2 m 66.14 90.78 0.09 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.077 0.769 . . . . 10.0 113.077 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.2 m -88.91 107.69 19.14 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.48 -0.563 . . . . 10.0 109.48 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.565 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 57.6 mt-10 -91.03 151.94 20.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.996 0.427 . . . . 10.0 111.914 -178.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -140.54 142.64 35.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.212 -0.904 . . . . 10.0 109.881 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.7 m -102.23 125.51 48.95 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.582 -0.281 . . . . 10.0 110.446 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.478 ' HB ' ' HB3' ' A' ' 77' ' ' LEU . 21.4 t -107.3 126.12 63.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.836 -0.62 . . . . 10.0 110.827 -178.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -112.4 134.39 53.96 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.226 -0.443 . . . . 10.0 110.652 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -102.43 123.63 46.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.27 -0.423 . . . . 10.0 111.532 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.8 t -119.8 119.69 61.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.154 -0.475 . . . . 10.0 109.737 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -104.07 136.07 44.39 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.809 0.338 . . . . 10.0 110.818 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -127.27 115.69 19.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.005 -0.543 . . . . 10.0 111.187 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.34 6.11 52.45 Favored Glycine 0 CA--C 1.518 0.261 0 CA-C-N 115.915 -0.584 . . . . 10.0 112.886 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 67.47 -3.15 1.13 Allowed 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.915 0.709 . . . . 10.0 112.915 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.2 ptmt -119.24 6.21 11.22 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.196 0.522 . . . . 10.0 111.605 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -140.06 132.58 28.66 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.167 -0.679 . . . . 10.0 109.167 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.8 m -117.72 130.37 56.28 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.397 0.517 . . . . 10.0 112.397 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -118.85 113.3 20.86 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.088 -1.078 . . . . 10.0 108.088 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 9' ' ' SER . 11.8 p -113.35 133.93 57.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 C-N-CA 120.449 -0.5 . . . . 10.0 111.29 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -127.9 148.33 50.48 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.048 -0.524 . . . . 10.0 111.795 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.6 t -126.27 113.85 35.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 108.82 -0.807 . . . . 10.0 108.82 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -129.44 144.58 51.31 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.172 0.511 . . . . 10.0 112.094 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -163.55 162.86 24.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.416 -0.811 . . . . 10.0 109.021 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -157.57 77.87 0.85 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.701 0.286 . . . . 10.0 110.491 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -172.41 -67.39 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.296 -0.411 . . . . 10.0 111.919 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.463 ' O ' ' HG2' ' A' ' 121' ' ' MET . 82.5 m-85 -81.57 -16.73 50.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.182 0.515 . . . . 10.0 111.579 -178.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -82.52 -16.8 47.32 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.828 -0.624 . . . . 10.0 110.67 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 77.8 mtt180 -91.65 32.2 1.12 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.181 0.438 . . . . 10.0 112.181 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.463 ' HG2' ' O ' ' A' ' 118' ' ' PHE . 21.3 ptp -136.19 23.32 3.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.086 0.47 . . . . 10.0 110.129 179.098 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -73.22 -106.67 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.701 -0.681 . . . . 10.0 112.789 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.2 m 53.41 -87.79 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.634 0.605 . . . . 10.0 112.634 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.479 ' O ' ' HG3' ' A' ' 128' ' ' ARG . 55.7 pttt -72.35 -35.61 68.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.838 0.352 . . . . 10.0 110.25 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -71.26 -31.99 68.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 10.0 110.883 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.6 -43.4 97.46 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.712 -0.676 . . . . 10.0 110.818 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -66.61 -37.15 84.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.934 -0.575 . . . . 10.0 111.02 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' A' ' 124' ' ' LYS . 45.9 mtp180 -69.31 -45.15 70.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 10.0 111.383 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.8 p -70.29 -20.42 22.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 112.205 0.446 . . . . 10.0 112.205 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.523 ' HG3' ' HB3' ' A' ' 134' ' ' ASP . 23.6 ttt180 -66.64 -15.42 63.46 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 121.067 0.461 . . . . 10.0 111.057 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -71.59 -4.21 25.8 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.233 0.457 . . . . 10.0 112.233 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -152.81 -50.29 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 119.999 -1.096 . . . . 10.0 113.744 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' MET . . . . . 0.681 ' HA ' ' O2 ' ' A' ' 632' ' ' MRP . 0.6 OUTLIER -63.09 -42.71 99.67 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.207 0.817 . . . . 10.0 113.207 -178.775 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.523 ' HB3' ' HG3' ' A' ' 130' ' ' ARG . 34.1 t70 -71.89 -3.03 20.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.179 0.514 . . . . 10.0 111.853 -179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.652 ' O ' ' H71' ' A' ' 632' ' ' MRP . 98.1 mttt -98.24 19.42 14.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.272 -0.422 . . . . 10.0 111.3 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.882 ' HA3' ' C7 ' ' A' ' 632' ' ' MRP . . . -175.08 -35.3 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 119.765 -1.207 . . . . 10.0 113.806 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -56.55 -58.05 19.52 Favored Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 113.457 0.91 . . . . 10.0 113.457 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.87 -41.23 46.97 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.118 1.879 . . . . 10.0 112.038 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.05 -38.18 87.69 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 116.045 -0.525 . . . . 10.0 111.04 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.461 ' HB ' ' O ' ' A' ' 136' ' ' GLY . 1.0 OUTLIER -65.34 -39.67 86.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.163 -0.471 . . . . 10.0 111.669 -179.504 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 93.4 mt -64.69 -35.59 81.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.498 -0.319 . . . . 10.0 111.275 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -80.4 -32.56 37.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.138 -0.483 . . . . 10.0 112.239 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 2.8 p -75.5 -34.6 60.85 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.987 -0.285 . . . . 10.0 111.368 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -61.13 -37.9 84.47 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.856 0.36 . . . . 10.0 111.27 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -56.76 -54.96 40.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.707 -0.678 . . . . 10.0 111.627 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -61.45 -37.08 82.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.455 -0.339 . . . . 10.0 111.616 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 48.6 tttp -64.9 -55.34 19.91 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.18 0.437 . . . . 10.0 112.18 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 32.7 mt -66.96 -38.38 81.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.722 0.296 . . . . 10.0 111.573 -178.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -65.17 -35.32 80.72 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-O 121.357 0.599 . . . . 10.0 109.915 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 1.027 ' HA ' ' HB3' ' A' ' 154' ' ' LYS . 32.7 tt0 -67.96 -48.38 66.04 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.391 -0.822 . . . . 10.0 109.724 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -79.89 56.97 2.46 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.038 -0.528 . . . . 10.0 110.879 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -177.82 -51.95 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.743 -0.662 . . . . 10.0 112.299 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -126.06 -45.37 1.72 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.332 0.493 . . . . 10.0 112.332 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 1.027 ' HB3' ' HA ' ' A' ' 150' ' ' GLU . 71.5 tttt -60.94 -35.6 77.15 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.496 0.554 . . . . 10.0 112.496 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt . . . . . 0 C--O 1.252 1.213 0 CA-C-O 118.427 -0.797 . . . . 10.0 110.106 179.881 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 622' ' ' DAG . . . . . 1.177 ' O1 ' ' H12' ' A' ' 634' ' ' MTC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 630' ' ' DSR . . . . . 1.44 ' S4 ' ' C7 ' ' A' ' 631' ' ' HIB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 631' ' ' HIB . . . . . 1.457 ' C2 ' ' O1 ' ' A' ' 632' ' ' MRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 632' ' ' MRP . . . . . 1.457 ' O1 ' ' C2 ' ' A' ' 631' ' ' HIB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 633' ' ' EMP . . . . . 1.009 ' C5 ' ' H72' ' A' ' 633' ' ' EMP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 634' ' ' MTC . . . . . 1.177 ' H12' ' O1 ' ' A' ' 622' ' ' DAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 110.703 -0.11 . . . . 10.0 110.703 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . 0.365 17.6 p90 63.63 -50.49 0.24 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 116.27 1.952 . . . . 10.0 116.27 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.81 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 16.7 t70 -74.47 -61.61 1.13 Allowed Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 112.886 0.699 . . . . 10.0 112.886 -178.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.81 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 3.6 Cg_exo -80.5 -32.64 1.17 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.292 1.995 . . . . 10.0 111.949 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.63 ' HA ' ' OD2' ' A' ' 119' ' ' ASP . 47.3 p90 -176.94 152.5 0.93 Allowed 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.346 -0.843 . . . . 10.0 109.648 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.5 p -101.54 138.58 25.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.021 0.438 . . . . 10.0 111.32 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 39.4 ttm180 -171.0 104.63 0.23 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.376 -0.829 . . . . 10.0 110.043 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 72.1 m-70 -131.04 157.21 43.63 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.06 -0.348 . . . . 10.0 110.06 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 0.0 OUTLIER -147.2 140.27 25.19 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.442 0.534 . . . . 10.0 112.442 -179.71 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.402 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 21.9 t -123.45 143.4 36.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 108.91 -0.774 . . . . 10.0 108.91 179.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.8 m -111.26 105.46 14.13 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.082 0.468 . . . . 10.0 111.991 -178.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.581 HG13 HG21 ' A' ' 148' ' ' ILE . 89.2 t -85.97 114.91 26.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.081 -0.509 . . . . 10.0 110.515 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt -98.74 57.95 1.16 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.213 0.53 . . . . 10.0 111.124 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -147.91 -83.26 0.11 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.556 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -163.47 157.99 20.42 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.725 -0.472 . . . . 10.0 109.725 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.7 ttt180 -66.99 -37.39 84.13 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.614 0.598 . . . . 10.0 112.614 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -70.59 -41.08 72.81 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.059 0.392 . . . . 10.0 112.059 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.97 -36.63 84.11 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.818 0.303 . . . . 10.0 111.818 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.58 -44.39 94.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.143 0.497 . . . . 10.0 110.233 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -67.35 -38.71 85.28 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.7 -0.682 . . . . 10.0 110.316 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.0 mmtt -66.17 -43.61 86.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.66 -0.7 . . . . 10.0 112.683 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.4 p -73.24 -26.34 61.08 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.09 0.774 . . . . 10.0 113.09 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -84.16 -34.4 24.04 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.03 0.752 . . . . 10.0 113.03 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.0 mp -102.36 -33.05 9.72 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.842 1.053 . . . . 10.0 113.842 -178.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -124.53 42.42 3.26 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.289 0.477 . . . . 10.0 112.289 -178.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -145.18 30.16 1.77 Allowed Glycine 0 C--O 1.228 -0.254 0 C-N-CA 120.516 -0.849 . . . . 10.0 112.524 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.558 ' HD1' ' HA2' ' A' ' 41' ' ' GLY . 0.6 OUTLIER -54.65 -56.36 28.01 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 113.366 0.876 . . . . 10.0 113.366 -179.141 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.654 ' HG3' ' HA ' ' A' ' 43' ' ' PRO . 92.6 Cg_endo -82.94 28.35 0.58 Allowed 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 122.095 1.863 . . . . 10.0 112.376 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -124.0 9.39 8.72 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.2 0.524 . . . . 10.0 111.446 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 19.8 m0 -98.61 162.59 13.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.949 -0.569 . . . . 10.0 109.668 179.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.669 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -144.85 46.85 0.64 Allowed Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 112.307 0.484 . . . . 10.0 112.307 179.172 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.669 ' HD3' ' N ' ' A' ' 31' ' ' TRP . 6.3 Cg_endo -89.88 -45.82 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.364 2.043 . . . . 10.0 112.509 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.446 ' H ' ' HD2' ' A' ' 32' ' ' PRO . 65.8 t30 -157.78 -32.3 0.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.113 0.482 . . . . 10.0 110.137 -179.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.439 ' OD1' ' HD2' ' A' ' 32' ' ' PRO . 16.6 p-10 -79.67 89.53 5.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.398 0.618 . . . . 10.0 111.168 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -99.73 -21.18 15.91 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.67 -0.695 . . . . 10.0 110.899 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -91.18 109.24 20.49 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.147 -0.479 . . . . 10.0 111.024 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.57 167.47 12.89 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.802 -0.636 . . . . 10.0 111.139 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.408 HG22 ' OD2' ' A' ' 57' ' ' ASP . 3.3 m 78.51 -62.8 0.32 Allowed 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.515 0.561 . . . . 10.0 112.515 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 17.1 mmtm -76.16 -24.72 54.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.863 0.363 . . . . 10.0 111.814 -179.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.4 p -163.21 91.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.77 0.795 . . . . 10.0 110.543 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.558 ' HA2' ' HD1' ' A' ' 27' ' ' PHE . . . 126.51 47.61 0.2 Allowed Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.477 -0.783 . . . . 10.0 111.753 -178.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.58 158.71 86.25 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 120.621 0.248 . . . . 10.0 111.097 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.654 ' HA ' ' HG3' ' A' ' 28' ' ' PRO . 34.3 Cg_exo -59.82 -20.46 59.33 Favored 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 122.677 2.252 . . . . 10.0 112.88 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.3 mp -98.74 -91.82 0.27 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.7 0.286 . . . . 10.0 110.579 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.85 -63.97 2.47 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.824 -0.703 . . . . 10.0 113.122 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.3 t -106.04 132.51 52.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 120.725 0.298 . . . . 10.0 110.996 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -95.31 125.77 40.16 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.398 -0.365 . . . . 10.0 110.355 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.485 ' HB2' ' HE3' ' A' ' 48' ' ' LYS . 37.3 mtmt -103.51 10.61 37.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.286 -0.415 . . . . 10.0 110.972 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.0 mtmm -89.09 -54.51 4.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.669 0.271 . . . . 10.0 110.533 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -111.15 -29.83 3.36 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 111.101 -0.799 . . . . 10.0 111.101 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.26 80.32 1.4 Allowed Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.655 -0.783 . . . . 10.0 111.97 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 52' ' ' ARG . 13.8 ptt180 -162.97 167.63 22.27 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.725 0.297 . . . . 10.0 110.505 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 60.0 m95 -107.33 134.52 50.27 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.883 -0.784 . . . . 10.0 108.883 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -164.22 120.05 1.56 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.053 0.454 . . . . 10.0 111.497 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -83.77 133.66 34.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.794 -0.639 . . . . 10.0 109.676 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.0 mm -96.14 111.27 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 116.069 -0.514 . . . . 10.0 110.823 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.979 ' HB2' ' HG2' ' A' ' 62' ' ' GLU . 15.9 t70 -106.62 163.49 12.85 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.921 -0.581 . . . . 10.0 109.597 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.38 -23.72 65.61 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.598 0.237 . . . . 10.0 110.514 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -87.42 -4.23 59.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.811 0.339 . . . . 10.0 110.775 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 134.1 -111.64 0.98 Allowed Glycine 0 CA--C 1.519 0.298 0 C-N-CA 121.209 -0.52 . . . . 10.0 112.482 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -115.76 137.24 52.28 Favored 'General case' 0 C--N 1.32 -0.676 0 O-C-N 122.41 -0.465 . . . . 10.0 110.759 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.979 ' HG2' ' HB2' ' A' ' 57' ' ' ASP . 15.2 mm-40 -97.45 -144.46 0.3 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.946 -0.57 . . . . 10.0 111.657 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 1.095 ' ND1' ' H92' ' A' ' 636' ' ' HIB . 3.3 p80 -75.07 -178.83 4.01 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 113.045 0.757 . . . . 10.0 113.045 -179.041 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.9 t -152.64 152.63 32.01 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.142 -0.936 . . . . 10.0 110.095 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 1.614 ' CE1' ' H61' ' A' ' 637' ' ' MRP . 98.5 m-85 -96.68 -22.1 17.21 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.475 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.463 ' HA3' ' O ' ' A' ' 80' ' ' GLY . . . 154.12 -146.75 15.22 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 121.032 -0.604 . . . . 10.0 112.42 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.9 pp -132.73 169.24 16.98 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.776 0.322 . . . . 10.0 110.704 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.411 HG21 HG13 ' A' ' 71' ' ' VAL . 67.4 mt -109.03 127.13 65.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.095 -0.705 . . . . 10.0 109.095 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -77.83 -45.88 23.11 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.418 -0.356 . . . . 10.0 111.255 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.0 tttm -161.81 145.33 12.3 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.229 -0.441 . . . . 10.0 110.604 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.411 HG13 HG21 ' A' ' 68' ' ' ILE . 0.4 OUTLIER -115.23 84.67 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.206 0.527 . . . . 10.0 110.478 179.555 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.26 61.95 5.92 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.982 -0.554 . . . . 10.0 111.161 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.405 ' C ' ' H ' ' A' ' 75' ' ' ASP . 3.8 pt-20 55.04 -179.01 0.03 OUTLIER Pre-proline 0 CA--C 1.547 0.841 0 O-C-N 123.871 0.732 . . . . 10.0 111.886 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.403 ' CD ' ' HB2' ' A' ' 73' ' ' GLU . 21.5 Cg_exo -69.29 33.65 0.19 Allowed 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 122.203 1.935 . . . . 10.0 113.359 178.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 73' ' ' GLU . 17.4 t70 -113.49 -56.46 2.4 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.639 0.257 . . . . 10.0 110.564 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.0 m -127.6 129.33 47.09 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.951 0.405 . . . . 10.0 110.594 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 28.9 tp -129.05 134.01 47.94 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.054 -0.521 . . . . 10.0 110.088 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.6 t -128.35 119.93 51.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.935 -0.394 . . . . 10.0 109.935 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 37.6 pt -133.57 167.7 25.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.719 0.295 . . . . 10.0 111.268 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.541 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -123.88 138.49 11.43 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 110.836 -0.905 . . . . 10.0 110.836 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -97.01 156.89 16.16 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.216 0.821 . . . . 10.0 113.216 -178.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.429 HH11 ' HX1' ' A' ' 636' ' ' HIB . 14.0 ttt180 -105.94 153.35 22.1 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.992 -1.004 . . . . 10.0 109.692 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.743 ' HG ' ' HB3' ' A' ' 91' ' ' PRO . 1.6 pp -98.84 170.6 8.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.647 0.26 . . . . 10.0 111.428 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -120.42 -173.05 2.49 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.44 -0.346 . . . . 10.0 110.84 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 134.45 147.01 5.51 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.4 -0.68 . . . . 10.0 111.4 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -83.29 -84.27 0.13 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.993 0.425 . . . . 10.0 110.73 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -87.03 92.73 1.83 Allowed Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.756 -0.735 . . . . 10.0 111.739 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.508 ' HD2' ' O ' ' A' ' 89' ' ' ILE . 0.0 OUTLIER -164.37 169.29 17.58 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.748 0.309 . . . . 10.0 110.723 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.508 ' O ' ' HD2' ' A' ' 88' ' ' ARG . 8.9 tp -74.79 164.59 3.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.151 -0.477 . . . . 10.0 110.606 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.453 ' H ' HG13 ' A' ' 89' ' ' ILE . 1.4 m-20 -65.15 146.27 98.96 Favored Pre-proline 0 C--O 1.232 0.176 0 CA-C-O 120.748 0.309 . . . . 10.0 111.241 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.743 ' HB3' ' HG ' ' A' ' 83' ' ' LEU . 19.2 Cg_endo -57.89 104.41 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 123.297 2.664 . . . . 10.0 113.914 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -106.77 -25.04 11.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.763 -0.653 . . . . 10.0 109.94 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -68.71 -77.71 0.08 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.514 -0.766 . . . . 10.0 111.134 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.9 m 69.07 161.57 0.21 Allowed 'General case' 0 CA--C 1.534 0.342 0 O-C-N 123.559 0.537 . . . . 10.0 112.216 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 16.1 m -144.34 124.84 13.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.449 -0.341 . . . . 10.0 111.229 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.541 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 12.2 pt-20 -100.69 153.04 19.76 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.151 -0.477 . . . . 10.0 110.222 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -139.15 147.03 41.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.667 -0.242 . . . . 10.0 110.914 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.18 126.36 42.31 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.363 -0.606 . . . . 10.0 109.363 179.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 39.0 t -116.97 127.25 74.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.419 -0.355 . . . . 10.0 111.31 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.74 130.57 55.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.564 -0.289 . . . . 10.0 110.864 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -100.21 84.14 2.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.391 -0.368 . . . . 10.0 111.109 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 34.6 t -85.66 111.09 20.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 110.01 -0.367 . . . . 10.0 110.01 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 109' ' ' THR . . . -102.82 137.72 40.66 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.734 0.302 . . . . 10.0 111.347 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -124.95 125.95 44.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.998 -0.546 . . . . 10.0 109.616 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 78.3 6.5 87.81 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.743 -0.742 . . . . 10.0 111.881 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 63.36 20.8 12.47 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.685 0.624 . . . . 10.0 112.685 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 16.6 pttt -140.95 -51.95 0.46 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.108 -0.496 . . . . 10.0 110.685 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -82.7 100.2 10.09 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.256 -0.646 . . . . 10.0 109.256 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 103' ' ' ALA . 7.2 m -103.25 115.64 30.95 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.774 -0.648 . . . . 10.0 111.268 -178.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 64.1 mtt180 -102.67 105.72 16.24 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.036 -0.529 . . . . 10.0 110.14 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 9' ' ' SER . 1.8 p -92.2 123.74 44.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.844 -0.617 . . . . 10.0 110.806 -179.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -114.41 145.44 41.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.021 -0.536 . . . . 10.0 111.483 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 24.1 t -123.21 122.38 65.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.797 -0.638 . . . . 10.0 109.527 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -135.68 155.51 50.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.206 0.527 . . . . 10.0 112.001 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -177.88 157.44 1.17 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.203 -0.908 . . . . 10.0 108.696 178.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.1 m -156.71 86.07 0.98 Allowed 'General case' 0 C--O 1.237 0.417 0 N-CA-C 109.825 -0.435 . . . . 10.0 109.825 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -177.02 -64.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.021 -0.536 . . . . 10.0 111.197 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.467 ' O ' ' HG2' ' A' ' 121' ' ' MET . 83.4 m-85 -90.07 2.41 55.26 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.276 -0.42 . . . . 10.0 111.919 -178.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.63 ' OD2' ' HA ' ' A' ' 5' ' ' PHE . 19.7 p-10 -90.12 -38.67 13.37 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.177 -0.465 . . . . 10.0 110.827 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -75.63 18.49 0.23 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.766 0.654 . . . . 10.0 112.766 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.467 ' HG2' ' O ' ' A' ' 118' ' ' PHE . 23.7 ptt? -118.15 13.67 13.84 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.518 -0.549 . . . . 10.0 109.518 178.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.453 ' HA2' ' HB2' ' A' ' 125' ' ' HIS . . . -77.6 -111.77 0.17 Allowed Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.611 -0.722 . . . . 10.0 113.394 -178.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.5 m 56.36 -92.17 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.48 0.312 . . . . 10.0 111.225 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.33 -31.06 70.2 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.62 -0.511 . . . . 10.0 109.62 178.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.453 ' HB2' ' HA2' ' A' ' 122' ' ' GLY . 7.5 m170 -72.24 -42.2 65.95 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.823 -0.626 . . . . 10.0 109.71 178.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.489 ' HA ' HG12 ' A' ' 129' ' ' VAL . . . -66.24 -38.87 88.91 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.757 -0.656 . . . . 10.0 110.04 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -60.03 -31.85 70.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.621 -0.718 . . . . 10.0 110.989 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.78 -43.64 19.81 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.1 -0.5 . . . . 10.0 111.501 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.489 HG12 ' HA ' ' A' ' 126' ' ' ALA . 4.6 p -71.02 -23.37 23.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 112.13 0.419 . . . . 10.0 112.13 -179.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -69.67 -4.59 20.18 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.003 0.372 . . . . 10.0 112.003 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -71.12 -27.54 63.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.867 0.365 . . . . 10.0 110.761 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -133.66 -30.23 0.45 Allowed Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.148 -1.025 . . . . 10.0 114.163 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 12.8 tpt -79.11 -29.87 43.45 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 117.358 0.579 . . . . 10.0 112.012 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -69.14 -9.54 53.32 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.14 -0.482 . . . . 10.0 111.858 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -95.76 -7.49 37.05 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.214 0.45 . . . . 10.0 112.214 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.451 ' HA3' ' O3 ' ' A' ' 637' ' ' MRP . . . -131.54 -39.78 0.24 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 119.794 -1.193 . . . . 10.0 114.362 -178.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.406 ' HB3' ' HD3' ' A' ' 138' ' ' PRO . 22.5 t90 -53.11 -59.6 8.72 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 113.781 1.03 . . . . 10.0 113.781 -178.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.406 ' HD3' ' HB3' ' A' ' 137' ' ' TRP . 42.7 Cg_endo -67.17 -36.42 21.58 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 121.551 1.501 . . . . 10.0 112.705 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.8 -41.41 91.97 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.111 -0.495 . . . . 10.0 111.645 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.2 mp -64.97 -41.27 91.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.166 -0.47 . . . . 10.0 111.586 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 96.1 mt -59.1 -47.71 84.25 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.259 -0.428 . . . . 10.0 111.478 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -63.46 -40.19 96.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.984 -0.553 . . . . 10.0 111.057 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 21.7 m -66.32 -43.65 85.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.08 -0.509 . . . . 10.0 111.307 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -63.96 -39.33 93.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.542 -0.299 . . . . 10.0 110.556 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -58.68 -34.59 71.44 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 123.8 0.687 . . . . 10.0 111.074 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -87.96 -35.52 17.6 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.332 0.493 . . . . 10.0 112.332 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -61.79 -50.86 70.64 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 111.616 0.228 . . . . 10.0 111.616 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.581 HG21 HG13 ' A' ' 12' ' ' VAL . 48.6 mt -63.81 -32.3 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.18 0.515 . . . . 10.0 110.644 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -73.39 -39.16 65.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.964 -0.562 . . . . 10.0 109.773 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -64.03 -53.32 51.84 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.883 -0.598 . . . . 10.0 109.851 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -87.08 56.87 4.19 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.38 -0.827 . . . . 10.0 110.78 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 175.14 -43.28 0.12 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.041 -1.076 . . . . 10.0 113.317 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -109.55 -49.65 3.08 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.103 0.408 . . . . 10.0 112.103 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 22.0 mttp -65.23 -55.3 19.23 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.791 0.329 . . . . 10.0 110.798 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.437 ' HE3' ' HB2' ' A' ' 155' ' ' LYS . 33.8 mtmt . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.024 -0.988 . . . . 10.0 109.705 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 623' ' ' DAG . . . . . 1.187 ' O1 ' ' H12' ' A' ' 639' ' ' MTC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 635' ' ' DSR . . . . . 1.46 ' S4 ' ' C7 ' ' A' ' 636' ' ' HIB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 636' ' ' HIB . . . . . 1.46 ' C7 ' ' S4 ' ' A' ' 635' ' ' DSR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 637' ' ' MRP . . . . . 1.614 ' H61' ' CE1' ' A' ' 65' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 638' ' ' EMP . . . . . 1.004 ' C5 ' ' H72' ' A' ' 638' ' ' EMP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 639' ' ' MTC . . . . . 1.187 ' H12' ' O1 ' ' A' ' 623' ' ' DAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.759 ' O ' ' HD2' ' A' ' 4' ' ' PRO . 17.6 p-10 . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 120.428 0.156 . . . . 10.0 110.806 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . 0.286 0.2 OUTLIER 47.84 -107.18 0.18 Allowed 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 115.899 1.815 . . . . 10.0 115.899 179.606 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.504 ' HB2' ' HD3' ' A' ' 4' ' ' PRO . 1.1 m-20 -48.54 -64.31 1.18 Allowed Pre-proline 0 N--CA 1.475 0.821 0 N-CA-C 115.353 1.612 . . . . 10.0 115.353 -177.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.759 ' HD2' ' O ' ' A' ' 1' ' ' ASN . 75.3 Cg_exo -51.34 -48.0 23.32 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.458 2.105 . . . . 10.0 112.84 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.459 ' HA ' ' OD2' ' A' ' 119' ' ' ASP . 51.8 p90 178.66 153.33 0.36 Allowed 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.705 -0.68 . . . . 10.0 109.705 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.9 p -107.27 96.3 4.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.323 0.582 . . . . 10.0 111.304 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.504 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 98.4 mtt180 -136.57 105.31 5.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.867 -0.606 . . . . 10.0 110.247 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 28.3 m-70 -121.18 152.28 38.97 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.316 -0.402 . . . . 10.0 110.044 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.9 m -140.38 133.28 29.19 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.607 0.241 . . . . 10.0 111.083 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.535 ' HB ' HG13 ' A' ' 111' ' ' VAL . 21.7 t -123.32 140.45 46.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 109.374 -0.602 . . . . 10.0 109.374 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.1 m -107.93 112.31 24.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.058 0.456 . . . . 10.0 110.91 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.567 HG11 ' HB2' ' A' ' 19' ' ' ALA . 70.3 t -98.94 132.8 43.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 116.299 -0.41 . . . . 10.0 110.178 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.2 mtmt -115.45 88.16 2.82 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.749 0.309 . . . . 10.0 111.676 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -172.54 -82.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.702 -0.681 . . . . 10.0 109.471 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -168.65 -178.91 3.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.009 -0.541 . . . . 10.0 110.152 178.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 50.2 ttt180 -76.25 -35.58 58.89 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.283 0.475 . . . . 10.0 112.283 -178.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -71.5 -46.58 59.34 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.474 0.546 . . . . 10.0 112.474 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.95 -46.62 75.02 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.031 0.382 . . . . 10.0 112.031 -179.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.567 ' HB2' HG11 ' A' ' 12' ' ' VAL . . . -61.93 -46.53 88.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.357 -0.383 . . . . 10.0 111.456 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -67.64 -37.49 82.51 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.309 -0.405 . . . . 10.0 111.613 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.8 mmtt -68.2 -44.65 75.34 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 111.921 0.341 . . . . 10.0 111.921 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.2 p -67.36 -28.17 67.73 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.362 0.505 . . . . 10.0 112.362 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -93.29 7.33 44.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.702 0.286 . . . . 10.0 111.618 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.0 tp -128.26 -55.86 1.25 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.454 0.539 . . . . 10.0 112.454 -178.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -108.82 -12.35 14.92 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.077 0.399 . . . . 10.0 112.077 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.51 86.83 1.5 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.652 -0.785 . . . . 10.0 111.725 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -111.66 -55.6 0.04 OUTLIER Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 112.731 0.641 . . . . 10.0 112.731 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -75.74 27.85 0.39 Allowed 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.273 1.982 . . . . 10.0 112.577 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -120.48 0.62 10.55 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.318 -0.401 . . . . 10.0 110.762 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 39.7 m0 -76.72 165.07 25.24 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.322 -0.621 . . . . 10.0 109.322 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.594 ' H ' ' HD2' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -146.07 -58.39 0.02 OUTLIER Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 112.585 0.587 . . . . 10.0 112.585 -179.735 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.594 ' HD2' ' H ' ' A' ' 31' ' ' TRP . 73.6 Cg_endo -74.31 52.58 2.8 Favored 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 122.068 1.845 . . . . 10.0 112.498 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -170.0 -67.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.978 -0.555 . . . . 10.0 110.659 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.463 HD22 ' HA3' ' A' ' 41' ' ' GLY . 18.2 p-10 -111.82 122.83 48.84 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.334 0.588 . . . . 10.0 111.549 -179.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -112.96 4.75 16.93 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.735 -0.666 . . . . 10.0 110.779 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -133.08 105.08 6.85 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.721 0.296 . . . . 10.0 111.198 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.06 166.19 14.29 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.117 -0.492 . . . . 10.0 110.302 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.1 m 75.46 -47.35 0.59 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 122.91 0.484 . . . . 10.0 111.562 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.1 -30.64 27.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.1 0.476 . . . . 10.0 109.896 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.8 p -161.81 104.19 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 115.301 -0.863 . . . . 10.0 109.343 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.463 ' HA3' HD22 ' A' ' 34' ' ' ASN . . . 107.83 62.24 0.56 Allowed Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.939 -0.864 . . . . 10.0 110.939 -178.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.462 ' CB ' ' H ' ' A' ' 56' ' ' ILE . . . -81.31 168.08 27.2 Favored Pre-proline 0 C--N 1.321 -0.669 0 C-N-CA 122.407 0.283 . . . . 10.0 110.896 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -74.74 45.58 1.32 Allowed 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 122.979 2.452 . . . . 10.0 112.963 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 27.4 tp -160.69 -86.85 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.744 -0.465 . . . . 10.0 109.744 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.65 -69.71 3.25 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.93 -0.652 . . . . 10.0 112.991 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.8 t -103.14 134.9 42.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.002 0.43 . . . . 10.0 111.461 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.436 ' HB3' ' HG3' ' A' ' 52' ' ' ARG . 6.6 t70 -103.26 112.29 25.1 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.421 -0.585 . . . . 10.0 109.421 178.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.61 23.2 8.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.754 -0.657 . . . . 10.0 111.02 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.5 mttp -99.65 -54.29 2.96 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.94 -0.763 . . . . 10.0 108.94 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -108.55 -21.96 7.3 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.309 -0.86 . . . . 10.0 112.085 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.472 ' HA2' HD12 ' A' ' 68' ' ' ILE . . . 98.3 67.43 0.9 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.747 -0.739 . . . . 10.0 112.082 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.436 ' HG3' ' HB3' ' A' ' 47' ' ' ASP . 33.1 ptt180 -151.48 173.87 14.06 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 122.654 -0.321 . . . . 10.0 110.361 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 35.6 m95 -123.79 132.21 53.74 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.402 -0.962 . . . . 10.0 108.402 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -163.29 132.16 3.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.23 0.538 . . . . 10.0 112.142 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.448 ' HB2' ' HB2' ' A' ' 62' ' ' GLU . 2.7 mm-40 -90.01 152.55 21.13 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.379 -0.828 . . . . 10.0 110.046 179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.462 ' H ' ' CB ' ' A' ' 42' ' ' ALA . 41.5 mm -107.07 123.78 62.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.292 -0.413 . . . . 10.0 110.528 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.827 ' HB2' ' HG2' ' A' ' 62' ' ' GLU . 21.1 t70 -127.13 166.01 18.47 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.973 -0.751 . . . . 10.0 108.973 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -64.15 -26.81 68.69 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.681 0.277 . . . . 10.0 111.629 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -88.4 -5.34 58.34 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.948 0.404 . . . . 10.0 111.066 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 135.18 -105.85 0.56 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.976 -0.631 . . . . 10.0 112.697 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.9 mp0 -115.55 140.2 49.38 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.728 0.299 . . . . 10.0 110.563 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.827 ' HG2' ' HB2' ' A' ' 57' ' ' ASP . 22.1 mm-40 -93.87 -135.26 0.18 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.367 -0.379 . . . . 10.0 110.809 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.653 ' ND1' ' H92' ' A' ' 641' ' ' HIB . 3.4 p80 -79.56 170.48 16.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.098 0.475 . . . . 10.0 111.601 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.4 t -145.11 132.54 20.72 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.027 -0.533 . . . . 10.0 110.652 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 1.381 ' CE1' ' H61' ' A' ' 642' ' ' MRP . 78.1 m-85 -72.83 -32.89 65.81 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.114 -0.494 . . . . 10.0 111.016 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 162.24 -143.32 8.66 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 121.171 -0.538 . . . . 10.0 112.558 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -137.73 168.92 18.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.78 0.324 . . . . 10.0 110.772 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.48 HG12 HG22 ' A' ' 79' ' ' ILE . 58.7 mt -106.48 141.13 22.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.968 -0.382 . . . . 10.0 109.968 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -93.06 -44.15 8.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.958 -0.564 . . . . 10.0 110.809 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.3 tttt -157.43 146.63 19.95 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.088 -0.505 . . . . 10.0 110.572 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.404 HG13 HG21 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -121.08 75.46 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.847 -0.615 . . . . 10.0 110.008 179.191 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 1.001 ' HB3' ' HB ' ' A' ' 76' ' ' THR . 6.6 t70 -86.57 69.42 10.36 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.564 -0.744 . . . . 10.0 111.23 -178.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 54.55 178.29 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.681 0 CA-C-N 115.357 -0.838 . . . . 10.0 112.0 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -72.17 49.49 1.35 Allowed 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 122.008 1.805 . . . . 10.0 110.845 177.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -137.66 -50.53 0.61 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.923 -0.58 . . . . 10.0 110.647 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . 1.001 ' HB ' ' HB3' ' A' ' 72' ' ' ASP . 11.7 m -118.39 109.24 16.03 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.769 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 28.6 tp -117.42 126.89 53.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.125 -0.489 . . . . 10.0 110.469 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.5 t -128.04 115.7 39.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-N 116.35 -0.386 . . . . 10.0 110.249 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.48 HG22 HG12 ' A' ' 68' ' ' ILE . 31.8 pt -131.08 166.35 28.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.795 0.331 . . . . 10.0 111.543 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -127.27 125.65 5.34 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.393 -0.683 . . . . 10.0 111.393 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -93.1 156.71 16.7 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.606 0.241 . . . . 10.0 110.873 -179.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 50.4 mtp180 -106.5 178.4 4.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.096 -0.502 . . . . 10.0 110.774 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.35 151.97 32.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.323 -0.399 . . . . 10.0 111.374 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.461 ' H ' HG23 ' A' ' 129' ' ' VAL . 1.6 t-20 -88.73 -165.46 1.34 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.165 -0.471 . . . . 10.0 110.887 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.498 ' HA3' ' HG2' ' A' ' 88' ' ' ARG . . . 131.18 156.37 8.48 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 121.091 -0.576 . . . . 10.0 112.067 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -101.66 -86.38 0.41 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.673 0.273 . . . . 10.0 110.611 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -84.44 58.0 5.01 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 121.122 -0.561 . . . . 10.0 111.871 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.498 ' HG2' ' HA3' ' A' ' 85' ' ' GLY . 0.4 OUTLIER -121.09 154.55 35.99 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.747 0.308 . . . . 10.0 110.923 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.565 HG12 ' H ' ' A' ' 90' ' ' ASP . 11.9 tt -68.68 175.39 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 115.738 -0.665 . . . . 10.0 110.319 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.565 ' H ' HG12 ' A' ' 89' ' ' ILE . 82.6 m-20 -55.99 140.86 68.9 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.021 0.439 . . . . 10.0 111.662 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 90' ' ' ASP . 43.3 Cg_endo -85.85 61.41 5.15 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.918 2.412 . . . . 10.0 112.906 -178.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -83.61 71.91 10.34 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.258 0.551 . . . . 10.0 110.45 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -152.29 -63.47 0.17 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.87 -0.789 . . . . 10.0 108.87 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.3 m 62.98 170.76 0.15 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.181 -0.918 . . . . 10.0 112.944 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.3 m -137.99 111.35 8.0 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.531 -0.544 . . . . 10.0 109.531 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.66 140.68 29.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.304 -0.407 . . . . 10.0 111.093 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -132.1 148.4 52.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.164 -0.471 . . . . 10.0 111.066 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.74 121.19 41.95 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.688 -0.486 . . . . 10.0 109.688 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 46.7 t -108.1 131.83 57.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.816 0.341 . . . . 10.0 111.233 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.8 m -118.77 139.89 50.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.024 -0.535 . . . . 10.0 110.287 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -112.97 109.04 18.2 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.35 -0.386 . . . . 10.0 111.181 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.3 t -114.88 110.41 31.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.073 0.463 . . . . 10.0 109.834 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -100.35 143.49 30.47 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.186 0.517 . . . . 10.0 111.508 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -125.83 109.94 13.11 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.741 -0.663 . . . . 10.0 109.32 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 78.96 13.63 82.86 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.908 -0.663 . . . . 10.0 111.96 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 72.28 -42.94 0.55 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.013 0.746 . . . . 10.0 113.013 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.402 ' H ' ' HG2' ' A' ' 107' ' ' LYS . 30.3 pttt -73.47 -37.29 65.82 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.637 0.606 . . . . 10.0 112.637 -178.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -96.45 108.69 21.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.668 0.27 . . . . 10.0 110.56 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.434 ' HB ' ' HB ' ' A' ' 12' ' ' VAL . 11.6 m -109.07 121.33 44.91 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.94 0.4 . . . . 10.0 110.701 -179.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -108.31 130.08 55.2 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.343 -0.389 . . . . 10.0 110.568 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.535 HG13 ' HB ' ' A' ' 10' ' ' VAL . 1.5 p -118.83 123.25 71.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.196 -0.456 . . . . 10.0 110.014 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -122.37 147.63 46.04 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.322 0.582 . . . . 10.0 111.871 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 38.7 t -113.23 131.16 65.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.48 -0.782 . . . . 10.0 109.672 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.75 135.36 34.61 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 123.282 0.363 . . . . 10.0 110.43 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -175.09 149.46 1.09 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.129 -0.487 . . . . 10.0 109.98 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -151.63 91.05 1.61 Allowed 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.151 -0.477 . . . . 10.0 110.675 179.034 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 14.8 t60 -175.82 -59.07 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.905 -0.588 . . . . 10.0 110.268 -179.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -89.62 -4.89 57.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.269 -0.423 . . . . 10.0 111.164 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.459 ' OD2' ' HA ' ' A' ' 5' ' ' PHE . 22.5 p-10 -86.27 -39.1 16.88 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.058 -0.519 . . . . 10.0 111.564 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -78.91 57.21 2.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.907 0.384 . . . . 10.0 111.899 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 18.3 ptt? -167.81 27.32 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.079 -0.509 . . . . 10.0 110.558 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -77.67 -101.91 0.18 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.845 -0.693 . . . . 10.0 112.85 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.447 ' HB ' ' H ' ' A' ' 124' ' ' LYS . 0.2 OUTLIER 53.3 -101.28 0.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 122.886 0.474 . . . . 10.0 111.945 -179.496 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.447 ' H ' ' HB ' ' A' ' 123' ' ' THR . 53.2 pttt -64.88 -34.42 78.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.928 0.394 . . . . 10.0 110.73 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 35.5 m170 -70.26 -38.82 75.2 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.611 -0.514 . . . . 10.0 109.611 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.76 -50.54 66.45 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.543 -0.753 . . . . 10.0 110.301 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -60.17 -29.4 68.65 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.194 -0.457 . . . . 10.0 111.128 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.436 HH11 ' HD2' ' A' ' 128' ' ' ARG . 9.0 mtp180 -79.62 -45.69 18.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.06 -0.518 . . . . 10.0 111.913 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.461 HG23 ' H ' ' A' ' 84' ' ' ASN . 9.5 p -73.1 -29.63 29.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 112.116 0.413 . . . . 10.0 112.116 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -74.24 -1.33 20.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.131 0.491 . . . . 10.0 111.712 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -72.14 -20.41 61.61 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.534 -0.543 . . . . 10.0 109.534 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -133.54 -44.77 0.12 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.557 -0.83 . . . . 10.0 112.78 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' MET . . . . . 0.474 ' HA ' ' O2 ' ' A' ' 642' ' ' MRP . 0.3 OUTLIER -62.9 -37.75 88.2 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.399 0.518 . . . . 10.0 112.399 -179.067 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -68.86 -11.32 60.39 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.795 0.331 . . . . 10.0 111.877 -178.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -84.01 -8.08 59.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.699 0.285 . . . . 10.0 111.693 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.987 ' HA3' ' O3 ' ' A' ' 642' ' ' MRP . . . -141.31 -34.4 0.11 Allowed Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.049 -1.072 . . . . 10.0 114.725 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.477 ' HB3' ' HD3' ' A' ' 138' ' ' PRO . 3.5 t90 -56.7 -61.55 6.65 Favored Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 113.573 0.953 . . . . 10.0 113.573 -178.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.477 ' HD3' ' HB3' ' A' ' 137' ' ' TRP . 37.0 Cg_endo -66.51 -14.15 42.85 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 121.795 1.664 . . . . 10.0 112.01 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.3 m -82.12 -47.14 12.91 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.872 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 10.7 tp -71.99 -31.87 41.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.41 -0.359 . . . . 10.0 111.202 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 61.7 mt -55.76 -41.78 74.49 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.036 0.446 . . . . 10.0 111.945 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -82.31 -42.62 18.55 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.481 -0.327 . . . . 10.0 111.405 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 19.6 m -62.16 -38.57 89.52 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.768 0.655 . . . . 10.0 112.768 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -63.49 -34.59 78.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.617 -0.265 . . . . 10.0 111.623 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -63.05 -43.94 97.25 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.981 0.419 . . . . 10.0 110.939 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -72.32 -31.1 65.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.265 -0.425 . . . . 10.0 111.458 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 8.6 ttpp -60.5 -51.0 71.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.495 . . . . 10.0 110.351 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.477 HG21 HG13 ' A' ' 12' ' ' VAL . 31.3 mt -67.34 -38.15 80.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.343 -0.39 . . . . 10.0 110.728 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -59.59 -37.34 78.28 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.426 0.631 . . . . 10.0 110.018 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 1.025 ' HA ' ' HB2' ' A' ' 154' ' ' LYS . 19.6 tt0 -72.04 -41.12 67.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.816 -0.629 . . . . 10.0 111.645 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -84.05 60.3 5.79 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.257 -0.428 . . . . 10.0 111.627 -179.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 161.39 -44.71 0.39 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.346 -0.93 . . . . 10.0 113.337 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -107.39 -55.66 2.31 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 122.728 -0.278 . . . . 10.0 111.69 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 1.025 ' HB2' ' HA ' ' A' ' 150' ' ' GLU . 53.6 mtpt -63.32 -38.47 91.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.083 -0.508 . . . . 10.0 111.931 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 90.9 mttt . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.375 -0.822 . . . . 10.0 110.348 -179.424 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 624' ' ' DAG . . . . . 1.18 ' O1 ' ' H12' ' A' ' 644' ' ' MTC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 640' ' ' DSR . . . . . 1.449 ' S4 ' ' C7 ' ' A' ' 641' ' ' HIB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 641' ' ' HIB . . . . . 1.449 ' C7 ' ' S4 ' ' A' ' 640' ' ' DSR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 642' ' ' MRP . . . . . 1.437 ' O1 ' ' C2 ' ' A' ' 641' ' ' HIB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 643' ' ' EMP . . . . . 1.002 ' C5 ' ' H72' ' A' ' 643' ' ' EMP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 644' ' ' MTC . . . . . 1.18 ' H12' ' O1 ' ' A' ' 624' ' ' DAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' ASN . . . . . 0.481 ' HA ' ' O ' ' A' ' 5' ' ' PHE . 25.6 p-10 . . . . . 0 N--CA 1.479 1.008 0 N-CA-C 110.471 -0.196 . . . . 10.0 110.471 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.424 ' HE1' ' CB ' ' A' ' 126' ' ' ALA 0.318 0.5 OUTLIER 67.2 -51.49 0.48 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.933 1.827 . . . . 10.0 115.933 178.369 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.744 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 10.9 t70 -92.46 -58.45 0.22 Allowed Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 112.674 0.62 . . . . 10.0 112.674 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.744 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 7.7 Cg_exo -75.57 -25.81 10.64 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.211 1.941 . . . . 10.0 112.475 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.609 ' HA ' ' OD2' ' A' ' 119' ' ' ASP . 36.5 p90 -178.67 140.6 0.19 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.677 -0.692 . . . . 10.0 110.138 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.7 p -97.56 115.08 36.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 121.365 0.602 . . . . 10.0 111.389 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 21.7 mtt180 -153.57 112.01 3.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.648 -0.706 . . . . 10.0 110.572 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -128.61 141.06 51.47 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.448 -0.575 . . . . 10.0 109.448 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.3 m -125.6 128.62 48.19 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.716 0.293 . . . . 10.0 111.029 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.622 ' HB ' HG13 ' A' ' 111' ' ' VAL . 40.2 t -119.59 136.8 55.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.324 -0.398 . . . . 10.0 110.264 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.43 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 34.4 m -105.08 125.36 50.9 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.372 -0.376 . . . . 10.0 110.415 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.556 HG12 ' H ' ' A' ' 14' ' ' ALA . 26.3 t -110.19 125.92 67.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.952 0.406 . . . . 10.0 110.067 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.8 mmmp? -91.7 28.34 1.8 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.742 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.556 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -130.46 -152.98 0.53 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.89 -0.596 . . . . 10.0 110.202 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -108.67 173.87 6.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.057 0.455 . . . . 10.0 112.055 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -60.6 -38.59 85.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.491 -0.777 . . . . 10.0 112.434 -178.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -74.45 -45.43 46.38 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.497 0.554 . . . . 10.0 112.497 -178.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.2 p -62.14 -36.95 83.37 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.92 -0.312 . . . . 10.0 111.832 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.481 ' HB2' HG11 ' A' ' 12' ' ' VAL . . . -70.1 -37.81 75.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.97 0.414 . . . . 10.0 111.197 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -74.01 -39.85 63.32 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.956 0.408 . . . . 10.0 111.488 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.3 tttm -66.48 -33.75 76.39 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.392 0.516 . . . . 10.0 112.392 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.0 p -79.52 -5.14 54.23 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.431 0.53 . . . . 10.0 112.431 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -112.19 -34.59 5.88 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.493 0.553 . . . . 10.0 112.493 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.57 ' HG ' HG11 ' A' ' 46' ' ' VAL . 1.0 OUTLIER -110.01 5.31 22.14 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 113.342 0.867 . . . . 10.0 113.342 -178.544 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -139.93 -55.44 0.55 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.288 0.477 . . . . 10.0 112.288 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.39 92.57 0.87 Allowed Glycine 0 C--O 1.224 -0.529 0 C-N-CA 120.889 -0.672 . . . . 10.0 112.607 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.52 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 2.0 t80 -96.83 -58.89 0.17 Allowed Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 112.384 0.512 . . . . 10.0 112.384 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.52 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 5.5 Cg_exo -79.92 22.43 0.73 Allowed 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.367 2.045 . . . . 10.0 111.375 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -109.09 9.62 26.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.796 -0.638 . . . . 10.0 110.518 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 46.9 m0 -87.08 -151.83 0.18 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.192 -0.458 . . . . 10.0 110.12 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.641 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 34.9 t90 -172.77 -51.17 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 112.204 0.446 . . . . 10.0 112.204 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.641 ' HD2' ' N ' ' A' ' 31' ' ' TRP . 99.7 Cg_exo -18.82 -63.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.369 1.618 1 C-N-CA 125.648 4.232 . . . . 10.0 117.227 -178.478 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -148.11 36.66 0.84 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.093 0.473 . . . . 10.0 110.69 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -123.79 48.59 1.86 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.356 0.598 . . . . 10.0 110.825 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -78.69 58.15 2.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.622 -0.717 . . . . 10.0 110.489 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 36' ' ' ARG . 0.1 OUTLIER -168.63 174.91 6.41 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.65 -0.5 . . . . 10.0 109.65 -179.648 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.21 161.76 36.63 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.355 -0.609 . . . . 10.0 109.355 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.527 HG22 ' HA ' ' A' ' 57' ' ' ASP . 1.7 m 72.03 -65.43 0.35 Allowed 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.644 0.609 . . . . 10.0 112.644 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.429 ' HD3' ' HA ' ' A' ' 39' ' ' LYS . 4.5 mmtp -68.97 -33.39 73.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.231 0.538 . . . . 10.0 111.688 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.0 p -153.15 121.17 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.591 -0.731 . . . . 10.0 109.289 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.34 54.73 1.79 Allowed Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.608 -0.997 . . . . 10.0 110.608 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.55 163.77 48.07 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.553 -0.324 . . . . 10.0 110.39 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -72.08 43.44 0.59 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.832 2.355 . . . . 10.0 113.014 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 33.5 tp -165.39 -91.23 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.266 -0.425 . . . . 10.0 110.025 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.73 -57.2 3.85 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.213 -0.518 . . . . 10.0 113.076 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.57 HG11 ' HG ' ' A' ' 24' ' ' LEU . 1.9 t -99.82 135.11 36.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.765 0.317 . . . . 10.0 111.006 -178.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -105.91 112.58 25.69 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.527 -0.546 . . . . 10.0 109.527 178.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.77 19.73 16.58 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.933 -0.576 . . . . 10.0 110.752 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -96.3 -57.31 2.36 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 109.393 -0.595 . . . . 10.0 109.393 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -105.81 -36.16 2.84 Favored Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 110.805 -0.918 . . . . 10.0 110.805 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.67 68.3 0.46 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.647 -0.787 . . . . 10.0 112.25 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -156.14 -179.27 7.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.8 0.333 . . . . 10.0 111.33 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.478 ' CZ3' HG22 ' A' ' 46' ' ' VAL . 75.3 m95 -122.73 136.88 55.01 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.422 -0.584 . . . . 10.0 109.422 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -165.98 122.34 1.33 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.799 0.333 . . . . 10.0 111.775 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.414 ' O ' ' HA ' ' A' ' 61' ' ' GLU . 2.0 mm-40 -86.12 149.54 25.06 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.071 -0.513 . . . . 10.0 110.297 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.9 mm -103.42 110.53 30.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.363 -0.38 . . . . 10.0 112.01 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.527 ' HA ' HG22 ' A' ' 38' ' ' THR . 13.1 t70 -108.34 165.73 11.29 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.612 -0.514 . . . . 10.0 109.612 178.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -57.22 -27.06 61.67 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.999 0.74 . . . . 10.0 112.999 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -103.03 -1.24 29.57 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.103 0.409 . . . . 10.0 112.103 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 132.29 -160.92 23.84 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.957 -0.64 . . . . 10.0 111.745 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 55' ' ' GLU . 60.4 mp0 -69.45 128.03 35.1 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.821 -0.437 . . . . 10.0 109.821 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.7 -95.35 0.2 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.936 0.717 . . . . 10.0 112.936 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -98.56 166.31 11.41 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.173 0.511 . . . . 10.0 112.232 -178.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.8 t -148.51 150.21 32.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.674 -0.694 . . . . 10.0 109.907 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -89.09 -43.83 10.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.942 -0.572 . . . . 10.0 111.11 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 174.23 -141.2 5.81 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.7 -0.762 . . . . 10.0 111.763 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -135.48 166.06 24.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.736 0.303 . . . . 10.0 111.001 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 65.4 mt -109.76 133.53 54.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.742 -0.466 . . . . 10.0 109.742 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.0 mmt180 -83.12 -54.08 5.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.583 -0.28 . . . . 10.0 110.596 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.6 mtpm? -150.43 147.66 27.81 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.347 -0.388 . . . . 10.0 111.294 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -119.99 82.91 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.517 -0.765 . . . . 10.0 109.728 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.749 ' HB2' ' HB ' ' A' ' 76' ' ' THR . 8.1 m-20 -92.33 68.23 4.96 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.772 -0.649 . . . . 10.0 111.191 -178.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 72' ' ' ASP . 5.5 pt-20 56.11 177.78 0.04 OUTLIER Pre-proline 0 N--CA 1.474 0.731 0 O-C-N 123.922 0.764 . . . . 10.0 112.078 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -71.31 47.36 0.82 Allowed 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.141 1.894 . . . . 10.0 111.532 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -135.82 -43.84 0.66 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.96 -0.564 . . . . 10.0 110.979 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.749 ' HB ' ' HB2' ' A' ' 72' ' ' ASP . 12.5 m -129.75 125.89 36.92 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.383 -0.371 . . . . 10.0 110.556 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 27.2 tp -136.5 128.62 29.68 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.487 -0.324 . . . . 10.0 110.773 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.2 t -121.08 123.21 69.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.936 -0.764 . . . . 10.0 108.936 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.444 HD12 ' CZ3' ' A' ' 81' ' ' TRP . 1.8 pt -133.79 168.14 24.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 112.445 0.535 . . . . 10.0 112.445 -178.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -135.2 130.39 5.42 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 110.549 -1.02 . . . . 10.0 110.549 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 0.444 ' CZ3' HD12 ' A' ' 79' ' ' ILE . 0.8 OUTLIER -106.36 156.91 18.03 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 112.741 0.645 . . . . 10.0 112.741 -178.238 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 43.6 mtp180 -100.79 -164.76 1.14 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.481 -0.781 . . . . 10.0 109.402 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.2 pp -139.26 161.22 37.97 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.63 0.252 . . . . 10.0 111.431 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -77.54 -160.39 0.18 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.117 -0.492 . . . . 10.0 111.794 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 120.8 135.89 4.97 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.988 -0.845 . . . . 10.0 110.988 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -93.85 -85.92 0.28 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.761 0.315 . . . . 10.0 111.222 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -82.66 67.93 3.64 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.972 -0.632 . . . . 10.0 112.005 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.83 151.71 38.35 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.57 0.224 . . . . 10.0 110.555 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 6.2 tp -62.73 144.67 14.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.718 -0.475 . . . . 10.0 109.718 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -52.39 130.82 43.69 Favored Pre-proline 0 C--N 1.331 -0.234 0 O-C-N 123.255 0.347 . . . . 10.0 111.061 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.88 89.89 0.24 Allowed 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 123.0 2.466 . . . . 10.0 112.776 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -87.77 71.77 9.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.999 -0.546 . . . . 10.0 110.231 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -162.12 -70.57 0.05 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.693 -0.685 . . . . 10.0 109.772 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.8 m 70.77 161.61 0.23 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.285 -0.871 . . . . 10.0 112.69 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.5 m -117.28 133.7 55.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.077 -0.51 . . . . 10.0 110.554 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -93.65 147.32 23.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.128 -0.487 . . . . 10.0 110.881 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -139.48 136.81 34.97 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 123.275 0.359 . . . . 10.0 110.507 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 6.4 m -101.91 123.01 45.11 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.662 -0.495 . . . . 10.0 109.662 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 95.5 t -107.87 121.95 61.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.189 -0.46 . . . . 10.0 110.948 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.68 129.07 56.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.267 -0.424 . . . . 10.0 110.781 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -101.41 125.45 48.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.812 0.339 . . . . 10.0 110.834 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 90.3 t -117.84 126.34 74.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.095 -0.502 . . . . 10.0 109.769 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -99.99 130.86 46.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.718 -0.219 . . . . 10.0 110.659 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -118.76 100.61 7.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.959 0.409 . . . . 10.0 111.164 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.05 12.35 65.13 Favored Glycine 0 CA--C 1.52 0.386 0 CA-C-N 116.042 -0.526 . . . . 10.0 113.381 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 68.31 -16.56 0.19 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.578 0.955 . . . . 10.0 113.578 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 46.2 pttt -99.82 -6.56 26.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.064 0.459 . . . . 10.0 111.483 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -136.48 147.84 47.37 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.056 -0.72 . . . . 10.0 109.056 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.83 146.81 47.9 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.272 0.558 . . . . 10.0 111.76 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -131.9 139.26 48.7 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.779 -0.646 . . . . 10.0 109.435 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.622 HG13 ' HB ' ' A' ' 10' ' ' VAL . 2.2 p -133.75 129.76 55.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-O 120.746 0.308 . . . . 10.0 111.005 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -125.93 155.79 40.75 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.25 -0.432 . . . . 10.0 111.534 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 98' ' ' THR . 48.6 t -115.98 127.97 73.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.828 -0.624 . . . . 10.0 109.61 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -127.25 136.97 52.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.35 -0.386 . . . . 10.0 111.671 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -175.99 155.31 1.58 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.857 -0.61 . . . . 10.0 111.347 178.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.4 m -160.14 91.89 0.97 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.772 -0.825 . . . . 10.0 108.772 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 179.01 -62.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 10.0 111.028 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -98.44 14.86 26.68 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.085 -0.507 . . . . 10.0 111.558 -178.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.609 ' OD2' ' HA ' ' A' ' 5' ' ' PHE . 20.6 p-10 -98.25 -46.06 5.96 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.593 -0.731 . . . . 10.0 109.699 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.439 ' HA ' ' O ' ' A' ' 3' ' ' ASP . 98.5 mtt180 -78.54 48.81 0.81 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.489 -0.778 . . . . 10.0 111.582 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 19.4 ptt? -146.25 18.22 1.38 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.918 -0.583 . . . . 10.0 109.624 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -74.23 -96.99 0.1 Allowed Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.591 -0.732 . . . . 10.0 112.789 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.1 m 55.24 -91.57 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 122.905 0.482 . . . . 10.0 111.573 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 35.9 pttt -74.04 -36.65 64.41 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.894 -0.41 . . . . 10.0 109.894 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 34.7 m170 -69.48 -24.17 63.74 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.957 -0.565 . . . . 10.0 110.603 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.424 ' CB ' ' HE1' ' A' ' 2' ' ' TYR . . . -60.0 -58.36 8.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.322 -0.854 . . . . 10.0 110.523 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -62.15 -33.07 73.79 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.098 -0.501 . . . . 10.0 111.048 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 30.5 mtp180 -65.06 -44.09 90.11 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.154 -0.476 . . . . 10.0 112.024 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 9.9 p -81.06 -30.83 11.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.849 0.357 . . . . 10.0 111.637 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 48.7 mtp180 -72.49 -4.38 30.1 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.083 0.468 . . . . 10.0 111.827 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -84.54 0.61 49.27 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.757 -0.656 . . . . 10.0 110.517 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -149.37 -53.8 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.584 -0.817 . . . . 10.0 112.988 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -66.23 -37.81 86.43 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.183 0.809 . . . . 10.0 113.183 -178.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -63.55 -22.94 67.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.855 0.359 . . . . 10.0 111.624 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -80.9 38.76 0.47 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.998 0.428 . . . . 10.0 111.465 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 171.18 -34.88 0.16 Allowed Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.774 -0.727 . . . . 10.0 113.419 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.469 ' HB3' ' HD3' ' A' ' 138' ' ' PRO . 11.2 t90 -57.0 -63.07 4.03 Favored Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 113.541 0.941 . . . . 10.0 113.541 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.469 ' HD3' ' HB3' ' A' ' 137' ' ' TRP . 33.2 Cg_endo -65.68 -29.79 51.25 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 121.279 1.32 . . . . 10.0 111.794 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.36 -43.75 76.73 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.799 -0.637 . . . . 10.0 111.493 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 11.2 tt -70.37 -32.55 50.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.561 -0.29 . . . . 10.0 111.461 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 70.6 mt -61.52 -45.76 92.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.039 0.447 . . . . 10.0 111.175 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -67.68 -40.99 84.38 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.713 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 15.2 m -67.37 -35.47 79.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.803 -0.635 . . . . 10.0 111.598 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.42 ' HD1' ' HA ' ' A' ' 144' ' ' PHE . 0.6 OUTLIER -59.55 -44.6 93.2 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.842 0.353 . . . . 10.0 111.024 179.289 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.43 ' HG3' ' O ' ' A' ' 11' ' ' THR . 8.6 tt0 -58.63 -49.56 77.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.856 -0.611 . . . . 10.0 110.947 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -65.64 -36.02 82.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.062 -0.517 . . . . 10.0 111.796 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -62.03 -53.65 52.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.934 -0.576 . . . . 10.0 110.766 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 57.3 mt -65.84 -34.71 72.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.029 -0.532 . . . . 10.0 110.044 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -61.78 -40.94 96.94 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.107 -0.497 . . . . 10.0 109.93 178.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 1.052 ' HA ' ' HB2' ' A' ' 154' ' ' LYS . 16.7 tt0 -70.89 -42.59 69.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.326 -0.397 . . . . 10.0 111.391 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -79.63 26.79 0.3 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.782 0.325 . . . . 10.0 111.798 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -155.28 -60.4 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.552 -0.832 . . . . 10.0 113.199 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -99.21 -48.16 4.93 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.839 0.681 . . . . 10.0 112.839 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 1.052 ' HB2' ' HA ' ' A' ' 150' ' ' GLU . 46.9 mtpt -60.95 -42.81 98.95 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.291 0.478 . . . . 10.0 112.291 -179.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 77.9 mttt . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.357 -0.83 . . . . 10.0 110.223 179.454 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' ASN . . . . . 0.551 ' HA ' ' O ' ' A' ' 5' ' ' PHE . 28.7 p-10 . . . . . 0 N--CA 1.479 0.989 0 CA-C-O 120.463 0.173 . . . . 10.0 110.728 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . 0.283 11.8 p90 50.44 30.18 4.44 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 115.572 1.693 . . . . 10.0 115.572 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.785 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 34.2 t70 -165.65 -63.64 0.01 OUTLIER Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 111.995 0.369 . . . . 10.0 111.995 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.785 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 92.0 Cg_endo -87.8 -31.86 0.19 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 121.77 1.647 . . . . 10.0 112.469 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.551 ' O ' ' HA ' ' A' ' 1' ' ' ASN . 12.6 p90 -174.26 141.6 0.74 Allowed 'General case' 0 C--O 1.24 0.56 0 CA-C-N 115.533 -0.758 . . . . 10.0 109.436 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.6 p -100.79 127.16 54.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.113 0.482 . . . . 10.0 111.258 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 7' ' ' ARG . 0.1 OUTLIER -159.23 108.52 1.89 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.843 -0.617 . . . . 10.0 110.348 -179.651 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -131.33 150.9 51.96 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.045 -0.525 . . . . 10.0 109.832 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 17.0 m -145.8 135.81 23.65 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.548 0.213 . . . . 10.0 111.084 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.0 t -121.52 132.89 69.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.052 -0.522 . . . . 10.0 109.639 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.97 122.25 39.75 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.501 -0.318 . . . . 10.0 110.746 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.2 t -131.04 141.89 44.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.017 -0.538 . . . . 10.0 109.801 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.7 mttp -84.63 54.44 3.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.05 0.452 . . . . 10.0 110.555 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -123.26 -163.03 1.08 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.897 -0.592 . . . . 10.0 110.325 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -113.38 166.97 10.97 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.224 -0.444 . . . . 10.0 111.79 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.477 HH21 ' HB2' ' A' ' 75' ' ' ASP . 36.4 ttt180 -55.11 -38.32 68.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.552 -0.749 . . . . 10.0 112.419 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -74.35 -54.63 7.26 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.96 0.356 . . . . 10.0 111.96 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -52.11 -43.08 63.78 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 112.607 0.595 . . . . 10.0 112.607 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.13 -42.43 80.2 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.992 0.368 . . . . 10.0 111.992 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -69.31 -36.88 77.44 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.182 0.515 . . . . 10.0 111.283 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.3 mtpt -69.66 -32.28 70.84 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 113.265 0.839 . . . . 10.0 113.265 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.28 -9.67 58.96 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.91 0.707 . . . . 10.0 112.91 -178.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -116.94 -19.63 9.73 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.923 0.712 . . . . 10.0 112.923 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.9 mp -120.55 10.77 11.18 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 114.33 1.234 . . . . 10.0 114.33 -178.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -155.64 -45.4 0.08 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.038 0.384 . . . . 10.0 112.038 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.99 104.24 2.2 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.492 -0.861 . . . . 10.0 111.262 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -109.15 -56.14 0.05 OUTLIER Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 112.338 0.496 . . . . 10.0 112.338 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.427 ' CG ' ' HA ' ' A' ' 43' ' ' PRO . 7.8 Cg_exo -74.15 14.96 0.65 Allowed 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.261 1.974 . . . . 10.0 112.359 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.63 8.96 37.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.215 0.531 . . . . 10.0 110.034 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.571 ' HB2' HD21 ' A' ' 34' ' ' ASN . 40.8 m0 -87.68 -164.84 1.16 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.621 -0.718 . . . . 10.0 110.363 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.633 ' H ' ' HD2' ' A' ' 32' ' ' PRO . 57.5 t90 -169.99 -50.62 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.513 0 CA-C-O 119.257 -0.402 . . . . 10.0 111.957 -178.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.633 ' HD2' ' H ' ' A' ' 31' ' ' TRP . 80.4 Cg_exo -26.28 -55.41 0.09 OUTLIER 'Trans proline' 0 C--N 1.367 1.525 0 C-N-CA 125.154 3.903 . . . . 10.0 116.9 -179.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -128.11 -41.43 1.6 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.694 0.627 . . . . 10.0 112.694 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.571 HD21 ' HB2' ' A' ' 30' ' ' TRP . 14.3 p-10 -77.95 93.87 4.5 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.372 0.605 . . . . 10.0 111.613 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -101.07 0.65 38.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.325 -0.852 . . . . 10.0 111.408 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.3 mtp180 -119.96 -160.18 0.81 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.737 0.303 . . . . 10.0 111.077 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.21 155.47 46.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.253 -0.43 . . . . 10.0 110.567 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.86 ' HB ' ' HA ' ' A' ' 57' ' ' ASP 0.267 9.8 p 67.66 -65.36 0.24 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 114.484 1.29 . . . . 10.0 114.484 178.726 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.671 ' HA ' ' HG3' ' A' ' 62' ' ' GLU . 5.4 mptt -74.81 -10.6 59.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.957 0.408 . . . . 10.0 111.006 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.4 p -173.85 89.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.34 -0.845 . . . . 10.0 109.971 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.69 68.49 0.55 Allowed Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.714 -0.675 . . . . 10.0 111.958 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.06 158.55 41.42 Favored Pre-proline 0 C--N 1.322 -0.591 0 O-C-N 122.656 -0.32 . . . . 10.0 110.799 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.427 ' HA ' ' CG ' ' A' ' 28' ' ' PRO . 41.7 Cg_exo -59.44 -28.35 87.32 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.763 2.308 . . . . 10.0 113.144 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 19.0 mt -95.29 -89.0 0.25 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.801 0.334 . . . . 10.0 111.058 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.25 -55.16 5.02 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.928 -0.653 . . . . 10.0 112.824 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.8 t -105.01 132.06 52.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.745 0.307 . . . . 10.0 111.087 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.478 ' OD1' ' HG2' ' A' ' 49' ' ' LYS . 1.0 OUTLIER -100.38 118.33 36.4 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.974 -0.557 . . . . 10.0 109.638 178.404 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.7 pttt -106.13 6.46 30.99 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.958 -0.565 . . . . 10.0 112.351 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.478 ' HG2' ' OD1' ' A' ' 47' ' ' ASP . 17.7 pttt -92.65 -24.1 18.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.861 0.362 . . . . 10.0 110.112 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -131.21 -60.02 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 111.269 -0.732 . . . . 10.0 111.269 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 135.02 71.34 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.716 -0.754 . . . . 10.0 112.363 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -159.77 168.5 25.74 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.75 -0.265 . . . . 10.0 110.65 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 43.1 m95 -116.02 135.62 53.79 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.601 -0.889 . . . . 10.0 108.601 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -165.77 122.64 1.41 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.332 0.493 . . . . 10.0 112.332 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -82.17 138.49 34.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.026 -0.534 . . . . 10.0 109.852 178.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 48.1 mm -98.46 124.75 51.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.284 -0.416 . . . . 10.0 110.279 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.86 ' HA ' ' HB ' ' A' ' 38' ' ' THR . 23.7 t70 -120.94 168.4 11.53 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.385 -0.37 . . . . 10.0 110.243 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -62.16 -29.3 70.26 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 122.829 0.452 . . . . 10.0 110.923 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -86.88 -9.59 55.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.28 -0.418 . . . . 10.0 111.463 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 138.59 -103.51 0.4 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.616 -0.802 . . . . 10.0 112.019 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -117.5 154.97 30.54 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.802 0.334 . . . . 10.0 110.892 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.671 ' HG3' ' HA ' ' A' ' 39' ' ' LYS . 3.0 mm-40 -118.29 -146.35 0.39 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.932 -0.576 . . . . 10.0 111.158 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.486 ' H ' ' HB3' ' A' ' 62' ' ' GLU . 4.5 p80 -67.5 172.64 4.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.338 0.59 . . . . 10.0 112.58 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.3 t -147.41 144.19 28.48 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.632 -0.713 . . . . 10.0 110.412 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -84.49 -38.74 19.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.111 -0.495 . . . . 10.0 111.151 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 171.27 -145.51 8.91 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.795 -0.717 . . . . 10.0 111.978 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.0 pp -140.47 161.93 36.55 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.731 0.3 . . . . 10.0 110.942 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.508 HG21 HG13 ' A' ' 71' ' ' VAL . 55.0 mt -106.44 123.4 61.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.803 -0.814 . . . . 10.0 108.803 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.3 ttm180 -93.09 -27.67 16.81 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.592 -0.276 . . . . 10.0 111.361 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.2 tptm -157.05 131.16 8.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.994 0.426 . . . . 10.0 111.84 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.508 HG13 HG21 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -129.0 102.96 8.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.427 -0.806 . . . . 10.0 108.901 178.683 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.76 ' HB2' ' HB ' ' A' ' 76' ' ' THR . 59.5 m-20 -118.54 78.93 1.31 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.566 -0.288 . . . . 10.0 110.794 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.513 ' HG2' ' O ' ' A' ' 72' ' ' ASP . 5.7 pt-20 55.4 178.7 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.663 0 O-C-N 123.971 0.794 . . . . 10.0 111.718 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -71.55 48.69 1.04 Allowed 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 121.955 1.77 . . . . 10.0 111.569 177.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.477 ' HB2' HH21 ' A' ' 16' ' ' ARG . 16.0 t70 -134.96 -55.52 0.82 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.306 -0.406 . . . . 10.0 111.088 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.76 ' HB ' ' HB2' ' A' ' 72' ' ' ASP . 5.0 m -113.23 119.18 36.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.159 -0.473 . . . . 10.0 110.753 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.478 ' HB3' ' HB ' ' A' ' 99' ' ' VAL . 59.7 tp -129.05 119.65 24.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.13 -0.486 . . . . 10.0 110.937 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 51.2 t -118.91 116.36 50.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.652 -0.499 . . . . 10.0 109.652 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 pp -133.95 161.99 40.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.353 -0.385 . . . . 10.0 111.943 -178.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.565 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -129.08 141.79 12.91 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 110.5 -1.04 . . . . 10.0 110.5 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -105.32 166.21 10.58 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.388 0.514 . . . . 10.0 112.388 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 82' ' ' ARG . 46.7 mtp180 -104.87 -168.76 1.52 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.802 -0.635 . . . . 10.0 110.53 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.421 ' HG ' ' HB3' ' A' ' 91' ' ' PRO . 0.3 OUTLIER -130.29 150.65 51.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.786 -0.643 . . . . 10.0 111.18 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -87.85 -168.49 2.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.883 -0.599 . . . . 10.0 110.529 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 131.73 157.58 8.77 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.828 -0.701 . . . . 10.0 112.915 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -104.98 -85.83 0.47 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.23 0.538 . . . . 10.0 110.046 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -88.73 81.0 1.56 Allowed Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 111.232 -0.747 . . . . 10.0 111.232 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 5.5 ptt85 -141.94 175.53 9.65 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.624 0.249 . . . . 10.0 110.592 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.763 HG12 ' H ' ' A' ' 90' ' ' ASP . 10.3 tt -83.21 -174.64 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.011 -0.54 . . . . 10.0 110.612 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.763 ' H ' HG12 ' A' ' 89' ' ' ILE . 29.2 t70 -59.8 141.48 89.16 Favored Pre-proline 0 C--N 1.331 -0.236 0 C-N-CA 123.134 0.574 . . . . 10.0 110.972 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 90' ' ' ASP . 14.8 Cg_exo -69.37 60.05 1.46 Allowed 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.135 2.557 . . . . 10.0 113.142 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -82.03 92.75 6.85 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.249 0.547 . . . . 10.0 110.714 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -164.41 -69.2 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.761 -0.654 . . . . 10.0 110.21 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.2 m 66.14 90.78 0.09 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.077 0.769 . . . . 10.0 113.077 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.2 m -88.91 107.69 19.14 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.48 -0.563 . . . . 10.0 109.48 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.565 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 57.6 mt-10 -91.03 151.94 20.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.996 0.427 . . . . 10.0 111.914 -178.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -140.54 142.64 35.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.212 -0.904 . . . . 10.0 109.881 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.7 m -102.23 125.51 48.95 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.582 -0.281 . . . . 10.0 110.446 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.478 ' HB ' ' HB3' ' A' ' 77' ' ' LEU . 21.4 t -107.3 126.12 63.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.836 -0.62 . . . . 10.0 110.827 -178.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -112.4 134.39 53.96 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.226 -0.443 . . . . 10.0 110.652 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -102.43 123.63 46.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.27 -0.423 . . . . 10.0 111.532 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.8 t -119.8 119.69 61.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.154 -0.475 . . . . 10.0 109.737 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -104.07 136.07 44.39 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.809 0.338 . . . . 10.0 110.818 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -127.27 115.69 19.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.005 -0.543 . . . . 10.0 111.187 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.34 6.11 52.45 Favored Glycine 0 CA--C 1.518 0.261 0 CA-C-N 115.915 -0.584 . . . . 10.0 112.886 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 67.47 -3.15 1.13 Allowed 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.915 0.709 . . . . 10.0 112.915 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.2 ptmt -119.24 6.21 11.22 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.196 0.522 . . . . 10.0 111.605 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -140.06 132.58 28.66 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.167 -0.679 . . . . 10.0 109.167 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.8 m -117.72 130.37 56.28 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.397 0.517 . . . . 10.0 112.397 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -118.85 113.3 20.86 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.088 -1.078 . . . . 10.0 108.088 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 9' ' ' SER . 11.8 p -113.35 133.93 57.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 C-N-CA 120.449 -0.5 . . . . 10.0 111.29 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -127.9 148.33 50.48 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.048 -0.524 . . . . 10.0 111.795 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.6 t -126.27 113.85 35.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 108.82 -0.807 . . . . 10.0 108.82 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -129.44 144.58 51.31 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.172 0.511 . . . . 10.0 112.094 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -163.55 162.86 24.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.416 -0.811 . . . . 10.0 109.021 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -157.57 77.87 0.85 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.701 0.286 . . . . 10.0 110.491 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -172.41 -67.39 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.296 -0.411 . . . . 10.0 111.919 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.463 ' O ' ' HG2' ' A' ' 121' ' ' MET . 82.5 m-85 -81.57 -16.73 50.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.182 0.515 . . . . 10.0 111.579 -178.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -82.52 -16.8 47.32 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.828 -0.624 . . . . 10.0 110.67 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 77.8 mtt180 -91.65 32.2 1.12 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.181 0.438 . . . . 10.0 112.181 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.463 ' HG2' ' O ' ' A' ' 118' ' ' PHE . 21.3 ptp -136.19 23.32 3.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.086 0.47 . . . . 10.0 110.129 179.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -73.22 -106.67 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.701 -0.681 . . . . 10.0 112.789 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.2 m 53.41 -87.79 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.634 0.605 . . . . 10.0 112.634 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.479 ' O ' ' HG3' ' A' ' 128' ' ' ARG . 55.7 pttt -72.35 -35.61 68.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.838 0.352 . . . . 10.0 110.25 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -71.26 -31.99 68.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 10.0 110.883 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.6 -43.4 97.46 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.712 -0.676 . . . . 10.0 110.818 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -66.61 -37.15 84.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.934 -0.575 . . . . 10.0 111.02 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' A' ' 124' ' ' LYS . 45.9 mtp180 -69.31 -45.15 70.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 10.0 111.383 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.8 p -70.29 -20.42 22.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 112.205 0.446 . . . . 10.0 112.205 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.523 ' HG3' ' HB3' ' A' ' 134' ' ' ASP . 23.6 ttt180 -66.64 -15.42 63.46 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 121.067 0.461 . . . . 10.0 111.057 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -71.59 -4.21 25.8 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.233 0.457 . . . . 10.0 112.233 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -152.81 -50.29 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 119.999 -1.096 . . . . 10.0 113.744 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -63.09 -42.71 99.67 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.207 0.817 . . . . 10.0 113.207 -178.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.523 ' HB3' ' HG3' ' A' ' 130' ' ' ARG . 34.1 t70 -71.89 -3.03 20.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.179 0.514 . . . . 10.0 111.853 -179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -98.24 19.42 14.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.272 -0.422 . . . . 10.0 111.3 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.461 ' O ' ' HB ' ' A' ' 140' ' ' ILE . . . -175.08 -35.3 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 119.765 -1.207 . . . . 10.0 113.806 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -56.55 -58.05 19.52 Favored Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 113.457 0.91 . . . . 10.0 113.457 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.87 -41.23 46.97 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.118 1.879 . . . . 10.0 112.038 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.05 -38.18 87.69 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 116.045 -0.525 . . . . 10.0 111.04 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.461 ' HB ' ' O ' ' A' ' 136' ' ' GLY . 1.0 OUTLIER -65.34 -39.67 86.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.163 -0.471 . . . . 10.0 111.669 -179.504 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 93.4 mt -64.69 -35.59 81.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.498 -0.319 . . . . 10.0 111.275 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -80.4 -32.56 37.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.138 -0.483 . . . . 10.0 112.239 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 2.8 p -75.5 -34.6 60.85 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.987 -0.285 . . . . 10.0 111.368 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -61.13 -37.9 84.47 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.856 0.36 . . . . 10.0 111.27 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -56.76 -54.96 40.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.707 -0.678 . . . . 10.0 111.627 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -61.45 -37.08 82.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.455 -0.339 . . . . 10.0 111.616 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 48.6 tttp -64.9 -55.34 19.91 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.18 0.437 . . . . 10.0 112.18 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 32.7 mt -66.96 -38.38 81.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.722 0.296 . . . . 10.0 111.573 -178.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -65.17 -35.32 80.72 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-O 121.357 0.599 . . . . 10.0 109.915 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 1.027 ' HA ' ' HB3' ' A' ' 154' ' ' LYS . 32.7 tt0 -67.96 -48.38 66.04 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.391 -0.822 . . . . 10.0 109.724 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -79.89 56.97 2.46 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.038 -0.528 . . . . 10.0 110.879 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -177.82 -51.95 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.743 -0.662 . . . . 10.0 112.299 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -126.06 -45.37 1.72 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.332 0.493 . . . . 10.0 112.332 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 1.027 ' HB3' ' HA ' ' A' ' 150' ' ' GLU . 71.5 tttt -60.94 -35.6 77.15 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.496 0.554 . . . . 10.0 112.496 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt . . . . . 0 C--O 1.252 1.213 0 CA-C-O 118.427 -0.797 . . . . 10.0 110.106 179.881 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 110.703 -0.11 . . . . 10.0 110.703 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . 0.365 17.6 p90 63.63 -50.49 0.24 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 116.27 1.952 . . . . 10.0 116.27 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.81 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 16.7 t70 -74.47 -61.61 1.13 Allowed Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 112.886 0.699 . . . . 10.0 112.886 -178.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.81 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 3.6 Cg_exo -80.5 -32.64 1.17 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.292 1.995 . . . . 10.0 111.949 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.63 ' HA ' ' OD2' ' A' ' 119' ' ' ASP . 47.3 p90 -176.94 152.5 0.93 Allowed 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.346 -0.843 . . . . 10.0 109.648 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.5 p -101.54 138.58 25.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.021 0.438 . . . . 10.0 111.32 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 39.4 ttm180 -171.0 104.63 0.23 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.376 -0.829 . . . . 10.0 110.043 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 72.1 m-70 -131.04 157.21 43.63 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.06 -0.348 . . . . 10.0 110.06 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 0.0 OUTLIER -147.2 140.27 25.19 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.442 0.534 . . . . 10.0 112.442 -179.71 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.402 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 21.9 t -123.45 143.4 36.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 108.91 -0.774 . . . . 10.0 108.91 179.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.8 m -111.26 105.46 14.13 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.082 0.468 . . . . 10.0 111.991 -178.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.581 HG13 HG21 ' A' ' 148' ' ' ILE . 89.2 t -85.97 114.91 26.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.081 -0.509 . . . . 10.0 110.515 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt -98.74 57.95 1.16 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.213 0.53 . . . . 10.0 111.124 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -147.91 -83.26 0.11 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.556 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -163.47 157.99 20.42 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.725 -0.472 . . . . 10.0 109.725 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.7 ttt180 -66.99 -37.39 84.13 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.614 0.598 . . . . 10.0 112.614 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -70.59 -41.08 72.81 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.059 0.392 . . . . 10.0 112.059 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.97 -36.63 84.11 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.818 0.303 . . . . 10.0 111.818 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.58 -44.39 94.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.143 0.497 . . . . 10.0 110.233 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -67.35 -38.71 85.28 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.7 -0.682 . . . . 10.0 110.316 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.0 mmtt -66.17 -43.61 86.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.66 -0.7 . . . . 10.0 112.683 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.4 p -73.24 -26.34 61.08 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.09 0.774 . . . . 10.0 113.09 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -84.16 -34.4 24.04 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.03 0.752 . . . . 10.0 113.03 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.0 mp -102.36 -33.05 9.72 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.842 1.053 . . . . 10.0 113.842 -178.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -124.53 42.42 3.26 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.289 0.477 . . . . 10.0 112.289 -178.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -145.18 30.16 1.77 Allowed Glycine 0 C--O 1.228 -0.254 0 C-N-CA 120.516 -0.849 . . . . 10.0 112.524 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.558 ' HD1' ' HA2' ' A' ' 41' ' ' GLY . 0.6 OUTLIER -54.65 -56.36 28.01 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 113.366 0.876 . . . . 10.0 113.366 -179.141 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.654 ' HG3' ' HA ' ' A' ' 43' ' ' PRO . 92.6 Cg_endo -82.94 28.35 0.58 Allowed 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 122.095 1.863 . . . . 10.0 112.376 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -124.0 9.39 8.72 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.2 0.524 . . . . 10.0 111.446 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 19.8 m0 -98.61 162.59 13.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.949 -0.569 . . . . 10.0 109.668 179.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.669 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -144.85 46.85 0.64 Allowed Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 112.307 0.484 . . . . 10.0 112.307 179.172 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.669 ' HD3' ' N ' ' A' ' 31' ' ' TRP . 6.3 Cg_endo -89.88 -45.82 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.364 2.043 . . . . 10.0 112.509 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.446 ' H ' ' HD2' ' A' ' 32' ' ' PRO . 65.8 t30 -157.78 -32.3 0.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.113 0.482 . . . . 10.0 110.137 -179.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.439 ' OD1' ' HD2' ' A' ' 32' ' ' PRO . 16.6 p-10 -79.67 89.53 5.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.398 0.618 . . . . 10.0 111.168 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -99.73 -21.18 15.91 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.67 -0.695 . . . . 10.0 110.899 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -91.18 109.24 20.49 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.147 -0.479 . . . . 10.0 111.024 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.57 167.47 12.89 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.802 -0.636 . . . . 10.0 111.139 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.408 HG22 ' OD2' ' A' ' 57' ' ' ASP . 3.3 m 78.51 -62.8 0.32 Allowed 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.515 0.561 . . . . 10.0 112.515 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 17.1 mmtm -76.16 -24.72 54.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.863 0.363 . . . . 10.0 111.814 -179.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.4 p -163.21 91.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.77 0.795 . . . . 10.0 110.543 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.558 ' HA2' ' HD1' ' A' ' 27' ' ' PHE . . . 126.51 47.61 0.2 Allowed Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.477 -0.783 . . . . 10.0 111.753 -178.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.58 158.71 86.25 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 120.621 0.248 . . . . 10.0 111.097 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.654 ' HA ' ' HG3' ' A' ' 28' ' ' PRO . 34.3 Cg_exo -59.82 -20.46 59.33 Favored 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 122.677 2.252 . . . . 10.0 112.88 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.3 mp -98.74 -91.82 0.27 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.7 0.286 . . . . 10.0 110.579 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.85 -63.97 2.47 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.824 -0.703 . . . . 10.0 113.122 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.3 t -106.04 132.51 52.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 120.725 0.298 . . . . 10.0 110.996 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -95.31 125.77 40.16 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.398 -0.365 . . . . 10.0 110.355 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.485 ' HB2' ' HE3' ' A' ' 48' ' ' LYS . 37.3 mtmt -103.51 10.61 37.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.286 -0.415 . . . . 10.0 110.972 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.0 mtmm -89.09 -54.51 4.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.669 0.271 . . . . 10.0 110.533 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -111.15 -29.83 3.36 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 111.101 -0.799 . . . . 10.0 111.101 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.26 80.32 1.4 Allowed Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.655 -0.783 . . . . 10.0 111.97 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 52' ' ' ARG . 13.8 ptt180 -162.97 167.63 22.27 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.725 0.297 . . . . 10.0 110.505 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 60.0 m95 -107.33 134.52 50.27 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.883 -0.784 . . . . 10.0 108.883 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -164.22 120.05 1.56 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.053 0.454 . . . . 10.0 111.497 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -83.77 133.66 34.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.794 -0.639 . . . . 10.0 109.676 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.0 mm -96.14 111.27 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 116.069 -0.514 . . . . 10.0 110.823 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.979 ' HB2' ' HG2' ' A' ' 62' ' ' GLU . 15.9 t70 -106.62 163.49 12.85 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.921 -0.581 . . . . 10.0 109.597 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.38 -23.72 65.61 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.598 0.237 . . . . 10.0 110.514 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -87.42 -4.23 59.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.811 0.339 . . . . 10.0 110.775 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 134.1 -111.64 0.98 Allowed Glycine 0 CA--C 1.519 0.298 0 C-N-CA 121.209 -0.52 . . . . 10.0 112.482 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -115.76 137.24 52.28 Favored 'General case' 0 C--N 1.32 -0.676 0 O-C-N 122.41 -0.465 . . . . 10.0 110.759 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.979 ' HG2' ' HB2' ' A' ' 57' ' ' ASP . 15.2 mm-40 -97.45 -144.46 0.3 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.946 -0.57 . . . . 10.0 111.657 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.507 ' H ' ' HB3' ' A' ' 62' ' ' GLU . 3.3 p80 -75.07 -178.83 4.01 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 113.045 0.757 . . . . 10.0 113.045 -179.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.9 t -152.64 152.63 32.01 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.142 -0.936 . . . . 10.0 110.095 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.446 ' HE2' ' HZ ' ' A' ' 27' ' ' PHE . 98.5 m-85 -96.68 -22.1 17.21 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.475 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.463 ' HA3' ' O ' ' A' ' 80' ' ' GLY . . . 154.12 -146.75 15.22 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 121.032 -0.604 . . . . 10.0 112.42 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.9 pp -132.73 169.24 16.98 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.776 0.322 . . . . 10.0 110.704 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.411 HG21 HG13 ' A' ' 71' ' ' VAL . 67.4 mt -109.03 127.13 65.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.095 -0.705 . . . . 10.0 109.095 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -77.83 -45.88 23.11 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.418 -0.356 . . . . 10.0 111.255 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.0 tttm -161.81 145.33 12.3 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.229 -0.441 . . . . 10.0 110.604 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.411 HG13 HG21 ' A' ' 68' ' ' ILE . 0.4 OUTLIER -115.23 84.67 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.206 0.527 . . . . 10.0 110.478 179.555 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.26 61.95 5.92 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.982 -0.554 . . . . 10.0 111.161 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.405 ' C ' ' H ' ' A' ' 75' ' ' ASP . 3.8 pt-20 55.04 -179.01 0.03 OUTLIER Pre-proline 0 CA--C 1.547 0.841 0 O-C-N 123.871 0.732 . . . . 10.0 111.886 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.403 ' CD ' ' HB2' ' A' ' 73' ' ' GLU . 21.5 Cg_exo -69.29 33.65 0.19 Allowed 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 122.203 1.935 . . . . 10.0 113.359 178.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 73' ' ' GLU . 17.4 t70 -113.49 -56.46 2.4 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.639 0.257 . . . . 10.0 110.564 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.0 m -127.6 129.33 47.09 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.951 0.405 . . . . 10.0 110.594 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 28.9 tp -129.05 134.01 47.94 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.054 -0.521 . . . . 10.0 110.088 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.6 t -128.35 119.93 51.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.935 -0.394 . . . . 10.0 109.935 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 37.6 pt -133.57 167.7 25.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.719 0.295 . . . . 10.0 111.268 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.541 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -123.88 138.49 11.43 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 110.836 -0.905 . . . . 10.0 110.836 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -97.01 156.89 16.16 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.216 0.821 . . . . 10.0 113.216 -178.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.0 ttt180 -105.94 153.35 22.1 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.992 -1.004 . . . . 10.0 109.692 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.743 ' HG ' ' HB3' ' A' ' 91' ' ' PRO . 1.6 pp -98.84 170.6 8.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.647 0.26 . . . . 10.0 111.428 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -120.42 -173.05 2.49 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.44 -0.346 . . . . 10.0 110.84 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 134.45 147.01 5.51 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.4 -0.68 . . . . 10.0 111.4 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -83.29 -84.27 0.13 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.993 0.425 . . . . 10.0 110.73 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -87.03 92.73 1.83 Allowed Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.756 -0.735 . . . . 10.0 111.739 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.508 ' HD2' ' O ' ' A' ' 89' ' ' ILE . 0.0 OUTLIER -164.37 169.29 17.58 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.748 0.309 . . . . 10.0 110.723 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.508 ' O ' ' HD2' ' A' ' 88' ' ' ARG . 8.9 tp -74.79 164.59 3.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.151 -0.477 . . . . 10.0 110.606 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.453 ' H ' HG13 ' A' ' 89' ' ' ILE . 1.4 m-20 -65.15 146.27 98.96 Favored Pre-proline 0 C--O 1.232 0.176 0 CA-C-O 120.748 0.309 . . . . 10.0 111.241 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.743 ' HB3' ' HG ' ' A' ' 83' ' ' LEU . 19.2 Cg_endo -57.89 104.41 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 123.297 2.664 . . . . 10.0 113.914 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -106.77 -25.04 11.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.763 -0.653 . . . . 10.0 109.94 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -68.71 -77.71 0.08 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.514 -0.766 . . . . 10.0 111.134 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.9 m 69.07 161.57 0.21 Allowed 'General case' 0 CA--C 1.534 0.342 0 O-C-N 123.559 0.537 . . . . 10.0 112.216 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 16.1 m -144.34 124.84 13.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.449 -0.341 . . . . 10.0 111.229 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.541 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 12.2 pt-20 -100.69 153.04 19.76 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.151 -0.477 . . . . 10.0 110.222 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -139.15 147.03 41.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.667 -0.242 . . . . 10.0 110.914 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.18 126.36 42.31 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.363 -0.606 . . . . 10.0 109.363 179.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 39.0 t -116.97 127.25 74.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.419 -0.355 . . . . 10.0 111.31 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.74 130.57 55.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.564 -0.289 . . . . 10.0 110.864 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -100.21 84.14 2.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.391 -0.368 . . . . 10.0 111.109 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 34.6 t -85.66 111.09 20.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 110.01 -0.367 . . . . 10.0 110.01 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 109' ' ' THR . . . -102.82 137.72 40.66 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.734 0.302 . . . . 10.0 111.347 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -124.95 125.95 44.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.998 -0.546 . . . . 10.0 109.616 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 78.3 6.5 87.81 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.743 -0.742 . . . . 10.0 111.881 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 63.36 20.8 12.47 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.685 0.624 . . . . 10.0 112.685 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 16.6 pttt -140.95 -51.95 0.46 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.108 -0.496 . . . . 10.0 110.685 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -82.7 100.2 10.09 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.256 -0.646 . . . . 10.0 109.256 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 103' ' ' ALA . 7.2 m -103.25 115.64 30.95 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.774 -0.648 . . . . 10.0 111.268 -178.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 64.1 mtt180 -102.67 105.72 16.24 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.036 -0.529 . . . . 10.0 110.14 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 9' ' ' SER . 1.8 p -92.2 123.74 44.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.844 -0.617 . . . . 10.0 110.806 -179.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -114.41 145.44 41.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.021 -0.536 . . . . 10.0 111.483 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 24.1 t -123.21 122.38 65.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.797 -0.638 . . . . 10.0 109.527 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -135.68 155.51 50.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.206 0.527 . . . . 10.0 112.001 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -177.88 157.44 1.17 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.203 -0.908 . . . . 10.0 108.696 178.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.1 m -156.71 86.07 0.98 Allowed 'General case' 0 C--O 1.237 0.417 0 N-CA-C 109.825 -0.435 . . . . 10.0 109.825 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -177.02 -64.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.021 -0.536 . . . . 10.0 111.197 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.467 ' O ' ' HG2' ' A' ' 121' ' ' MET . 83.4 m-85 -90.07 2.41 55.26 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.276 -0.42 . . . . 10.0 111.919 -178.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.63 ' OD2' ' HA ' ' A' ' 5' ' ' PHE . 19.7 p-10 -90.12 -38.67 13.37 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.177 -0.465 . . . . 10.0 110.827 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -75.63 18.49 0.23 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.766 0.654 . . . . 10.0 112.766 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.467 ' HG2' ' O ' ' A' ' 118' ' ' PHE . 23.7 ptt? -118.15 13.67 13.84 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.518 -0.549 . . . . 10.0 109.518 178.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.453 ' HA2' ' HB2' ' A' ' 125' ' ' HIS . . . -77.6 -111.77 0.17 Allowed Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.611 -0.722 . . . . 10.0 113.394 -178.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.5 m 56.36 -92.17 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.48 0.312 . . . . 10.0 111.225 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.33 -31.06 70.2 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.62 -0.511 . . . . 10.0 109.62 178.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.453 ' HB2' ' HA2' ' A' ' 122' ' ' GLY . 7.5 m170 -72.24 -42.2 65.95 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.823 -0.626 . . . . 10.0 109.71 178.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.489 ' HA ' HG12 ' A' ' 129' ' ' VAL . . . -66.24 -38.87 88.91 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.757 -0.656 . . . . 10.0 110.04 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -60.03 -31.85 70.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.621 -0.718 . . . . 10.0 110.989 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.78 -43.64 19.81 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.1 -0.5 . . . . 10.0 111.501 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.489 HG12 ' HA ' ' A' ' 126' ' ' ALA . 4.6 p -71.02 -23.37 23.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 112.13 0.419 . . . . 10.0 112.13 -179.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -69.67 -4.59 20.18 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.003 0.372 . . . . 10.0 112.003 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -71.12 -27.54 63.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.867 0.365 . . . . 10.0 110.761 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -133.66 -30.23 0.45 Allowed Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.148 -1.025 . . . . 10.0 114.163 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 12.8 tpt -79.11 -29.87 43.45 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 117.358 0.579 . . . . 10.0 112.012 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -69.14 -9.54 53.32 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.14 -0.482 . . . . 10.0 111.858 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -95.76 -7.49 37.05 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.214 0.45 . . . . 10.0 112.214 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -131.54 -39.78 0.24 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 119.794 -1.193 . . . . 10.0 114.362 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.406 ' HB3' ' HD3' ' A' ' 138' ' ' PRO . 22.5 t90 -53.11 -59.6 8.72 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 113.781 1.03 . . . . 10.0 113.781 -178.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.406 ' HD3' ' HB3' ' A' ' 137' ' ' TRP . 42.7 Cg_endo -67.17 -36.42 21.58 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 121.551 1.501 . . . . 10.0 112.705 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.8 -41.41 91.97 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.111 -0.495 . . . . 10.0 111.645 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.2 mp -64.97 -41.27 91.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.166 -0.47 . . . . 10.0 111.586 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 96.1 mt -59.1 -47.71 84.25 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.259 -0.428 . . . . 10.0 111.478 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -63.46 -40.19 96.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.984 -0.553 . . . . 10.0 111.057 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 21.7 m -66.32 -43.65 85.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.08 -0.509 . . . . 10.0 111.307 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -63.96 -39.33 93.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.542 -0.299 . . . . 10.0 110.556 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -58.68 -34.59 71.44 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 123.8 0.687 . . . . 10.0 111.074 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -87.96 -35.52 17.6 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.332 0.493 . . . . 10.0 112.332 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -61.79 -50.86 70.64 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 111.616 0.228 . . . . 10.0 111.616 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.581 HG21 HG13 ' A' ' 12' ' ' VAL . 48.6 mt -63.81 -32.3 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.18 0.515 . . . . 10.0 110.644 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -73.39 -39.16 65.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.964 -0.562 . . . . 10.0 109.773 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -64.03 -53.32 51.84 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.883 -0.598 . . . . 10.0 109.851 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -87.08 56.87 4.19 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.38 -0.827 . . . . 10.0 110.78 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 175.14 -43.28 0.12 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.041 -1.076 . . . . 10.0 113.317 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -109.55 -49.65 3.08 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.103 0.408 . . . . 10.0 112.103 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 22.0 mttp -65.23 -55.3 19.23 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.791 0.329 . . . . 10.0 110.798 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.437 ' HE3' ' HB2' ' A' ' 155' ' ' LYS . 33.8 mtmt . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.024 -0.988 . . . . 10.0 109.705 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' ASN . . . . . 0.759 ' O ' ' HD2' ' A' ' 4' ' ' PRO . 17.6 p-10 . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 120.428 0.156 . . . . 10.0 110.806 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . 0.286 0.2 OUTLIER 47.84 -107.18 0.18 Allowed 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 115.899 1.815 . . . . 10.0 115.899 179.606 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.504 ' HB2' ' HD3' ' A' ' 4' ' ' PRO . 1.1 m-20 -48.54 -64.31 1.18 Allowed Pre-proline 0 N--CA 1.475 0.821 0 N-CA-C 115.353 1.612 . . . . 10.0 115.353 -177.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.759 ' HD2' ' O ' ' A' ' 1' ' ' ASN . 75.3 Cg_exo -51.34 -48.0 23.32 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.458 2.105 . . . . 10.0 112.84 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.459 ' HA ' ' OD2' ' A' ' 119' ' ' ASP . 51.8 p90 178.66 153.33 0.36 Allowed 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.705 -0.68 . . . . 10.0 109.705 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.9 p -107.27 96.3 4.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.323 0.582 . . . . 10.0 111.304 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.504 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 98.4 mtt180 -136.57 105.31 5.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.867 -0.606 . . . . 10.0 110.247 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 28.3 m-70 -121.18 152.28 38.97 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.316 -0.402 . . . . 10.0 110.044 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.9 m -140.38 133.28 29.19 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.607 0.241 . . . . 10.0 111.083 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.535 ' HB ' HG13 ' A' ' 111' ' ' VAL . 21.7 t -123.32 140.45 46.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 109.374 -0.602 . . . . 10.0 109.374 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.1 m -107.93 112.31 24.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.058 0.456 . . . . 10.0 110.91 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.567 HG11 ' HB2' ' A' ' 19' ' ' ALA . 70.3 t -98.94 132.8 43.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 116.299 -0.41 . . . . 10.0 110.178 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.2 mtmt -115.45 88.16 2.82 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.749 0.309 . . . . 10.0 111.676 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -172.54 -82.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.702 -0.681 . . . . 10.0 109.471 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -168.65 -178.91 3.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.009 -0.541 . . . . 10.0 110.152 178.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 50.2 ttt180 -76.25 -35.58 58.89 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.283 0.475 . . . . 10.0 112.283 -178.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -71.5 -46.58 59.34 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.474 0.546 . . . . 10.0 112.474 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.95 -46.62 75.02 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.031 0.382 . . . . 10.0 112.031 -179.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.567 ' HB2' HG11 ' A' ' 12' ' ' VAL . . . -61.93 -46.53 88.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.357 -0.383 . . . . 10.0 111.456 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -67.64 -37.49 82.51 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.309 -0.405 . . . . 10.0 111.613 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.8 mmtt -68.2 -44.65 75.34 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 111.921 0.341 . . . . 10.0 111.921 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.2 p -67.36 -28.17 67.73 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.362 0.505 . . . . 10.0 112.362 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -93.29 7.33 44.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.702 0.286 . . . . 10.0 111.618 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.0 tp -128.26 -55.86 1.25 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.454 0.539 . . . . 10.0 112.454 -178.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -108.82 -12.35 14.92 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.077 0.399 . . . . 10.0 112.077 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.51 86.83 1.5 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.652 -0.785 . . . . 10.0 111.725 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -111.66 -55.6 0.04 OUTLIER Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 112.731 0.641 . . . . 10.0 112.731 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -75.74 27.85 0.39 Allowed 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.273 1.982 . . . . 10.0 112.577 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -120.48 0.62 10.55 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.318 -0.401 . . . . 10.0 110.762 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 39.7 m0 -76.72 165.07 25.24 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.322 -0.621 . . . . 10.0 109.322 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.594 ' H ' ' HD2' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -146.07 -58.39 0.02 OUTLIER Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 112.585 0.587 . . . . 10.0 112.585 -179.735 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.594 ' HD2' ' H ' ' A' ' 31' ' ' TRP . 73.6 Cg_endo -74.31 52.58 2.8 Favored 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 122.068 1.845 . . . . 10.0 112.498 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -170.0 -67.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.978 -0.555 . . . . 10.0 110.659 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.463 HD22 ' HA3' ' A' ' 41' ' ' GLY . 18.2 p-10 -111.82 122.83 48.84 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.334 0.588 . . . . 10.0 111.549 -179.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -112.96 4.75 16.93 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.735 -0.666 . . . . 10.0 110.779 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -133.08 105.08 6.85 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.721 0.296 . . . . 10.0 111.198 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.06 166.19 14.29 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.117 -0.492 . . . . 10.0 110.302 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.1 m 75.46 -47.35 0.59 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 122.91 0.484 . . . . 10.0 111.562 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.1 -30.64 27.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.1 0.476 . . . . 10.0 109.896 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.8 p -161.81 104.19 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 115.301 -0.863 . . . . 10.0 109.343 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.463 ' HA3' HD22 ' A' ' 34' ' ' ASN . . . 107.83 62.24 0.56 Allowed Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.939 -0.864 . . . . 10.0 110.939 -178.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.462 ' CB ' ' H ' ' A' ' 56' ' ' ILE . . . -81.31 168.08 27.2 Favored Pre-proline 0 C--N 1.321 -0.669 0 C-N-CA 122.407 0.283 . . . . 10.0 110.896 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -74.74 45.58 1.32 Allowed 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 122.979 2.452 . . . . 10.0 112.963 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 27.4 tp -160.69 -86.85 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.744 -0.465 . . . . 10.0 109.744 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.65 -69.71 3.25 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.93 -0.652 . . . . 10.0 112.991 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.8 t -103.14 134.9 42.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.002 0.43 . . . . 10.0 111.461 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.436 ' HB3' ' HG3' ' A' ' 52' ' ' ARG . 6.6 t70 -103.26 112.29 25.1 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.421 -0.585 . . . . 10.0 109.421 178.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.61 23.2 8.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.754 -0.657 . . . . 10.0 111.02 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.5 mttp -99.65 -54.29 2.96 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.94 -0.763 . . . . 10.0 108.94 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -108.55 -21.96 7.3 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.309 -0.86 . . . . 10.0 112.085 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.472 ' HA2' HD12 ' A' ' 68' ' ' ILE . . . 98.3 67.43 0.9 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.747 -0.739 . . . . 10.0 112.082 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.436 ' HG3' ' HB3' ' A' ' 47' ' ' ASP . 33.1 ptt180 -151.48 173.87 14.06 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 122.654 -0.321 . . . . 10.0 110.361 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 35.6 m95 -123.79 132.21 53.74 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.402 -0.962 . . . . 10.0 108.402 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -163.29 132.16 3.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.23 0.538 . . . . 10.0 112.142 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.448 ' HB2' ' HB2' ' A' ' 62' ' ' GLU . 2.7 mm-40 -90.01 152.55 21.13 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.379 -0.828 . . . . 10.0 110.046 179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.462 ' H ' ' CB ' ' A' ' 42' ' ' ALA . 41.5 mm -107.07 123.78 62.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.292 -0.413 . . . . 10.0 110.528 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.827 ' HB2' ' HG2' ' A' ' 62' ' ' GLU . 21.1 t70 -127.13 166.01 18.47 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.973 -0.751 . . . . 10.0 108.973 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -64.15 -26.81 68.69 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.681 0.277 . . . . 10.0 111.629 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -88.4 -5.34 58.34 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.948 0.404 . . . . 10.0 111.066 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 135.18 -105.85 0.56 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.976 -0.631 . . . . 10.0 112.697 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.9 mp0 -115.55 140.2 49.38 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.728 0.299 . . . . 10.0 110.563 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.827 ' HG2' ' HB2' ' A' ' 57' ' ' ASP . 22.1 mm-40 -93.87 -135.26 0.18 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.367 -0.379 . . . . 10.0 110.809 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.479 ' H ' ' HB3' ' A' ' 62' ' ' GLU . 3.4 p80 -79.56 170.48 16.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.098 0.475 . . . . 10.0 111.601 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.4 t -145.11 132.54 20.72 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.027 -0.533 . . . . 10.0 110.652 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -72.83 -32.89 65.81 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.114 -0.494 . . . . 10.0 111.016 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 162.24 -143.32 8.66 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 121.171 -0.538 . . . . 10.0 112.558 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -137.73 168.92 18.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.78 0.324 . . . . 10.0 110.772 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.48 HG12 HG22 ' A' ' 79' ' ' ILE . 58.7 mt -106.48 141.13 22.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.968 -0.382 . . . . 10.0 109.968 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -93.06 -44.15 8.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.958 -0.564 . . . . 10.0 110.809 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.3 tttt -157.43 146.63 19.95 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.088 -0.505 . . . . 10.0 110.572 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.404 HG13 HG21 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -121.08 75.46 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.847 -0.615 . . . . 10.0 110.008 179.191 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 1.001 ' HB3' ' HB ' ' A' ' 76' ' ' THR . 6.6 t70 -86.57 69.42 10.36 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.564 -0.744 . . . . 10.0 111.23 -178.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 54.55 178.29 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.681 0 CA-C-N 115.357 -0.838 . . . . 10.0 112.0 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -72.17 49.49 1.35 Allowed 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 122.008 1.805 . . . . 10.0 110.845 177.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -137.66 -50.53 0.61 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.923 -0.58 . . . . 10.0 110.647 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 1.001 ' HB ' ' HB3' ' A' ' 72' ' ' ASP . 11.7 m -118.39 109.24 16.03 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.769 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 28.6 tp -117.42 126.89 53.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.125 -0.489 . . . . 10.0 110.469 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.5 t -128.04 115.7 39.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-N 116.35 -0.386 . . . . 10.0 110.249 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.48 HG22 HG12 ' A' ' 68' ' ' ILE . 31.8 pt -131.08 166.35 28.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.795 0.331 . . . . 10.0 111.543 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -127.27 125.65 5.34 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.393 -0.683 . . . . 10.0 111.393 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -93.1 156.71 16.7 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.606 0.241 . . . . 10.0 110.873 -179.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 50.4 mtp180 -106.5 178.4 4.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.096 -0.502 . . . . 10.0 110.774 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.35 151.97 32.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.323 -0.399 . . . . 10.0 111.374 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.461 ' H ' HG23 ' A' ' 129' ' ' VAL . 1.6 t-20 -88.73 -165.46 1.34 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.165 -0.471 . . . . 10.0 110.887 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.498 ' HA3' ' HG2' ' A' ' 88' ' ' ARG . . . 131.18 156.37 8.48 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 121.091 -0.576 . . . . 10.0 112.067 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -101.66 -86.38 0.41 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.673 0.273 . . . . 10.0 110.611 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -84.44 58.0 5.01 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 121.122 -0.561 . . . . 10.0 111.871 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.498 ' HG2' ' HA3' ' A' ' 85' ' ' GLY . 0.4 OUTLIER -121.09 154.55 35.99 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.747 0.308 . . . . 10.0 110.923 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.565 HG12 ' H ' ' A' ' 90' ' ' ASP . 11.9 tt -68.68 175.39 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 115.738 -0.665 . . . . 10.0 110.319 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.565 ' H ' HG12 ' A' ' 89' ' ' ILE . 82.6 m-20 -55.99 140.86 68.9 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.021 0.439 . . . . 10.0 111.662 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 90' ' ' ASP . 43.3 Cg_endo -85.85 61.41 5.15 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.918 2.412 . . . . 10.0 112.906 -178.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -83.61 71.91 10.34 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.258 0.551 . . . . 10.0 110.45 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -152.29 -63.47 0.17 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.87 -0.789 . . . . 10.0 108.87 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.3 m 62.98 170.76 0.15 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.181 -0.918 . . . . 10.0 112.944 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.3 m -137.99 111.35 8.0 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.531 -0.544 . . . . 10.0 109.531 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.66 140.68 29.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.304 -0.407 . . . . 10.0 111.093 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -132.1 148.4 52.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.164 -0.471 . . . . 10.0 111.066 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.74 121.19 41.95 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.688 -0.486 . . . . 10.0 109.688 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 46.7 t -108.1 131.83 57.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.816 0.341 . . . . 10.0 111.233 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.8 m -118.77 139.89 50.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.024 -0.535 . . . . 10.0 110.287 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -112.97 109.04 18.2 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.35 -0.386 . . . . 10.0 111.181 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.3 t -114.88 110.41 31.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.073 0.463 . . . . 10.0 109.834 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -100.35 143.49 30.47 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.186 0.517 . . . . 10.0 111.508 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -125.83 109.94 13.11 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.741 -0.663 . . . . 10.0 109.32 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 78.96 13.63 82.86 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.908 -0.663 . . . . 10.0 111.96 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 72.28 -42.94 0.55 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.013 0.746 . . . . 10.0 113.013 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.402 ' H ' ' HG2' ' A' ' 107' ' ' LYS . 30.3 pttt -73.47 -37.29 65.82 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.637 0.606 . . . . 10.0 112.637 -178.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -96.45 108.69 21.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.668 0.27 . . . . 10.0 110.56 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.434 ' HB ' ' HB ' ' A' ' 12' ' ' VAL . 11.6 m -109.07 121.33 44.91 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.94 0.4 . . . . 10.0 110.701 -179.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -108.31 130.08 55.2 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.343 -0.389 . . . . 10.0 110.568 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.535 HG13 ' HB ' ' A' ' 10' ' ' VAL . 1.5 p -118.83 123.25 71.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.196 -0.456 . . . . 10.0 110.014 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -122.37 147.63 46.04 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.322 0.582 . . . . 10.0 111.871 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 38.7 t -113.23 131.16 65.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.48 -0.782 . . . . 10.0 109.672 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.75 135.36 34.61 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 123.282 0.363 . . . . 10.0 110.43 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 -175.09 149.46 1.09 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.129 -0.487 . . . . 10.0 109.98 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -151.63 91.05 1.61 Allowed 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.151 -0.477 . . . . 10.0 110.675 179.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 14.8 t60 -175.82 -59.07 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.905 -0.588 . . . . 10.0 110.268 -179.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -89.62 -4.89 57.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.269 -0.423 . . . . 10.0 111.164 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.459 ' OD2' ' HA ' ' A' ' 5' ' ' PHE . 22.5 p-10 -86.27 -39.1 16.88 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.058 -0.519 . . . . 10.0 111.564 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -78.91 57.21 2.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.907 0.384 . . . . 10.0 111.899 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 18.3 ptt? -167.81 27.32 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.079 -0.509 . . . . 10.0 110.558 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -77.67 -101.91 0.18 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.845 -0.693 . . . . 10.0 112.85 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.447 ' HB ' ' H ' ' A' ' 124' ' ' LYS . 0.2 OUTLIER 53.3 -101.28 0.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 122.886 0.474 . . . . 10.0 111.945 -179.496 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.447 ' H ' ' HB ' ' A' ' 123' ' ' THR . 53.2 pttt -64.88 -34.42 78.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.928 0.394 . . . . 10.0 110.73 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 35.5 m170 -70.26 -38.82 75.2 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.611 -0.514 . . . . 10.0 109.611 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.76 -50.54 66.45 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.543 -0.753 . . . . 10.0 110.301 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -60.17 -29.4 68.65 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.194 -0.457 . . . . 10.0 111.128 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.436 HH11 ' HD2' ' A' ' 128' ' ' ARG . 9.0 mtp180 -79.62 -45.69 18.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.06 -0.518 . . . . 10.0 111.913 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.461 HG23 ' H ' ' A' ' 84' ' ' ASN . 9.5 p -73.1 -29.63 29.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 112.116 0.413 . . . . 10.0 112.116 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -74.24 -1.33 20.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.131 0.491 . . . . 10.0 111.712 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -72.14 -20.41 61.61 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.534 -0.543 . . . . 10.0 109.534 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -133.54 -44.77 0.12 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.557 -0.83 . . . . 10.0 112.78 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -62.9 -37.75 88.2 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.399 0.518 . . . . 10.0 112.399 -179.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -68.86 -11.32 60.39 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.795 0.331 . . . . 10.0 111.877 -178.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -84.01 -8.08 59.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.699 0.285 . . . . 10.0 111.693 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -141.31 -34.4 0.11 Allowed Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.049 -1.072 . . . . 10.0 114.725 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.477 ' HB3' ' HD3' ' A' ' 138' ' ' PRO . 3.5 t90 -56.7 -61.55 6.65 Favored Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 113.573 0.953 . . . . 10.0 113.573 -178.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.477 ' HD3' ' HB3' ' A' ' 137' ' ' TRP . 37.0 Cg_endo -66.51 -14.15 42.85 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 121.795 1.664 . . . . 10.0 112.01 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.3 m -82.12 -47.14 12.91 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.872 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 10.7 tp -71.99 -31.87 41.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.41 -0.359 . . . . 10.0 111.202 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 61.7 mt -55.76 -41.78 74.49 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.036 0.446 . . . . 10.0 111.945 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -82.31 -42.62 18.55 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.481 -0.327 . . . . 10.0 111.405 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 19.6 m -62.16 -38.57 89.52 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.768 0.655 . . . . 10.0 112.768 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -63.49 -34.59 78.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.617 -0.265 . . . . 10.0 111.623 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -63.05 -43.94 97.25 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.981 0.419 . . . . 10.0 110.939 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -72.32 -31.1 65.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.265 -0.425 . . . . 10.0 111.458 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 8.6 ttpp -60.5 -51.0 71.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.495 . . . . 10.0 110.351 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.477 HG21 HG13 ' A' ' 12' ' ' VAL . 31.3 mt -67.34 -38.15 80.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.343 -0.39 . . . . 10.0 110.728 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -59.59 -37.34 78.28 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.426 0.631 . . . . 10.0 110.018 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 1.025 ' HA ' ' HB2' ' A' ' 154' ' ' LYS . 19.6 tt0 -72.04 -41.12 67.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.816 -0.629 . . . . 10.0 111.645 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -84.05 60.3 5.79 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.257 -0.428 . . . . 10.0 111.627 -179.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 161.39 -44.71 0.39 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.346 -0.93 . . . . 10.0 113.337 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -107.39 -55.66 2.31 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 122.728 -0.278 . . . . 10.0 111.69 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 1.025 ' HB2' ' HA ' ' A' ' 150' ' ' GLU . 53.6 mtpt -63.32 -38.47 91.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.083 -0.508 . . . . 10.0 111.931 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 90.9 mttt . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.375 -0.822 . . . . 10.0 110.348 -179.424 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.481 ' HA ' ' O ' ' A' ' 5' ' ' PHE . 25.6 p-10 . . . . . 0 N--CA 1.479 1.008 0 N-CA-C 110.471 -0.196 . . . . 10.0 110.471 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.424 ' HE1' ' CB ' ' A' ' 126' ' ' ALA 0.318 0.5 OUTLIER 67.2 -51.49 0.48 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.933 1.827 . . . . 10.0 115.933 178.369 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.744 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 10.9 t70 -92.46 -58.45 0.22 Allowed Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 112.674 0.62 . . . . 10.0 112.674 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.744 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 7.7 Cg_exo -75.57 -25.81 10.64 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.211 1.941 . . . . 10.0 112.475 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.609 ' HA ' ' OD2' ' A' ' 119' ' ' ASP . 36.5 p90 -178.67 140.6 0.19 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.677 -0.692 . . . . 10.0 110.138 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.7 p -97.56 115.08 36.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 121.365 0.602 . . . . 10.0 111.389 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 21.7 mtt180 -153.57 112.01 3.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.648 -0.706 . . . . 10.0 110.572 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -128.61 141.06 51.47 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.448 -0.575 . . . . 10.0 109.448 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.3 m -125.6 128.62 48.19 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.716 0.293 . . . . 10.0 111.029 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.622 ' HB ' HG13 ' A' ' 111' ' ' VAL . 40.2 t -119.59 136.8 55.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.324 -0.398 . . . . 10.0 110.264 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.43 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 34.4 m -105.08 125.36 50.9 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.372 -0.376 . . . . 10.0 110.415 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.556 HG12 ' H ' ' A' ' 14' ' ' ALA . 26.3 t -110.19 125.92 67.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.952 0.406 . . . . 10.0 110.067 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.8 mmmp? -91.7 28.34 1.8 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.742 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.556 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -130.46 -152.98 0.53 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.89 -0.596 . . . . 10.0 110.202 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -108.67 173.87 6.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.057 0.455 . . . . 10.0 112.055 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -60.6 -38.59 85.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.491 -0.777 . . . . 10.0 112.434 -178.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -74.45 -45.43 46.38 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.497 0.554 . . . . 10.0 112.497 -178.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.2 p -62.14 -36.95 83.37 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.92 -0.312 . . . . 10.0 111.832 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.481 ' HB2' HG11 ' A' ' 12' ' ' VAL . . . -70.1 -37.81 75.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.97 0.414 . . . . 10.0 111.197 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -74.01 -39.85 63.32 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.956 0.408 . . . . 10.0 111.488 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.3 tttm -66.48 -33.75 76.39 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.392 0.516 . . . . 10.0 112.392 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.0 p -79.52 -5.14 54.23 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.431 0.53 . . . . 10.0 112.431 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -112.19 -34.59 5.88 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.493 0.553 . . . . 10.0 112.493 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.57 ' HG ' HG11 ' A' ' 46' ' ' VAL . 1.0 OUTLIER -110.01 5.31 22.14 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 113.342 0.867 . . . . 10.0 113.342 -178.544 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -139.93 -55.44 0.55 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.288 0.477 . . . . 10.0 112.288 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.39 92.57 0.87 Allowed Glycine 0 C--O 1.224 -0.529 0 C-N-CA 120.889 -0.672 . . . . 10.0 112.607 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.52 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 2.0 t80 -96.83 -58.89 0.17 Allowed Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 112.384 0.512 . . . . 10.0 112.384 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.52 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 5.5 Cg_exo -79.92 22.43 0.73 Allowed 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.367 2.045 . . . . 10.0 111.375 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -109.09 9.62 26.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.796 -0.638 . . . . 10.0 110.518 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 46.9 m0 -87.08 -151.83 0.18 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.192 -0.458 . . . . 10.0 110.12 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.641 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 34.9 t90 -172.77 -51.17 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 112.204 0.446 . . . . 10.0 112.204 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.641 ' HD2' ' N ' ' A' ' 31' ' ' TRP . 99.7 Cg_exo -18.82 -63.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.369 1.618 1 C-N-CA 125.648 4.232 . . . . 10.0 117.227 -178.478 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -148.11 36.66 0.84 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.093 0.473 . . . . 10.0 110.69 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -123.79 48.59 1.86 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.356 0.598 . . . . 10.0 110.825 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -78.69 58.15 2.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.622 -0.717 . . . . 10.0 110.489 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 36' ' ' ARG . 0.1 OUTLIER -168.63 174.91 6.41 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.65 -0.5 . . . . 10.0 109.65 -179.648 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.21 161.76 36.63 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.355 -0.609 . . . . 10.0 109.355 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.527 HG22 ' HA ' ' A' ' 57' ' ' ASP . 1.7 m 72.03 -65.43 0.35 Allowed 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.644 0.609 . . . . 10.0 112.644 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.429 ' HD3' ' HA ' ' A' ' 39' ' ' LYS . 4.5 mmtp -68.97 -33.39 73.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.231 0.538 . . . . 10.0 111.688 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.0 p -153.15 121.17 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.591 -0.731 . . . . 10.0 109.289 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.34 54.73 1.79 Allowed Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.608 -0.997 . . . . 10.0 110.608 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.55 163.77 48.07 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.553 -0.324 . . . . 10.0 110.39 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -72.08 43.44 0.59 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.832 2.355 . . . . 10.0 113.014 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 33.5 tp -165.39 -91.23 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.266 -0.425 . . . . 10.0 110.025 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.73 -57.2 3.85 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.213 -0.518 . . . . 10.0 113.076 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.57 HG11 ' HG ' ' A' ' 24' ' ' LEU . 1.9 t -99.82 135.11 36.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.765 0.317 . . . . 10.0 111.006 -178.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -105.91 112.58 25.69 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.527 -0.546 . . . . 10.0 109.527 178.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.77 19.73 16.58 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.933 -0.576 . . . . 10.0 110.752 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -96.3 -57.31 2.36 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 109.393 -0.595 . . . . 10.0 109.393 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -105.81 -36.16 2.84 Favored Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 110.805 -0.918 . . . . 10.0 110.805 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.67 68.3 0.46 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.647 -0.787 . . . . 10.0 112.25 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -156.14 -179.27 7.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.8 0.333 . . . . 10.0 111.33 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.478 ' CZ3' HG22 ' A' ' 46' ' ' VAL . 75.3 m95 -122.73 136.88 55.01 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.422 -0.584 . . . . 10.0 109.422 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -165.98 122.34 1.33 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.799 0.333 . . . . 10.0 111.775 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.414 ' O ' ' HA ' ' A' ' 61' ' ' GLU . 2.0 mm-40 -86.12 149.54 25.06 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.071 -0.513 . . . . 10.0 110.297 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.9 mm -103.42 110.53 30.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.363 -0.38 . . . . 10.0 112.01 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.527 ' HA ' HG22 ' A' ' 38' ' ' THR . 13.1 t70 -108.34 165.73 11.29 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.612 -0.514 . . . . 10.0 109.612 178.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -57.22 -27.06 61.67 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.999 0.74 . . . . 10.0 112.999 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -103.03 -1.24 29.57 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.103 0.409 . . . . 10.0 112.103 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 132.29 -160.92 23.84 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.957 -0.64 . . . . 10.0 111.745 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 55' ' ' GLU . 60.4 mp0 -69.45 128.03 35.1 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.821 -0.437 . . . . 10.0 109.821 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.7 -95.35 0.2 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.936 0.717 . . . . 10.0 112.936 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -98.56 166.31 11.41 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.173 0.511 . . . . 10.0 112.232 -178.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.8 t -148.51 150.21 32.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.674 -0.694 . . . . 10.0 109.907 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.774 ' CD2' ' H61' ' A' ' 627' ' ' MRP . 15.5 m-85 -89.09 -43.83 10.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.942 -0.572 . . . . 10.0 111.11 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 174.23 -141.2 5.81 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.7 -0.762 . . . . 10.0 111.763 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -135.48 166.06 24.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.736 0.303 . . . . 10.0 111.001 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 65.4 mt -109.76 133.53 54.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.742 -0.466 . . . . 10.0 109.742 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.0 mmt180 -83.12 -54.08 5.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.583 -0.28 . . . . 10.0 110.596 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.6 mtpm? -150.43 147.66 27.81 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.347 -0.388 . . . . 10.0 111.294 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -119.99 82.91 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.517 -0.765 . . . . 10.0 109.728 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.749 ' HB2' ' HB ' ' A' ' 76' ' ' THR . 8.1 m-20 -92.33 68.23 4.96 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.772 -0.649 . . . . 10.0 111.191 -178.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 72' ' ' ASP . 5.5 pt-20 56.11 177.78 0.04 OUTLIER Pre-proline 0 N--CA 1.474 0.731 0 O-C-N 123.922 0.764 . . . . 10.0 112.078 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -71.31 47.36 0.82 Allowed 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.141 1.894 . . . . 10.0 111.532 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -135.82 -43.84 0.66 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.96 -0.564 . . . . 10.0 110.979 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.749 ' HB ' ' HB2' ' A' ' 72' ' ' ASP . 12.5 m -129.75 125.89 36.92 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.383 -0.371 . . . . 10.0 110.556 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 27.2 tp -136.5 128.62 29.68 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.487 -0.324 . . . . 10.0 110.773 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.2 t -121.08 123.21 69.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.936 -0.764 . . . . 10.0 108.936 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.444 HD12 ' CZ3' ' A' ' 81' ' ' TRP . 1.8 pt -133.79 168.14 24.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 112.445 0.535 . . . . 10.0 112.445 -178.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -135.2 130.39 5.42 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 110.549 -1.02 . . . . 10.0 110.549 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.444 ' CZ3' HD12 ' A' ' 79' ' ' ILE . 0.8 OUTLIER -106.36 156.91 18.03 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 112.741 0.645 . . . . 10.0 112.741 -178.238 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 43.6 mtp180 -100.79 -164.76 1.14 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.481 -0.781 . . . . 10.0 109.402 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.2 pp -139.26 161.22 37.97 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.63 0.252 . . . . 10.0 111.431 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -77.54 -160.39 0.18 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.117 -0.492 . . . . 10.0 111.794 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 120.8 135.89 4.97 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.988 -0.845 . . . . 10.0 110.988 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -93.85 -85.92 0.28 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.761 0.315 . . . . 10.0 111.222 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.446 ' N ' ' H5 ' ' A' ' 629' ' ' MTC . . . -82.66 67.93 3.64 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.972 -0.632 . . . . 10.0 112.005 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.83 151.71 38.35 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.57 0.224 . . . . 10.0 110.555 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 6.2 tp -62.73 144.67 14.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.718 -0.475 . . . . 10.0 109.718 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -52.39 130.82 43.69 Favored Pre-proline 0 C--N 1.331 -0.234 0 O-C-N 123.255 0.347 . . . . 10.0 111.061 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.88 89.89 0.24 Allowed 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 123.0 2.466 . . . . 10.0 112.776 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -87.77 71.77 9.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.999 -0.546 . . . . 10.0 110.231 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -162.12 -70.57 0.05 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.693 -0.685 . . . . 10.0 109.772 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.8 m 70.77 161.61 0.23 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.285 -0.871 . . . . 10.0 112.69 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.5 m -117.28 133.7 55.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.077 -0.51 . . . . 10.0 110.554 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -93.65 147.32 23.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.128 -0.487 . . . . 10.0 110.881 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -139.48 136.81 34.97 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 123.275 0.359 . . . . 10.0 110.507 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 6.4 m -101.91 123.01 45.11 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.662 -0.495 . . . . 10.0 109.662 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 95.5 t -107.87 121.95 61.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.189 -0.46 . . . . 10.0 110.948 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.68 129.07 56.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.267 -0.424 . . . . 10.0 110.781 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -101.41 125.45 48.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.812 0.339 . . . . 10.0 110.834 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 90.3 t -117.84 126.34 74.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.095 -0.502 . . . . 10.0 109.769 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -99.99 130.86 46.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.718 -0.219 . . . . 10.0 110.659 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -118.76 100.61 7.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.959 0.409 . . . . 10.0 111.164 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.05 12.35 65.13 Favored Glycine 0 CA--C 1.52 0.386 0 CA-C-N 116.042 -0.526 . . . . 10.0 113.381 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 68.31 -16.56 0.19 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.578 0.955 . . . . 10.0 113.578 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 46.2 pttt -99.82 -6.56 26.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.064 0.459 . . . . 10.0 111.483 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -136.48 147.84 47.37 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.056 -0.72 . . . . 10.0 109.056 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.83 146.81 47.9 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.272 0.558 . . . . 10.0 111.76 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -131.9 139.26 48.7 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.779 -0.646 . . . . 10.0 109.435 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.622 HG13 ' HB ' ' A' ' 10' ' ' VAL . 2.2 p -133.75 129.76 55.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-O 120.746 0.308 . . . . 10.0 111.005 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -125.93 155.79 40.75 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.25 -0.432 . . . . 10.0 111.534 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 98' ' ' THR . 48.6 t -115.98 127.97 73.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.828 -0.624 . . . . 10.0 109.61 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -127.25 136.97 52.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.35 -0.386 . . . . 10.0 111.671 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -175.99 155.31 1.58 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.857 -0.61 . . . . 10.0 111.347 178.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.4 m -160.14 91.89 0.97 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.772 -0.825 . . . . 10.0 108.772 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 179.01 -62.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 10.0 111.028 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -98.44 14.86 26.68 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.085 -0.507 . . . . 10.0 111.558 -178.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.609 ' OD2' ' HA ' ' A' ' 5' ' ' PHE . 20.6 p-10 -98.25 -46.06 5.96 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.593 -0.731 . . . . 10.0 109.699 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.439 ' HA ' ' O ' ' A' ' 3' ' ' ASP . 98.5 mtt180 -78.54 48.81 0.81 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.489 -0.778 . . . . 10.0 111.582 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 19.4 ptt? -146.25 18.22 1.38 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.918 -0.583 . . . . 10.0 109.624 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -74.23 -96.99 0.1 Allowed Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.591 -0.732 . . . . 10.0 112.789 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.1 m 55.24 -91.57 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 122.905 0.482 . . . . 10.0 111.573 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 35.9 pttt -74.04 -36.65 64.41 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.894 -0.41 . . . . 10.0 109.894 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 34.7 m170 -69.48 -24.17 63.74 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.957 -0.565 . . . . 10.0 110.603 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.424 ' CB ' ' HE1' ' A' ' 2' ' ' TYR . . . -60.0 -58.36 8.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.322 -0.854 . . . . 10.0 110.523 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -62.15 -33.07 73.79 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.098 -0.501 . . . . 10.0 111.048 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 30.5 mtp180 -65.06 -44.09 90.11 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.154 -0.476 . . . . 10.0 112.024 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 9.9 p -81.06 -30.83 11.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.849 0.357 . . . . 10.0 111.637 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 48.7 mtp180 -72.49 -4.38 30.1 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.083 0.468 . . . . 10.0 111.827 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -84.54 0.61 49.27 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.757 -0.656 . . . . 10.0 110.517 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -149.37 -53.8 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.584 -0.817 . . . . 10.0 112.988 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . 0.651 ' HE1' ' HX3' ' A' ' 626' ' ' HIB . 0.8 OUTLIER -66.23 -37.81 86.43 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.183 0.809 . . . . 10.0 113.183 -178.588 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -63.55 -22.94 67.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.855 0.359 . . . . 10.0 111.624 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -80.9 38.76 0.47 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.998 0.428 . . . . 10.0 111.465 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.504 ' HA3' ' C7 ' ' A' ' 627' ' ' MRP . . . 171.18 -34.88 0.16 Allowed Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.774 -0.727 . . . . 10.0 113.419 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.469 ' HB3' ' HD3' ' A' ' 138' ' ' PRO . 11.2 t90 -57.0 -63.07 4.03 Favored Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 113.541 0.941 . . . . 10.0 113.541 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.469 ' HD3' ' HB3' ' A' ' 137' ' ' TRP . 33.2 Cg_endo -65.68 -29.79 51.25 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 121.279 1.32 . . . . 10.0 111.794 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.36 -43.75 76.73 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.799 -0.637 . . . . 10.0 111.493 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 11.2 tt -70.37 -32.55 50.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.561 -0.29 . . . . 10.0 111.461 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 70.6 mt -61.52 -45.76 92.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.039 0.447 . . . . 10.0 111.175 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -67.68 -40.99 84.38 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.713 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 15.2 m -67.37 -35.47 79.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.803 -0.635 . . . . 10.0 111.598 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.42 ' HD1' ' HA ' ' A' ' 144' ' ' PHE . 0.6 OUTLIER -59.55 -44.6 93.2 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.842 0.353 . . . . 10.0 111.024 179.289 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.43 ' HG3' ' O ' ' A' ' 11' ' ' THR . 8.6 tt0 -58.63 -49.56 77.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.856 -0.611 . . . . 10.0 110.947 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -65.64 -36.02 82.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.062 -0.517 . . . . 10.0 111.796 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -62.03 -53.65 52.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.934 -0.576 . . . . 10.0 110.766 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 57.3 mt -65.84 -34.71 72.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.029 -0.532 . . . . 10.0 110.044 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -61.78 -40.94 96.94 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.107 -0.497 . . . . 10.0 109.93 178.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 1.052 ' HA ' ' HB2' ' A' ' 154' ' ' LYS . 16.7 tt0 -70.89 -42.59 69.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.326 -0.397 . . . . 10.0 111.391 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -79.63 26.79 0.3 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.782 0.325 . . . . 10.0 111.798 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -155.28 -60.4 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.552 -0.832 . . . . 10.0 113.199 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -99.21 -48.16 4.93 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.839 0.681 . . . . 10.0 112.839 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 1.052 ' HB2' ' HA ' ' A' ' 150' ' ' GLU . 46.9 mtpt -60.95 -42.81 98.95 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.291 0.478 . . . . 10.0 112.291 -179.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 77.9 mttt . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.357 -0.83 . . . . 10.0 110.223 179.454 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 621' ' ' DAG . . . . . 1.162 ' O1 ' ' H12' ' A' ' 629' ' ' MTC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 625' ' ' DSR . . . . . 1.45 ' S4 ' ' C7 ' ' A' ' 626' ' ' HIB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 626' ' ' HIB . . . . . 1.45 ' C7 ' ' S4 ' ' A' ' 625' ' ' DSR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 627' ' ' MRP . . . . . 1.439 ' O1 ' ' C2 ' ' A' ' 626' ' ' HIB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 628' ' ' EMP . . . . . 0.998 ' H72' ' C5 ' ' A' ' 628' ' ' EMP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 629' ' ' MTC . . . . . 1.162 ' H12' ' O1 ' ' A' ' 621' ' ' DAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.551 ' HA ' ' O ' ' A' ' 5' ' ' PHE . 28.7 p-10 . . . . . 0 N--CA 1.479 0.989 0 CA-C-O 120.463 0.173 . . . . 10.0 110.728 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . 0.283 11.8 p90 50.44 30.18 4.44 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 115.572 1.693 . . . . 10.0 115.572 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.785 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 34.2 t70 -165.65 -63.64 0.01 OUTLIER Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 111.995 0.369 . . . . 10.0 111.995 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.785 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 92.0 Cg_endo -87.8 -31.86 0.19 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 121.77 1.647 . . . . 10.0 112.469 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.551 ' O ' ' HA ' ' A' ' 1' ' ' ASN . 12.6 p90 -174.26 141.6 0.74 Allowed 'General case' 0 C--O 1.24 0.56 0 CA-C-N 115.533 -0.758 . . . . 10.0 109.436 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.6 p -100.79 127.16 54.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.113 0.482 . . . . 10.0 111.258 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 7' ' ' ARG . 0.1 OUTLIER -159.23 108.52 1.89 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.843 -0.617 . . . . 10.0 110.348 -179.651 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -131.33 150.9 51.96 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.045 -0.525 . . . . 10.0 109.832 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 17.0 m -145.8 135.81 23.65 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.548 0.213 . . . . 10.0 111.084 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.0 t -121.52 132.89 69.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.052 -0.522 . . . . 10.0 109.639 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.97 122.25 39.75 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.501 -0.318 . . . . 10.0 110.746 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.2 t -131.04 141.89 44.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.017 -0.538 . . . . 10.0 109.801 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.7 mttp -84.63 54.44 3.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.05 0.452 . . . . 10.0 110.555 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -123.26 -163.03 1.08 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.897 -0.592 . . . . 10.0 110.325 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -113.38 166.97 10.97 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.224 -0.444 . . . . 10.0 111.79 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.477 HH21 ' HB2' ' A' ' 75' ' ' ASP . 36.4 ttt180 -55.11 -38.32 68.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.552 -0.749 . . . . 10.0 112.419 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -74.35 -54.63 7.26 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.96 0.356 . . . . 10.0 111.96 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -52.11 -43.08 63.78 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 112.607 0.595 . . . . 10.0 112.607 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.13 -42.43 80.2 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.992 0.368 . . . . 10.0 111.992 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -69.31 -36.88 77.44 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.182 0.515 . . . . 10.0 111.283 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.3 mtpt -69.66 -32.28 70.84 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 113.265 0.839 . . . . 10.0 113.265 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.28 -9.67 58.96 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.91 0.707 . . . . 10.0 112.91 -178.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -116.94 -19.63 9.73 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.923 0.712 . . . . 10.0 112.923 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.9 mp -120.55 10.77 11.18 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 114.33 1.234 . . . . 10.0 114.33 -178.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -155.64 -45.4 0.08 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.038 0.384 . . . . 10.0 112.038 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.99 104.24 2.2 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.492 -0.861 . . . . 10.0 111.262 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -109.15 -56.14 0.05 OUTLIER Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 112.338 0.496 . . . . 10.0 112.338 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.427 ' CG ' ' HA ' ' A' ' 43' ' ' PRO . 7.8 Cg_exo -74.15 14.96 0.65 Allowed 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.261 1.974 . . . . 10.0 112.359 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.63 8.96 37.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.215 0.531 . . . . 10.0 110.034 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.571 ' HB2' HD21 ' A' ' 34' ' ' ASN . 40.8 m0 -87.68 -164.84 1.16 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.621 -0.718 . . . . 10.0 110.363 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.633 ' H ' ' HD2' ' A' ' 32' ' ' PRO . 57.5 t90 -169.99 -50.62 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.513 0 CA-C-O 119.257 -0.402 . . . . 10.0 111.957 -178.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.633 ' HD2' ' H ' ' A' ' 31' ' ' TRP . 80.4 Cg_exo -26.28 -55.41 0.09 OUTLIER 'Trans proline' 0 C--N 1.367 1.525 0 C-N-CA 125.154 3.903 . . . . 10.0 116.9 -179.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -128.11 -41.43 1.6 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.694 0.627 . . . . 10.0 112.694 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.571 HD21 ' HB2' ' A' ' 30' ' ' TRP . 14.3 p-10 -77.95 93.87 4.5 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.372 0.605 . . . . 10.0 111.613 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -101.07 0.65 38.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.325 -0.852 . . . . 10.0 111.408 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.3 mtp180 -119.96 -160.18 0.81 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.737 0.303 . . . . 10.0 111.077 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.21 155.47 46.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.253 -0.43 . . . . 10.0 110.567 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.86 ' HB ' ' HA ' ' A' ' 57' ' ' ASP 0.267 9.8 p 67.66 -65.36 0.24 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 114.484 1.29 . . . . 10.0 114.484 178.726 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.671 ' HA ' ' HG3' ' A' ' 62' ' ' GLU . 5.4 mptt -74.81 -10.6 59.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.957 0.408 . . . . 10.0 111.006 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.4 p -173.85 89.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.34 -0.845 . . . . 10.0 109.971 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.69 68.49 0.55 Allowed Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.714 -0.675 . . . . 10.0 111.958 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.06 158.55 41.42 Favored Pre-proline 0 C--N 1.322 -0.591 0 O-C-N 122.656 -0.32 . . . . 10.0 110.799 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.427 ' HA ' ' CG ' ' A' ' 28' ' ' PRO . 41.7 Cg_exo -59.44 -28.35 87.32 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.763 2.308 . . . . 10.0 113.144 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 19.0 mt -95.29 -89.0 0.25 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.801 0.334 . . . . 10.0 111.058 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.25 -55.16 5.02 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.928 -0.653 . . . . 10.0 112.824 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.8 t -105.01 132.06 52.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.745 0.307 . . . . 10.0 111.087 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.478 ' OD1' ' HG2' ' A' ' 49' ' ' LYS . 1.0 OUTLIER -100.38 118.33 36.4 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.974 -0.557 . . . . 10.0 109.638 178.404 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.7 pttt -106.13 6.46 30.99 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.958 -0.565 . . . . 10.0 112.351 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.478 ' HG2' ' OD1' ' A' ' 47' ' ' ASP . 17.7 pttt -92.65 -24.1 18.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.861 0.362 . . . . 10.0 110.112 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -131.21 -60.02 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 111.269 -0.732 . . . . 10.0 111.269 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 135.02 71.34 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.716 -0.754 . . . . 10.0 112.363 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -159.77 168.5 25.74 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.75 -0.265 . . . . 10.0 110.65 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 43.1 m95 -116.02 135.62 53.79 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.601 -0.889 . . . . 10.0 108.601 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -165.77 122.64 1.41 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.332 0.493 . . . . 10.0 112.332 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -82.17 138.49 34.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.026 -0.534 . . . . 10.0 109.852 178.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 48.1 mm -98.46 124.75 51.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.284 -0.416 . . . . 10.0 110.279 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.86 ' HA ' ' HB ' ' A' ' 38' ' ' THR . 23.7 t70 -120.94 168.4 11.53 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.385 -0.37 . . . . 10.0 110.243 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -62.16 -29.3 70.26 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 122.829 0.452 . . . . 10.0 110.923 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -86.88 -9.59 55.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.28 -0.418 . . . . 10.0 111.463 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 138.59 -103.51 0.4 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.616 -0.802 . . . . 10.0 112.019 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -117.5 154.97 30.54 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.802 0.334 . . . . 10.0 110.892 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.671 ' HG3' ' HA ' ' A' ' 39' ' ' LYS . 3.0 mm-40 -118.29 -146.35 0.39 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.932 -0.576 . . . . 10.0 111.158 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.486 ' H ' ' HB3' ' A' ' 62' ' ' GLU . 4.5 p80 -67.5 172.64 4.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.338 0.59 . . . . 10.0 112.58 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.3 t -147.41 144.19 28.48 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.632 -0.713 . . . . 10.0 110.412 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 1.185 ' CD1' ' H61' ' A' ' 632' ' ' MRP . 75.5 m-85 -84.49 -38.74 19.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.111 -0.495 . . . . 10.0 111.151 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 171.27 -145.51 8.91 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.795 -0.717 . . . . 10.0 111.978 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.0 pp -140.47 161.93 36.55 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.731 0.3 . . . . 10.0 110.942 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.508 HG21 HG13 ' A' ' 71' ' ' VAL . 55.0 mt -106.44 123.4 61.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.803 -0.814 . . . . 10.0 108.803 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.3 ttm180 -93.09 -27.67 16.81 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.592 -0.276 . . . . 10.0 111.361 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.2 tptm -157.05 131.16 8.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.994 0.426 . . . . 10.0 111.84 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.508 HG13 HG21 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -129.0 102.96 8.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.427 -0.806 . . . . 10.0 108.901 178.683 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.76 ' HB2' ' HB ' ' A' ' 76' ' ' THR . 59.5 m-20 -118.54 78.93 1.31 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.566 -0.288 . . . . 10.0 110.794 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.513 ' HG2' ' O ' ' A' ' 72' ' ' ASP . 5.7 pt-20 55.4 178.7 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.663 0 O-C-N 123.971 0.794 . . . . 10.0 111.718 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -71.55 48.69 1.04 Allowed 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 121.955 1.77 . . . . 10.0 111.569 177.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.477 ' HB2' HH21 ' A' ' 16' ' ' ARG . 16.0 t70 -134.96 -55.52 0.82 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.306 -0.406 . . . . 10.0 111.088 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.76 ' HB ' ' HB2' ' A' ' 72' ' ' ASP . 5.0 m -113.23 119.18 36.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.159 -0.473 . . . . 10.0 110.753 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.478 ' HB3' ' HB ' ' A' ' 99' ' ' VAL . 59.7 tp -129.05 119.65 24.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.13 -0.486 . . . . 10.0 110.937 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 51.2 t -118.91 116.36 50.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.652 -0.499 . . . . 10.0 109.652 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 pp -133.95 161.99 40.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.353 -0.385 . . . . 10.0 111.943 -178.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.565 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -129.08 141.79 12.91 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 110.5 -1.04 . . . . 10.0 110.5 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -105.32 166.21 10.58 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.388 0.514 . . . . 10.0 112.388 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 82' ' ' ARG . 46.7 mtp180 -104.87 -168.76 1.52 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.802 -0.635 . . . . 10.0 110.53 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.421 ' HG ' ' HB3' ' A' ' 91' ' ' PRO . 0.3 OUTLIER -130.29 150.65 51.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.786 -0.643 . . . . 10.0 111.18 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -87.85 -168.49 2.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.883 -0.599 . . . . 10.0 110.529 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.709 ' O ' ' O3 ' ' A' ' 630' ' ' DSR . . . 131.73 157.58 8.77 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.828 -0.701 . . . . 10.0 112.915 179.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.735 ' O ' ' H61' ' A' ' 622' ' ' DAG . 62.6 m-85 -104.98 -85.83 0.47 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.23 0.538 . . . . 10.0 110.046 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -88.73 81.0 1.56 Allowed Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 111.232 -0.747 . . . . 10.0 111.232 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 5.5 ptt85 -141.94 175.53 9.65 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.624 0.249 . . . . 10.0 110.592 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.763 HG12 ' H ' ' A' ' 90' ' ' ASP . 10.3 tt -83.21 -174.64 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.011 -0.54 . . . . 10.0 110.612 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.763 ' H ' HG12 ' A' ' 89' ' ' ILE . 29.2 t70 -59.8 141.48 89.16 Favored Pre-proline 0 C--N 1.331 -0.236 0 C-N-CA 123.134 0.574 . . . . 10.0 110.972 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 90' ' ' ASP . 14.8 Cg_exo -69.37 60.05 1.46 Allowed 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.135 2.557 . . . . 10.0 113.142 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -82.03 92.75 6.85 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.249 0.547 . . . . 10.0 110.714 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -164.41 -69.2 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.761 -0.654 . . . . 10.0 110.21 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.2 m 66.14 90.78 0.09 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.077 0.769 . . . . 10.0 113.077 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.2 m -88.91 107.69 19.14 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.48 -0.563 . . . . 10.0 109.48 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.565 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 57.6 mt-10 -91.03 151.94 20.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.996 0.427 . . . . 10.0 111.914 -178.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -140.54 142.64 35.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.212 -0.904 . . . . 10.0 109.881 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.7 m -102.23 125.51 48.95 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.582 -0.281 . . . . 10.0 110.446 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.478 ' HB ' ' HB3' ' A' ' 77' ' ' LEU . 21.4 t -107.3 126.12 63.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.836 -0.62 . . . . 10.0 110.827 -178.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -112.4 134.39 53.96 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.226 -0.443 . . . . 10.0 110.652 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -102.43 123.63 46.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.27 -0.423 . . . . 10.0 111.532 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.8 t -119.8 119.69 61.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.154 -0.475 . . . . 10.0 109.737 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -104.07 136.07 44.39 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.809 0.338 . . . . 10.0 110.818 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -127.27 115.69 19.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.005 -0.543 . . . . 10.0 111.187 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.34 6.11 52.45 Favored Glycine 0 CA--C 1.518 0.261 0 CA-C-N 115.915 -0.584 . . . . 10.0 112.886 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 67.47 -3.15 1.13 Allowed 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.915 0.709 . . . . 10.0 112.915 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.2 ptmt -119.24 6.21 11.22 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.196 0.522 . . . . 10.0 111.605 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -140.06 132.58 28.66 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.167 -0.679 . . . . 10.0 109.167 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.8 m -117.72 130.37 56.28 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.397 0.517 . . . . 10.0 112.397 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -118.85 113.3 20.86 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.088 -1.078 . . . . 10.0 108.088 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 9' ' ' SER . 11.8 p -113.35 133.93 57.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 C-N-CA 120.449 -0.5 . . . . 10.0 111.29 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -127.9 148.33 50.48 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.048 -0.524 . . . . 10.0 111.795 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.6 t -126.27 113.85 35.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 108.82 -0.807 . . . . 10.0 108.82 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -129.44 144.58 51.31 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.172 0.511 . . . . 10.0 112.094 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -163.55 162.86 24.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.416 -0.811 . . . . 10.0 109.021 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -157.57 77.87 0.85 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.701 0.286 . . . . 10.0 110.491 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -172.41 -67.39 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.296 -0.411 . . . . 10.0 111.919 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.463 ' O ' ' HG2' ' A' ' 121' ' ' MET . 82.5 m-85 -81.57 -16.73 50.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.182 0.515 . . . . 10.0 111.579 -178.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -82.52 -16.8 47.32 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.828 -0.624 . . . . 10.0 110.67 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 77.8 mtt180 -91.65 32.2 1.12 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.181 0.438 . . . . 10.0 112.181 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.463 ' HG2' ' O ' ' A' ' 118' ' ' PHE . 21.3 ptp -136.19 23.32 3.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.086 0.47 . . . . 10.0 110.129 179.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -73.22 -106.67 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.701 -0.681 . . . . 10.0 112.789 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.2 m 53.41 -87.79 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.634 0.605 . . . . 10.0 112.634 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.479 ' O ' ' HG3' ' A' ' 128' ' ' ARG . 55.7 pttt -72.35 -35.61 68.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.838 0.352 . . . . 10.0 110.25 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -71.26 -31.99 68.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 10.0 110.883 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.6 -43.4 97.46 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.712 -0.676 . . . . 10.0 110.818 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -66.61 -37.15 84.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.934 -0.575 . . . . 10.0 111.02 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' A' ' 124' ' ' LYS . 45.9 mtp180 -69.31 -45.15 70.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 10.0 111.383 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.8 p -70.29 -20.42 22.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 112.205 0.446 . . . . 10.0 112.205 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.523 ' HG3' ' HB3' ' A' ' 134' ' ' ASP . 23.6 ttt180 -66.64 -15.42 63.46 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 121.067 0.461 . . . . 10.0 111.057 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -71.59 -4.21 25.8 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.233 0.457 . . . . 10.0 112.233 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -152.81 -50.29 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 119.999 -1.096 . . . . 10.0 113.744 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . 0.681 ' HA ' ' O2 ' ' A' ' 632' ' ' MRP . 0.6 OUTLIER -63.09 -42.71 99.67 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.207 0.817 . . . . 10.0 113.207 -178.775 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.523 ' HB3' ' HG3' ' A' ' 130' ' ' ARG . 34.1 t70 -71.89 -3.03 20.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.179 0.514 . . . . 10.0 111.853 -179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.652 ' O ' ' H71' ' A' ' 632' ' ' MRP . 98.1 mttt -98.24 19.42 14.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.272 -0.422 . . . . 10.0 111.3 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.882 ' HA3' ' C7 ' ' A' ' 632' ' ' MRP . . . -175.08 -35.3 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 119.765 -1.207 . . . . 10.0 113.806 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -56.55 -58.05 19.52 Favored Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 113.457 0.91 . . . . 10.0 113.457 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.87 -41.23 46.97 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.118 1.879 . . . . 10.0 112.038 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.05 -38.18 87.69 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 116.045 -0.525 . . . . 10.0 111.04 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.461 ' HB ' ' O ' ' A' ' 136' ' ' GLY . 1.0 OUTLIER -65.34 -39.67 86.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.163 -0.471 . . . . 10.0 111.669 -179.504 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 93.4 mt -64.69 -35.59 81.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.498 -0.319 . . . . 10.0 111.275 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -80.4 -32.56 37.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.138 -0.483 . . . . 10.0 112.239 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 2.8 p -75.5 -34.6 60.85 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.987 -0.285 . . . . 10.0 111.368 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -61.13 -37.9 84.47 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.856 0.36 . . . . 10.0 111.27 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -56.76 -54.96 40.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.707 -0.678 . . . . 10.0 111.627 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -61.45 -37.08 82.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.455 -0.339 . . . . 10.0 111.616 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 48.6 tttp -64.9 -55.34 19.91 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.18 0.437 . . . . 10.0 112.18 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 32.7 mt -66.96 -38.38 81.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.722 0.296 . . . . 10.0 111.573 -178.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -65.17 -35.32 80.72 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-O 121.357 0.599 . . . . 10.0 109.915 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 1.027 ' HA ' ' HB3' ' A' ' 154' ' ' LYS . 32.7 tt0 -67.96 -48.38 66.04 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.391 -0.822 . . . . 10.0 109.724 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -79.89 56.97 2.46 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.038 -0.528 . . . . 10.0 110.879 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -177.82 -51.95 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.743 -0.662 . . . . 10.0 112.299 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -126.06 -45.37 1.72 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.332 0.493 . . . . 10.0 112.332 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 1.027 ' HB3' ' HA ' ' A' ' 150' ' ' GLU . 71.5 tttt -60.94 -35.6 77.15 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.496 0.554 . . . . 10.0 112.496 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt . . . . . 0 C--O 1.252 1.213 0 CA-C-O 118.427 -0.797 . . . . 10.0 110.106 179.881 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 622' ' ' DAG . . . . . 1.177 ' O1 ' ' H12' ' A' ' 634' ' ' MTC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 630' ' ' DSR . . . . . 1.44 ' S4 ' ' C7 ' ' A' ' 631' ' ' HIB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 631' ' ' HIB . . . . . 1.457 ' C2 ' ' O1 ' ' A' ' 632' ' ' MRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 632' ' ' MRP . . . . . 1.457 ' O1 ' ' C2 ' ' A' ' 631' ' ' HIB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 633' ' ' EMP . . . . . 1.009 ' H72' ' C5 ' ' A' ' 633' ' ' EMP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 634' ' ' MTC . . . . . 1.177 ' H12' ' O1 ' ' A' ' 622' ' ' DAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 110.703 -0.11 . . . . 10.0 110.703 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . 0.365 17.6 p90 63.63 -50.49 0.24 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 116.27 1.952 . . . . 10.0 116.27 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.81 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 16.7 t70 -74.47 -61.61 1.13 Allowed Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 112.886 0.699 . . . . 10.0 112.886 -178.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.81 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 3.6 Cg_exo -80.5 -32.64 1.17 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.292 1.995 . . . . 10.0 111.949 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.63 ' HA ' ' OD2' ' A' ' 119' ' ' ASP . 47.3 p90 -176.94 152.5 0.93 Allowed 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.346 -0.843 . . . . 10.0 109.648 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.5 p -101.54 138.58 25.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.021 0.438 . . . . 10.0 111.32 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 39.4 ttm180 -171.0 104.63 0.23 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.376 -0.829 . . . . 10.0 110.043 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 72.1 m-70 -131.04 157.21 43.63 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.06 -0.348 . . . . 10.0 110.06 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 0.0 OUTLIER -147.2 140.27 25.19 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.442 0.534 . . . . 10.0 112.442 -179.71 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.402 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 21.9 t -123.45 143.4 36.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 108.91 -0.774 . . . . 10.0 108.91 179.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.8 m -111.26 105.46 14.13 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.082 0.468 . . . . 10.0 111.991 -178.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.581 HG13 HG21 ' A' ' 148' ' ' ILE . 89.2 t -85.97 114.91 26.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.081 -0.509 . . . . 10.0 110.515 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt -98.74 57.95 1.16 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.213 0.53 . . . . 10.0 111.124 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -147.91 -83.26 0.11 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.556 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -163.47 157.99 20.42 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.725 -0.472 . . . . 10.0 109.725 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.7 ttt180 -66.99 -37.39 84.13 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.614 0.598 . . . . 10.0 112.614 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -70.59 -41.08 72.81 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.059 0.392 . . . . 10.0 112.059 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.97 -36.63 84.11 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.818 0.303 . . . . 10.0 111.818 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.58 -44.39 94.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.143 0.497 . . . . 10.0 110.233 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -67.35 -38.71 85.28 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.7 -0.682 . . . . 10.0 110.316 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.0 mmtt -66.17 -43.61 86.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.66 -0.7 . . . . 10.0 112.683 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.4 p -73.24 -26.34 61.08 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.09 0.774 . . . . 10.0 113.09 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -84.16 -34.4 24.04 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.03 0.752 . . . . 10.0 113.03 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.0 mp -102.36 -33.05 9.72 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.842 1.053 . . . . 10.0 113.842 -178.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -124.53 42.42 3.26 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.289 0.477 . . . . 10.0 112.289 -178.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -145.18 30.16 1.77 Allowed Glycine 0 C--O 1.228 -0.254 0 C-N-CA 120.516 -0.849 . . . . 10.0 112.524 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.558 ' HD1' ' HA2' ' A' ' 41' ' ' GLY . 0.6 OUTLIER -54.65 -56.36 28.01 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 113.366 0.876 . . . . 10.0 113.366 -179.141 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.654 ' HG3' ' HA ' ' A' ' 43' ' ' PRO . 92.6 Cg_endo -82.94 28.35 0.58 Allowed 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 122.095 1.863 . . . . 10.0 112.376 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -124.0 9.39 8.72 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.2 0.524 . . . . 10.0 111.446 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 19.8 m0 -98.61 162.59 13.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.949 -0.569 . . . . 10.0 109.668 179.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.669 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -144.85 46.85 0.64 Allowed Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 112.307 0.484 . . . . 10.0 112.307 179.172 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.669 ' HD3' ' N ' ' A' ' 31' ' ' TRP . 6.3 Cg_endo -89.88 -45.82 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.364 2.043 . . . . 10.0 112.509 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.446 ' H ' ' HD2' ' A' ' 32' ' ' PRO . 65.8 t30 -157.78 -32.3 0.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.113 0.482 . . . . 10.0 110.137 -179.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.439 ' OD1' ' HD2' ' A' ' 32' ' ' PRO . 16.6 p-10 -79.67 89.53 5.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.398 0.618 . . . . 10.0 111.168 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -99.73 -21.18 15.91 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.67 -0.695 . . . . 10.0 110.899 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -91.18 109.24 20.49 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.147 -0.479 . . . . 10.0 111.024 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.57 167.47 12.89 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.802 -0.636 . . . . 10.0 111.139 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.408 HG22 ' OD2' ' A' ' 57' ' ' ASP . 3.3 m 78.51 -62.8 0.32 Allowed 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.515 0.561 . . . . 10.0 112.515 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 17.1 mmtm -76.16 -24.72 54.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.863 0.363 . . . . 10.0 111.814 -179.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.4 p -163.21 91.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.77 0.795 . . . . 10.0 110.543 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.558 ' HA2' ' HD1' ' A' ' 27' ' ' PHE . . . 126.51 47.61 0.2 Allowed Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.477 -0.783 . . . . 10.0 111.753 -178.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.58 158.71 86.25 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 120.621 0.248 . . . . 10.0 111.097 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.654 ' HA ' ' HG3' ' A' ' 28' ' ' PRO . 34.3 Cg_exo -59.82 -20.46 59.33 Favored 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 122.677 2.252 . . . . 10.0 112.88 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.3 mp -98.74 -91.82 0.27 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.7 0.286 . . . . 10.0 110.579 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.85 -63.97 2.47 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.824 -0.703 . . . . 10.0 113.122 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.3 t -106.04 132.51 52.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 120.725 0.298 . . . . 10.0 110.996 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -95.31 125.77 40.16 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.398 -0.365 . . . . 10.0 110.355 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.485 ' HB2' ' HE3' ' A' ' 48' ' ' LYS . 37.3 mtmt -103.51 10.61 37.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.286 -0.415 . . . . 10.0 110.972 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.0 mtmm -89.09 -54.51 4.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.669 0.271 . . . . 10.0 110.533 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -111.15 -29.83 3.36 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 111.101 -0.799 . . . . 10.0 111.101 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.26 80.32 1.4 Allowed Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.655 -0.783 . . . . 10.0 111.97 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 52' ' ' ARG . 13.8 ptt180 -162.97 167.63 22.27 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.725 0.297 . . . . 10.0 110.505 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 60.0 m95 -107.33 134.52 50.27 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.883 -0.784 . . . . 10.0 108.883 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -164.22 120.05 1.56 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.053 0.454 . . . . 10.0 111.497 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -83.77 133.66 34.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.794 -0.639 . . . . 10.0 109.676 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.0 mm -96.14 111.27 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 116.069 -0.514 . . . . 10.0 110.823 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.979 ' HB2' ' HG2' ' A' ' 62' ' ' GLU . 15.9 t70 -106.62 163.49 12.85 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.921 -0.581 . . . . 10.0 109.597 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.38 -23.72 65.61 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.598 0.237 . . . . 10.0 110.514 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -87.42 -4.23 59.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.811 0.339 . . . . 10.0 110.775 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 134.1 -111.64 0.98 Allowed Glycine 0 CA--C 1.519 0.298 0 C-N-CA 121.209 -0.52 . . . . 10.0 112.482 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -115.76 137.24 52.28 Favored 'General case' 0 C--N 1.32 -0.676 0 O-C-N 122.41 -0.465 . . . . 10.0 110.759 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.979 ' HG2' ' HB2' ' A' ' 57' ' ' ASP . 15.2 mm-40 -97.45 -144.46 0.3 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.946 -0.57 . . . . 10.0 111.657 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 1.095 ' ND1' ' H92' ' A' ' 636' ' ' HIB . 3.3 p80 -75.07 -178.83 4.01 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 113.045 0.757 . . . . 10.0 113.045 -179.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.9 t -152.64 152.63 32.01 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.142 -0.936 . . . . 10.0 110.095 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 1.614 ' CE1' ' H61' ' A' ' 637' ' ' MRP . 98.5 m-85 -96.68 -22.1 17.21 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.475 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.463 ' HA3' ' O ' ' A' ' 80' ' ' GLY . . . 154.12 -146.75 15.22 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 121.032 -0.604 . . . . 10.0 112.42 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.9 pp -132.73 169.24 16.98 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.776 0.322 . . . . 10.0 110.704 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.411 HG21 HG13 ' A' ' 71' ' ' VAL . 67.4 mt -109.03 127.13 65.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.095 -0.705 . . . . 10.0 109.095 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -77.83 -45.88 23.11 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.418 -0.356 . . . . 10.0 111.255 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.0 tttm -161.81 145.33 12.3 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.229 -0.441 . . . . 10.0 110.604 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.411 HG13 HG21 ' A' ' 68' ' ' ILE . 0.4 OUTLIER -115.23 84.67 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.206 0.527 . . . . 10.0 110.478 179.555 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.26 61.95 5.92 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.982 -0.554 . . . . 10.0 111.161 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.405 ' C ' ' H ' ' A' ' 75' ' ' ASP . 3.8 pt-20 55.04 -179.01 0.03 OUTLIER Pre-proline 0 CA--C 1.547 0.841 0 O-C-N 123.871 0.732 . . . . 10.0 111.886 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.403 ' CD ' ' HB2' ' A' ' 73' ' ' GLU . 21.5 Cg_exo -69.29 33.65 0.19 Allowed 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 122.203 1.935 . . . . 10.0 113.359 178.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 73' ' ' GLU . 17.4 t70 -113.49 -56.46 2.4 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.639 0.257 . . . . 10.0 110.564 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.0 m -127.6 129.33 47.09 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.951 0.405 . . . . 10.0 110.594 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 28.9 tp -129.05 134.01 47.94 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.054 -0.521 . . . . 10.0 110.088 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.6 t -128.35 119.93 51.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.935 -0.394 . . . . 10.0 109.935 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 37.6 pt -133.57 167.7 25.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.719 0.295 . . . . 10.0 111.268 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.541 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -123.88 138.49 11.43 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 110.836 -0.905 . . . . 10.0 110.836 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -97.01 156.89 16.16 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.216 0.821 . . . . 10.0 113.216 -178.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.429 HH11 ' HX1' ' A' ' 636' ' ' HIB . 14.0 ttt180 -105.94 153.35 22.1 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.992 -1.004 . . . . 10.0 109.692 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.743 ' HG ' ' HB3' ' A' ' 91' ' ' PRO . 1.6 pp -98.84 170.6 8.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.647 0.26 . . . . 10.0 111.428 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -120.42 -173.05 2.49 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.44 -0.346 . . . . 10.0 110.84 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 134.45 147.01 5.51 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.4 -0.68 . . . . 10.0 111.4 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -83.29 -84.27 0.13 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.993 0.425 . . . . 10.0 110.73 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -87.03 92.73 1.83 Allowed Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.756 -0.735 . . . . 10.0 111.739 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.508 ' HD2' ' O ' ' A' ' 89' ' ' ILE . 0.0 OUTLIER -164.37 169.29 17.58 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.748 0.309 . . . . 10.0 110.723 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.508 ' O ' ' HD2' ' A' ' 88' ' ' ARG . 8.9 tp -74.79 164.59 3.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.151 -0.477 . . . . 10.0 110.606 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.453 ' H ' HG13 ' A' ' 89' ' ' ILE . 1.4 m-20 -65.15 146.27 98.96 Favored Pre-proline 0 C--O 1.232 0.176 0 CA-C-O 120.748 0.309 . . . . 10.0 111.241 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.743 ' HB3' ' HG ' ' A' ' 83' ' ' LEU . 19.2 Cg_endo -57.89 104.41 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 123.297 2.664 . . . . 10.0 113.914 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -106.77 -25.04 11.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.763 -0.653 . . . . 10.0 109.94 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -68.71 -77.71 0.08 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.514 -0.766 . . . . 10.0 111.134 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.9 m 69.07 161.57 0.21 Allowed 'General case' 0 CA--C 1.534 0.342 0 O-C-N 123.559 0.537 . . . . 10.0 112.216 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 16.1 m -144.34 124.84 13.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.449 -0.341 . . . . 10.0 111.229 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.541 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 12.2 pt-20 -100.69 153.04 19.76 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.151 -0.477 . . . . 10.0 110.222 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -139.15 147.03 41.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.667 -0.242 . . . . 10.0 110.914 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.18 126.36 42.31 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.363 -0.606 . . . . 10.0 109.363 179.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 39.0 t -116.97 127.25 74.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.419 -0.355 . . . . 10.0 111.31 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.74 130.57 55.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.564 -0.289 . . . . 10.0 110.864 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -100.21 84.14 2.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.391 -0.368 . . . . 10.0 111.109 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 34.6 t -85.66 111.09 20.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 110.01 -0.367 . . . . 10.0 110.01 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 109' ' ' THR . . . -102.82 137.72 40.66 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.734 0.302 . . . . 10.0 111.347 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -124.95 125.95 44.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.998 -0.546 . . . . 10.0 109.616 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 78.3 6.5 87.81 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.743 -0.742 . . . . 10.0 111.881 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 63.36 20.8 12.47 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.685 0.624 . . . . 10.0 112.685 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 16.6 pttt -140.95 -51.95 0.46 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.108 -0.496 . . . . 10.0 110.685 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -82.7 100.2 10.09 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.256 -0.646 . . . . 10.0 109.256 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 103' ' ' ALA . 7.2 m -103.25 115.64 30.95 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.774 -0.648 . . . . 10.0 111.268 -178.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 64.1 mtt180 -102.67 105.72 16.24 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.036 -0.529 . . . . 10.0 110.14 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 9' ' ' SER . 1.8 p -92.2 123.74 44.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.844 -0.617 . . . . 10.0 110.806 -179.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -114.41 145.44 41.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.021 -0.536 . . . . 10.0 111.483 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 24.1 t -123.21 122.38 65.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.797 -0.638 . . . . 10.0 109.527 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -135.68 155.51 50.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.206 0.527 . . . . 10.0 112.001 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -177.88 157.44 1.17 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.203 -0.908 . . . . 10.0 108.696 178.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.1 m -156.71 86.07 0.98 Allowed 'General case' 0 C--O 1.237 0.417 0 N-CA-C 109.825 -0.435 . . . . 10.0 109.825 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -177.02 -64.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.021 -0.536 . . . . 10.0 111.197 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.467 ' O ' ' HG2' ' A' ' 121' ' ' MET . 83.4 m-85 -90.07 2.41 55.26 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.276 -0.42 . . . . 10.0 111.919 -178.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.63 ' OD2' ' HA ' ' A' ' 5' ' ' PHE . 19.7 p-10 -90.12 -38.67 13.37 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.177 -0.465 . . . . 10.0 110.827 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -75.63 18.49 0.23 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.766 0.654 . . . . 10.0 112.766 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.467 ' HG2' ' O ' ' A' ' 118' ' ' PHE . 23.7 ptt? -118.15 13.67 13.84 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.518 -0.549 . . . . 10.0 109.518 178.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.453 ' HA2' ' HB2' ' A' ' 125' ' ' HIS . . . -77.6 -111.77 0.17 Allowed Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.611 -0.722 . . . . 10.0 113.394 -178.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.5 m 56.36 -92.17 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.48 0.312 . . . . 10.0 111.225 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.33 -31.06 70.2 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.62 -0.511 . . . . 10.0 109.62 178.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.453 ' HB2' ' HA2' ' A' ' 122' ' ' GLY . 7.5 m170 -72.24 -42.2 65.95 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.823 -0.626 . . . . 10.0 109.71 178.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.489 ' HA ' HG12 ' A' ' 129' ' ' VAL . . . -66.24 -38.87 88.91 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.757 -0.656 . . . . 10.0 110.04 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -60.03 -31.85 70.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.621 -0.718 . . . . 10.0 110.989 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.78 -43.64 19.81 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.1 -0.5 . . . . 10.0 111.501 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.489 HG12 ' HA ' ' A' ' 126' ' ' ALA . 4.6 p -71.02 -23.37 23.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 112.13 0.419 . . . . 10.0 112.13 -179.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -69.67 -4.59 20.18 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.003 0.372 . . . . 10.0 112.003 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -71.12 -27.54 63.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.867 0.365 . . . . 10.0 110.761 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -133.66 -30.23 0.45 Allowed Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.148 -1.025 . . . . 10.0 114.163 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 12.8 tpt -79.11 -29.87 43.45 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 117.358 0.579 . . . . 10.0 112.012 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -69.14 -9.54 53.32 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.14 -0.482 . . . . 10.0 111.858 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -95.76 -7.49 37.05 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.214 0.45 . . . . 10.0 112.214 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.451 ' HA3' ' O3 ' ' A' ' 637' ' ' MRP . . . -131.54 -39.78 0.24 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 119.794 -1.193 . . . . 10.0 114.362 -178.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.406 ' HB3' ' HD3' ' A' ' 138' ' ' PRO . 22.5 t90 -53.11 -59.6 8.72 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 113.781 1.03 . . . . 10.0 113.781 -178.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.406 ' HD3' ' HB3' ' A' ' 137' ' ' TRP . 42.7 Cg_endo -67.17 -36.42 21.58 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 121.551 1.501 . . . . 10.0 112.705 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.8 -41.41 91.97 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.111 -0.495 . . . . 10.0 111.645 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.2 mp -64.97 -41.27 91.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.166 -0.47 . . . . 10.0 111.586 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 96.1 mt -59.1 -47.71 84.25 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.259 -0.428 . . . . 10.0 111.478 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -63.46 -40.19 96.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.984 -0.553 . . . . 10.0 111.057 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 21.7 m -66.32 -43.65 85.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.08 -0.509 . . . . 10.0 111.307 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -63.96 -39.33 93.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.542 -0.299 . . . . 10.0 110.556 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -58.68 -34.59 71.44 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 123.8 0.687 . . . . 10.0 111.074 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -87.96 -35.52 17.6 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.332 0.493 . . . . 10.0 112.332 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -61.79 -50.86 70.64 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 111.616 0.228 . . . . 10.0 111.616 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.581 HG21 HG13 ' A' ' 12' ' ' VAL . 48.6 mt -63.81 -32.3 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.18 0.515 . . . . 10.0 110.644 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -73.39 -39.16 65.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.964 -0.562 . . . . 10.0 109.773 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -64.03 -53.32 51.84 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.883 -0.598 . . . . 10.0 109.851 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -87.08 56.87 4.19 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.38 -0.827 . . . . 10.0 110.78 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 175.14 -43.28 0.12 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.041 -1.076 . . . . 10.0 113.317 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -109.55 -49.65 3.08 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.103 0.408 . . . . 10.0 112.103 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 22.0 mttp -65.23 -55.3 19.23 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.791 0.329 . . . . 10.0 110.798 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.437 ' HE3' ' HB2' ' A' ' 155' ' ' LYS . 33.8 mtmt . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.024 -0.988 . . . . 10.0 109.705 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 623' ' ' DAG . . . . . 1.187 ' O1 ' ' H12' ' A' ' 639' ' ' MTC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 635' ' ' DSR . . . . . 1.46 ' S4 ' ' C7 ' ' A' ' 636' ' ' HIB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 636' ' ' HIB . . . . . 1.46 ' C7 ' ' S4 ' ' A' ' 635' ' ' DSR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 637' ' ' MRP . . . . . 1.614 ' H61' ' CE1' ' A' ' 65' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 638' ' ' EMP . . . . . 1.004 ' H72' ' C5 ' ' A' ' 638' ' ' EMP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 639' ' ' MTC . . . . . 1.187 ' H12' ' O1 ' ' A' ' 623' ' ' DAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.759 ' O ' ' HD2' ' A' ' 4' ' ' PRO . 17.6 p-10 . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 120.428 0.156 . . . . 10.0 110.806 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . 0.286 0.2 OUTLIER 47.84 -107.18 0.18 Allowed 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 115.899 1.815 . . . . 10.0 115.899 179.606 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.504 ' HB2' ' HD3' ' A' ' 4' ' ' PRO . 1.1 m-20 -48.54 -64.31 1.18 Allowed Pre-proline 0 N--CA 1.475 0.821 0 N-CA-C 115.353 1.612 . . . . 10.0 115.353 -177.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.759 ' HD2' ' O ' ' A' ' 1' ' ' ASN . 75.3 Cg_exo -51.34 -48.0 23.32 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.458 2.105 . . . . 10.0 112.84 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.459 ' HA ' ' OD2' ' A' ' 119' ' ' ASP . 51.8 p90 178.66 153.33 0.36 Allowed 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.705 -0.68 . . . . 10.0 109.705 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.9 p -107.27 96.3 4.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.323 0.582 . . . . 10.0 111.304 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.504 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 98.4 mtt180 -136.57 105.31 5.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.867 -0.606 . . . . 10.0 110.247 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 28.3 m-70 -121.18 152.28 38.97 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.316 -0.402 . . . . 10.0 110.044 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.9 m -140.38 133.28 29.19 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.607 0.241 . . . . 10.0 111.083 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.535 ' HB ' HG13 ' A' ' 111' ' ' VAL . 21.7 t -123.32 140.45 46.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 109.374 -0.602 . . . . 10.0 109.374 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.1 m -107.93 112.31 24.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.058 0.456 . . . . 10.0 110.91 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.567 HG11 ' HB2' ' A' ' 19' ' ' ALA . 70.3 t -98.94 132.8 43.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 116.299 -0.41 . . . . 10.0 110.178 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.2 mtmt -115.45 88.16 2.82 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.749 0.309 . . . . 10.0 111.676 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -172.54 -82.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.702 -0.681 . . . . 10.0 109.471 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -168.65 -178.91 3.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.009 -0.541 . . . . 10.0 110.152 178.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 50.2 ttt180 -76.25 -35.58 58.89 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.283 0.475 . . . . 10.0 112.283 -178.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -71.5 -46.58 59.34 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.474 0.546 . . . . 10.0 112.474 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.95 -46.62 75.02 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.031 0.382 . . . . 10.0 112.031 -179.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.567 ' HB2' HG11 ' A' ' 12' ' ' VAL . . . -61.93 -46.53 88.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.357 -0.383 . . . . 10.0 111.456 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -67.64 -37.49 82.51 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.309 -0.405 . . . . 10.0 111.613 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.8 mmtt -68.2 -44.65 75.34 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 111.921 0.341 . . . . 10.0 111.921 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.2 p -67.36 -28.17 67.73 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.362 0.505 . . . . 10.0 112.362 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -93.29 7.33 44.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.702 0.286 . . . . 10.0 111.618 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.0 tp -128.26 -55.86 1.25 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.454 0.539 . . . . 10.0 112.454 -178.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -108.82 -12.35 14.92 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.077 0.399 . . . . 10.0 112.077 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.51 86.83 1.5 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.652 -0.785 . . . . 10.0 111.725 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -111.66 -55.6 0.04 OUTLIER Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 112.731 0.641 . . . . 10.0 112.731 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -75.74 27.85 0.39 Allowed 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.273 1.982 . . . . 10.0 112.577 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -120.48 0.62 10.55 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.318 -0.401 . . . . 10.0 110.762 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 39.7 m0 -76.72 165.07 25.24 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.322 -0.621 . . . . 10.0 109.322 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.594 ' H ' ' HD2' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -146.07 -58.39 0.02 OUTLIER Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 112.585 0.587 . . . . 10.0 112.585 -179.735 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.594 ' HD2' ' H ' ' A' ' 31' ' ' TRP . 73.6 Cg_endo -74.31 52.58 2.8 Favored 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 122.068 1.845 . . . . 10.0 112.498 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -170.0 -67.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.978 -0.555 . . . . 10.0 110.659 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.463 HD22 ' HA3' ' A' ' 41' ' ' GLY . 18.2 p-10 -111.82 122.83 48.84 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.334 0.588 . . . . 10.0 111.549 -179.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -112.96 4.75 16.93 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.735 -0.666 . . . . 10.0 110.779 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -133.08 105.08 6.85 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.721 0.296 . . . . 10.0 111.198 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.06 166.19 14.29 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.117 -0.492 . . . . 10.0 110.302 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.1 m 75.46 -47.35 0.59 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 122.91 0.484 . . . . 10.0 111.562 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.1 -30.64 27.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.1 0.476 . . . . 10.0 109.896 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.8 p -161.81 104.19 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 115.301 -0.863 . . . . 10.0 109.343 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.463 ' HA3' HD22 ' A' ' 34' ' ' ASN . . . 107.83 62.24 0.56 Allowed Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.939 -0.864 . . . . 10.0 110.939 -178.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.462 ' CB ' ' H ' ' A' ' 56' ' ' ILE . . . -81.31 168.08 27.2 Favored Pre-proline 0 C--N 1.321 -0.669 0 C-N-CA 122.407 0.283 . . . . 10.0 110.896 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -74.74 45.58 1.32 Allowed 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 122.979 2.452 . . . . 10.0 112.963 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 27.4 tp -160.69 -86.85 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.744 -0.465 . . . . 10.0 109.744 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.65 -69.71 3.25 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.93 -0.652 . . . . 10.0 112.991 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.8 t -103.14 134.9 42.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.002 0.43 . . . . 10.0 111.461 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.436 ' HB3' ' HG3' ' A' ' 52' ' ' ARG . 6.6 t70 -103.26 112.29 25.1 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.421 -0.585 . . . . 10.0 109.421 178.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.61 23.2 8.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.754 -0.657 . . . . 10.0 111.02 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.5 mttp -99.65 -54.29 2.96 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.94 -0.763 . . . . 10.0 108.94 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -108.55 -21.96 7.3 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.309 -0.86 . . . . 10.0 112.085 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.472 ' HA2' HD12 ' A' ' 68' ' ' ILE . . . 98.3 67.43 0.9 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.747 -0.739 . . . . 10.0 112.082 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.436 ' HG3' ' HB3' ' A' ' 47' ' ' ASP . 33.1 ptt180 -151.48 173.87 14.06 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 122.654 -0.321 . . . . 10.0 110.361 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 35.6 m95 -123.79 132.21 53.74 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.402 -0.962 . . . . 10.0 108.402 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -163.29 132.16 3.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.23 0.538 . . . . 10.0 112.142 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.448 ' HB2' ' HB2' ' A' ' 62' ' ' GLU . 2.7 mm-40 -90.01 152.55 21.13 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.379 -0.828 . . . . 10.0 110.046 179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.462 ' H ' ' CB ' ' A' ' 42' ' ' ALA . 41.5 mm -107.07 123.78 62.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.292 -0.413 . . . . 10.0 110.528 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.827 ' HB2' ' HG2' ' A' ' 62' ' ' GLU . 21.1 t70 -127.13 166.01 18.47 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.973 -0.751 . . . . 10.0 108.973 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -64.15 -26.81 68.69 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.681 0.277 . . . . 10.0 111.629 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -88.4 -5.34 58.34 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.948 0.404 . . . . 10.0 111.066 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 135.18 -105.85 0.56 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.976 -0.631 . . . . 10.0 112.697 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.9 mp0 -115.55 140.2 49.38 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.728 0.299 . . . . 10.0 110.563 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.827 ' HG2' ' HB2' ' A' ' 57' ' ' ASP . 22.1 mm-40 -93.87 -135.26 0.18 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.367 -0.379 . . . . 10.0 110.809 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.653 ' ND1' ' H92' ' A' ' 641' ' ' HIB . 3.4 p80 -79.56 170.48 16.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.098 0.475 . . . . 10.0 111.601 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.4 t -145.11 132.54 20.72 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.027 -0.533 . . . . 10.0 110.652 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 1.381 ' CE1' ' H61' ' A' ' 642' ' ' MRP . 78.1 m-85 -72.83 -32.89 65.81 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.114 -0.494 . . . . 10.0 111.016 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 162.24 -143.32 8.66 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 121.171 -0.538 . . . . 10.0 112.558 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -137.73 168.92 18.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.78 0.324 . . . . 10.0 110.772 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.48 HG12 HG22 ' A' ' 79' ' ' ILE . 58.7 mt -106.48 141.13 22.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.968 -0.382 . . . . 10.0 109.968 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -93.06 -44.15 8.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.958 -0.564 . . . . 10.0 110.809 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.3 tttt -157.43 146.63 19.95 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.088 -0.505 . . . . 10.0 110.572 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.404 HG13 HG21 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -121.08 75.46 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.847 -0.615 . . . . 10.0 110.008 179.191 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 1.001 ' HB3' ' HB ' ' A' ' 76' ' ' THR . 6.6 t70 -86.57 69.42 10.36 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.564 -0.744 . . . . 10.0 111.23 -178.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 54.55 178.29 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.681 0 CA-C-N 115.357 -0.838 . . . . 10.0 112.0 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -72.17 49.49 1.35 Allowed 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 122.008 1.805 . . . . 10.0 110.845 177.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -137.66 -50.53 0.61 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.923 -0.58 . . . . 10.0 110.647 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 1.001 ' HB ' ' HB3' ' A' ' 72' ' ' ASP . 11.7 m -118.39 109.24 16.03 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.769 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 28.6 tp -117.42 126.89 53.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.125 -0.489 . . . . 10.0 110.469 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.5 t -128.04 115.7 39.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-N 116.35 -0.386 . . . . 10.0 110.249 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.48 HG22 HG12 ' A' ' 68' ' ' ILE . 31.8 pt -131.08 166.35 28.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.795 0.331 . . . . 10.0 111.543 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -127.27 125.65 5.34 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.393 -0.683 . . . . 10.0 111.393 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -93.1 156.71 16.7 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.606 0.241 . . . . 10.0 110.873 -179.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 50.4 mtp180 -106.5 178.4 4.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.096 -0.502 . . . . 10.0 110.774 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.35 151.97 32.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.323 -0.399 . . . . 10.0 111.374 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.461 ' H ' HG23 ' A' ' 129' ' ' VAL . 1.6 t-20 -88.73 -165.46 1.34 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.165 -0.471 . . . . 10.0 110.887 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.498 ' HA3' ' HG2' ' A' ' 88' ' ' ARG . . . 131.18 156.37 8.48 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 121.091 -0.576 . . . . 10.0 112.067 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -101.66 -86.38 0.41 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.673 0.273 . . . . 10.0 110.611 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -84.44 58.0 5.01 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 121.122 -0.561 . . . . 10.0 111.871 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.498 ' HG2' ' HA3' ' A' ' 85' ' ' GLY . 0.4 OUTLIER -121.09 154.55 35.99 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.747 0.308 . . . . 10.0 110.923 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.565 HG12 ' H ' ' A' ' 90' ' ' ASP . 11.9 tt -68.68 175.39 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 115.738 -0.665 . . . . 10.0 110.319 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.565 ' H ' HG12 ' A' ' 89' ' ' ILE . 82.6 m-20 -55.99 140.86 68.9 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.021 0.439 . . . . 10.0 111.662 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 90' ' ' ASP . 43.3 Cg_endo -85.85 61.41 5.15 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.918 2.412 . . . . 10.0 112.906 -178.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -83.61 71.91 10.34 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.258 0.551 . . . . 10.0 110.45 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -152.29 -63.47 0.17 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.87 -0.789 . . . . 10.0 108.87 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.3 m 62.98 170.76 0.15 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.181 -0.918 . . . . 10.0 112.944 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.3 m -137.99 111.35 8.0 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.531 -0.544 . . . . 10.0 109.531 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.66 140.68 29.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.304 -0.407 . . . . 10.0 111.093 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -132.1 148.4 52.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.164 -0.471 . . . . 10.0 111.066 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.74 121.19 41.95 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.688 -0.486 . . . . 10.0 109.688 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 46.7 t -108.1 131.83 57.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.816 0.341 . . . . 10.0 111.233 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.8 m -118.77 139.89 50.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.024 -0.535 . . . . 10.0 110.287 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -112.97 109.04 18.2 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.35 -0.386 . . . . 10.0 111.181 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.3 t -114.88 110.41 31.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.073 0.463 . . . . 10.0 109.834 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -100.35 143.49 30.47 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.186 0.517 . . . . 10.0 111.508 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -125.83 109.94 13.11 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.741 -0.663 . . . . 10.0 109.32 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 78.96 13.63 82.86 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.908 -0.663 . . . . 10.0 111.96 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 72.28 -42.94 0.55 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.013 0.746 . . . . 10.0 113.013 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.402 ' H ' ' HG2' ' A' ' 107' ' ' LYS . 30.3 pttt -73.47 -37.29 65.82 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.637 0.606 . . . . 10.0 112.637 -178.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -96.45 108.69 21.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.668 0.27 . . . . 10.0 110.56 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.434 ' HB ' ' HB ' ' A' ' 12' ' ' VAL . 11.6 m -109.07 121.33 44.91 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.94 0.4 . . . . 10.0 110.701 -179.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -108.31 130.08 55.2 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.343 -0.389 . . . . 10.0 110.568 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.535 HG13 ' HB ' ' A' ' 10' ' ' VAL . 1.5 p -118.83 123.25 71.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.196 -0.456 . . . . 10.0 110.014 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -122.37 147.63 46.04 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.322 0.582 . . . . 10.0 111.871 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 38.7 t -113.23 131.16 65.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.48 -0.782 . . . . 10.0 109.672 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.75 135.36 34.61 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 123.282 0.363 . . . . 10.0 110.43 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 -175.09 149.46 1.09 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.129 -0.487 . . . . 10.0 109.98 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -151.63 91.05 1.61 Allowed 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.151 -0.477 . . . . 10.0 110.675 179.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 14.8 t60 -175.82 -59.07 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.905 -0.588 . . . . 10.0 110.268 -179.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -89.62 -4.89 57.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.269 -0.423 . . . . 10.0 111.164 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.459 ' OD2' ' HA ' ' A' ' 5' ' ' PHE . 22.5 p-10 -86.27 -39.1 16.88 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.058 -0.519 . . . . 10.0 111.564 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -78.91 57.21 2.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.907 0.384 . . . . 10.0 111.899 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 18.3 ptt? -167.81 27.32 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.079 -0.509 . . . . 10.0 110.558 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -77.67 -101.91 0.18 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.845 -0.693 . . . . 10.0 112.85 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.447 ' HB ' ' H ' ' A' ' 124' ' ' LYS . 0.2 OUTLIER 53.3 -101.28 0.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 122.886 0.474 . . . . 10.0 111.945 -179.496 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.447 ' H ' ' HB ' ' A' ' 123' ' ' THR . 53.2 pttt -64.88 -34.42 78.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.928 0.394 . . . . 10.0 110.73 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 35.5 m170 -70.26 -38.82 75.2 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.611 -0.514 . . . . 10.0 109.611 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.76 -50.54 66.45 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.543 -0.753 . . . . 10.0 110.301 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -60.17 -29.4 68.65 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.194 -0.457 . . . . 10.0 111.128 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.436 HH11 ' HD2' ' A' ' 128' ' ' ARG . 9.0 mtp180 -79.62 -45.69 18.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.06 -0.518 . . . . 10.0 111.913 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.461 HG23 ' H ' ' A' ' 84' ' ' ASN . 9.5 p -73.1 -29.63 29.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 112.116 0.413 . . . . 10.0 112.116 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -74.24 -1.33 20.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.131 0.491 . . . . 10.0 111.712 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -72.14 -20.41 61.61 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.534 -0.543 . . . . 10.0 109.534 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -133.54 -44.77 0.12 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.557 -0.83 . . . . 10.0 112.78 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . 0.474 ' HA ' ' O2 ' ' A' ' 642' ' ' MRP . 0.3 OUTLIER -62.9 -37.75 88.2 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.399 0.518 . . . . 10.0 112.399 -179.067 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -68.86 -11.32 60.39 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.795 0.331 . . . . 10.0 111.877 -178.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -84.01 -8.08 59.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.699 0.285 . . . . 10.0 111.693 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.987 ' HA3' ' O3 ' ' A' ' 642' ' ' MRP . . . -141.31 -34.4 0.11 Allowed Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.049 -1.072 . . . . 10.0 114.725 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.477 ' HB3' ' HD3' ' A' ' 138' ' ' PRO . 3.5 t90 -56.7 -61.55 6.65 Favored Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 113.573 0.953 . . . . 10.0 113.573 -178.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.477 ' HD3' ' HB3' ' A' ' 137' ' ' TRP . 37.0 Cg_endo -66.51 -14.15 42.85 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 121.795 1.664 . . . . 10.0 112.01 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.3 m -82.12 -47.14 12.91 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.872 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 10.7 tp -71.99 -31.87 41.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.41 -0.359 . . . . 10.0 111.202 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 61.7 mt -55.76 -41.78 74.49 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.036 0.446 . . . . 10.0 111.945 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -82.31 -42.62 18.55 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.481 -0.327 . . . . 10.0 111.405 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 19.6 m -62.16 -38.57 89.52 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.768 0.655 . . . . 10.0 112.768 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -63.49 -34.59 78.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.617 -0.265 . . . . 10.0 111.623 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -63.05 -43.94 97.25 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.981 0.419 . . . . 10.0 110.939 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -72.32 -31.1 65.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.265 -0.425 . . . . 10.0 111.458 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 8.6 ttpp -60.5 -51.0 71.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.495 . . . . 10.0 110.351 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.477 HG21 HG13 ' A' ' 12' ' ' VAL . 31.3 mt -67.34 -38.15 80.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.343 -0.39 . . . . 10.0 110.728 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -59.59 -37.34 78.28 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.426 0.631 . . . . 10.0 110.018 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 1.025 ' HA ' ' HB2' ' A' ' 154' ' ' LYS . 19.6 tt0 -72.04 -41.12 67.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.816 -0.629 . . . . 10.0 111.645 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -84.05 60.3 5.79 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.257 -0.428 . . . . 10.0 111.627 -179.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 161.39 -44.71 0.39 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.346 -0.93 . . . . 10.0 113.337 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -107.39 -55.66 2.31 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 122.728 -0.278 . . . . 10.0 111.69 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 1.025 ' HB2' ' HA ' ' A' ' 150' ' ' GLU . 53.6 mtpt -63.32 -38.47 91.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.083 -0.508 . . . . 10.0 111.931 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 90.9 mttt . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.375 -0.822 . . . . 10.0 110.348 -179.424 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 624' ' ' DAG . . . . . 1.18 ' O1 ' ' H12' ' A' ' 644' ' ' MTC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 640' ' ' DSR . . . . . 1.449 ' S4 ' ' C7 ' ' A' ' 641' ' ' HIB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 641' ' ' HIB . . . . . 1.449 ' C7 ' ' S4 ' ' A' ' 640' ' ' DSR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 642' ' ' MRP . . . . . 1.437 ' O1 ' ' C2 ' ' A' ' 641' ' ' HIB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 643' ' ' EMP . . . . . 1.002 ' C5 ' ' H72' ' A' ' 643' ' ' EMP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 644' ' ' MTC . . . . . 1.18 ' H12' ' O1 ' ' A' ' 624' ' ' DAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_